POST GRADUATES - ESOT

esot.org

POST GRADUATES - ESOT

POST GRADUATES

COURSES


ELITA

EUROPEAN LIVER AND INTESTINE

TRANSPLANT ASSOCIATION

The European Liver and Intestine Transplant Association (ELITA) is a section

of ESOT. Its membership represents the expertise on liver and intestinal

transplantation in Europe.

The European Liver Transplant Association was founded in 1993 as a section

of ESOT with the aim of creating within ESOT a body representing the liver

transplant community in Europe and to support the European Liver Transplant

Registry (ELTR). In 2005 Intestine Transplantation was incorporated and the

Association was named European Liver and Intestine Transplant Association

(ELITA).

At the biennial congress of ESOT, ELITA is responsible for the scientifi c

content of the ELITA Postgraduate course and the State of the Art session

on liver transplantation. In addition, ELITA is organizing the Basic Science

and Liver Transplantation symposium in cooperation with the ESOT Basic

Science committee.

We look forward to your participation in these events, which have become an

important integral part of the ESOT biennial Meeting.

� ELITA Board

CHAIRMAN

Patrizia Burra, Padua, Italy

VICE CHAIRMAN

Michael Olausson, Gothenburg, Sweden

SECRETARY

Robert J. Porte, Groningen, The Netherlands

TREASURER

Michele Colledan, Bergamo, Italy

CUSTODIAN OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR)

René Adam, Villejuif, France

MEMBERS

Gabriela B.A. Berlakovich, Vienna, Austria

Andrew K. Burroughs, London, United Kingdom

Bernard de Hemptinne, Ghent, Belgium

Pietro E. Majno, Geneva, Switzerland

Paolo Muiesan, Birmingham, United Kingdom

Jacques Pirenne, Leuven, Belgium

40

ELITA

European Liver and Intestine Transplant Association


09:00

12:50

09:00

10:30

ELITA PROGRAMME AT ESOT 2009

ELITA POST GRADUATE COURSE

Room 242 - AB

The hepatic artery in liver transplantation

Chairs: Patrizia Burra, Padua, Italy

Ramon Charco, Barcelona, Spain

> 09:00 Welcome from the ELITA Chairman

Patrizia Burra, Padua, Italy

> 09:05 Introduction:

The artery in liver transplantation “the facts”

René Adam, Paris, France

> 09:10 Technique of arterial revascularization of the liver

Peter Neuhaus, Berlin, Germany

> 09:30 Arterial vs. portal reperfusion for extended criteria grafts

Jacques Belghiti, Paris, France

> 09:50 Anti-thrombotic prophylaxis and therapy

Ton Lisman, Groningen, The Netherlands

> 10:10 Importance of perioperative fl ow monitoring

Roberto Troisi, Ghent, Belgium

10:30 Coffee break

> 11:00 Arterial revascularization after thrombosis: ‘CON’

John O’Grady, London, United Kingdom

> 11:20 Arterial revascularisation after thrombosis: ‘PRO’

Paolo Muiesan, Birmingham, United Kingdom

> 11:40 Immediate causes of graft failure after liver transplantation and

retransplantation

Darius Mirza, Birmingham, United Kingdom

> 12:00 Discussion

STATE OF THE ART 1

BASIC SCIENCE AND LIVER TRANSPLANTATION

Blue Amphitheatre

Regenerative medicine and stem cells

Chairs: Carla Baan, Rotterdam, The Netherlands

Patrizia Burra, Padua, Italy

> 09:00 Stem cell differentiation

Malcolm Alison, London, United Kingdom

> 09:20 The heterogenous pool of intrahepatic stem cells

Daniele Prati, Lecco, Italy

41

ELITA


for successful

acceptance

JUST SAY "YES" TO EQUORAL!

Because it’s:

Clinically supported

Bioequivalent

Interchangeable

Economical

Used successfully by thousands

of transplant patients in 40 countries worldwide

Algeria, Armenia, Austria, Azerbaijan, Bulgaria, Croatia, Czech Republic, Estonia,

Georgia, Germany, Hong-Kong, Chile, Ireland, Kazachstan, Kuwait, Latvia, Libia,

Lithuania, Macedonia, Mexico, Moldova, Morocco, Peru, Poland, Portugal, Romania,

Russia, Saudi Arabia, Slovakia, Sweden, Tailand, Taiwan, Tunisia, UAE, Ukraine, Uruguay,

USA, Uzbekistan, Vietnam, Yemen

www.equoral.net

cyclosporine

EQUORAL ® Capsules 25 mg, 50 mg, 100 mg and Oral solution 100mg/ml

Active substance: cyclosporine. Therapeutic Indications: Prevention of graft rejection following allogenic kidney, liver, heart,

combined heart-lung, lung or pancreas transplants. Treatment of transplant rejection in patients previously receiving other

immunosuppressants. Prevention of graft rejection following bone marrow transplantation and prophylaxis of graftversus- host disease

(GVHD). Treatment of established graft-versushost disease (GVHD). Psoriasis: in patients with severe psoriasis in whom conventional

therapy is ineffective or inappropriate. Atopic Dermatitis: in patients with severe atopic dermatitis, when systemic therapy is required.

Rheumatoid Arthritis: for treatment of severe, active rheumatoid arthritis in patients for whom classical slow-acting anti-rheumatic

agents are inappropriate or ineffective. Nephrotic syndrome: for the treatment of adults and children to induce remissions and for

maintenance treatment. It can also be used for the maintenance of steroid-induced remission, allowing withdraw of steroids. Dosage:

Organ transplantation: Treatment should be initiated within 12 hours before transplantation at a dose of 10 to 15mg/kg body weight

given in two divided doses and continue at this dose for one to two weeks post-operatively. Dosage should then be gradually reduced

until a maintenance dose of 2 to 6 mg/kg per day is reached. Dosage should be adjusted by monitoring cyclosporin trough levels and

kidney function. When Equoral ® is given with other immunosuppressants, lower doses may be used for the initial treatment. Bone

Marrow Transplantation: to initiate therapy, the recommended dose is 12.5 to 15 mg/kg per day, starting on the day before

transplantation and given for at least three and preferably six months before tailing off to zero. If GVHD develops after Equoral ® is

withdrawn it should respond to reinstitution of therapy. Low doses of Equoral ® should be used for mild, chronic GVHD. For dosages

in autoimmune disease patients please refer to full SPC. Grapefruit or grapefruit juice should not be ingested for one hour prior to

dose administration. Contra-Indications: Known hypersensitivity to cyclosporine. Equoral ® is contra-indicated in antuimmune diseasa

patients with abnormal renal function, uncontrolled hypertension, uncontrolled infections or any kind of malignancy other than of the

skin. Special Warnings: Close monitoring of serum creatinine and urea is required and dosage adjustment may be necessary.

Regular monitoring of blood pressure is required during treatment with cyclosporine. Cyclosporine can induce a reversible increase

in blood lipids. Interactions: Various agents are known to either increase or decrease the plasma or whole blood concentrations of

cyclosporine. Please refer to full SPC. Pregnancy and Lactation: cyclosporine is not teratogenic in animals. Mothers receiving

treatment with cyclosporine should not breast-feed their infants. Undesirable Effects: They are usually dose dependent and

responsive to dose reduction. Increase in serum creatinine and urea during the first few weeks of therapy is frequent. Less frequently,

renal structural changes (e.g. interstitial fibrosis) may develop during long-term treatment. Apart from impaired renal function, the most

frequently observed side effects include hypertrichosis, tremor, hypertension (particularly in heart transplant patients), hepatic

dysfunction, fatigue, gingival hypertrophy, gastrointestinal disturbances (abdominal pain, anorexia, nausea, vomiting, diarrhoea) and

burning sensations of the hands and feet (usually during the first week of treatment).

Please read the full Summary of Product Characteristics before prescribing Equoral ® .


13:00

14:00

09:00

10:30

> 09:40 Ex-vivo engineering of liver tissue with adult stem cells

Carlos Semino, Barcelona, Spain

43

ELITA

> 10:00 Clinical trial on stem cells as alternative or bridge to liver

transplantation

Stuart J. Forbes, Edinburgh, United Kingdom

> 10:20 Discussion

ELITA GENERAL ASSEMBLY (Members ONLY)

Room 241

STATE OF THE ART 8

LIVER TRANSPLANTATION

Blue Amphitheatre

Life Style in liver transplantation

Chairs: Andrew K. Burroughs, London, United Kingdom

René Adam, Paris, France

> 09:00 Schooling and psycho-social adaptation after liver transplantation

Barbara Wildhaber, Geneva, Switzerland

> 09:20 Sexual and reproductive function in men and women after liver

transplantation

Patrizia Burra, Padua, Italy

> 09:40 Employment after liver transplantation

Pietro Majno, Geneva, Switzerland

> 10:00 Sporting and hobbies after organ transplantation

Jacques Pirenne, Leuven, Belgium

> 10:20 Discussion


EPITA

EUROPEAN PANCREAS AND ISLET

TRANSPLANT ASSOCIATION

The European Pancreas and Islet Transplant Association was founded in

2007 as a section of ESOT. The aims of EPITA are to provide a forum for the

pancreas and islet transplantation community in Europe and to contribute to

the development of this fi eld and of alternate forms of beta-cell replacement

therapy for the benefi t of patients suffering from diabetes throughout Europe.

The founding of EPITA was materialized by a successful pre-transplant

symposium on the occasion of the 2007 Congress of ESOT in Prague. As

EPITA is taking off and pancreas and islet transplantation gain visibility in

the ESOT educational programmes, we invite you to join this dynamic new

section of your society and contribute to its growth, and we welcome you to

its activities during the 2009 biannual Meeting of ESOT.

EPITA membership is available to all ESOT members in good standing and

is gained at no additional fee by registering on the ESOT website. EPITA

membership gives free access to the EPITA post-graduate course.

� EPITA Board

The European Pancreas and Islet Transplant Association (EPITA) is a section

of ESOT. Its membership represents the expertise on pancreas and islet

transplantation in Europe.

CHAIR

Thierry Berney, Geneva, Switzerland

SECRETARY

Frantisek Saudek, Prague, Czech Republic

MEMBERS

Mathias D. Brendel, Giessen, Germany

Torbjörn Lundgren, Huddinge, Sweden

Johann Pratschke, Berlin, Germany

Alexander F. Schaapherder, Leiden, The Netherlands

Antonio Secchi, Milan, Italy

44


09:00

12:50

EPITA PROGRAMME AT ESOT 2009

EPITA POST GRADUATE COURSE

Room 251

Session 1: The role of coagulation

Chairs: Thierry Berney, Geneva, Switzerland

Antonio Secchi, Milan, Italy

> 09:00 The IBMIR: why it occurs and how to prevent it

Torbjörn Lundgren, Stockholm, Sweden

> 09:20 Thrombosis of the pancreatic graft: why it occurs and how to prevent it

Peter Friend, Oxford, United Kingdom

Session 2: Therapeutic options for severe hypoglycemia

Chairs: Thierry Berney, Geneva, Switzerland

Antonio Secchi, Milan, Italy

> 09:40 Medical therapy

Eric Renard, Montpellier, France

> 10:00 Islet transplantation

Mathias Brendel, Giessen, Germany

> 10:20 Pancreas transplantation

Ugo Boggi, Pisa, Italy

10:40 Coffee break

Session 3: Beta-replacement for type 2 diabetes

Chairs: Johann Pratschke, Berlin, Germany

Alexander Schaapherder, Leiden, The Netherlands

> 11:00 For:

Rainer Gruessner, Tucson, United States

> 11:20 Against:

Frantisek Saudek, Prague, Czech Republic

Session 4: Organ selection for beta-cell replacement

Chairs: Johann Pratschke, Berlin, Germany

Alexander Schaapherder, Leiden, The Netherlands

> 11:40 Role of islet size in islet transplantation outcome

Roger Lehmann, Zurich, Switzerland

45

EPITA

> 12:00 Selection criteria for whole pancreas transplantation: The PPASS

score

Helmut Arbogast, Münster, Germany

> 12:20 Discussion


09:00

10:30

STATE OF THE ART 4

PANCREAS AND ISLET TRANSPLANTATION,

STEADY-STATE OR PROGRESS?

Room Maillot

Chairs: Rainer Gruessner, Tucson, United States

François Pattou, Lille, France

> 09:00 Algorithms for islet vs pancreas transplantation

Thierry Berney, Geneva, Switzerland

> 09:20 Beta-cell toxicity of IS drugs in pancreas and islet Tx

Antonio Secchi, Milan, Italy

> 09:40 Alternative sites for islet transplantation

Olle Korsgren, Uppsala, Sweden

> 10:00 Alternative sources of insulin-producing tissue

Shimon Efrat, Tel Aviv, Israel

> 10:20 Discussion

EPITA Awards

Best abstract in the fi elds of Pancreas transplantation Anand

Sivaprakash Rathnasamy Muthusamy

LB-6 PANCREAS TRANSPLANTATION FROM NON-HEART

BEATING DONORS IN THE UNITED KINGDOM

Anand Sivaprakash Rathnasamy Muthusamy, Alexander Hudson, Lisa

Mumford and Peter J. Friend; Oxford, Oxfordshire, United Kingdom;

Bristol, United Kingdom and Oxford, United Kingdom.

Best abstract in the fi elds of Islet transplantation

Nadja Niclauss

P-179 INFLUENCE OF DONOR AGE ON ISLET ISOLATION

AND TRANSPLANTATION OUTCOME

Nadja Niclauss, Domenico Bosco, Philippe Morel, Sandrine Demuylder-

Mischler, Coralie Brault, Antonino Sgroi, Géraldine Parnaud, Yannick

Muller, Laurianne Giovannoni, Pierre-Yves Benhamou and Thierry

Berney; Geneva, Switzerland; Lyon, France and Grenoble, France

46


09:00

12:50

THORACIC

COMMITTEE

47

THORACIC

COMMITTEE

The Thoracic Committee of ESOT was founded in 2006 as a separate

section within ESOT to support and represent the Heart and Lung Transplant

community in Europe. A close collaboration is established with the European

Society for Heart and Lung Transplantation (ESHLT). The aim of the thoracic

committee is to group all people interested in heart and lung transplantation

under the umbrella of ESOT to share common interest and benefi t from the

organizational and fi nancial support for educational activities.

No membership fee other than ESOT membership is required to participate

in the activities organized by the Thoracic Committee.

A successful postgraduate course and state of the art session has been

conducted by the Thoracic Committee during the previous biennial meeting

in Prague in 2007.

The Committee will participate in the European Donor Surgery Masterclass

to offer training in thoracic organ procurement. Several members of the

committee participate as lecturers in the Hesperis Course organised by

ESOT.

Thoracic Committee

CHAIR

Dirk Van Raemdonck, Leuven, Belgium

THORACIC

COMMITTEE

ESHLT REPRESENTATIVE

Paul Corris, Newcastle-upon-Tyne, United Kingdom

MEMBERS

Nicolas Banner, London, United Kingdom

Annette Boehler, Zurich, Switzerland

Michiel E. Erasmus, Groningen, The Netherlands

Günther Laufer, Innsbruck, Austria

Ugolino Livi, Udine, Italy

Bruno Meiser, Münster, Germany

PROGRAMME ACTIVITIES AT ESOT 2009

THORACIC POSTGRADUATE COURSE

Room 252-A

Chairs: Marc Stern, Paris, France

Michiel Erasmus, Groningen, The Netherlands

> 09:00 Is there a role for induction therapy following thoracic organ

transplantation

Andreas Zuckermann, Vienna, Austria

> 09:30 Surgical complication in the early period after lung transplantation;

diagnosis and management

Elie Fadel, Le Plessis Robison, France


09:00

10:30

> 10:00 What are therapeutic approaches in a patient with recurrent acute

rejection after lung transplantation

Amparo Solé, Barcelona, Spain

> 10:30 Early markers of chronic allograft rejection

Paul Corris, Newcastle-upon-Tyne, United Kingdom

11:00 - 11:20 Coffee break

Chairs: Nicholas Banner, London, United Kingdom

Günther Laufer, Innsbruck, Austria

> 11:20 Heart preservation using ex vivo perfusion

Steven Tsui, Cambridge, United Kingdom

> 11:50 The management of antibody-mediated rejection in cardiac transplantation

Nicholas Banner, London, United Kingdom

> 12:20 The role of M TOR inhibitors after heart transplantation

Bruno Meiser, Münster, Germany

STATE OF THE ART 7

THORACIC TRANSPLANTATION

Room 252 AB

New concepts and modalities

Chairs: Ugolino Livi, Udine, Italy

Martin Strüber, Hannover, Germany

> 09:00 Current status of cellular therapy in cardiac repair

Alfred Kocher, Innsbruck, Austria

> 09:20 Role of mesenchymal stem cells in modulating rejection following

cardiac transplantation

Denis Angoulvant, Lyon, France

> 09:40 Artifi cial lung as bridge to lung transplantation

Martin Strüber, Hannover, Germany

> 10:00 Preserving renal function following thoracic transplantation

Maryvonne Hourmant, Nantes, France

> 10:20 Discussion

48


09:00

11:00

EUROPEAN DONATION

COMMITTEE

In 2005 a new ESOT Committee, the European Donation Committee (EDC),

was founded in order to enhance national, regional and/or local initiatives

and create a win-win situation with a common European denominator. Since

then, the EDC is working on a number of new initiatives in this fi eld. Among

these, is a new ESOT course to be launched in 2009 and centred on the three

professional types of procurement coordination: Deceased-Living-Transplant

Clinical Coordinators the TRIPLE Course. The aim of the EDC is to promote

and exchange expertise and knowledge in the fi eld of donation.

CHAIRMAN

Alessandro Nanni Costa, Rome, Italy

SECRETARY

Rutger J.Ploeg, Groningen, The Netherlands

MEMBERS

Peter J. Friend, Oxford, United Kingdom

Bernadette J.J.M. Haase, Leiden, The Netherlands

Günter Kirste, Neu-Isenburg, Germany

Dirk Ysebaert, Antwerp, Belgium

PROGRAMME ACTIVITIES AT ESOT 2009

The European Donation Committee is organizing for the fi rst time a forum

on Organ Procurement, with the intent to create an active participation

and exchange of ideas among investigators in this fi eld. We encourage

the participation of all those coming from a multidisciplinary background,

including donation and transplantation professionals active in deceased

donor procurement, living donation, recipient coordination and national

transplant organizations. ESOT wishes to establish, during its future biennial

meetings, an interesting and attractive forum for discussion.

Access to the Organ Procurement Forum is free.

ORGAN PROCUREMENT FORUM

Room 241

Chairs: Bernadette Haase-Kromwijk, Rotterdam, The Netherlands

Dirk Ysebaert, Antwerpen, Belgium

> 09:00 Welcome and Introduction of EDC Chairman

Alessandro Nanni Costa, Rome, Italy

> 09:20 Organ Procurement in Europe: state-of-the Art

Rafael Matesanz, Madrid, Spain

> 09:45 Safety management in organ procurement system

Bernard Loty, Saint-Denis La Plaine, France

> 10:10 HIV infection and new infections: the donor evaluation

Albert Heim, Hannover, Germany

49

EUROPEAN

DONATION


11:00

13:00

WORKSHOP

Room 251

EUROPEAN DONATION COMMITTEE

Quality assurance in organ donation and transplantation

Moderators:

Clinical coordination: Marcello Castellese, Palermo, Italy

Deceased donation: Marti Manyalich, Barcelona, Spain

Living donation: Silvia Termeulen, Amsterdam, The Netherlands

Discussants:

In clinical coordination: Christine Jansen, Glasgow, United Kingdom

In deceased donation: Francesco Procaccio, Verona, Italy

In living donation: Annette Lennerling, Gothenburg, Sweden

50


10:30

12:50

BASIC SCIENCE

COMMITTEE

51

BASIC SCIENCE

COMMITTEE

In 2003, the Basic Science Committee (BSC) was founded to promote scientifi c

issues and transplantation research within ESOT. For the future of ESOT it is

crucial to link clinical activities and basic research. To stimulate collaboration

between scientists a network of European Laboratories of Excellence has

been established called the Basic Science Network in transplantation.

Basic Science Committee

CHAIRMAN

Carla Baan, Rotterdam, The Netherlands

MEMBERS

Ignacio Anegon, Nantes, France

Manuela Battaglia, Milan, Italy

Michel Braun, Brussels, Belgium

Andrew Bushell, Oxford, United Kingdom

Johann Pratschke, Berlin, Germany

Thomas Wekerle, Vienna, Austria

PROGRAMME ACTIVITIES AT ESOT 2009

BASIC SCIENCE POST GRADUATE COURSE

Room 252-B

Novel research tools in transplantation:

tips and tricks

Chairs: Manuela Battaglia, Milan, Italy

Bernard Vanhove, Nantes, France

> 10:30 Introduction

> 10:40 The role of micro RNAs in organ transplantation

Stefan Tullius, Boston, United States

> 11:10 Laser-microdissection for cell type- and compartment-specifi c

analyses

Klaus Dornmair, Martinsried, Germany

> 11:40 Multicolor fl owcytometry

Laurel Nomura, San Jose, United States

> 12:10 Reprogramming human cells to generate induced pluripotent stem

cells

Kevin Eggan, Cambridge MA, United States

> 12:40 Discussion


09:00

10:30

09:00

10:30

STATE OF THE ART 1

BASIC SCIENCE AND LIVER TRANSPLANTATION

Blue Amphitheatre

Regenerative medicine and stem cells

Chairs: Carla Baan, Rotterdam, The Netherlands

Patrizia Burra, Padua, Italy

> 09:00 Stem cell differentiation

Malcolm Alison, London, United Kingdom

> 09:20 The heterogenous pool of intrahepatic stem cells

Daniele Prati, Lecco, Italy

> 09:40 Ex-vivo engineering of liver tissue with adult stem cells

Carlos Semino, Barcelona, Spain

> 10:00 Clinical trial on stem cells as alternative or bridge to liver transplantation

Stuart J. Forbes, Edinburgh, United Kingdom

> 10:20 Discussion

STATE OF THE ART 9

BASIC SCIENCE

Room Maillot

Innate immunity in transplantation

Chairs: Michel Braun, Brussels, Belgium

Johann Pratschke, Berlin, Germany

> 09:00 Evolution of innate allorecognition

Fadi Lakkis, Pittsburg, United States

> 09:20 The role of dentritic cells

Francesca Fallarino, Perugia, Italy

> 09:40 Toll like Receptors: coming of age

Maria Luisa Alegre, Chicago, United States

>10:00 New roles of complements in transplantation

Steven H. Sacks, London, United Kingdom

> 10:20 Discussion

BASIC SCIENCE COMMITTEE

52


09:00

10:30

ELPAT

ELPAT is a European platform that brings continuity and progress in European

research and dialogue on ‘’Ethical, Legal and Psychosocial Aspects of organ

Transplantation’’. Since February 2008 ELPAT also functions as the offi cial,

advisory committee of the European Society for Organ Transplantation (ESOT)

on ethical, legal and psychosocial aspects of organ transplantation. It aims to

integrate and structure this fi eld of science by bringing together European

professionals. These experts range from (bio)ethicists, philosophers, lawyers

and psychologists to clinicians, physicians, sociologists, anthropologists,

policy makers and criminologists. ELPAT currently consists of over 100

experts from more than 25 European countries.

CHAIR

Willem Weimar, Rotterdam, The Netherlands

COORDINATOR

Frederike Ambagtsheer

SECRETARY

Marian van Noord

ELPAT PROGRAMME AT ESOT 2009

STATE OF THE ART

ETHICAL, LEGAL AND PSYCOSOCIAL ASPECTS

OF ORGAN TRANSPLANTATION

Blue Amphitheatre

Living unrelated organ donation. From caring

partner to good Samaritan

Chairs: Annette Lennerling, Gothenburg, Sweden

Willem Weimar, Rotterdam, The Netherlands

> 09:00 Caring partner. Is it only love? Pitfalls in living related organ donation

Nikola Biller-Andorno, Zurich, Switzerland

> 09:20 In between. Hurdles for living unrelated organ donation

Bijan Fateh-Moghadam, Münster, Germany

> 09:40 Good Samaritan. An update on European practices

Willij C. Zuidema, Rotterdam, The Netherlands

> 10:00 Discussion

53

ELPAT


Changing tomorrow

Astellas (formerly Fujisawa) has been committed to the European

transplant community since the early 1990s, with the aim of

CHANGING TOMORROW for surgeons, physicians and patients alike.

Through sustained investment in almost 100 European clinical studies, we

are continually striving to advance transplant care by developing both new

treatment regimens and innovative therapies that target specific pathways.

We are also proud to be able to support many patient organisations, helping

to offer hope for the future. However, it is only as your partner that we are

able to change tomorrow in transplantation.

www.astellas-europe.co.uk

© December 2008 Astellas Pharma Europe Ltd. CSC0038

ASTELLAS, LEADING LIGHT FOR LIFE, CHANGING TOMORROW

and the Star logo are trade marks of Astellas Pharma, Inc. and

its related entities.


13:00

14:00

KDIGO CARE

55

KDIGO CARE

KDIGO CLINICAL PRACTICE GUIDELINE FOR THE

CARE OF KIDNEY TRANSPLANT RECIPIENT

Room 252 - AB

KDIGO will present the Clinical Practice Guideline for the Care of Kidney

Transplant Recipient.

The session will cover the following topics:

> Induction therapy

> Use of fi rst-line, maintenance and generic immunosuppressive medications

> Treatments for acute rejection.

Overview of KDIGO and the Guideline Process and

Recommendations on Immunosuppressive Medication.

Bertram Kasiske, Minneapolis, United States

Surveillance and Preventing Complications.

Martin Zeier, Heidelberg, Germany

Question and Answer: Panel Discussion

The presentation will also address the importance of monitoring for kidney

allograft function, recurrent kidney disease, allograft dysfunction via

proteinuria screening, and clinical indications for allograft biopsy.

In addition, the session will allow for discussions on the early detection and

prevention of common post-transplant complications such as: infections,

cardiovascular diseases, and malignancies.

KDIGO is an independently incorporated foundation, governed by an

international Board and managed by the National Kidney Foundation with the

stated mission: “To improve the care and outcomes of kidney disease patients

worldwide through promoting coordination, collaboration and integration of

initiatives to develop and implement clinical practice guidelines“.


SCIENTIFIC

PROGRAMME


PROGRAMME OVERVIEW

8:00

8:15

8:30

8:45

9:00

9:15

9:30

9:45

10:00

10:15

10:30

10:45

11:00

11:15

11:30

11:45

12:00

12:15

12:30

12:50

13:00

13:15

13:30

13:45

14:00

14:15

14:30

14:45

15:00

15:15

15:30

15:45

16:00

16:10

16:30

16:45

17:00

17:10

17:30

17:45

18:00

18:15

18:30

18:45

19:00

19:15

19:30

19:45

20:00

20:15

20:30

20:45

21:00

23:00

ELITA PG Course

242-AB

ASTELLAS

Parallel

Satellite

Symposium

Sunday, August 30 th

p 40 p 44 p 49

EPITA PG Course

251

58

Organ Procurement Forum

241

GENZYME

Parallel

Satellite

Symposium

p 47

Thoracic PG Course

252-A

NOVARTIS

Plenary Satellite Symposium

ROCHE

Plenary Satellite Symposium

Opening

& Plenary Session 1

The Future in Transplantation

Basic Science

PG Course

MILTENYI

BIOTEC

Parallel Satellite

Symposium

Grand A. p 225 Blue A. p 225 Maillot

Blue Amphitheatre

Grand Amphitheatre

Grand Amphitheatre

Posters Viewing

& Welcome Cocktail

Hall Maillot & Exhibit Area

p 51

252-B

p 226

p 226

p 227

p 59

p 59


18:15

20:00

20:00

OPENING SESSION

Grand Amphitheatre

Congress Chairs: Bernard Charpentier, Paris, France

Yvon Lebranchu, Tours, France

Welcome address

> 18:15 Paris 2009 Chairs: Bernard Charpentier - Yvon Lebranchu

Honorary Membership celebration

59

SCIENTIFIC

PROGRAMME

> 18:30 Peter Friend, Past-President of the British Society of Transplantation,

introduces

Honorary Member Sir Peter Morris, Oxford, United Kingdom

> 18:45 Bernard Charpentier, Past-President of ESOT, introduces

Honorary Member Christian Cabrol, Paris, France

> 19:00 The future is Education: Our programme

John L.R. Forsythe, Chair Education Committee

Hesperis celebrates 15 years

ESOT awards co-founders Jean-Michel Dubernard and Henri Kreis

The Tree of Life

Ferdinand Mühlbacher, ESOT President, introduces a new extensive project

on education.

PLENARY SESSION 1

The future in transplantation

> 19:20 Suppressor T cells revisited

Harvey Cantor, Boston, United States

> 19:40 Translating tissue engineering into clinical transplantation: time has

come

Paolo Macchiarini, Barcelona, Spain

POSTER OPENING & WELCOME COCKTAIL

Hall Maillot and Exhibit Area


PROGRAMME OVERVIEW

8:00

8:15

8:30

8:45

9:00

9:15

9:30

9:45

10:00

10:15

10:30

10:45

11:00

11:15

11:30

11:45

12:00

12:15

12:30

12:50

13:00

13:15

13:30

13:45

14:00

14:15

14:30

14:45

15:00

15:15

15:30

15:45

16:00

16:10

16:30

16:45

17:00

17:10

17:30

17:45

18:00

18:15

18:30

18:45

19:00

19:15

19:30

19:45

20:00

20:15

20:30

20:45

21:00

23:00

State-ofthe-Art

Basic Science

and Liver

Transplantation

p 66

Monday, August 31 st

Parallel Sessions

1-6

60

State-ofthe-Art

Kidney

Transplantation

p66

Blue A. Grand A. Maillot

Coffee Break

Parallel Sessions

7-12

State-ofthe-Art

Infections in

Transplantation

p 67

ASTELLAS NOVARTIS WYETH

Parallel Satellite Symposia y p

Grand A. p 228 Blue A. p 228 Maillot p 229

Plenary Session 2

ESOT & AST & ASTS

Immunosuppression Revisited

Grand Amphitheatre

Coffee Break

Parallel Sessions

13-18

ASTELLAS

Plenary Satellite Symposium

Grand Amphitheatre

ESOT Reception

Musée des Arts Forains

p 61-65

p 67-74

p 74

p 75-83

p 229

p 33


08:00

09:00

PARALLEL SESSION 1

Blue Amphitheatre

Translational research in kidney transplantation

Chairs: Carla Baan, Rotterdam, The Netherlands

Klemens Budde, Berlin, Germany

61

SCIENTIFIC

PROGRAMME

> 08:00 O-1 EXPRESSION OF REGULATORY T CELL-RELATED MOLECULE-

GENES AND CLINICAL OUTCOME IN KIDNEY TRANSPLANT

RECIPIENTS

Caner Süsal, Dorottya Nemeth, Cristiam Alvarez, Jörg Ovens, Claudia

Sommerer, Markus Mieth, Luis Garcia, Robert Langer, Jan Schmidt, Martin

Zeier and Gerhard Opelz; Heidelberg, Germany; Medellin, Colombia and

Budapest, Hungary

> 08:10 O-2 2D-DIGE ANALYSIS OF THE URINE PROTEOME IN CHRONIC

ALLOGRAPH DYSFUNCTION

Elisenda Bañón-Maneus, Fritz K. Diekmann, Daniel Moya-Rull, Luis F.

Quintana, María José Ramírez-Bajo, Jordi Rovira, Ignacio Revuelta, Alex

Gutierrez-Dalmau, Amanda Sole-Gonzalez and Josep M. Campistol;

Barcelona, Catalunya, Spain

> 08:20 O-3 TCF7L2 POLYMORPHISM IS AN INDEPENDENT RISK FACTOR

FOR NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION:

A COHORT STUDY ON 1229 RENAL TRANSPLANT PATIENTS

Lidia Ghisdal, Christophe Baron, Yvon Lebranchu, Jean-Michel Halimi, Yann

Lemeur, Jean-Philippe Rerolle, Mireille Drouet, Arnaud Lionet, François

Glowacki, Christian Noël, Karl Martin Wissing, Daniel Abramowicz and Marc

Abramowicz; Brussels, Belgium; Tours, France; Limoges, Belgium and Lille,

France

> 08:30 O-4 PRETREATMENT WITH MONOCYTE CHEMOTACTIC

PROTEIN-1 PREVENTS THE DESTRUCTIVE EFFECT OF OVERDOSE

MESENCHYMAL STEM CELL IN ACUTE KIDNEY TRANSPLANTATION

Bo Chen, Jessy Deshane, Lingling Guo, James F. George and Sifeng Chen;

Birmingham, AL, United States and Shanghai, China

> 08:40 O-5 NAKED SIRNAS SILENCING CASPASE-3 GENE

REDUCEDAPOPTOSIS AND IMPROVED CELL VIABILITY IN

PORCINE PROXIMAL TUBULAR CELLS WITH OR WITHOUT

HYDROGEN PEROXIDE TREATMENT

Bin Yang, Joshua E. Elias and Michael L. Nicholson; Leicester, United

Kingdom

> 08:50 O-6 THE RENAL LYMPHATIC SYSTEM IN HEALTH AND DISEASE

David G. Vass, John Haylor, Bardi Shrestha, Jeremy Hughes, Lorna Marson

and Lorna Marson; Edinburgh, United Kingdom and Sheffi eld, United

Kingdom


08:00

09:00

PARALLEL SESSION 2

Room Maillot

Large programs and registries in small bowel liver

transplantation

Chairs: Bernard de Hemptinne, Ghent, Belgium

Ferdinand Mühlbacher, Vienna, Austria

> 08:00 O-7 IS INTESTINAL TRANSPLANTATION A VALUABLE ALTERNATIVE

FOR CHILDREN WITH TOTAL AND DEFINITIVE INTESTINAL FAILURE?

Florence Lacaille, Frederique Sauvat, Francisca Joly, Jean-Pierre Hugot,

Bernard Messing, Frank Ruemmele and Olivier Goulet; Paris, France and

Clichy, France

> 08:10 O-8 EVALUATING SURVIVAL BENEFIT-BASED DECEASED-DONOR

LIVER ALLOCATION THROUGH MICROSIMULATION

Douglas E. Schaubel, Mary K. Guidinger and Robert M. Merion; Ann Arbor,

MI, United States

> 08:20 O-9 CURRENT STATUS OF LIVER TRANSPLANTATION IN EUROPE:

AN ANALYSIS OF ELTR DATA

Rene Adam, Vincent Karam, Valerie Delvart, John Buckels, John O’Grady,

Denis Castaing, Jurgen Klempnauer, Neville Jamieson, Peter Neuhaus, Jan

Lerut, Stephen Pollard, Mauro Salizzoni, Lutz Fischer, Juan Garcia-Valdecasas,

Ferdinand Mulhbacher, Jose Mir and European Liver and Intestine Transplant

Assoc (ELITA); Villejuif, France; Birmingham, United Kingdom; London,

United Kingdom; Hannover, Germany; Cambridge, United Kingdom; Berlin,

Germany; Brussels, Belgium; Leeds, United Kingdom; Torino, Italy; Hamburg,

Germany; Barcelona, Spain; Wien, Austria and Valencia, Spain

> 08:30 O-10 LIVER TRANSPLANTATION IN PATIENTS IN UNOS STATUS

1: OUTCOME OF 419 TRANSPLANTATIONS IN THE NORTH ITALY

TRANSPLANT PROGRAMME

Tullia M. De Feo, Nicola De Fazio, Enzo Andorno, Umberto Baccarani,

Umberto Cillo, Michele Colledan, Luciano De Carlis, Matteo Donataccio,

Enrico Regalia, Andrea Risaliti, Giorgio Rossi, Francesco Procaccio and Mario

Scalamogna; Milan, Italy; Genova, Italy; Udine, Italy; Padua, Italy; Bergamo,

Italy; Verona, Italy and Ancona, Italy

> 08:40 O-11 LIVING DONOR LIVER TRANSPLANTATION: A EUROPEAN LIVER

TRANSPLANT REGISTRY (ELTR) REPORT ON 2634 CASES

R. Adam, V. Karam, V. Delvart, L. Fischer, M. Kilic, J. Lerut, P. Neuhaus, P.

Kalicinski, D. Castaing, B. De Hemptine, O. Boillot, Y. Tokat, G. Klampnauer,

J. O’Grady, Y. Revillon, J. Belghiti and European Liver and Intestine Transplant

Assoc (ELITA); Villejuif, France; Hamburg, Germany; Izmir, Turkey; Brussels,

Belgium; Berlin, Germany; Warsaw, Poland; Ghent, Belgium; Lyon, France;

Istanbul, Turkey; Hannover, Germany; London, United Kingdom; Paris,

France and Clichy, France

> 08:50 O-12 CURRENT STATUS OF LIVER TRANSPLANTATION (LTX) FOR

HEREDITARY AMYLOIDOSES AND DOMINO LIVER TRANSPLANTATION

(DLT): THE FAMILIAL AMYLOIDOTIC POLYNEUROPATHY WORLD

TRANSPLANT REGISTRY (FAPWTR) AND THE DOMINO LIVER

TRANSPLANT REGISTRY (DLTR) PERSPECTIVE

Henryk E. Wilczek, Marie Larsson and Bo-Göran Ericzon; Stockholm,

Sweden

62


08:00

09:00

08:00

09:00

PARALLEL SESSION 3

Room 241

Pancreas transplantation: technical aspects

Chairs: Ugo Boggi, Pisa, Italy

Johann Pratschke, Berlin, Germany

63

SCIENTIFIC

PROGRAMME

> 08:00 O-13 TECHNICAL ASPECTS OF PANCREAS RETRANSPLANTATION A

SINGLE CENTER EXPERIENCE

Matthias Biebl, Michael Lienegger, Manuel Maglione, Schneeberger

Stefan, Robert Öllinger, Christine Holzknecht, Ricardo-Pupo Yamila, Sabine

Brandstätter, Aigner Felix, Mark Walter and Margreiter Raimund; Innsbruck,

Tyrol, Austria

> 08:10 O-14 PANCREAS RETRANSPLANTATION: CHALLENGING BUT JUSTIFIED

Deep J. Malde, Afshin Tavakoli, Ravi Pararajasingam, Babatunde Campbell,

Hany Riad, Neil Parrott and Titus Augustine; Manchester, United Kingdom

> 08:20 O-15 INDICATIONS, SAFETY PROFILE, AND SUCCESS RATE OF

PANCREAS GRAFT BIOPSY FOLLOWING PANCREAS TRANSPLANTATION

Ugo Boggi, Fabio Vistoli, Luca Morelli, Alessandro Campatelli, Marco Del

Chiaro, Chiara Croce, Carlo Moretto, Stefano Signori, Gabriella Amorese,

Sabrina Gabbriellini, Vittorio Perrone, Simone D’Imporzano, Piero Marchetti

and Franco Mosca; Pisa, Italy

> 08:30 O-16 INTRAPYLORIC INJECTION OF BOTULINUM TOXIN A: AN

ALTERNATIVE TREATMENT IN PANCREAS TRANSPLANT RECIPIENTS

WITH SEVERE DIABETIC GASTROPARESIS

Manuel Maglione, Gerald Brandacher, Robert Öllinger, Matthias Biebl,

Walter Mark, Helmut Weiss and Raimund Margreiter; Innsbruck, Austria

> 08:40 O-17 TREATMENT WITH A CXCR4 ANTAGONIST CURES DIABETES IN

NOD MICE

Alice Schwarznau, Anja Barwig, Ulrike Bourquain, Veronika Auer, Nikolaus

Schantz and Manfred J. Stangl; Münster, Germany and Garching, Germany

> 08:50 O-18 PORTAL-ENTERIC OR SYSTEMIC-ENTERIC DRAINAGE FOR

RETROPERITONEAL PANCREAS TRANSPLANTATION

Ugo Boggi, Fabio Vistoli, Chiara Croce, Marco Del Chiaro, Carlo Moretto,

Stefano Signori, Gabriella Amorese, Sabrina Gabbriellini, Vittorio Perrone,

Simone D’Imporzano, Nelide De Lio, Piero Marchetti and Franco Mosca;

Pisa, Italy

PARALLEL SESSION 4

Room 242-AB

Experimental immunosuppression

Chairs: Edward Geissler, Regensburg, Germany

Denis Glotz, Paris, France

> 08:00 O-19 RECOMBINANT HUMAN C1-INHIBITOR PREVENTS ACUTE

ANTIBODY-MEDIATED REJECTION IN ALLOIMMUNIZED BABOONS

Xavier Tillou, Nicolas Poirier, Stephanie LeBas-Bernardet, Jeremy Hervouet,

David Minault, Karine Renaudin, Fabio Vistoli, Georges Karam, Mohamed

Daha and Gilles Blancho; Nantes, France and Leinden, Netherlands


08:00

09:00

> 08:10 O-20 ENDOTOXIN CHALLENGE INDUCES MYELOID-DERIVED

SUPPRESSOR CELLS CONTROLLING ALLOGRAFT REJECTION THROUGH

HEME OXYGENASE-1

Nicolas Van Rompaey, Virginie De Wilde, Marcelo Hill, Maria-Cristina Cuturi,

Michel Goldman and Alain Le Moine; Gosselies, Belgium and Nantes,

France

> 08:20 O-21 PLASMACYTOID DENDRITIC CELLS: A PROMISING TOOL

FOR IMMUNE-CONDITIONING THERAPY OF ORGAN TRANSPLANT

RECIPIENTS

Patrick Boor, Herold J. Metselaar, Sarina de Jonge, Luc J. van der Laan and

Jaap Kwekkeboom; Rotterdam, Netherlands

> 08:30 O-22 EPIDERMAL GROWTH FACTOR INHIBITION, A NOVEL PATHWAY

TO PREVENT CHRONIC RENAL ALLOGRAFT REJECTION

Johanna Savikko, Jukka Rintala, Niina Malmström, Sini Rintala and Petri

Koskinen; Helsinki, Finland

> 08:40 O-23 THE IMMUNOSUPPRESSANT RAPAMYCIN REDUCES

NEOPLASIA IN APCMIN/+ MICE AND NORMALISES ION CHANNELS

Gudrun E. Koehl, Melanie Spitzner, Jiraporn Ousingsawat, Rainer Schreiber,

Karl Kunzelmann and Edward K. Geissler; Regensburg, Germany

> 08:50 O-24 LIVER SINUSOIDAL ENDOTHELIAL CELLS TOLERIZE

ALLOREACTIVE T CELLS IN A LIVER ENDOTHELIUM REPOPULATION

IN VIVO MODEL

Masataka Banshodani, Yuka Igarashi, Yuka Tanaka and Hideki Ohdan;

Hiroshima, Japan

PARALLEL SESSION 5

Room 252 AB

Optimisation of current immunosuppressive

strategies in kidney transplantation

Chairs: Andrew Bradley, Bristol, United Kingdom

Antoine Durrbach, Le Kremlin-Bicêtre, France

> 08:00 O-25 OPTIMISATION OF MYCOPHENOLIC ACID (MPA) EXPOSURE

FOR EARLY STEROID WITHDRAWAL IN KIDNEY GRAFT RECIPIENTS:

THE OPERA TRIAL

Y. Le Meur, G. Touchard, F. Glowacki, J.P. Rerolle, V. Garrigue, N. Ouali, A.E.

Heng, M. Delahousse, L. Albano, L. Couzi, P. Lang, PF Westeel, F. Allano,

N. Tagieva and L. Rostaing; Brest, France; Poitiers, France; Lille, France;

Limoges, France; Montpellier, France; Paris, France; Clermont Ferrand,

France; Suresnes, France; Nice, France; Bordeaux, France; Creteil, France;

Amiens, France; Neuilly, France and Toulouse, France

> 08:10 O-26 RELATIONSHIP OF TACROLIMUS EXPOSURE AND MMF

(CELLCEPT®) DOSE WITH RENAL FUNCTION AT ONE YEAR AFTER

RENAL TRANSPLANTATION

Henrik Ekberg, Teun van Gelder, Bruce Kaplan and Corrado Bernasconi;

Malmö, Sweden; Rotterdam, Netherlands; Tucson, AZ, United States and

Basel, Switzerland

> 08:20 O-27 EARLY CORTICOSTEROID DISCONTINUATION AFTER

KIDNEY TRANSPLANT DOES NOT DETERIORATE MIDDLE TERM GRAFT

HISTOLOGY OF PROTOCOL BIOPSIES

Masayoshi Miura, Hiroshi Harada, Naohiko Shimoda, Kanako C. Kubota,

Yayoi Ogawa, Nobuyuki Fukuzawa, Tatsu Tanabe, Tetsuo Hirano and Katsuya

Nonomura; Sapporo, Japan

64


08:00

09:00

65

SCIENTIFIC

PROGRAMME

> 08:30 O-28 SWITCHING AZATHIOPRINE TO MYCOPHENOLATE MOFETIL

REDUCES SKIN UVA PHOTOSENSITIVITY AND WHITE CELL DNA

6-THIOGUANINE LEVELS IN RENAL TRANSPLANT RECIPIENTS

Gunther F. Hofbauer, Gilles Straub, Robert Meyer, Peter Karran, Natalie

Attard, Lars French, Rudolf P. Wuthrich and Andreas L. Serra; Zurich,

Switzerland and Hertfordshire, United Kingdom

> 08:40 O-29 SOTRASTAURIN AND MYCOPHENOLIC ACID IN DE NOVO

RENAL TRANSPLANT PATIENTS: EFFICACY AND SAFETY OF A

CNI-FREE REGIMEN

Styrbjorn Friman, Wolfgang Arns, Bernhard Banas, Larry Chan, Shamkant

Mulgaonkar, Bjorn Nashan, Marianne Soergel, Flavio Vincenti, Karl-Martin

Wissing, Steffen Witte and E. Steve Woodle; Gothenburg, Sweden and

Basel, Switzerland

> 08:50 O-30 NOVEL PROTEIN KINASE C-INHIBITOR SOTRASTAURIN PLUS

TACROLIMUS IN RENAL TRANSPLANTION

Markus Weber, Claudia Sommerer, Thomas Becker, Argiris Asderakis, Frank

Pietruck, Josep M. Grinyo, Paolo Rigotti, Jacques Dantal, Jennifer Ng, Markus

J. Barten and Klemens Budde; Zurich, Switzerland and Basel, Switzerland

PARALLEL SESSION 6

Room 251

Cell therapies for regeneration and immunomodulation

Chairs: Malcolm Alison, London, United Kingdom

Patrizia Burra, Padua, Italy

> 08:00 O-31 EVIDENCE OF ISLET SURVIVAL AND REVASCULARIZATION

FOLLOWING INTRAMUSCULAR AUTOTRANSPLANTATION IN THE MINIPIG

Adrien Sterkers, Thomas Hubert, Robert Caizzo, Valery Gmyr and François

Pattou; Lille, France

> 08:10 O-32 INCREASED PANCREATIC ISLET CELL VIABILITY AND INSULIN

SECRETION AFTER ENZYMATIC DIGESTION USING EDTA AS A

COLLAGENASE INHIBITOR

Soroush Sohrabi, Susan Stamp, Bob Peaston, Noel Carter and David Talbot;

Sunderland, United Kingdom and Newcastle, United Kingdom

> 08:20 O-33 NEURAL PROGENITORS DERIVED FROM HUMAN EMBRYONIC

STEM CELLS ARE TARGETED BY ALLOGENEIC T AND NATURAL

KILLER CELLS

Casimir de Rham, Olivier Preynat-Seauve, Sylvie Ferrari-Lacraz, Diderik

Tirefort, Karlheinz Krause and Jean Villard; Geneva, Switzerland

> 08:30 O-34 PROLONGATION OF COMPOSITE TISSUE ALLOGRAFT

SURVIVAL USING ALTERNATIVE ROUTES OF BONE MARROW

TRANSPLANTATION

Arkadiusz Jundzill, Aleksandra Klimczak, Erhan Sonmez, James Gatherwright

and Maria Siemionow; Cleveland, OH, United States

> 08:40 O-35 EFFECT OF CHIMERISM INDUCTION AFTER BONE

MARROW TRANSPLANTATION INTO ALTERNATIVE ANATOMICAL

COMPARTMENTS

Arkadiusz Jundzill, Erhan Sonmez, Aleksandra Klimczak, Grzegorz Brzezicki,

James Gatherwright and Maria Siemionow; Cleveland, OH, United States

> 08:50 O-36 HUMAN MESENCHYMAL STEM CELLS STIMULATE T-CELL

PROLIFERATION AND GENERATE REGULATORY LYMPHOCYTES THAT

INHIBIT ALLOREACTIVITY

Meindert J. Crop, Carla C. Baan, Sander S. Korevaar, Willem Weimar and

Martin J. Hoogduijn; Rotterdam, Netherlands


09:00

10:30

09:00

10:30

STATE OF THE ART

BASIC SCIENCE AND LIVER TRANSPLANTATION

Blue Amphitheatre

Regenerative medicine and stem cells

Chairs: Carla Baan, Rotterdam, The Netherlands

Patrizia Burra, Padua, Italy

> 09:00 Stem cell plasticity in the gut and liver: fact or fi ction?

Malcolm Alison, London, United Kingdom

> 09:20 The heterogenous pool of intrahepatic stem cells

Daniele Prati, Lecco, Italy

> 09:40 Ex-vivo engineering of liver tissue with adult stem cells

Carlos Semino, Barcelona, Spain

> 10:00 Clinical trial on stem cells as alternative or bridge to liver

transplantation

Stuart J. Forbes, Edinburgh, United Kingdom

> 10:20 Discussion

STATE OF THE ART

KIDNEY TRANSPLANTATION

Grand Amphitheatre

Long term renal dysfunction

Chairs: Josep Grinyo, Barcelona, Spain

Yvon Lebranchu, Tours, France

> 09:00 Chronic fi brosis: immune-mediated or not?

Dirk Kuypers, Leuven, Belgium

> 09:20 Lymphoid neogenesis and chronic rejection

Olivier Thaunat, Lyon, France

> 09:40 Appearamce of anti-donor specifi c antibodies and chronic

rejection

Frans Claas, Leiden, The Netherlands

> 10:00 New gene chip technology in the continuum of chronic rejection

Phillip Halloran, Edmonton, Canada

> 10:20 Discussion

66


09:00

10:30

11:00

13:00

STATE OF THE ART

INFECTIONS IN TRANSPLANTATION

Room Maillot

Chairs: Ulrich Frei, Berlin, Germany

Wojciech Rowinski, Warsaw, Poland

> 09:00 New emerging viruses in transplantation

Hans Hirsch, Basel, Switzerland

> 09:20 Viral hepatitis in the transplant patient

Stanislas Pol, Paris, France

> 09:40 Fungal and virus infection as surrogate markers of over

immunosuppression

Cecilia Söderberg-Nauclér, Stockholm, Sweden

> 10:00 HIV and transplantation

Didier Samuel, Paris, France

> 10:20 Discussion

PARALLEL SESSION 7

Room Maillot

Liver transplantation & tumors

Chairs: Pietro Majno, Geneva, Switzerland

Hans Schlitt, Regensburg, Germany

> 11:00 O-37 WITHDRAW

> 11:10 O-38 WITHDRAW

> 11:20 O-39 TRANSARTERIAL CHEMOEMBOLISATION BEFORE LIVER

TRANSPLANTATION: WHO DROPS OUT?

Gerd Otto, Maria Hoppe-Lotichius, Dagmar Laubert-Reh, Anja Lautem,

Fernandes Bittinger and Michael Pitton; Mainz, Germany

> 11:30 O-40 OPTIMIZATION OF LIVER TRANSPLANTATION FOR THE

TREATMENT OF LIVER HEPATOCELLULAR CARCINOMA RECURRENCE.

EXPERIENCE OF A SINGLE EUROPEAN CENTER

Gonzalo Sapisochin, Bilbao Itxarone, Joaquin Balsells, Cristina Dopazo,

Mireia Caralt, Laia Blanco, Amaia Gantxegi, Luis Castells, Jose Luis Lázaro,

Hellena Allende and Ramón Charco; Barcelona, Spain

> 11:40 O-41 PREDICTING RECURRENCE AFTER LIVER TRANSPLANTATION

IN PATIENTS WITH HEPATOCELLULAR CARCINOMA EXCEEDING THE

UP-TO-SEVEN CRITERIA

Francesco D’Amico, Myron Schwartz, Alessandro Vitale, Sasan Roayaie, Swan

Thung, Maria Guido, Juan del Rio Martin, Thomas Schiano and Umberto

Cillo; Padua, Italy and New York, United States

67

SCIENTIFIC

PROGRAMME


11:00

13:00

> 11:50 O-42 FROM MILAN-OUT TO MILAN-IN THROUGH AN AGGRESSIVE

DOWNSTAGING PRIOR TO TRANSPLANTATION FOR HCC SEEMS TO

BE AN EFFECTIVE STRATEGY

Alessandro Giacomoni, Andrea Lauterio, Abdallah Slim, Stefano Di Sandro,

Paolo Aseni, Vincenzo Pirotta, Mohamed Al Kofahi and Luciano De Carlis;

Milan, Italy

> 12:00 O-43 LIVER RESECTION VERSUS LIVER TRANSPLANTATION AS

TREATMENT OF EARLY HEPATOCELLULAR CARCINOMA: A CASE-

CONTROL STUDY

Roberto Montalti, Valentina Serra, Gianluca Rompianesi, Fabrizio Di

Benedetto, Nicola De Ruvo, Nicola Cautero, Roberto Ballarin, Rosa M.

Iemmolo, Stefano Busani, Gian Piero Guerrini and Giorgio E. Gerunda;

Modena, Italy

> 12:10 O-44 ESTIMATION OF THE HARM TO THE WAITING LIST AS CRUCIAL

FACTOR IN THE SELECTION OF PATIENTS WITH HEPATOCELLULAR

CARCINOMA FOR LIVER TRANSPLANTATION

Alessandro Vitale, Martina Gambato, Michael Volk, Alberto Brolese, Giacomo

Zanus, Francesco D’Amico, Daniele Neri, Marco Senzolo, Francesco Russo

and Umberto Cillo; Padua, Italy and Ann Arbor, MI, United States

> 12:20 O-45 SALVAGE TRANSPLANTATION AFTER LIVER RESECTION FOR

HEPATOCELLULAR CARCINOMA WITH CIRRHOSIS (HCC-CIR)

Rene Adam, Eric Vibert, Daniel Azoulay, Jean-Charles Duclos-Vallee, Faouzi

Saliba, Didier Samuel, Henri Bismuth and Denis Castaing; Villejuif, France

> 12:30 O-46 PROTEOMIC ANALYSIS OF NUCLEAR ENRICHED FRACTIONS

FROM HUMAN HEPATOCELLULAR CARCINOMA TISSUES

Umberto Baccarani, Erika Codarin, Claudio Avellini, Lory Crocè, Claudio

Tiribelli, Dario Lorenzin, Gian Luigi Adani, Franco Quadrifoglio, Andrea

Scaloni and Gianluca Tell; Udine, Italy

> 12:40 O-47 INCREASED RISK OF EARLY DE NOVO CANCER IN LIVER GRAFT

RECIPIENTS TRANSPLANTED IN RECENT YEARS

Angela S.W. Tjon, Jerome Sint Nicolaas, Jaap Kwekkeboom, Hugo W.

Tilanus, Geert Kazemier, Rob A. de Man, Luc J.W. van der Laan, Bettina E.

Hansen, Thanyalak Tha-In and Herold J. Metselaar; Rotterdam, Netherlands

PARALLEL SESSION 8

Room 242-AB

Novel pathways of recipient sensitization

Chairs: Martin Hoogduijn, Rotterdam, The Netherlands

Alain Le Moine, Brussels, Belgium

> 11:00 O-48 TARGETING THE NK CELL CYTOTOXICITY RECEPTOR NKP46

DELAYS ACUTE GRAFT REJECTION IN A MURINE MODEL OF HEART

TRANSPLANTATION

Cam-Tien Le, Katrin Klippert, Diana Stauch and Katja Kotsch; Berlin,

Germany

> 11:10 O-49 THE FATE AND FUNCTIONS OF NK CELL SUBSETS ARE

DIFFERENTIALLY REGULATED BY T-BET, EOMES, AND IL-15

Alexander H.K. Kroemer, Xiang Xiao, Karoline Edtinger, Gulcin Demirci and

Xian C. Li; Boston, MA, United States

68


69

SCIENTIFIC

PROGRAMME

> 11:20 O-50 ROLE OF ABC TRANSPORTERS (MDR1 AND MRPS) ON

DENDRITIC CELL MATURATION AND LYMPHOCYTE PROLIFERATION

AFTER HYPOXIA

Nuria Lloberas, Ines Rama, Linda Cassis, Ines Llaudó, Marcel•la Franquesa,

Joan Torras, Josep M. Cruzado, Oriol Bestard, Esther Castaño and Josep M.

Grinyó; Barcelona, Spain

> 11:30 O-51 RECIPIENT DCS GENERATE CYTOTOXIC AND ALLOANTIBODY

RESPONSES BY A NOVEL PATHWAY OF ALLOANTIGEN PRESENTATION

Sivasuriya Sivaganesh, Kourosh Saeb-Parsy, Reza Motalleb-Zadeh,

Christopher J. Callaghan, Thomas M. Conlon, Margaret C. Negus, Eleanor

M. Bolton, Andrew Bradley and Gavin J. Pettigrew; Cambridge, United

Kingdom

> 11:40 O-52 CYTOTOXIC CD8 T CELLS RECEIVE HELP FROM INDIRECT

PATHWAY CD4 T CELLS BY PRESENTING PROCESSED ALLOANTIGEN

ON MHC II

K. Saeb-Parsy, T.M. Conlon, A.L. Taylor, M. Negus, S.L. Negus, E.M. Bolton,

J.A. A. Bradley and G.J. Pettigrew; Cambridge, United Kingdom

> 11:50 O-53 IMPAIRED VARICELLA ZOSTER VIRUS (VZV) SPECIFIC IMMUNE

RESPONSE IN TRANSPLANT RECIPIENTS

Nicole M. van Besouw, George M.G.M. Verjans, Joke M. Zuijderwijk,

Annemarie L. Geel and Willem Weimar; Rotterdam, Netherlands

> 12:00 O-54 INTRA-GRAFT CD40 SILENCING SWITCHES IMMUNE RESPONSE

FROM HUMORAL TOWARDS CELLULAR REJECTION

Èlia Ripoll Llagostera, August Vidal Bel, Marcel•la Franquesa Bartolomé,

Joan Torras Ambrós, Josep Maria Grinyó Boira and Immaculada Herrero

Fresneda; Barcelona, Spain

> 12:10 O-55 AUTOANTIBODY AND CONVENTIONAL ALLOIMMUNITY

TOGETHER CONTRIBUTE TO DEVELOPMENT OF ALLOGRAFT

VASCULOPATHY

Ines Harper, Kourosh Saeb-Parsy, Thet Su Win, Martin Goddard, Eleanor

Bolton, Andrew Bradley and Gavin Pettigrew; Cambridge, United Kingdom

and Papworth Everard, United Kingdom

> 12:20 O-56 MYCOPHENOLIC ACID DISABLED HUMAN DENDRITIC CELLS

TO INDUCE ALLOGENEIC CYTOTOXIC CD8+ T CELLS THROUGH

INHIBITION OF INTERFERON GAMMA SYNTHESIS IN DENDRITIC

CELLS

Roxane Lemoine, Florence Velge-Roussel, Hubert Nivet, Yvon Lebranchu

and Christophe Baron; Tours, France

> 12:30 O-57 HUMAN MESENCHYMAL STEM CELLS ARE SUSCEPTIBLE FOR

LYSIS BY CYTOTOXIC IMMUNE CELLS

Meindert J. Crop, Sander S. Korevaar, Carla C. Baan, Ronella de Kuiper,

Nicole M. van Besouw, Willem Weimar and Martin J. Hoogduijn; Rotterdam,

Netherlands

> 12:40 O-58 ANTI-CD3 THERAPY INDUCES RAPID RENAISSANCE OF

B220LOW B LYMPHOCYTES FOLLOWING B-CELL DEPLETION BY

ANTI-CD20

Gordon D. Wu and Andrew S. Klein; Los Angeles, CA, United States


11:00

13:00

PARALLEL SESSION 9

Blue Amphitheatre

Long-term kidney graft survival parameters

Chairs: Hans Neumayer, Berlin, Germany

Kaija Salmela, Helsinki, Finland

> 11:00 O-59 CLINICAL VALIDITY OF TIME-ZERO BIOPSIES IN RENAL

ALLOGRAFT

Dong Jin Joo, Soo Jin Kim, Kyung Ock Jeon, Jong Hoon Lee, Kiil Park,

Soon Il Kim, Gi Hong Choi, Jinsub Choi and Yu Seun Kim; Seoul, Korea and

Goyang, Korea

> 11:10 O-60 EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES DIRECTLY

INFLUENCE PATIENT MANAGEMENT

A.O. Mahendran, M. Elvey, M. Mahendran, A.J. Howie, P. Dupont and P.S.

Veitch; London, United Kingdom

> 11:20 O-61 FOXP3 LEVELS PREDICT CLINICAL OUTCOME IN PATIENTS WITH

BORDERLINE CHANGE AFTER RENAL TRANSPLANTATION

Sébastien Homs, Hicham Mansour, Dominique Desvaux, Philippe Lang and

Philippe Grimbert; Créteil, France

> 11:30 O-62 A MODEL BASED ON DONOR FACTORS FOR PREDICTING

LONG TERM SURVIVAL OF LIVING RELATED RENAL TRANSPLANTS

Mirza Naqi Zafar, S.A. Anwar Naqvi and S. Adibul Hasan Rizvi; Karachi, Sindh,

Pakistan

> 11:40 O-63 LONG-TERM OUTCOME OF KIDNEY TRANSPLANTATION

FROM LIVING DONORS OLDER THAN 65 YEARS: A SINGLE CENTER

EXPERIENCE

Yasuo ishii, Kazuhiro iwado, Ichiro Nakajima, Shohei Fuchinoue and Satoshi

Teraoka; Tokyo, Japan

> 11:50 O-64 PRE-TRANSPLANT CELLULAR ALLOREACTIVITY IS PREDICTIVE

OF ACUTE GRAFT REJECTION AND LONG TERM GRAFT FUNCTION

IN KIDNEY TRANSPLANT RECIPIENTS

Katarzyna Koscielska-Kasprzak, Dominika Drulis-Fajdasz, Dorota Kaminska,

Oktawia Mazanowska, Magdalena Krajewska, Wojciech Bieniecki, Pawel

Chudoba, Wojciech Polak, Dariusz Janczak, Dariusz Patrzalek and Marian

Klinger; Wroclaw, Poland and Lodz, Poland

> 12:00 O-65 NATURAL HISTORY OF ISOLATED TRANSPLANT GLOMERULITIS

IN RENAL TRANSPLANTATION

David Buob, François Glowacki, Myriam Labalette, Emmanuel Boleslawaski,

Françoise Dufossé, Marie Christine Copin, Christian Noël and Marc Hazzan;

Lille, France

> 12:10 O-66 EARLY HIGH PULSE PRESSURE IS ASSOCIATED WITH GRAFT

DYSFUNCTION AND PREDICTS POOR KIDNEY ALLOGRAFT SURVIVAL

Fernando Vetromile, Ilan Szwarc, Valérie Garrigue, Sylvie Delmas and

Georges Mourad; Montpellier, France

> 12:20 O-67 SCREENING FOR GENETIC VARIATIONS IN THE KEY MOLECULE

OF TOLL LIKE RECEPTOR SIGNALING – IMPLICATIONS FOR RENAL

TRANSPLANT OUTCOMES

Andreas Walberer, Bernd Krüger, Michael Fischereder, Bernhard Banas and

Bernhard K. Krämer; Herne, Germany; Regensburg, Germany and München,

Germany

> 12:30 O-68 VASCULAR ENDOTHELIAL GROWTH FACTOR GENETIC

POLYMORPHISM AND CARDIOVASCULAR RISK IN RENAL

TRANSPLANT RECIPIENTS

Maria L. Cappuccilli, Gaetano La Manna, Elisa Persici, Laura Panicali, Diletta

Conte, Nicole Lanci, Serena Corsini, Giuseppe Cianciolo, Maria P. Scolari and

Sergio Stefoni; Bologna, BO, Italy

70


11:00

13:00

71

SCIENTIFIC

PROGRAMME

> 12:40 O-69 PREDICTION OF TRANSPLANT SUCCESS WITH SERUM

ANGIOPOIETIN-2 LEVELS MEASURED IN THE DONOR

Lyan G. Koudstaal, Cyril Moers, Hans Burgerhof, Andreas Paul, Jacques

Pirenne, Harry van Goor, Rutger J. Ploeg and Henri G.D. Leuvenink;

Groningen, Netherlands; Essen, Germany and Leuven, Belgium

PARALLEL SESSION 10

Room 241

Ethical, legal and psychosocial aspects of transplantation

Chairs: Bernadette J.J.M Haase-Kromwijk, Leiden, The Netherlands

Annika Tibell, Stockholm, Sweden

> 11:00 O-70 LEGAL PROHIBITION OF ORGAN COMMERCIALISM: DO WE

TAKE IT SERIOUSLY?

Michael Bos; The Hague, Netherlands

> 11:10 O-71 INFERIOR GRAFT SURVIVAL IN PATIENTS TRANSPLANTED

OVERSEAS: A SUMMARY OF UK DATA

Antonia J. Cronin, Rachel Johnson and Robert Lechler; Manchester, United

Kingdom; Bristol, United Kingdom and London, United Kingdom

> 11:20 O-72 ATTITUDES OF HEALTHCARE PROFESSIONALS AND

PATIENTS TOWARDS NON-DIRECTED DONATION (NDD) AND

COMMERCIALISATION OF LIVE DONOR KIDNEY TRANSPLANTATION

(LDKT)

Evangelos M. Mazaris, Anthony W. Warrens, Glenn Smith, Paris Tekkis and

Vassilios E. Papalois; London, United Kingdom

> 11:30 O-73 TRANSPLANT TOURISM FROM THE NETHERLANDS

Frederike Ambagtsheer, Willem Weimar, Willij Zuidema and Mike Bos;

Rotterdam, Netherlands and The Hague, Netherlands

> 11:40 O-74 LIVE DONOR KIDNEY TRANSPLANTATION (LDKT): ATTITUDES

TOWARDS DONOR APPROACH, MOTIVES AND FACTORS

PROMOTING DONATION

Evangelos M. Mazaris, Anthony W. Warrens, Glenn Smith, Paris Tekkis and

Vassilios E. Papalois; London, United Kingdom

> 11:50 O-75 FOLLOW-UP STUDY AMONG SAMARITAN DONORS:

MOTIVATION TO DONATE

Willij Zuidema, Emma K. Massey, Leonieke W. Kranenburg, Gert Hak, Ruud

A.M. Erdman, Medard T. Hilhorst, Jan N.M. Ijzermans and Willem Weimar;

Rotterdam, Netherlands

> 12:00 O-76 WHAT THE CHILD THINKS; CHILDREN’S OPINIONS ON ORGAN

DONATION

Marion J. Siebelink, H.B.M. van de Wiel, M.J.I.J. Albers and P.F. Roodbol;

Groningen, Netherlands

> 12:10 O-77 UK RELIGIOUS LEADERS UNITED IN THEIR SUPPORT FOR

ORGAN DONATION – THE FINDINGS FROM THE ORGAN DONATION

TASKFORCE

Gurch Randhawa; Luton, United Kingdom

> 12:20 O-78 THE “BLOOD GROUP 0 PROBLEM” IN RENAL TRANSPLANTATION

– TIME TO CHANGE?

Petra Glander, Danilo Schmidt, Florian Füller, Markus Giessing, Klemens

Budde, Hans H. Neumayer and Lutz Liefeldt; Berlin, Germany and Düsseldorf,

Germany


11:00

13:00

> 12:30 O-79 INTENSIVE PHYSICAL EXERCISE AFTER ORGAN

TRANSPLANTATION

Diethard Monbaliu, Glenn Vanhelleputte, Pieter Dauwen, Pieter Gillard, Bert

Bammens, Tom Cornelis, Sigmund Keuleers, Peter Hespel, Rik Gosselinck

and Jacques Pirenne; Leuven, Belgium

> 12:40 O-80 QUALITY OF LIFE AFTER LIVER TRANSPLANTATION IN

ESTABLISHED AND INDIVIDUAL SCALES

Martin Schenk, Kerstin Landgrebe, Christian Thiel, Karolin Thiel, Wolfgang

Steurer and Alfred Koenigsrainer; Tuebingen, Germany

PARALLEL SESSION 11

Room 252 AB

Viral infections tuberculosis in kidney transplantation

Chairs: Taieb Ben Abdallah, Tunis, Tunisia

Patrick Peters, Ghent, Belgium

> 11:00 O-81 IMPACT OF CONCURRENT HHV-6 AND HHV-7 INFECTION ON

CHRONIC ALLOGRAFT NEPHROPATHY DEVELOPMENT

Inese Folkmane, Svetlana Chapenko, Ieva Ziedina, Maxim Chistyakovs, Rafail

Rozental and Modra Murovska; Riga, Latvia

> 11:10 O-82 CMV MISMATCH DOES NOT AFFECT PATIENT AND ALLOGRAFT

SURVIVAL IN UK RENAL TRANSPLANT RECIPIENTS

Menna R. Clatworthy, Rachel Johnson, Rhiannon Birch, Abdul Hammed and

J. Andrew Bradley; Cambridge, United Kingdom; Bristol, United Kingdom

and Liverpool, United Kingdom

> 11:20 O-83 INTERACTION BETWEEN CMV/EBV VIRUSES AND DE NOVO

COLONIC TUMOUR AFTER KIDNEY TRANSPLANTATION

Gian Luigi Adani, Umberto Baccarani, Dario Lorenzin, Patrizia Tulissi,

Domenico Montanaro and Vittorio Bresadola; Udine, Italy

> 11:30 O-84 TUBERCULOSIS AFTER KIDNEY TRANSPLANTATION; SINGLE

CENTER EXPERIENCE IN ENDEMIC AREA

Dong Jin Joo, Soo Jin Kim, Kyung Ock Jeon, Jong Hoon Lee, Kiil Park, Jinsub

Choi, Soon Il Kim and Yu Seun Kim; Seoul, Korea and Goyang, Korea

> 11:40 O-85 SEVERE NOSOCOMIAL TUBERCULOSIS IN A KIDNEY

TRANSPLANT UNIT

Carlos Frangié, Cécile Thorette, Antonin Levy, François-Xavier Blanc, Nicolas

Fortineau, Antoine Jacquet, Hélène François, Séverine Beaudreuil, Antoine

Durrbach and Bernard Charpentier; Le Kremlin-Bicêtre, France

> 11:50 O-86 RENAL TRANSPLANTATION IN HIV INFECTED PATIENTS: THE

FRENCH EXPERIENCE

Maxime Touzot, Evangeline Pillebout, Jean-Paul Viard, Eric Rondeau, Michal

Delahousse, Christophe Legendre, Denis Glotz, Philippe Lang and Marie-

Noelle Peraldi; Paris, France; Suresnes, France and Créteil, France

> 12:00 O-87 INTRADERMAL INFLUENZA VACCINATION OF ADULT RENAL

TRANSPLANT RECIPIENTS: RANDOMISED CONTROLLED PHASE 2

TRIAL

Emmanuel Morelon, Claire Pouteil-Noble, Sameh Daoud, Remi Cahen, Jean-

Louis Touraine, Catherine Goujon-Henry, Françoise Weber, Pascal Laurent,

Dominique Kaiserlian and Jean-Francois Nicolas; Lyon, France; Pierre Bénite,

France and Marcy l’Etoile, France

72


11:00

13:00

73

SCIENTIFIC

PROGRAMME

> 12:10 O-88 DETECTION OF VIRAL NUCLEIC ACIDS IN RENAL GRAFT

PRESERVATION AND WASHING SOLUTIONS PREDICT THE

OCCURRENCE OF POST-TRANSPLANT INFECTIONS

Luisa Murer, Elisa Benetti, Manuela Della Vella, Giovanni Franco Zanon,

Piergiorgio Gamba, Giorgio Palù and Luisa Barzon; Padua, Italy

> 12:20 O-89 THE EFFECT OF PREOPERATIVE INTRAVESICAL AMIKACIN

SOLUTION IN THE PROPHYLAXIS OF URINARY TRACT INFECTION

AFTER RENAL TRANSPLANTATION

Mehdi Salehipour, Heshmatollah Salahi, Ali Bahador, Nikeghbalian Saman,

Kourosh Kazemi, Farzad Kakaei, Ali FathiKaljahi and Seyed Ali Malekhosseini;

Shiraz, Fars, Islamic Republic of Iran

> 12:30 O-90 SCREENING AND EARLY TREATMENT OF BK VIREMIA IMPROVES

THE OUTCOME AFTER KIDNEY TRANSPLANTATION

Amir Sedigh, Lars Wennberg, Gunnar Tydén and Jarmo Henriksson;

Stockholm, Sweden

> 12:40 O-91 POLYOMAVIRUS ASSOCIATED NEPHROPATHY TYPE B AND

LATE ACUTE CELLULAR REJECTION GRADE 1: MORPHOLOGICALLY

INDISTINGUISHABLE OR NOT?

Nadine Karremans, Maarten Naesens, Yves Vanrenterghem, Dirk R.J. Kuypers

and Evelyne Lerut; Leuven, Belgium

PARALLEL SESSION 12

Room 251

How can we make the heart beating better?

Chairs: Guenther Laufer, Innsbruck, Austria

Johan Van Cleemput, Leuven, Belgium

> 11:00 O-92 RISK FACTORS FOR POST-TRANSPLANTATION MALIGNANCY

IN HEART, LUNG AND HEART-LUNG TRANSPLANT RECIPIENTS

REPORTED BY UNOS 1988-2006

Andrew Brett, Cara R. Baker, Mohammed Morsy, Iain MacPhee, Jiri Fronek

and Nicos Kessaris; London, United Kingdom

> 11:10 O-93 LONG-TERM RESULTS OF COMBINED HEART AND KIDNEY

TRANSPLANTATION: A FRENCH MULTICENTER STUDY

Emmanuelle Vermes, Philippe Grimbert, Philippe Lang, Benoit Barrou, Jean

François Obadia, Laurent Sebbag, Alain Pavie, Claire Pouteil-Noble and

Mathias Kirsch; Créteil, France, Metropolitan; Créteil, France; Paris, France

and Lyon, France

> 11:20 O-94 DONOR CORONAROPATHY AND HEART TRANSPLANTATION:

IS THERE ANY INFLUENCE ON OUTCOME?

Giorgio Guzzi, Massimo Maiani, Vincenzo Tursi, Fabio Ius, Enrico Spagna,

Blanca Martinez, Maria Cecilia Albanese, Daniela MIANI and Ugolino Livi;

Udine, Italy

> 11:30 O-95 PRETRANSPLANT CYTOMEGALOVIRUS MISMATCH SEROLOGY

(D+/R-) IS A RISK FACTOR FOR MORTALITY DURING THE FIRST THREE

YEARS AFTER HEART TRANSPLANTATION

Entela Bollano, Bert Andersson, Bengt Rundqvist, Ulla Nyström, Vilborg

Sigurdardottir, Folke Nilsson and Nedim Selimovic; Gothenburg, Sweden


14:15

15:45

> 11:40 O-96 NT-PROBNP ASSAY MAY PRECLUDE THE NEED FOR ROUTINE

ENDOMYOCARDIAL BIOPSY TO DETECT CARDIAC ALLOGRAFT

REJECTION, BUT NOT EARLY AFTER TRANSPLANTATION

Maria José Rebocho, Carlos Aguiar, Marta Marques, Miguel Abecasis, José

Pedro Neves, João Figueira, Rosa Gouveia and João Melo; Carnaxide,

Portugal

> 11:50 O-97 STANDARD IN SURVEILLANCE ENDOMYOCARDIAL BIOSPY (EMB)

PROTOCOL IN THE FIRST MONTH AFTER HEART TRANSPLANTATION:

TIME FOR A REAPPRAISAL?

Antonio Gambino, Chiara d’Agostino, Gianluca Torregrossa, Giuseppe

Toscano, Giusppe Feltrin, Francesco Tona, Alessandra Andreotti, Annalisa

Angelini, Gaetano Thiene and Gino Gerosa; Padua, Italy

> 12:00 O98 PROGNOSTIC IMPACT OF NON-HLA ANTIBODIES

TARGETING VASCULAR RECEPTORS FOR THE DEVELOPMENT

OF MICROVASCULOPATHY IN BIOPSY AFTER HEART

TRANSPLANTATION

Nicola E. Hiemann, Christiane Renner, Rudolf Meyer, Ernst Wellnhofer,

Costanze Schoenemann, Heike Heidecke, Hans B. Lehmkuhl, Roland Hetzer

and Duska Dragun; Berlin, Germany and Luckenwalde, Germany

> 12:10 O-99 CORRELATING MICROARRAY GENE EXPRESSION DATA WITH

HISTOPATHOLOGICAL LESIONS IN HUMAN HEART ALLOGRAFT

BIOPSIES

Michael H. Mengel, Jessica Chang, Daniel Kim, Banu Sis, Thomas Mueller,

Jeffrey Burton, Wayne Tymchak and Philip F. Halloran; Edmonton, AB,

Canada and Edmonton, Canada

> 12:20 O-100 ADVANCED GLYCATION END-PRODUCTS IN PATHOLOGY OF

THE TRANSPLANTED HEART

Michael Zakliczynski, Jerzy Nozynski, Dominika Konecka-Mrowka and Marian

Zembala; Zabrze, Poland

> 12:30 O-101 PROTECTIVE EFFECTS OF N-ACETYLCYSTEINE AFTER

EXPERIMENTAL HEART TRANSPLANTATION

Zhanqing Li, Arash Nickkholgh, Xue Yi, Helge Bruns, Marie-Luise Gross,

Markus W. Büchler and Peter Schemmer; Heidelberg, Germany

> 12:40 O-102 ISCHEMIC TOLERANCE OF OLDER DONOR HEARTS IN A RAT

TRANSPLANTATION MODEL

Gábor Szabó, Shivakannan Loganathan, Achim Koch and Matthias Karck;

Heidelberg, Germany

PLENARY SESSION 2

JOINT SESSION ESOT & AST & ASTS

Grand Amphitheatre

Immunosuppression revisited

Chairs: Flavio Vincenti, AST Past-President, San Francisco, United States

Rutger J. Ploeg, ESOT Secretary General, Groningen, The Netherlands

> 14:15 The future of new anti B-cell agents

Mark Pescovitz, Indianapolis, United States

> 14:35 Anti-TNF therapies in high-risk renal allograft recipients

Petra Reinke, Berlin, Germany

74


16:00

18:00

> 14:55 Costimulatory blockade: Lessons from non-human primates

Stuart Knechtle, Atlanta, United States

> 15:15 Immunosuppression: Does one regimen fi t all?

Yves Vanrenterghem, Leuven, Belgium

> 15:35 Discussion

PARALLEL SESSION 13

Room Maillot

Infections in liver transplantation

Chairs: Lluis Castells, Barcelona, Spain

Didier Samuel, Paris, France

> 16:10 O-103 WEANING OF HBV PROPHYLAXIS AFTER LIVER

TRANSPLANTATION IS FEASIBLE IN THOSE PATIENTS TRANSPLANTED

FOR HEPATITIS B CIRRHOSIS WITH UNDETECTABLE CCCDNA IN

GRAFT TISSUE

Lenci Ilaria, Mario Angelico, Luca Toti, Tommaso Maria Manzia, Manuele

Berlanda, C.F. Perno, Daniele Di Paolo, Arianna Brega, Laura Tariciotti and

Giuseppe Tisone; Rome, Italy

> 16:20 O-104 OUTCOME OF LIVER TRANSPLANTATION IN HIV VERSUS

NON-HIV PATIENTS

Umberto Baccarani, Gian Luigi Adani, Marcello Tavio, Dario Lorenzin, Angela

Londero, Francesco Bragantini, Chiara Comuzzi, Anna Rossetto, Andrea

Risaliti, Claudio Avellini, Federico Pea, Vittorio Bresadola and Pierluigi Viale;

Udine, Italy

> 16:30 O-105 PROGNOSIS OF SEVERE RECURRENCE OF HCV INFECTION

AFTER LIVER TRANSPLANTATION IN A LARGE COHORT OF HIV

INFECTED PATIENTS

Teresa Maria Antonini, Anne-Marie Roque-Afonso, Mylene Sebagh, Bruno

Roche, Didier Samuel and Jean-Charles Duclos-Vallee; Villejuif, France

> 16:40 O-106 PEG-IFN-ALFA 2B WITH RIBAVIRIN FOR THE PREVENTION OF

HISTOLOGICAL FIBROSIS PROGRESSION IN PATIENTS WITH HCV

HEPATITIS RECURRENCE. A MULTICENTER RANDOMIZED

CONTROLLED STUDY. INTERIM REPORT

Luca S. Belli, Riccardo Volpes, Ivo Graziadei, Peter Starkel, Andy K. Burroughs,

Patrizia Burra, Stefano Fagiuoli, Alberto B. Alberti, Maria Guido, Luisa

Pasulo, Wolfgang Vogel, Bruno Gridelli, Umberto Cillo, Luciano De Carlis

and Giovambattista Pinzello; Milan, Italy; Palermo, Italy; Innsbruck, Austria;

Brussels, Belgium; London, United Kingdom; Padua, Italy and Bergamo,

Italy

> 16:50 O-107 ANTIVIRAL TREATMENT (AT) FOR HCV RECURRENCE

FOLLOWING LIVER TRANSPLANTATION: THE IMPACT ON FIBROSIS

PROGRESSION

Eleonora De Martin, Marco Senzolo, Francesca R. Ponziani, Raffaella Viganò,

Luca Belli, Giovambattista Pinzello, Michele Colledan, Francesca Donato,

Daniele Di Paolo, Mario Angelico, Maria Rendina, Maurizio Pompili, Antonio

Gasbarrini, Francesco P. Russo, Umberto Cillo and Stefano Fagiuoli; Padua,

Italy; Rome, Italy; Milano, Italy; Bergamo, Italy; Milan, Italy and Bari, Italy

> 17:00 O-108 IN VIVO PROTECTION AGAINST HCV BY BROADLY

NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES

Norman Kneteman, M. Law, T. Maruyama, J. Lewis and E. Giang; Edmonton,

AB, Canada; La Jolla, CA, United States and La Jolla, CA, United States

75

SCIENTIFIC

PROGRAMME


16:00

18:00

> 17:10 O-109 LONG TERM SURVIVAL AND FIBROSIS PROGRESSION

ANALYSIS IN RETRANSPLANTED PATIENTS FOR HCV RECURRENCE

Rodolphe Sobesky, Valerie Delvart, Paul Carrier, Teresa Maria Antonini, Bruno

Roche, Faouzi Saliba, Philippe Ichai, Daniel Azoulay, Rene Adam, Anne-Marie

Roque-Afonso, Mylene Sebagh, Catherine Guettier, Denis Castaing, Didier

Samuel and Jean-Charles Duclos-Vallee; Villejuif, France

> 17:20 O-110 GB-VIRUS-C VIREMIA AFTER LIVER TRANSPLANTATION IS

ASSOCIATED WITH BETTER 10-YEAR-SURVIVAL

Kinan Rifai, Heiner Wedemeyer, Juergen Klempnauer, Michael P. Manns and

Hans L. Tillmann; Hannover, Germany and Durham, United States

> 17:30 O-111 REEVALUATION OF RISK FACTORS OF FUNGAL INFECTION

AFTER LIVER TRANSPLANTATION (LT) WITHIN THE MELD ERA

Faouzi Saliba, Valerie Delvart, Philippe Ichai, Najiby Kassis, Francoise

Botterel, Marie Kouassi, Denis Castaing and Didier Samuel; Villejuif, France

and Le Kremlin Bicetre, France

> 17:40 O-112 EFFICACY AND LONG-TERM OUTCOME OF AMPHOTERICIN B LIPID

COMPLEX (ABLC) PROPHYLAXIS IN HIGH RISK LIVER TRANSPLANT

RECIPIENTS IN THE CURRENT PRACTICE

Faouzi Saliba, Valerie Delvart, Philippe Ichai, Najiby Kassis, Francoise

Botterel, Marie Kouassi, Daniel Azoulay, Rene Adam, Denis Castaing,

Stephane Bretagne and Didier Samuel; Villejuif, France; Le Kremlin Bicetre,

France and Creteil, France

> 17:50 O-113 RETROSPECTIVE COHORT INVESTIGATION OF RISK FACTORS

FOR SURGICAL SITE INFECTION AFTER LIVER TRANSPLANTATION

Walter C. Hellinger, Michael G. Heckman, Hani P. Grewal, Winston R. Hewitt,

Christopher B. Hughes, C. Burcin Taner, Darrin L. Willingham and Justin H.

Nguyen; Jacksonville, FL, United States and Atlanta, GA, United States

PARALLEL SESSION 14

Room 241

Operational tolerance: approaches & mechanisms

Chairs: Gilles Blancho, Nantes, France

Katja Kotsch, Berlin,Germany

> 16:10 O-114 HUMAN MACROPHAGES DRIVEN TO A NOVEL STATE OF

ACTIVATION SUPPRESS T CELL RESPONSES IN VITRO

Paloma Riquelme, James A. Hutchinson, Fred Fändrich and Edward K.

Geissler; Regensburg, Germany and Kiel, Germany

> 16:20 O-115 THE ROLE OT LT&R SIGNALING IN THE FORMATION OF

ECTOPIC LYMPHOID TISSUE WITHIN CARDIAC ALLOGRAFTS

Reza Motallebzadeh, Sylvia Rehakova, Thet Su Win, Chris Callaghan, Siva

Sivaganesh, Eleanor Bolton, Nancy Ruddle, Andrew Bradley and Gavin

Pettigrew; Cambridge, United Kingdom and New Haven, United States

> 16:30 O-116 CRITICAL ROLE OF NEWLY IDENTIFIED CD4+CD25++CD45RA+

NAIVE REGULATORY T CELLS IN OPERATIONAL TOLERANCE AFTER

PEDIATRIC LIVING-DONOR LIVER TRANSPLANTATION

Hanaa Abdelhakeem Nafady-Hego, Ying Li, Shimon Sakaguchi, Kathryn

Wood, Shinji Uemoto and Takaaki Koshiba; Kyoto, Japan and Headington,

Oxford, United Kingdom

76


77

SCIENTIFIC

PROGRAMME

> 16:40 O-117 ADOPTIVE TRANSFER OF EX VIVO DONOR ALLOANTIGEN-

STIMULATED CD4+CD25++ REGULATORY T CELLS AMELIORATES

REJECTION OF LUNG TRANSPLANTATION BETWEEN FULLY

MISMATCHED MINIATURE SWINES

Naoki Satoda, Ying Li, Tsuyoshi Shoji, Xiangdong Zhao, Hiroyuki Kanazawa,

Hidenori Ohe, Toru Bando, Junichi Tottori, Shimon Sakaguchi, Eiji Kobayashi,

Shinji Uemoto, Hiromi Wada, Hiroshi Date and Takaaki Koshiba; Kyoto,

Japan; Isa, Kagoshima, Japan and Shimono, Tochigi, Japan

> 16:50 O-118 SELECTIVE CD28 BLOCKADE SYNERGIZES WITH REGULATORY

T CELL ACTIVITY IN A CTLA-4 DEPENDENT MANNER

Nahzli Dilek, Nicolas Poirier, Philippe Hulin, Bernard Vanhove and Gilles

Blancho; Nantes, France

> 17:00 O-119 BONE MARROW DERIVED MESENCHYMAL STEM CELLS

ATTENUATE RENAL ALLOGRAFT INJURY AFTER PROLONGED COLD

ISCHEMIA

Yoshiaki Hara, Meaghan Stolk, Maria Dams, Elke Effenberger, Juliane

Ladhoff, Katja Kotsch, Anja Reutzel-Selke, Hans-Dieter Volk and Martina

Seifert; Berlin, Germany

> 17:10 O-120 THE REGULATORY FUNCTION OF TOLEROGENIC

CD8+CD45RCLOW T CELLS IS INFLUENCED BY CELL CONTACT WITH

NAIVE CD4+CD25- T CELLS

Xian Liang Li, Séverine Ménoret, Dominique Chabannes, Marcelo Hill, Claire

Usal, Régis Josien and Ignacio Anegon; Nantes, France

> 17:20 O-121 MYCOPHENOLIC ACID-INDUCED REGULATORY CD4+ T CELLS

CONFER TOLEROGENIC PROPERTIES TO HUMAN DENDRITIC CELLS

Roxane Lemoine, Florence Velge-Roussel, Hubert Nivet, Yvon Lebranchu

and Christophe Baron; Tours, France

> 17:30 O-122 LIVER SINUSOIDAL ENDOTHELIAL CELLS TOLERIZE B CELLS

SPECIFIC FOR BLOOD GROUP CARBOHYDRATE ANTIGENS AFTER

ABO-INCOMPATIBLE LIVER TRANSPLANTATION

Yuka Igarashi, Toshimitsu Irei, Masataka Bansyodani, Yuka Tanaka and Hideki

Ohdan; Hiroshima, Japan

> 17:40 O-123 TH17 AND REGULATORY T CELLS RELATIONSHIP DURING

ALLOGRAFT REJECTION

Louis-Marie Charbonnier, Benoit Vokaer, Fleur S. Benghiat, Michel Y. Braun,

Michel Goldman and Alain Le Moine; Brussels, Belgium

> 17:50 O-124 INHIBITION OF TLR-STIMULATED NK CELLS CYTOTOXICITY: A

NOVEL IMMUNOREGULATORY FUNCTION OF MESENCHYMAL STEM

CELLS

Massimo Giuliani, Noufi ssa Oudrhiri, Amelia Vernochet, Simone Negrini,

Bernard Charpentier, Annelise Bennaceur and Antoine Durrbach; Villejuif,

France


16:00

18:00

PARALLEL SESSION 15

Room 251

Deceased donation: procurement, allocation, safety

& best practise

Chairs: Benoit Barrou, Paris, France

Günter Kirste, Frankfurt, Germany

> 16:10 O-125 CRITICAL CARE STAFFS’ ATTITUDES TO ORGAN DONATION

IMPACT ON NATIONAL DONATION FIGURES – DATA FROM THE

DONOR ACTION DATABASE

Leo Roels, Caroline Spaight, Jacqueline Smits and Bernard Cohen; Linden,

Belgium and Leiden, Netherlands

> 16:20 O-126 KIDNEY, KIDNEY-PANCREAS AND LIVER-KIDNEY

TRANSPLANTATION IN HIV INFECTED INDIVIDUALS: THE ITALIAN

EXPERIENCE

P.A. Grossi, C. De Cillia, S. Venettoni, L. Rizzato, D. Donati, D. Dalla

Gasperina, M. Tozzi, S. Sandrini, U. Boggi, P. Castelli, S.M. Giulini, P. Gerunda,

F. Bresadola, L. Lazzaroni, A. Vaglio, R Dionigi and A. Nanni Costa; Varese,

Italy; Rome, Italy; Brescia, Italy; Pisa, Italy; Modena, Italy; Udine, Italy and

Parma, Italy

> 16:30 O-127 VIROLOGICALLY COMPROMISED DECEASED ORGAN DONORS

IN THE UNITED KINGDOM

Sonia J. Wakelin, James J. Powell, Mark Jones, Rachel Johnson and John

L.R. Forsythe; Edinburgh, United Kingdom and Bristol, United Kingdom

> 16:40 O-128 HBV AND HBC POSITIVE ORGAN GRAFTS IN FRANCE

François Lamy, Fabienne Pessione, Aurélie Deshayes, Hervé Creusveaux,

Marina Roche, Marie Thuong and Bernard Loty; Saint-Denis La Plaine,

France

> 16:50 O-129 A UK REGISTRY STUDY OF THE INCIDENCE OF TRANSMISSION

OF INTRACRANIAL MALIGNANCY

rebecca roberts, karen wright, david greenberg, claire hamilton, Dave Collett

and Christopher Watson; Cambridge, United Kingdom and Bristol, United

Kingdom

> 17:00 O-130 GENDER-BASED DISPARITIES IN ACCESS TO LIVER

TRANSPLANTATION FROM THE WAITING LIST

Amit K. Mathur, Douglas E. Schaubel, Qi Gong, Mary K. Guidinger and

Robert M. Merion; Ann Arbor, MI, United States

> 17:10 O-131 EXPERIENCE OF A HIGH VOLUME LIVER TRANSPLANTATION

CENTER WITH THE INTRODUCTION OF THE MELD ALLOCATION

SYSTEM IN EUROPE (EUROTRANSPLANT COLLABORATIVE REGION)

Frank Ulrich, Panagiotis Fikatas, Michael Hippler-Benscheidt, Andreas

Pascher, Gero Puhl, Olaf Guckelberger, Ulf Neumann, Peter Neuhaus and

Johann Pratschke; Berlin, Germany

> 17:20 O-132 KIDNEY DONATION AND TRANSPLANTATION IN

EUROTRANSPLANT: MINIMIZING DISCARD RATES BY USING A

RESCUE ALLOCATION POLICY

Maurits T. Vinkers, Jacqueline M. Smits, Ineke C. Tieken, Jan de Boer, Hans

de Fijter, Dirk Ysebaert and Axel Rahmel; Leiden, Netherlands and Antwerp,

Belgium

> 17:30 O-133 PREEMPTIVE CADAVERIC RENAL TRANSPLANTATION:

FAIRNESS AND UTILITY IN THE CASE OF HIGH DONATION RATE

Elisabetta Bertoni, Giuseppina Rosso, Aida Larti, Alberto Rosati and Maurizio

Salvadori; Florence, Italy

78


16:00

18:00

79

SCIENTIFIC

PROGRAMME

> 17:40 O-134 INCREASING THE DONOR POOL BY THE USE OF A LUNG

DONOR QUALITY SCORE

Jacqueline M. Smits, Wim Van der Bij, Dirk Van Raemdonck, Maurits Vinkers

and Axel Rahmel; Leiden, Netherlands; Groningen, Netherlands and Leuven,

Belgium

> 17:50 O-135 HOW EFFECTIVE IS A THEORY-BASED INTERVENTION TO

INCREASE ADOLESCENTS’ INTENTION TO REGISTER AS A DONOR?

Fabienne Dobbels, Frank Van Gelder and Jacques Pirenne; Leuven,

Belgium

PARALLEL SESSION 16

Room 252 AB

Risk factors, mechanisms & treatment of kidney

humoral rejection

Chairs: Menna Clatworthy, Cambridge, United Kingdom

Willem Weimar, Rotterdam, The Netherlands

> 16:10 O-136 EXPERIENCE WITH 50 CONSECUTIVE ABO INCOMPATIBLE

KIDNEY TRANSPLANTATIONS AT THE KAROLINSKA UNIVERSITY

HOSPITAL

Gunnar Tydén, Gunilla Kumlien, Helena Genberg, Mats Efvergren, John

Sandberg, Johan Nordström, Amir Sedigh, Lars Wennberg and Henrik

Gjertsen; Stockholm, Sweden

> 16:20 O-137 NATIONAL REGISTRY OF ANTIBODY INCOMPATIBLE RENAL

TRANSPLANTATION, 2001-2008: PRELIMINARY ANALYSIS

Rachel Johnson, Rob Higgins, Susan Fuggle, David Taube, Jack Galliford,

Nizam Mahmode and Andrew Bradley; Bristol, United Kingdom; Coventry,

United Kingdom and London, United Kingdom

> 16:30 O-138 THE EVALUATION OF TWO DIFFERENT PRECONDITIONING

REGIMENS FOR ABO-INCOMPATIBLE LIVING KIDNEY DONOR

TRANSPLANTATION. A COMPARISON OF SPLENECTOMY VS.

RITUXIMAB-TREATED NON-SPLENECTOMY PRECONDITIONING

REGIMENS

Toshihito Hirai, Hideki ishida, Yuuki Miyauchi, Tomokazu Shimizu, Hiroki

Shirakawa, Kazuya Omoto and Kazunari Tanabe; Shinjuku-ku, Tokyo, Japan

> 16:40 O-139 ABO INCOMPATIBLE TRANSPLANTATION WITHOUT RITUXIMAB

OR SPLENECTOMY - EXCELLENT CLINICAL AND HISTOLOGICAL

OUTCOMES BEYOND 12 MONTHS

Shlomo (Solomon) J. Cohney, Rowan G. Walker, Gavin Becker, Rosemary

Masterson, Amanda Robertson and Shaun Flint; Melbourne, VC, Australia

> 16:50 O-140 PRESENSITIZED KIDNEY GRAFT RECIPIENTS WITH HLA CLASS

I AND II ANTIBODIES ARE AT INCREASED RISK OF GRAFT FAILURE. A

COLLABORATIVE TRANSPLANT STUDY REPORT

Caner Süsal, Bernd Döhler and Gerhard Opelz; Heidelberg, Germany

> 17:00 O-141 NATURAL HISTORY OF SUBCLINICAL ANTIBODY-MEDIATED

REJECTION (SAMR) IN KIDNEY TRANSPLANT RECIPIENTS WITH

DONOR SPECIFIC ANTIBODIES (DSA)

A. Loupy, C. Suberbielle, G. Hill, C. Lefaucheur, D. Anglicheau, J. Zuber, Mo

Timsit, F. Martinez, E. Thervet, P. Bruneval, C. Legendre and D. Nochy; Paris,

France


16:00

18:00

> 17:10 O-142 PREFORMED DONOR-SPECIFIC ANTIBODIES BY SINGLE

ANTIGEN BEADS WITH A HIGH TITER ARE THE BEST PREDICTOR FOR

HUMORAL REJECTION AFTER KIDNEY TRANSPLANTATION

Sebastian Riethmüller, Thomas Fehr, Barbara Rüsi, Carine Hadaya, Jean

Villard and Sylvie Ferrari; Zurich, Switzerland and Geneva, Switzerland

> 17:20 O-143 ACUTE HLA ANTIBODY-MEDIATED REJECTION: CELLULAR

INFILTRATION OF RENAL ALLOGRAFTS BY NEUTROPHILS AND

CD3+VE CELLS

Rob Higgins, Klaus Chen, Daniel Zehnder, Rizwan Hamer, Nithya Krishnan,

Habib Kashi, Chris Imray, Lam Chin Tan, For T. Lam, Dave Lowe and David

Briggs; Coventry, United Kingdom and Birmingham, United Kingdom

> 17:30 O-144 COMPARATIVE STUDY OF LIVING RELATED-DONOR/SPOUSAL-

DONOR KIDNEY TRANSPLANTATION AND TRANSPLANTATION WITH/

WITHOUT DESENSITIZATION BY RITUXIMAB. SINGLE-CENTER ANALYSIS

OF THE INCIDENCE OF ACUTE REJECTION

Toshihito Hirai, Hideki Ishida, Junpei Iizuka, Daisuke Tokita, Houichi Shimizu,

Hiroki Shirakawa, Kazuya Omoto and Kazunari Tanabe; Shinjuku-ku, Tokyo,

Japan

> 17:40 O-145 THE EFFECT OF SIMVASTATIN ON DESENSITIZATION OF

PANEL-POSITIVE KIDNEY TRANSPLANT CANDIDATES

Jamshid Roozbeh, Azar Sattarinezhad, Mohammad Mehdi Sagheb, Ahad

Eshraghian, Ghanbarali Raeesjalali, Saeed Behzadi, Heshmatollahi Salahi, Ali

Bahador, Saman Nikeghbalian and Seyed Ali Malek-hosseini; Shiraz, Fars,

Islamic Republic of Iran

> 17:50 O-146 A MESF OF GREATER THAN 1.2 FOR DONOR B-CELL

REACTIVITY AS DETECTED BY FLOW CYTOMETRY IS ASSOCIATED

WITH A SIGNIFICANTLY HIGHER BPAR RATE IN THE FIRST 6 MONTHS

POST RENAL TRANSPLANTATION

Yasha Johari, David Bryson, Terry Horsborough and Michael L. Nicholson;

Leicester, Leicestershire, United Kingdom

PARALLEL SESSION 17

Room 242-AB

Liver transplantation: immunobiology, genetics,

infl ammations & bioartifi cial devices

Chairs: Umberto Baccarani, Udine, Italy

Francesco Paolo Russo, Padua, Italy

> 16:10 O-147 GRAFT FIBROSIS IN OPERATIONALLY TOLERANT PATIENTS

AFTER LIVER TRANSPLANTATION; ANTIGEN-DEPENDENT OR

INDEPENDENT?

Hidenori Ohe, Hiroto Egawa, Aya Miyagawa, Hironori Haga, Shinya Okamoto,

Shinji Uemoto and Takaaki Koshiba; Kyoto, Japan

> 16:20 O-148 IMPACT OF “SINUSOIDAL/PARENCHYMAL RELAXATION” ON

MICROCIRCULATORY PERFUSION FAILURE IN HEPATIC ISCHEMIA/

REPERFUSION

Koichiro Hata, Rene H. Tolba, Shunichi Saito, Tomohide Hori, Shintaro Yagi,

Yuzo Yamamoto and Shinji Uemoto; Kyoto, Japan; Bonn, Germany; Aachen,

Germany and Akita, Japan

80


81

SCIENTIFIC

PROGRAMME

> 16:30 O-149 VIABILITY ASSESSMENT OF HUMAN LIVERS BY RELEASE OF

AST DURING HYPOTHERMIC MACHINE PERFUSION

Qiang Liu, Katrien Vekemans, Veerle Heedfeld, Tine Wylin, John Brassil,

Peter Demuylder, Bert Theunis, Jonathan Vercruysse, Jos van Pelt, Jacques

Pirenne and Diethard Monbaliu; Leuven, Belgium and Zaventem, Belgium

> 16:40 O-150 MITOCHONDRIAL FUNCTION DURING ISCHAEMIA-

REPERFUSION IN DCD LIVERS

Debabrata Roy, Karl Morten, Constantin Coussious, Reza Morovat, Jens

Brockman and Peter J. Friend; Oxford, United Kingdom

> 16:50 O-151 ROLE OF HIPOXIA INDUCIBLE FACTOR (HIF) IN FATTY LIVER

PRESERVATION: AN EX VIVO APPROACH USING IGL-1 SOLUTION

Amine Zaouali, Ismail Ben Mosbah, Hassen Ben Abdennebi, Olivier Boillot,

Joan Rosello-Catafau and Carmen Peralta; Barcelona, Spain; Monastir,

Tunisia and Lyon, France

> 16:00 O-152 IMPACT OF CCR5Δ32 MUTATION ON ISCHEMIC TYPE BILIARY

LESIONS AFTER LIVER TRANSPLANTATION

Ines Ruth, Maria Hoppe-Lotichius, Christian Mönch and Gerd Otto; Mainz,

Germany and Frankfurt, Germany

> 17:10 O-153 TUMOR NECROSIS FACTOR ALPHA-INHIBITORS AS

IMMUNOMODULATORY ANTI-REJECTION AGENTS IN INTESTINAL

TRANSPLANTATION

Undine A. Gerlach, Sven Kohler, Peter Neuhaus, Johann Pratschke and

Andreas Pascher; Berlin, Germany

> 17:20 O-154 DIFFERENTIAL GENE EXPRESSION PROFILE IN BIOMODULATED

LIVERS AFTER NON-HEART BEATING TRANSPLANTATION

Katrien Vekemans, Diethard Monbaliu, Veerle Heedfeld, Hannah van

Malenstein, Erica Balligand, Qiang Liu, Tine Wylin, Paul van Hummelen,

Jacques Pirenne and Jos van Pelt; Leuven, Belgium

> 17:30 O-155 DIFFERENTIAL GENE EXPRESSION PROFILE IN WARM

ISCHEMIA PORCINE LIVERS

Katrien Vekemans, Erica Balligand, Qiang Liu, Hannah van Malenstein,

Diethard Monbaliu, Veerle Heedfeld, Tine Wylin, Paul Van Hummelen,

Jacques Pirenne and Jos van Pelt; Leuven, Belgium

> 17:40 O-156 PORCINE MODEL OF EXTRA-CORPOREAL MEMBRANE

OXYGENATION (ECMO) IN THE UNCONTROLLED NON-HEART

BEATING DONOR (NHBD); THE EFFECT ON LIVER VIABILITY

Aditya Kanwar, Christopher Ray, Stephen Ray, Mohamed Saleem

Noormohamed, Susan Stamp, Soroush Sohrabi, Alex Navarro, Hugh Wyrley-

Birch, Brian Shenton, Anne Cunningham, Noel Carter, Steve White, Jon Smith

and David Talbot; Newcastle Upon Tyne, United Kingdom and Sunderland,

United Kingdom

> 17:50 O-157 CONSTRUCTION OF AN IN VIVO UTILIZING BIO-ARTIFICIAL

LIVER BASED ON HEPATIC CELLS AND DECELLULARIZED LIVER

MATRIX

Ji Bao, Yujun Shi, Huaiqiang Sun, Hong Bu and Youping Li; Chengdu, Sichuan,

China


16:00

18:00

PARALLEL SESSION 18

Blue Amphitheatre

Improving donor kidney quality palliation of I/R

injury

Chairs: John L.R Forsythe, Edinburgh, United Kingdom

Peter Schnuelle, Heidelberg, Germany

> 16:10 O-158 MACHINE PERFUSION VERSUS COLD STORAGE

PRESERVATION IN NON-HEART-BEATING KIDNEY DONATION AND

TRANSPLANTATION: FIRST RESULTS OF A MULTICENTRE TRIAL IN

EUROTRANSPLANT

Jacques Pirenne, Jacqueline M. Smits, Cyril Moers, Mark-Hugo J. Maathuis,

Jürgen Treckmann, Bogdan P. Napieralski, Margitta van Kasterop-Kutz, Jaap

J. Homan van der Heide, Ernst van Heurn, Günter R. Kirste, Axel Rahmel,

Henri G.D. Leuvenink, Andreas Paul, Diethard Monbaliu, Ina Jochmans, Jean-

Paul Squiffl et and Rutger J. Ploeg; Leuven, Belgium; Leiden, Netherlands;

Groningen, Netherlands; Essen, Germany; Maastricht, Netherlands;

Frankfurt, Germany and Liège, Belgium

> 16:20 O-159 GST AND HFABP VALUES DURING MACHINE PERFUSION

OF DECEASED DONOR KIDNEYS ARE INDEPENDENT PREDICTORS

OF DELAYED GRAFT FUNCTION, BUT NOT OF PRIMARY NON-

FUNCTION AND GRAFT SURVIVAL

Cyril Moers, Oana C. Varnav, Jürgen Treckmann, Diethard Monbaliu, Gerhard

Rakhorst, Andreas Paul, Jacques Pirenne, Henri G.D. Leuvenink and Rutger

J. Ploeg; Groningen, Netherlands; Essen, Germany and Leuven, Belgium

> 16:30 O-160 DONOR EMPLOYMENT OF DESMOPRESSIN (DDAVP) IS

ASSOCIATED WITH SUPERIOR LONG-TERM ALLOGRAFT SURVIVAL,

BUT HAS NO EFFECT ON DELAYED GRAFT FUNCTION AFTER KIDNEY

TRANSPLANTATION

Uwe Gottmann, Urs Benck, Hui Song, Simone Hoeger, Benito Yard and Peter

Schnuelle; Mannheim, Germany

> 16:40 O-161 IMMEDIATE DOPPLER ULTRASONOGRAPHY AFTER KIDNEY

TRANSPLANT CAN HELP TO RESCUE THE GRAFT

Alireza Hamidian Jahromi, Nicos Kessaris, Rene Chang, Eric Chemla, Helen

Gregson, Mohamed Morsy and Jiri Fronek; London, United Kingdom

> 16:50 O-162 THE WEAK SPOT OF ISCHEMIA REPERFUSION INJURY:

THROMBIN INHIBITION RESCUES CHRONIC KIDNEY INFLAMMATION

AND FIBROSIS

Frederic Favreau, Raphael Thuillier, Olivier Page, Lilach O. Lerman and

Thierry Hauet; Poitiers, France; Rochester, MN, United States and France

> 17:00 O-163 MINIMALLY INVASIVE ROBOTIC ASSISTED RENAL

TRANSPLANTATION - THE INITIAL 5 CASES

Stuart Geffner, Harry Sun, Shamkant Mulgaonkar, Francis Weng and Erin

Vermeulen; Livingston, NJ, United States

> 17:10 O-164 STRATEGIES TO IMPROVE THE QUALITY OF ORGANS FROM

DCD

Rui Maio, Nuno Figueiredo, Isa Santos, Christoph Thiemermann, Helder Mota-

Filipe and Paulo Costa; Lisboa, Portugal and London, United Kingdom

> 17:20 O-165 ATORVASTATIN PROTECTS AGAINST REPERFUSION INJURY

IN THE RAT KIDNEY THROUGH DIRECT INHIBITION OF ACTIVE

CASPASE-3

John L. Haylor, Kevin P.G. Harris, Michael L. Nicholson, Helen L. Waller and

Bin Yang; Sheffi eld, United Kingdom and Leicester, United Kingdom

82


83

SCIENTIFIC

PROGRAMME

> 17:30 O-166 BRAIN DEATH PREDISPOSES THE KIDNEY TO A PRO

INFLAMMATORY RESPONSE UPON REPERFUSION

Dorottya K. de Vries, Jan H.N. Lindeman, Jan Ringers, Ton J. Rabelink and

Alexander F.M. Schaapherder; Leiden, Netherlands

> 17:40 O-167 THE PHYSIOLOGICAL EFFECTS OF HYDROGEN SULPHIDE ON

ISCHAEMIA REPERFUSION INJURY IN DONATION AFTER CARDIAC

DEATH KIDNEYS

Sarah A. Hosgood, Phillip J. Yates and Michael L. Nicholson; Leicester,

Leicestershire, United Kingdom

> 17:50 O-168 IMMUNOLOGIC CAMOUFLAGE AND EXTRACELLULAR

COMPOSITION PROTECTS AGAIN ISCHEMIA REPERFUSION INJURY

AND ALLOGRAFT FIBROSIS

Emilie Manguy, Raphael Thuillier, Giraud Sebastien, Frederic Favreau, Jean-

Michel Goujon, Thibeau Desurmont, Michel Eugene and Thierry Hauet;

Poitiers, France and France


PROGRAMME OVERVIEW

8:00

8:15

8:30

8:45

9:00

9:15

9:30

9:45

10:00

10:15

10:30

10:45

11:00

11:15

11:30

11:45

12:00

12:15

12:30

12:50

13:00

13:15

13:30

13:45

14:00

14:15

14:30

14:45

15:00

15:15

15:30

15:45

16:00

16:10

16:30

16:45

17:00

17:10

17:30

17:45

18:00

18:15

18:30

18:45

19:00

19:15

19:30

19:45

20:00

20:15

20:30

20:45

21:00

23:00

State-ofthe-Art

Pancreas &

Islet Transplantation

Maillot

p 89

Tuesday, September 1 st

Parallel Sessions

19-24

84

State-ofthe-Art

Quality & Safety

of organs

Coffee Break

Parallel Sessions

25-30

BMS NOVARTIS IGL ELITA

General

Parallel Satellite Symposia Assembly

p 230 p 230 p 231 p 43

Grand Amphi

Grand Amphi

p 90

Plenary Session 3

State-ofthe-Art

ELPAT

KDIGO

Workshop

The emerging role of t cells in transplantation

Coffee Break

Parallel Sessions

31-36

ESOT General Assembly

Blue Amphitheatre

WYETH

Plenary Satellite Symposium

VIROPHARMA

Night Satellite Symposium

Blue Amphi

p 85-89

p 90

p 91-98

Blue Amphi Maillot 241

p 55

252-AB

Grand Amphitheatre

Grand Amphitheatre

Pavillon Gabriel

p 98

p 99-103

p 34

p 231

p 231


08:00

09:00

08:00

09:00

PARALLEL SESSION 19

Room 241

Experimental & Clinical islet transplantation

Chairs: Thierry Berney, Geneva, Switzerland

François Pattou, Lille, France

> 08:00 O-169 WITHDRAW

85

SCIENTIFIC

PROGRAMME

> 08:10 O-170 IN VITRO XENOGENEIC IBMIR IS MORE AGGRESSIVE THAN

ALLOGENEIC AND IS MEDIATED BY CLASSICAL AND ALTERNATIVE

COMPLEMENT PATHWAYS

Dirk J. van der Windt, Jing He, David K.C. Cooper, Massimo Trucco and Rita

Bottino; Pittsburgh, PA, United States

> 08:20 O-171 PRO-INFLAMMATORY CYTOKINE MEDIATED DYSFUNTION IN

CULTURED RAT ISLETS IS PREVENTED BY IL-1RA TREATMENT

Alice Schwarznau, Matthew S. Hanson, Jamie Sperger, Brian R. Schram, Juan

S Danobeitia, Krista Greenwood, Ashwanth Vijayan and Luis A. Fernandez;

Münster, Germany and Madison, WI, United States

> 08:30 O-172 QUANTIFICATION OF TRANSPLANTED IRON OXIDE-LABELLED

ISLET CELLS BY 3-DIMENSIONAL 3T MAGNETIC RESONANCE

IMAGING (MRI)

Frederic Ris, Lindsey Crowe, Phillipe Morel, Mathieu Armanet, Solange

Masson, Sonia Nielles-Vallespin, Domenico Bosco, Peter Speier, Jean-Paul

Vallee and Thierry Berney; Geneva, Switzerland and Erlangen, Germany

> 08:40 O-173 2009 UPDATE FROM THE COLLABORATIVE ISLET TRANSPLANT

REGISTRY

Francois Pattou, Rodolfo Alejandro, Franca B. Barton, Bernard J. Hering,

Steeve Wease and CITR Investigators; Lille, France; Miami, United States;

Rockville, MD, United States and Minneapolis, United States

> 08:50 O-174 DIFFERENCES IN BASELINE LYMPHOCYTE COUNTS AND

AUTOREACTIVITY ARE ASSOCIATED WITH DIFFERENCES IN

OUTCOME OF ISLET CELL TRANSPLANTATION IN TYPE 1 DIABETIC

PATIENTS

Robert Hilbrands, Volkert A.L. Huurman, Pieter Gillard, Jurjen H.L. Velthuis,

Marc De Waele, Chantal Mathieu, Leonard Kaufman, Miriam Pipeleers-

Marichal, Babak Movahedi, Daniel Jacobs-Tulleneers-Thevissen, Diethard

Monbaliu, Dirk Ysebaert, Frans K. Gorus, Bart O. Roep, Daniel G. Pipeleers

and Bart Keymeulen; Brussels, Belgium; Leiden, The Netherlands; Leuven,

Belgium and Antwerp, Belgium

PARALLEL SESSION 20

Room 251

Ischemia/reperfusion injury & intervention

Chairs: Thierry Hauet, Poitiers, France

Thomas Minor, Bonn, Germany

> 08:00 O-175 THE ROLE OF COMPLEMENT REGULATORY PROTEINS IN

CARDIOPROTECTION OF ISCHEMIC POSTCONDITIONING IN HEART

ISCHEMIC-REPERFUSION INJURY

Wei Wang, Yuchuan Huang, Huaiqiang Sun, Li Zhang and Hong Bu; Chengdu,

Sichuan, China and Chengdu, China


08:00

09:00

> 08:10 O-176 TETRAHYDROBIOPTERIN OFFSETS MICROVASCULAR

RENAL ISCHEMIA REPERFUSION INJURY VIA SUSTAINMENT OF NO

HOMEOSTASIS

Robert Sucher, Philipp Gehwolf, Rupert Oberhuber, Christian Margreiter,

Ernst R. Werner, Peter Obrist, Stefan Schneeberger, Robert Oellinger,

Raimund Margreiter and Gerald Brandacher; Innsbruck, Austria and Zams,

Austria

> 08:20 O-177 A NEW P38MAPKINASE-INHIBITOR IN ISCHEMIA AND

REPERFUSION INJURY IN PIGS

Dietmar K. Abendroth, Laura deJong, Desiree Klöpfer, Angela Unger and

Wolfgang Albrecht; Ulm, Germany

> 08:30 O-178 PROTECTION OF AGED DONOR LIVER FROM ISCHEMIA

REPERFUSION INJURY BY RNAI

Xusheng Zhang, Roberto Hernandez-Alejandro, Xiufeng Zheng, Marianne

Beduhn, Aminah Shunnar, Dauglas Quan and Weiping Min; London, ON,

Canada

> 08:40 O-179 DONOR TETRAHYDROBIOPTERIN PRE-TREATMENT PROLONGS

RECIPIENT SURVIVAL IN A MURINE GRAFT PANCREATITIS MODEL

Rupert Oberhuber, Paul Hengster, Martin Hermann, Peter Obrist, Gabriele

Werner-Felmayer, Ernst R. Werner, Raimund Margreiter, Gerald Brandacher

and Manuel Maglione; Innsbruck, Austria and Zams, Austria

> 08:50 O-180 THE RENAL COMPARTMENT SYNDROME: NEW PERSPECTIVES

IN KIDNEY TRANSPLANTATION

Tanja Herrler, Anne Tischer, Andreas Meyer, Sergej Feiler, Sebastian Nowak,

Peter Bartenstein, Marcus Hacker and Karl W. Jauch; Münster, Germany

PARALLEL SESSION 21

Grand Amphitheatre

Long term complications in kidney transplantation

Chairs: Emmanuel Morelon, Lyon, France

Maurizio Salvadori, Florence, Italy

> 08:00 O-181 AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: RISK

FACTOR FOR NON-MELANOMA SKIN CANCER FOLLOWING KIDNEY

TRANSPLANTATION

Anne Bretagnol, Jean-Michel Halimi, Melanie Roland, Christelle Barbet,

Azmi Al Najjar, Julie Badin, Laurent Machet, Yvon Lebranchu and Matthias

Büchler; Tours, France

> 08:10 O-182 MEASURING TOTAL BLOOD CALCIUM DISPLAYS A LOW

SENSITIVITY FOR THE DIAGNOSIS OF HYPERCALCEMIA IN RENAL

TRANSPLANT RECIPIENTS

Pieter Evenepoel, Björn Meijers, Bert Bammens, Kathleen Claes, Dirk Kuypers

and Yves Vanrenterghem; Leuven, Belgium

> 08:20 O-183 LOW SERUM MANNOSE BINDING LECTIN AS A RISK

FACTOR FOR NEW ONSET DIABETES MELLITUS AFTER RENAL

TRANSPLANTATION

Meritxell Ibernon, Francesc Moreso, Jose Maria Moreno, Oriol Bestard,

Josep Maria Cruzado, Josep Maria Grinyó, Wifredo Ricart, Jose Manuel

Fernández-Real and Daniel Serón; Badalona, Spain; Barcelona, Spain and

Girona, Spain

86


08:00

09:00

87

SCIENTIFIC

PROGRAMME

> 08:30 O-184 THE USE OF ORAL GLUCOSE TOLERANCE TEST TO STRATIFY

THE RISK OF DIABETES MELLITUS AFTER KIDNEY TRANSPLANTATION

Naohiko Shimoda, Masayoshi Miura, Hiroshi Harada, Nobuyuki Fukuzawa

and Katsuya Nonomura; Sapporo, Japan

> 08:40 O-185 POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN

RENAL ALLOGRAFT RECIPIENTS: FRENCH REGISTRY UPDATE AT 10

YEARS

Sophie Caillard, François Xavier Lamy, Fabienne Pessione and Bruno Moulin;

Strasbourg, France and Saint Denis, France

> 08:50 O-186 PREVALENCE OF VITAMIN D DEFICIENCY IN RENAL

TRANSPLANT RECIPIENTS. EFFECTS OF 25OHD SUPPLEMENTS

Roberto Marcen Letosa, Cristina Galeano Alvarez, Belen Ponte Martinez,

Ana M. Fernandez Rodriguez, Nuria Rodriguez Mendiola, Juan J. Villafruela

Sanz, Jose L. Teruel Briones, Francisco J. Burgos Revilla and Joaquin Ortuño

Mirete; Madrid, Spain

PARALLEL SESSION 22

Room Maillot

Pediatric liver transplantation

Chairs: Michele Colledan, Bergamo, Italy

Piotr Jerzy Kaliciński, Krakow, Poland

> 08:00 O-187 BENEFICIAL USAGE OF ANATOMICAL FULL-LEFT SPLIT LIVER

GRAFT FOR MIDDLEWEIGHT PEDIATRIC RECIPIENT UNDER HIGH

URGENCY STATUS

Atsushi Takebe, Harald Schrem, Bastian Ringe, Frank Lehner, Juergen

Klempnauer and Thomas Becker; Kobe, Hyogo, Japan and Hannover,

Germany

> 08:10 O-188 EFFICACY OF VALGANCICLOVIR AS PREEMPTIVE THERAPY

OF INFECTION DUE TO EPSTEIN BARR VIRUS IN PEDIATRIC LIVER

TRANSPLANTATION

Carla Venturi, Javier Bueno, Joan Gavalda, Teresa Tortola, Gemma Codina,

Leonor Pou, Juan Ortega, Albert Pahisa and Ramon Charco; Barcelona,

Spain

> 08:20 O-189 LONG-TERM EVOLUTION OF DE NOVO HEPATITIS C INFECTION

(HCV) AFTER PEDIATRIC LIVER TRANSPLANTATION

Carla Venturi, Javier Bueno, Isabel Casas, Jesus Quintero, Juan Ortega,

Ramon Charco and Luis Castells; Barcelona, Spain

> 08:30 O-190 CENTRAL SINUSOIDAL FIBROSIS (CSF) AS AN INDICATOR

OF INADEQUATE IMMUNOSUPPRESSION IN CHILDREN WITH

TACROLIMUS WITHDRAWAL AFTER LDLT

Hiroto Egawa, Aya Miyagawa-Hayashino, Hidenori Ohe, Takaaki Koshiba,

Yasutsugu Takada and Shinji Uemoto; Kyoto, Japan

> 08:40 O-191 PREDICTORS OF OPERATIONAL TOLERANCE AFTER

PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION; THE ABSENCE

OF EARLY REJECTION, THE PRESENCE OF DONOR-RECIPIENT HLA-B

MISMATCH AND FEMALE DONOR

Hidenori Ohe, Mami Yoshitomi, Tsuyoshi Morimoto, Shinya Okamoto, Shinji

Uemoto and Takaaki Koshiba; Kytoto, Japan and Kyoto, Japan

> 08:50 O-192 THREE HUNDRED LIVING DONOR LIVER TRANSPLANTATIONS

IN ADULTS AND CHILDREN: TECHNICAL EVOLUTIONS AND LESSENS

LEARNED

Yuji Soejima, Akinobu Taketomi, Toru Ikegami, Shigeyuki Nagata and

Yoshihiko Maehara; Fukuoka, Japan


08:00

09:00

08:00

09:00

PARALLEL SESSION 23

Room 252 AB

Mechanisms & evolution of chronic allograft

nephropathy

Chairs: Jose Maria Morales-Cerdan, Madrid, Spain

Georges Mourad, Montpellier, France

> 08:00 O-193 THE AUTOANTIBODY LEVEL OF CITRATE SYNTHASE IS

CORRELATED WITH C4D DEPOSITION IN RATS WITH CHRONIC

ALLOGRAFT NEPHROPATHY

Li Yuan Zhang, Yi Ping Lu, Li Yang, Guang Heng Luo, Jun Song, You Ping Li

and Guo Biao Liang; Chengdu, Sichuan, China

> 08:10 O-194 INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY (IFTA)

AFTER RENAL TRANSPLANTATION: TIME COURSE AND FACTORS

INFLUENCING SCARRING

Frieder Kleemann, Joanna M. Stewart and Helen L. Pilmore; Auckland, New

Zealand

> 08:20 O-195 INDIRECT ALLORECOGNITION OF HLA ‘PUBLIC’ T-CELL EPITOPES

IS ASSOCIATED WITH CHRONIC ALLOGRAFT DYSFUNCTION

Rajesh Hanvesakul, Helen Smith, Andrew Bentall, Shazia Shabir, Matthew

Morgan, David Briggs, Paul Cockwell, Richard Borrows, Mark Larche and

Simon Ball; Birmingham, United Kingdom

> 08:30 O-196 DIFFERENTIAL EVOLUTION OF STRUCTURAL AND

FUNCTIONAL CHANGES DURING THE FIRST YEAR OF KIDNEY

TRANSPLANTATION (KT)

A. Loupy, S. Escolano, D. Anglicheau, A. Méjean, F. Martinez, E Thervet,

G. Friedlander, P. Houillier, X. Jouven, C. Legendre and M. Froissart; Paris,

France

> 08:40 O-197 INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY IN KIDNEY

ALLOGRAFTS ARE ASSOCIATED WITH TUBULAR ENDOPLASMIC

RETICULUM STRESS DETECTION

Nicolas Pallet, Nicolas Bouvier, Philippe Beaune, Christophe Legendre, Eric

Thervet and Dany Anglicheau; Paris, France

> 08:50 O-198 LONG-TERM RENAL FUNCTION AFTER ALLOGENIC

HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULTS

PATIENTS: A SINGLE-CENTRE STUDY

Maxime Touzot, Caroline Elie, Jill van Massenhoven, Natacha Maillard,

Agnes Buzyn and Fadi Fakhouri; Paris, France

PARALLEL SESSION 24

Blue Amphitheatre

Clinical immunosuppression: news

Chairs: Henrik Ekberg, Malmö, Sweden

Rainer Oberbauer, Vienna, Austria

> 08:00 O-199 SOTRASTAURIN: PHARMACOKINETICS AND EXPOSURE-

EFFICACY RELATIONSHIP IN RENAL TRANSPLANT RECIPIENTS

K. Budde, J.U. Steiger, J.M. Grinyo, L. Rostaing, W. Arns, J. Dantal, P. Proot,

M.J. Barten and J.M. Kovarik; Berlin, Germany and Basel, Switzerland

88


09:00

10:30

SCIENTIFIC

PROGRAMME

> 08:10 O-200 COMPARISON OF COMBINATION PLASMAPHERESIS/IVIG/

ANTI-CD20 VERSUS HIGH-DOSE IVIG IN THE TREATMENT OF

ANTIBODY-MEDIATED REJECTION

Carmen Lefaucheur, Joao Andrade, Dominique Nochy, Jérome Verine,

Dominique Charron, Gary S. Hill, Denis Glotz and Caroline Suberbielle-

Boissel; Paris, France

> 08:20 O-201 EVEROLIMUS WITH LOW OR VERY LOW EXPOSURE OF

TACROLIMUS IN DE NOVO RENAL TRANSPLANT RECIPIENTS: THE

ASSET STUDY

stefan vitko, ronald hene, robert Langer, Maarten Christiaans, Helio Tedesco,

Kazimierz Ciechanowski, Elizabeth Cassuto, Lionel Rostaing, Mario Vilatoba

and Julio Pascual; Prague, Czech Republic; Utrecht, Netherlands; Budapest,

Hungary; Maastricht, Netherlands; Sao Paolo, Brazil; Szczecin, Poland; Nice,

France; Toulouse, France; México, Mexico and Madrid, Spain

> 08:30 O-202 EFFICACY AND SAFETY OF AN EVEROLIMUS/ENTERIC-

COATED MYCOPHENOLATE SODIUM REGIMEN AFTER CALCINEURIN

INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT

PATIENTS: RESULTS OF THE ZEUS TRIAL

P. Reinke, W. Arns, T. Becker, U. Eisenberger, W. Fischer, S. Kramer, F. Pietruck,

C. Sommerer and K. Budde; Berlin, Germany; Cologne, Germany; Hannover,

Germany; Bern, Switzerland; Nuremberg, Germany; Essen, Germany and

Heidelberg, Germany

> 08:40 O-203 INITIATION OF EVEROLIMUS WITH CALCINEURIN INHIBITOR

(CNI) REDUCTION IN THORACIC TRANSPLANT PATIENTS WITH

IMPAIRED RENAL FUNCTION: A MULTICENTER, RANDOMIZED STUDY

Lars Gullestad, Martin Iversen, Hans Eiskjaer, Gerdt C. Riise, Dag Solbu and

Claes-Håkan Bergh; Oslo, Norway; Copenhagen, Denmark; Aarhus, Denmark

and Gothenburg, Sweden

> 08:50 O-204 TACROLIMUS REDUCES THE RISK FOR BRONCHIOLITIS

OBLITERANS SYNDROME 3 YEARS AFTER LUNG-TRANSPLANTATION

BY 50% IN COMPARISON TO CYCLOSPORINE IN A PROSPECTIVE

RANDOMIZED INTERNATIONAL TRIAL OF 248 PATIENTS

Hendrik Treede, Walter Klepetko, Allan Glanville, Raffael Lama, Carlos

Bravo, Marc Estenne, Jean-David Aubert, Christina Aboyoun, Hermann

Reichenspurner and European and Australian Investigators in Lung

Transplantation; Hamburg, Germany; Vienna, Austria; Sydney, NSW, Australia;

La Coruna, Spain; Barcelona, Spain; Bruxelles, Belgium and Lausanne, Vaud,

Switzerland

STATE OF THE ART

PANCREAS AND ISLET TRANSPLANTATION

Room Maillot

Steady-state or progress?

Chairs: Rainer Gruessner, Tucson, United States

François Pattou, Lille, France

> 09:00 Algorithms for islet vs pancreas transplantation

Thierry Berney, Geneva, Switzerland

> 09:20 Beta-cell toxicity of Is drugs in pancreas and islet Tx

Antonio Secchi, Milan, Italy

> 09:40 Alternative sites for islet transplantation

Olle Korsgren, Uppsala, Sweden

89


09:00

10:30

09:00

10:30

> 10:00 Alternative sources of insulin-producing tissue

Shimon Efrat, Tel Aviv, Israel

> 10:20 Discussion

STATE OF THE ART

QUALITY AND SAFETY OF ORGANS

Grand Amphitheatre

Chairs: Bernard Charpentier, Paris, France

Alessandro Nanni Costa, Rome, Italy

> 09:00 Safety and infectious diseases: the old-new challenge in

transplantation

Paolo Grossi, Varese, Italy

> 09:20 The value of the expert: improving a medical approach

Ferdinand Mühlbacher, Vienna, Austria

> 09:40 Success of transplantation begins with the donor

Rutger J. Ploeg, Groningen, The Netherlands

> 10:00 Undesirable but not restricted: Europe facing transplant tourism

Luc P.J. Nöel, World Health Organization, Geneva, Switzerland

> 10:20 Discussion

STATE OF THE ART

ETHICAL, LEGAL AND PSYCOSOCIAL ASPECTS

OF ORGAN TRANSPLANTATION (ELPAT)

Blue Amphitheatre

Living unrelated organ donation.

From caring partner to good Samaritan

Chairs: Annette Lennerling, Gothenburg, Sweden

Willem Weimar, Rotterdam, The Netherlands

> 09:00 Caring partner. Is it only love? Pitfalls in living related organ

donation

Nikola Biller-Andorno, Zurich, Switzerland

> 09:20 In between. Hurdles for living unrelated organ donation

Bijan Fateh-Moghadam, Münster, Germany

> 09:40 Good Samaritan. An update on European practices

Willij C. Zuidema, Rotterdam, The Netherlands

> 10:00 Discussion

90


11:00

13:00

PARALLEL SESSION 25

Room Maillot

Novel insight in perfusion & preservation

Chairs: Peter J. Friend, Oxford, United Kingdom

Henri G.D Leuvenink, Groningen, The Netherlands

91

SCIENTIFIC

PROGRAMME

> 11:00 O-205 FOXP3+ REGULATORY T-CELLS PLAY A DOMINANT ROLE OVER

ROR T+ TH17-CELLS IN DECEASED DONOR KIDNEYS

Carla C. Baan, Annemiek M.A. Peeters, Sander S. Korevaar, Jan N.M.

Ijzermans and Willem Weimar; Rotterdam, The Netherlands

> 11:10 O-206 PERITONEAL COOLING MAY PROVIDE ADDITIONAL

ISCHAEMIC PROTECTION FOR UNCONTROLLED NON HEART

BEATING KIDNEY DONORS

Alex P. Navarro, Asher John, Soroush Sohrabi, Noel Carter and David Talbot;

Newcastle Upon Tyne, United Kingdom and Sunderland, United Kingdom

> 11:20 O-207 “TWO LAYER PRESERVATION METHOD” (TLM) IMPROVES

POST-TRANSPLANT SURVIVAL AND EARLY KIDNEY FUNCTION

FOLLOWING PROLONGED COLD ISCHEMIA

Tomáš Marada, Klára Zacharovová, Zuzana Berková and František Saudek;

Prague, Czech Republic and Prague, Czech Republic

> 11:30 O-208 ENISCHEMIC HYPOTHERMIC RECONDITIONING REVERSES

PRESERVATION INDUCED LIVER INJURY BY MITOCHONDRIAL

PROTECTION PRIOR TO REPERFUSION

Thomas Minor and Judith Stegemann; Bonn, Germany

> 11:40 O-209 MITOCHONDRIAL PROTECTION BY OXYGENATED PERFUSION

AFTER WARM ISCHAEMIA

Debabrata Roy, Karl Morten, Constantin Coussius, Reza Morovat, Dino

Guerriero, David Hughes, Jens Brockman and Peter J. Friend; Oxford,

United Kingdom

> 11:50 O-210 RELEASE OF AST AND LFABP FROM ISCHEMICALLY DAMAGED

LIVERS DURING MACHINE PERFUSION: A NEW TOOL TO PREDICT

VIABILITY AND PRIMARY-NON-FUNCTION

Qiang Liu, Diethard Monbaliu, Katrien Vekemans, Veerle Heedfeld, Tine

Wylin, John Brassil, Jacques Pirenne and Jos van Pelt; Leuven, Belgium and

Zaventem, Belgium

> 12:00 O-211 HYPOTHERMIC IN SITU MACHINE PERFUSION WITH UW

DURING DECEASED CARDIAC DEATH DONATION IMPROVES EARLY

RENAL FUNCTION

Henri G.D. Leuvenink, Arjan van der Plaats, Petra J. Ottens, Gerhard Rakhorst

and Rutger J. Ploeg; Groningen, Netherlands

> 12:10 O-212 RENAL RESISTANCE DURING MACHINE PERFUSION IS A RISK

FACTOR FOR DELAYED GRAFT FUNCTION AND POORER GRAFT

SURVIVAL

Jacques Pirenne, Jacqueline Smits, Diethard Monbaliu, Henri Leuvenink, Cyril

Moers, John Brassil, Bert Theunis, Jonathan Vercruysse, Jürgen Treckmann,

Andreas Paul, Rutger J. Ploeg and Peter De Muylder; Leuven, Belgium;

Leiden, Netherlands; Groningen, The Netherlands; Zaventem, Belgium and

Essen, Germany

> 12:20 O-213 IGL-1 SOLUTION PROTECTS AGAINST LIVER ISCHEMIA

REPERFUSION INJURY BY INHIBITION OF ENDOPLASMIC RETICULUM-

STRESS

Ismail Ben Mosbah, Rosa Franco Gou, Cecile Martel, Catherine Brenner,

Hassen Ben Abdennebi, Joan Rosello-Catafau and Carmen Peralta;

Barcelona, Spain; Versailles, France and Monastir, Tunisia


11:00

13:00

> 12:30 O-214 ANALYSIS OF MACHINE PERFUSION PARAMETERS OF

KIDNEYS PROCURED FROM EXPANDED CRITERIA DONORS

Piotr Domagala, Artur Kwiatkowski, Michal Wszola, Tomasz Kasprzyk,

Slawomir Fesolowicz, Agnieszka Kulik, Krzysztof Ostrowski and Andrzej

Chmura; Warsaw, Poland

> 12:40 O-215 PREVENTION OF OXIDATIVE STRESS INDUCED ORGAN

DAMAGE IN A PORCINE BRAIN DEAD DONOR MODEL

Philipp Stiegler, Martin Schweiger, Michael Sereinigg, Thomas Seifert,

Thomas Marko, Carolin Lackner, Nadja Dandachi, Stephanie Stanzer, Florian

Iberer, Florian Iberer, Joachim Greilberger, Seth Hallström and Karlheinz

Tscheliessnigg; Graz, Austria

PARALLEL SESSION 26

Grand Amphitheatre

Impact of donor risk factors on kidney graft survival

Chairs: Christophe Legendre, Paris, France

Stefan Vitko, Prague, Czech Republic

> 11:00 O-216 THE CUMULATIVE NEGATIVE IMPACT OF DONOR RISK

FACTORS ON KIDNEY GRAFT HISTOLOGY AND FUNCTION

Jaanus Kahu, Kaija Salmela and Lauri Kyllonen; Tartu, Estonia and Helsinki,

Finland

> 11:10 O-217 ACCEPTABLE LONG-TERM RESULTS WITH KIDNEYS FROM OLD

DONORS GIVEN TO OLD RECIPIENTS

Claudia Bösmüller, Stefan Strasser, Stefan Scheidl, Christian Margreiter and

Raimund Margreiter; Innsbruck, Austria

> 11:20 O-218 EVALUATION OF IMMUNOLOGICAL RISK IN RENAL

TRANSPLANT RECIPIENT FROM EXTENDED CRITERIA DONORS

Carine Diet, Vincent Audard, Françoise Roudot-Thoraval, Philippe Lang and

Philippe Grimbert; Creteil, France

> 11:30 O-219 SURVIVAL BENEFIT OF KIDNEY TRANSPLANTATION FROM

DONORS AFTER CARDIAC DEATH

Maarten G.J. Snoeijs, Douglas E. Schaubel, Ronald Hene, Andries J. Hoitsma,

Mirza M. Idu, Jan N. Ijzermans, Rutger J. Ploeg, Jan Ringers, Maarten

H.L. Christiaans, Wim A. Buurman and L.W. Ernest van Heurn; Maastricht,

Netherlands; Ann Arbor, MI, United States; Utrecht, Netherlands; Nijmegen,

Netherlands; Amsterdam, Netherlands; Rotterdam, Netherlands; Groningen,

Netherlands and Leiden, Netherlands

> 11:40 O-220 LONG-TERM OUTCOME OF KIDNEY TRANSPLANTATION

FROM DONORS AFTER CARDIAC DEATH

Maarten G.J. Snoeijs, Bjorn Winkens, Martin B.A. Heemskerk, Andries J.

Hoitsma, Maarten H.L. Christiaans, Wim A. Buurman and L.W. Ernest van

Heurn; Maastricht, The Netherlands and Leiden, The Netherlands

> 11:50 O-221 DECEASED AFTER CARDIAC DEATH DONATION: LONG TERM

RESULTS IN A MATCHED SINGLE-CENTER STUDY

Ivan Kristo, Julian Marschalek, Georg P. Györi, Christopher K. Burghuber,

Gabriela A. Berlakovich, Thomas Soliman, Rudolf Steininger and Ferdinand

Mühlbacher; Vienna, Austria

> 12:00 O-222 DUAL KIDNEY TRANSPLANTATION FROM ELDERLY DONORS:

LONG TERM OUTCOME AND HISTOLOGICAL FEATURES

Alessandro Broggiato, Cristina Silvestre, Burcin Ekser, Lucrezia Furian,

Emiliano d’alessandro, Marialuisa Valente, Francesco Marchini, Luciana

Bonfante and Paolo Rigotti; Padua, Italy

92


11:00

13:00

93

SCIENTIFIC

PROGRAMME

> 12:10 O-223 KIDNEY ARTERIOLAR HYALINOSIS AND INTIMAL FIBROSIS

INHERITED FROM DONOR IS A RISK FACTOR FOR LONG-TERM

GRAFT DYSFUNCTION

Carlos Frangié, Sophie Ferlicot, Antoine Jacquet, Hélène François, Séverine

Beaudreuil, Antoine Durrbach and Bernard Charpentier; Le Kremlin-Bicêtre,

France

> 12:20 O-224 SYSTEMIC AND LOCAL RENAL COMPLEMENT ACTIVATION IN

BRAIN-DEAD DONORS

Jeffrey Damman, Henri G.D. Leuvenink, Willemijn N. Nijboer, Wim van

Oeveren, Rutger J. Ploeg and Marc A. Seelen; Groningen, The Netherlands

> 12:30 O-225 RISK FACTORS FOR DETERIORATION OF RENAL FUNCTION

AFTER DONOR NEPHRECTOMY

Hideki Ishida, Toshihito Hirai, Taiji Nozaki, Hiroki Shirakawa, Tomokazu

Shimizu, Kazuya Omoto, Keiko Uchida, Kosaku Nitta and Kazunari Tanabe;

Shinjuku-ku, Toko, Japan; Toda-shi, Saitama, Japan and Shinjuku-ku, Tokyo,

Japan

> 12:40 O-226 MEDIUM-TERM FOLLOW UP OF RENAL TRANSPLANT

RECIPIENTS FROM A RANDOMISED CONTROLLED TRIAL OF

LAPAROSCOPIC VERSUS OPEN LIVE DONOR NEPHRECTOMY

Rosemary Elwell, Atul Bagul, Jenny Moorhouse, Peter S. Veitch and Michael

L. Nicholson; Leicester, United Kingdom

PARALLEL SESSION 27

Blue Amphitheatre

Surgical challanges in liver transplantation

Chairs: Jacques Belghiti, Paris, France

Paolo Muiesan, Birmingham, United Kingdom

> 11:00 O-227 INTENTIONAL PORTAL PRESSURE CONTROL IS A KEY

TO IMPROVE THE OUTCOME OF ADULT LIVING DONOR LIVER

TRANSPLANTATION (A-LDLT) WITH SMALLER GRAFTS

Yasuhiro Ogura, Tomohide Hori, Walid Elmoghazy, Fumitaka Oike and Shinji

Uemoto; Kyoto City, Japan

> 11:10 O-228 DUAL GRAFT LIVING DONOR LIVER TRANSPLANTATION WITH

RIGHT AND LEFT LIVER GRAFT COMBINATION

Gi-Won Song, Sung-Gyu Lee, Shin Hwang, Tae-Yong Ha and Dong-Hwan

Jung; Seoul, Korea

> 11:20 O-229 REAPPRAISAL OF EFFICACY AND SAFETY OF SELECTIVE

HEMI-PORTOCAVAL SHUNT IN ADULT LIVING DONOR LIVER

TRANSPLANTATION

Takako Yamada, Kenji Uryuhara, Satoshi Kaihara, Shinji Uemoto and Koichi

Tanaka; Kobe, Japan and Kyoto, Japan

> 11:30 O-230 LIVING LIVER DONOR MORTALITY AND MORBIDITY DEMAND

GENUINE TRANSPARENCY: THE SITUATION IN EGYPT

Hesham M. Abdeldayem, Naglaa A. Allam, Mohamed Hussein, Amr Helmy,

Hisham Gad, Essam Salah, Amr Sadek, Khaled Abulella, Maher Ossman and

Bassem Soliman Hegab; Menoufeyi, Egypt

> 11:40 O-231 LEFT LIVER LOBE TRANSPLANTATION IN ADULT RECIPIENTS

FROM SPLIT LIVERS AND LIVING DONORS

Olivier Boillot, Gabriella Pittau, Yves Bouffard, Pierre Sagnard and Catherine

Boucaud; Lyon, France


11:00

13:00

> 11:50 O-232 RECIPIENT OUTCOMES IN DOMINO LIVER TRANSPLANTATION

WITH DONOR VENA CAVA PRESERVATION

Raquel GarcíapRoca, María Marta Modolo, Josep Martí Sánchez, Pilar Taurá,

David Calatayud, Constantino Fondevila, Joana Ferrer, Santiago Sánchez

Cabús, Josep Fuster and Juan Carlos García Valdecasas; Barcelona, Spain

> 12:00 O-233 AUXILIARY LIVER TRANSPLANTATION FOR ACUTE LIVER

FAILURE: A REAPPRAISAL

Daniele Sommacale, Safi Dokmak, Claire Francoz, Francois Durand, Federica

Dondero, Catherine Paugam and Jacques Belghiti; Clichy, France

> 12:10 O-234 LIVER TRANSPLANTATION (LT) FROM DONATION AFTER

CARDIAC DEATH (DCD) DONORS: MULTICENTRE BELGIAN

EXPERIENCE 2003-2007

Olivier Detry, Vincent Donckier, Valerio Lucidi, Dirk Ysebaert, Thierry

Chapelle, Jan Lerut, Olga Ciccarelli, Jacques Pirenne, Diethard Monbaliu,

Arnaud Deroover, Pierre Honoré, Xavier Rogiers, Bernard de Hemptinne

and Roberto Troisi; Liège, Belgium; Brussels, Belgium; Antwerp, Belgium;

Leuven, Belgium and Ghent, Belgium

> 12:20 O-235 NEW NATURAL BANDING METHOD OF PORTO-CAVAL SHUNT BY

USING A PARAUMBILICAL VEIN AS SHAPE MEMORY GRAFT IN SMALL-

FOR-SIZE GRAFT LIVING DONOR LIVER TRANSPLANTATION

Yoshinobu Sato, Satoshi Yamamoto, Hiroshi Oya, Takashi Kobayashi and

Katsuyoshi Hatakeyama; Niigata, Niigata, Japan

> 12:30 O-236 THE EFFECT OF DIFFERENT TECHNIQUES FOR BILE DUCT

ANASTOMOSIS ON POST-TRANSPLANT BILIARY COMPLICATION IN

LIVING DONOR LIVER TRANSPLANTATION

Jinsub Choi, Soo Jin Kim, Gi Hong Choi, Kyung Ock Jeon, Jong Hoon Lee,

Kiil Park, Soon Il Kim and Yu Seun Kim; Seoul, Korea and Goyang, Korea

> 12:40 O-237 POLYCYSTIC LIVER AND KIDNEY DISEASE: LIVER

TRANSPLANTATION ALONE OR COMBINED LIVER KIDNEY

TRANSPLANTATION?

Tom Darius, Erwin Denies, Annemie Van Breussegem, Ilke Marien, Diethard

Monbaliu, Raymond Aerts, Willy Coosemans, Tania Roskams, Werner Van

Steenbergen, David Cassiman, Chris Verslype, Wim Laleman, Dirk Kuypers,

Pieter Evenepoel, Bert Bammens, Kathleen Claes, Yves Vanrenterghem,

Frederik Nevens and Jacques Pirenne; Leuven, Belgium

PARALLEL SESSION 28

Room 252 AB

New organ donation challenge: from living donor to

non-heart-beating donor

Chairs: Axel Rahmel, Leiden, The Netherlands

Dirk Ysebaert, Antewerp, Belgium

> 11:00 O-238 SUCCESSFUL EXPANSION OF THE LIVING DONOR POOL BY

ALTERNATIVE LIVING DONOR PROGRAMMES

Joke I. Roodnat, Judith A. Kal-van Gestel, Willij Zuidema, Marian A.A. Noord

van, Jacqueline Weteringvan de, Jan N.M. Ijzermans and Willem Weimar;

Rotterdam, The Netherlands

> 11:10 O-239 DONOR ETHNICITY AND PARTICIPATION TO (ALTERNATIVE)

LIVING KIDNEY DONATION PROGRAMMES

Joke I. Roodnat, Marian A.A. Noord van, Judith A. Kal-van Gestel, Willij

Zuidema, Jacqueline Wetering van de, Jan N.M. Ijzermans and Willem

Weimar; Rotterdam, The Netherlands

94


95

SCIENTIFIC

PROGRAMME

> 11:20 O-240 APPROACHES FOR LAPAROSCOPIC LIVE DONOR

NEPHRECTOMY SHOULD BE SELECTED ACCORDING TO SURGEON’S

SKILL AND DONOR’S PHYSICAL STATUS

Masayoshi Miura, Hiroshi Harada, Norikata Takada, Nobuyuki Fukuzawa,

Toshimori Seki, Naohiko Shimoda, Tatsu Tanabe, Kouichi Kanagawa and

Katsuya Nonomura; Sapporo, Japan and Asahikawa, Japan

> 11:30 O-241 COMPLICATION RATES IN 1019 CONSECUTIVE LIVING DONOR

NEPHRECTOMIES

Geir H. Mjøen, Pål-Dag Line, Ole Øyen, Karsten Midtvedt and Hallvard

Holdaas; Oslo, Norway

> 11:40 O-242 5-YEARS EVALUATION OF THE NATIONAL LIVING DONOR

KIDNEY EXCHANGE PROGRAMME IN THE NETHERLANDS

Marry de Klerk, Marian D. Witvliet, Bernadette J.J.M. Haase-Kromwijk, Frans

H.J. Claas and Willem Weimar; Rotterdam, The Netherlands and Leiden, The

Netherlands

> 11:50 O-243 LIVING KIDNEY DONORS INCREASE KIDNEY FUNCTION OVER

LONG TIME

Ingela Fehrman-Ekholm, Annette Lennerling, Niclas Kvarnström, Marie

Felldin, Rizell Magnus and Michael Olausson; Gothenburg, Sweden

> 12:00 O-244 ELEVEN YEAR EXPERIENCE OF NON-DIRECTED LIVING RENAL

DONATION IN CHRISTCHURCH, NEW ZEALAND

Sarah Armstrong, Zoltan Endre, Kelvin Lynn, Stephen Mark, David McGregor,

John Morton, Richard Robson, John Schollum, Martin Searle, Rob Walker

and Justin Roake; Christchurch, New Zealand and Dunedin, New Zealand

> 12:10 O-245 VERY LONG-TERM DATA ON LIVING KIDNEY DONORS: A

SINGLE CENTER EXPERIENCE SINCE 1959

Catherine Fournier, Henri Kreis, Sylvie Pucheu, Eric Thervet, Frank Martinez,

Marie-France Mamzer, Renaud Snanoudj, Lynda Bererhi, Arnaud Méjean and

Christophe Legendre; Paris, France

> 12:20 O-246 HOW FRANCE LAUNCHED ITS NHBD PROGRAMME

Corinne Antoine, Lionel Badet, Laurent Jacob, Benoit Barrou, Frederic Brun,

Emilie Savoye, Gaelle Cheisson, Frederic Adnet, Bernard Loty and National

Steering Committee Non Heart Beating Donors; Saint Denis, France; Lyon,

France; Paris, France; Kremlin Bicêtre, France and Bobigny, France

> 12:30 O-247 PREDICTION OF DEATH IN POTENTIAL CONTROLLED NON-

HEART-BEATING DONORS: PRELIMINARY RESULTS OF A PROSPECTIVE

STUDY

Tineke J. Wind, Maarten G.J. Snoeijs, Janneke Vervelde, Cees A. Brugman

and Ernst L.W.E. van Heurn; Maastricht, Netherlands; Amsterdam, The

Netherlands and Groningen, The Netherlands

> 12:40 O-248 TRENDS IN ORGAN DONATION AND TRANSPLANTATION IN

RUSSIA. ANALYSIS OF 2006-2008 NATIONAL REGISTRY DATA

Sergey V. Gautier, Yan G. Moysyuk, Marina G. Minina and Oleg N. Reznik;

Moscow, Russian Federation and S.Petersburg, Russian Federation


11:00

13:00

PARALLEL SESSION 29

Room 241

Pharmaco & immunological monitoring

Chairs: Yannick Le Meur, Limoges, France

Teun Van Gelder, Rotterdam, The Netherlands

> 11:00 O-249 IMPACT OF STEROID WITHDRAWAL ON THE IMMUNE

RESPONSE OF RENAL TRANSPLANT RECIPIENTS

Rolf Weimer, Sabine Deisz, Fabrice Renner, Hartmut Dietrich, Caner Suesal,

Shirin Kamali-Ernst, Wolfgang Ernst, Winfried Padberg and Gerhard

Opelz; Giessen, Germany; Heidelberg, Germany; Wetzlar, Germany and

Langenselbold, Germany

> 11:10 O-250 THE ASSOCIATION OF EARLY SUBTHERAPEUTIC MPA

EXPOSURE ( 11:20 O-251 PHARMACOMETRICS OF VOCLOSPORIN IN A PHASE 2B

RENAL TRANSPLANT TRIAL

Rita Alloway, Osama Gaber, Shamkant Mulgaonkar, Herwig-Ulf Meier-

Kriesche, Spencer Ling, Pat Mayo and Anthony Jevnikar; Cincinnati, United

States; Houston, United States; Livingston, United States; Gainesville, United

States; Edmonton, Canada and London, Canada

> 11:30 O-252 CYP3A5 AND ABCB1 POLYMORPHISMS INFLUENCE

TACROLIMUS CONCENTRATIONS IN PERIPHERAL BLOOD

MONONUCLEAR CELLS IN RENAL TRANSPLANT PATIENTS

Arnaud Capron, Michel Mourad, Vincent Haufroid and Pierre Wallemacq;

Brussels, Belgium

> 11:40 O-253 FINAL RESULTS OF PRETRANSPLANT PHARMACOGENETIC

ADAPTATION OF TACROLIMUS (TAC) TREATMENT AFTER RENAL

TRANSPLANTATION

Eric Thervet, Marie Anne Loriot, Stephane Barbier, Matthias Buchler, Maxence

Ficheux, Gabriel Choukroun, Christophe Legendre, Olivier Toupance, Guy

Touchard, Jo Rivalan, Bruno Moulin, Corinne Alberti and Philippe Beaune;

Paris, France; Rouen, France; Tours, France; Caen, France; Amiens, France;

Reims, France; Poitiers, France; Rennes, France and Strasbourg, France

> 11:50 O-254 AN INTENSIFIED DOSING OF ENTERIC-COATED

MYCOPHENOLATE SODIUM IN RENAL TRANSPLANT PATIENTS

RESULTS IN IMPROVED EFFICACY WITHOUT COMPROMISING

SAFETY

C. Sommerer, W. Arns, M. Zeier, T. Ariatabar, P. Glander, E.-M. Vogel and K.

Budde; Heidelberg, Germany; Koeln-Merheim, Germany; Berlin, Germany

and Nuremberg, Germany

> 12:00 O-255 PROTON PUMP INHIBITORS REDUCE MYCOPHENOLATE

EXPOSURE IN HEART TRANSPLANT RECIPIENTS - A PROSPECTIVE

CASE CONTROLLED STUDY

Sieglinde Kofl er, Amir Bigdeli, Natalja Shvets, Bruno Meiser, Bruno Reichart

and Ingo Kaczmarek; Münster, Germany

> 12:10 O-256 NOVEL T-CELL ASSAY TO ASSESS EFFECTS OF SOTRASTAURIN,

A PROTEIN KINASE C-INHIBITOR, IN COMBINATION WITH

TACROLIMUS

K. Budde, J.U. Steiger, P. Glander, J.M. Grinyo, N. Kamar, W. Arns, J. Dantal,

A. Slade, A. Vitaliti, J.M. Kovarik and M.J. Barten; Berlin, Germany and Basel,

Switzerland

96


11:00

13:00

97

SCIENTIFIC

PROGRAMME

> 12:20 O-257 THE JAK-INHIBITOR CP-690,550 INHIBITS EFFECTOR

T-CELLS BUT DOES NOT AFFECT THE FUNCTION OF HUMAN

CD4+CD25BRIGHTFOXP3+ REGULATORY T-CELLS

Varsha D.K.D. Sewgobind, Monique E. Quaedackers, Luc J.W. van der Laan,

Rens Kraaijeveld, Gary Chan, Willem Weimar and Carla C. Baan; Rotterdam,

The Netherlands and New London, United States

> 12:30 O-258 IMPACT OF BASILIXIMAB THERAPY ON REGULATORY

T-CELLS EARLY AFTER KIDNEY TRANSPLANTATION: CD25 DOWN-

REGULATION BY RECEPTOR MODULATION

Florian W.R. Vondran, Kai Timrott, Janice Troß, Sonja Kollrich, Thomas Becker,

Frank Lehner, Anke Schwarz, Jürgen Klempnauer and Reinhard Schwinzer;

Hannover, Germany

> 12:40 O-259 PREFERENTIAL INCREASE IN MEMORY AND REGULATORY

SUBSETS DURING CD4+ T-CELL IMMUNE RECONSTITUTION AFTER

THYMOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT

PATIENTS RECEIVING SIROLIMUS VS CYCLOSPORINE

Emmanuel Morelon, Nicole Lefrançois, Caroline Besson, Julie Prévautel,

Maria Brunet, Jean-Louis Touraine, Lionel Badet, Francoise Touraine-Moulin,

Olivier Thaunat and Christophe Malcus; Lyon, France

PARALLEL SESSION 30

Room 251

New approaches to diagnostic prediction

Chairs: David Roelen, Leiden, The Netherlands

Nicole Van Besouw, Rotterdam, The Netherlands

> 11:00 O-260 HLA CLASS-I ALLOANTIGEN IMMUNOGENICITY CAN BE

PREDICTED BY TERTIARY STRUCTURE AND ELECTROSTATIC CHARGE

DISPARITY

Vasilis Kosmoliaptsis, Afzal N. Chaudhry, Linda D. Sharples, David J. Halsall,

Timothy R. Dafforn, J. Andrew Bradley and Craig J. Taylor; Cambridge,

United Kingdom and Birmingham, United Kingdom

> 11:10 O-261 MICA ANTIBODIES ASSOCIATE WITH BIOPSY-PROVEN

CELLULAR REJECTION IN RENAL TRANSPLANT RECIPIENTS

Henry A. Stephens, Steven Cox, Ray Fernando, Alec J. Howie, Mark Harber

and Ann-Margaret Little; London, United Kingdom

> 11:20 O-262 HLA-DP ANTIBODY FORMATION BEFORE AND AFTER RENAL

TRANSPLANTATION

Evy V.A. Billen, Maarten H.L. Christiaans, Christien E.M. Voorter and Ella M.

van den Berg-Loonen; Maastricht, The Netherlands

> 11:30 O-263 EFFICACY OF AN ACCEPTABLE MISMATCH PROGRAMME

(AM) FOR THE ACCESS TO RENAL TRANSPLANTATION OF HIGHLY

SENSITIZED PATIENTS: THE FRENCH EXPERIENCE

Corinne Antoine, Caroline Suberbielle-Boissel, Emilie Savoye, Michel Abbal,

Jacques Cohen and Jean-Denis Bignon; Saint Denis, France; Paris, France;

Toulouse, France; Reims, France and Nantes, France

> 11:40 O-264 ANTI-INFLAMMATORY EFFECTS AFTER STEROID PRETREATMENT

OF BRAIN DEAD DONORS ARE REFLECTED IN ZERO-HOUR BIOPSIES –

NO PROTECTIVE EFFECTS IN ELDERLY BRAIN DEAD DONORS

Anja Reutzel-Selke, Frank Ulrich, Sascha Weiss, Sabine Schulz, Sandy Wendt,

Andreas Pascher, Peter Neuhaus, Johann Pratschke and Katja Kotsch; Berlin,

Germany


14:15

15:45

> 11:50 O-265 ALTERATIONS IN INTRAGRAFT MICRORNA EXPRESSION

DURING ACUTE REJECTION OF THE RENAL ALLOGRAFT: IMPLICATION

FOR DIAGNOSIS AND MECHANISM OF THE ALLO-IMMUNE INJURY

Dany Anglicheau, Vijay K. Sharma, Ruchuang Ding, Aurélie Hummel,

Catherine Snopkowski, Darshana Dadhania, Surya Seshan and Manikkam

Suthanthiran; New York, NY, United States

> 12:00 O-266 POST TRANSPLANT HLA AND MICA IMMUNISATION AND

CHRONIC REJECTION IN HEART/LUNG TRANSPLANTATION: ONE

CENTER STUDY

Anne Cesbron Gautier, Sabine Pattier, Anne Devys, Nadine Paint, Sylvie Cury,

Michele Treilhaud, Alain Haloun and Jean Denis Bignon; Nantes, France

> 12:10 O-267 INTRAGRAFT ECTOPIC LYMPHOID TISSUE DURING CHRONIC

REJECTION: HIJACKING OF AN EMBRYONIC DEVELOPMENTAL

PROGRAMME PROMOTES THE DEVELOPMENT OF A LOCAL

AGGRESSIVE ALLOIMMUNE RESPONSE

Olivier Thaunat, Natacha Patey, Chantal Gautreau, Emmanuel Morelon,

Stéphanie Graff-Dubois and Antonino Nicoletti; Lyon, France and Paris,

France

> 12:20 O-268 DONOR NATURAL KILLER CELLS DETERMINE LONG-TERM

HUMAN KIDNEY TRANSPLANT OUTCOMES THROUGH HLA-C

SUB-GROUP DEPENDENT RECIPIENT DENDRITIC-CELL MATURATION

Rajesh Hanvesakul, David Briggs, Chandrashekhar Kubal, Jason Moore,

Alison Whitelegg, Desley Neil, Nicholas Inston, Simon Ball, Paul Moss and

Paul Cockwell; Birmingham, United Kingdom

> 12:30 O-269 THE IMMUNOREGULATORY MOLECULE HLA-G INHIBITS THE

MTOR PATHWAY AND CELL CYCLE OF ACTIVATED T CELLS THROUGH

SHP2

Farah Ketroussi, Rajia Bahri, Bernard Charpentier and Antoine Durrbach;

Villejuif, France

> 12:40 O-270 ADULT BONE MARROW AND FETAL LIVER MESENCHYMAL

STEM CELLS (MSC) AFFECT LYMPHOCYTES PROLIFERATION BY

PREVENTING ENTRY INTO THE CELLULAR CYCLE: DIRECT

INVOLVING OF HLA-G

Massimo Giuliani, Maud Fleury, Bernard Charpentier, Jean Jacques Lataillade

and Antoine Durrbach; Villejuif, France and Clamart, France

PLENARY SESSION 3

Grand Amphitheatre

The emerging role of T cells in transplantation

Chairs: Ignacio Anegon, Nantes, France

Stefan Tullius, Boston, United States

> 14:15 The creative role for Memory T-cells

Federica Sallusto, Bellinzona, Switzerland

> 14:35 Analysis of tolerant kydney transplant patients

Sophie Brouard, Nantes, France

> 14:55 TH 17 in transplantation

Kathryn Wood, Oxford, United Kingdom

> 15:15 Treatment with regulatory T-cells

Manuela Battaglia, Milan, Italy

> 15:35 Discussion

98


16:10

18:00

16:10

18:00

PARALLEL SESSION 31

Room Maillot

Cardiovascular risk factors in kidney transplantation

Chairs: Thomas Fehr, Zurich, Switzerland

Philippe Lang, Paris, France

99

SCIENTIFIC

PROGRAMME

> 16:10 O-271 REGIONAL VARIATION IN CARDIOVASCULAR RISK POST

KIDNEY TRANSPLANT: THE PORT INTERNATIONAL DATA

COLLABORATION

Jon J. Snyder, Ajay K. Israni, Melissa A. Skeans, Yi Peng, J. Ross Maclean

and Bertram L. Kasiske; Minneapolis, MN, United States and Plainsboro, NJ,

United States

> 16:20 O-272 THROMBOPHILIC FACTORS DO NOT PREDICT OUTCOMES IN

PATIENTS RECEIVING A RENAL TRANSPLANTATION AFTER 2000

Lidia Ghisdal, Emine Broeders, Karl Martin Wissing, Anissa Saïdi, Joseph

Mbaba Mena, Anne Lemy, Walter Wijns, Olivier Pradier, Anh-Dung Hoang,

Dimitri Mikhalski, Vincent Donckier, Hakim El Housni, Pascale Cochaux,

Pierre Vereerstraeten, Marc Abramowicz and Daniel Abramowicz; Brussels,

Belgium

> 16:30 O-273 OBSTRUCTIVE SLEEP APNEA IS HIGHLY PREVALENT AMONG

KIDNEY TRANSPLANTED PATIENTS AND IS ASSOCIATED WITH

INCREASED CARDIOVASCULAR RISK

Miklos Z. Molnar, Anett Lindner, Katalin Fornadi, Alpar Lazar, Adam Remport,

Istvan Mucsi, Andrea Dunai, Rezso Zoller, Andras Szentkiralyi and Marta

Novak; Budapest, Hungary and Toronto, Canada

> 16:40 O-274 USE OF CARDIOVASCULAR MEDICATIONS AFTER KIDNEY

TRANSPLANTATION: ASSOCIATIONS WITH CARDIOVASCULAR RISK

PROFILE

Helen L. Pilmore, Bertram L. Kasiske, Ajay K. Israni, Melissa A. Skeans and

Jon J. Snyder; Auckland, New Zealand and Minneapolis, MN, United States

> 16:50 O-275 HOW TO PREDICT THE CARDIOVASCULAR (CV) RISK AFTER

RENAL TRANSPLANTATION

Maria Paola Salerno, Evelina Zichichi, Elisabetta Rossi, Franco Citterio,

Evaldo Favi, Gionata Spagnoletti and Marco Castagneto; Rome, Italy

> 17:00 O-276 METABOLIC SYNDROME AFTER RENAL TRANSPLANTATION:

CHANGES IN MARKERS OF INFLAMMATION AND ADHESION

MOLECULES

Giorgia Comai, Elisa Persici, Giuseppe Cianciolo, Gaetano La Manna,

Gabriele Donati, Maria L. Cappuccilli, Maria P. Scolari and Sergio Stefoni;

Bologna, BO, Italy

PARALLEL SESSION 32

Room 241

Composite tissues & Xenotransplantation

Chairs: Jean-Michel Dubernard, Lyon, France

Jean-Paul Soulillou, Nantes, France

> 16:10 O-277 FIRST FACE ALLOGRAFT: A THREE YEARS FOLLOW UP

Emmanuel Morelon, Sylvie Testelin, Palmina Petruzzo, Lionel Badet, Jean

Kanitakis, Assia Eljafari, Christophe Malcus, Nathalie Parquet, Benoit

Lengele, Xavier Martin, Bernard Devauchelle, Olivier Hequet, Mauricette

Michallet and Jean-Michel Dubernard; Lyon, France; Amiens, France; Paris,

France and Bruxelles, Belgium


16:10

18:00

> 16:20 O-278 CHRONIC REJECTION IN COMPOSITE TISSUE ALLOGRAFT

Palmina Petruzzo, Lionel Badet, Celine Dagot, Jean-Baptiste Piallat, Roland

Charpulat, Stephanie Boutroy, Pascale Bureau Du Colombier, Jean Kanitakis,

Xavier Martin, Jean Michel Dubernard and Emmanuel Morelon; Lyon,

France

> 16:30 O-279 VASCULARIZED BONE MARROW TRANSPLANTATION: AN

ALTERNATIVE TO CONVENTIONAL CELLULAR BONE MARROW

TRANSPLANTATION

Dragos Zamfi rescu, Ioan Lascar, Ion Zegrea, Marius Popescu, Maya

Simionescu and Marco Lanzetta; Bucharest, Romania; Monza, Milan, Italy

and Canberra, Australia

> 16:40 O-280 TRANSPLANTATION OF HCD46 TRANSGENIC PORCINE ISLETS

INTO DIABETIC NONHUMAN PRIMATES RESULTS IN LONG-TERM

NORMOGLYCEMIA UNDER LIMITED IMMUNOSUPPRESSION

Dirk J. van der Windt, Rita Bottino, Anna Casu, Nathalie Campanile, Cynthia

Smetanka, Jing He, Noriko Murase, Hidetaka Hara, Suyapa Ball, Bruce E.

Loveland, David Ayares, Fadi G. Lakkis, David K.C. Cooper and Massimo

Trucco; Pittsburgh, PA, United States; Blacksburg, PA, United States and

Heidelberg, VC, Australia

> 16:50 O-281 IMPROVEMENT IN CARDIAC FUNCTION AFTER PRECLINICAL

ORTHOTOPIC CARDIAC XENOTRANSPLANTATION

Christopher G.A. McGregor, Guerard W. Byrne, Michal Vlasin, Randall C.

Walker, Henry D. Tazelaar, William R. Davies, Krishnaswamy Chandrasekaran,

Elise A. Oehler, Barry A. Boilson, Barry S. Wiseman and John S. Logan;

Rochester, MN, United States

> 17:00 O-282 LIVER XENOTRANSPLANTATION USING Α1,3

GALACTOSYLTRANSFERASE GENE KNOCK-OUT (GTKO) PIGS

Burcin Ekser, Cassandra Long, Mohamed Ezzelarab, Chih Che Lin, Gabriel

J. Echeverri, Hidetaka Hara, Carol Phelps, David Ayares, Michael E. de Vera,

Anthony J. Demetris, David K.C. Cooper and Bruno Gridelli; Pittsburgh,

PA, United States; Padua, Italy; Blacksburg, VA, United States and Palermo,

Italy

PARALLEL SESSION 33

Room 251

How can we make the lungs breathing better?

Chairs: Annette Boehler, Zurich, Switzerland

Michiel E. Erasmus, Groningen, The Netherlands

> 16:10 O-283 INCIDENCE AND OUTCOME OF ABDOMINAL SURGICAL

INTERVENTIONS FOLLOWING THORACIC TRANSPLANTATION

Kai Timrott, Florian W.R Vondran, Mark D. Jäger, Andre Simon, Marius

Höper, Michael Neipp, Jürgen Klempnauer and Thomas Becker; Hannover,

Germany

> 16:20 O-284 INCIDENCE OF DE NOVO MALIGNANCIES IN LUNG

TRANSPLANT RECIPIENTS IN ITALY: A SINGLE-INSTITUTION

EXPERIENCE, 1991-2008

M. Agozzino, P. Piselli, M. Viganò, A. D’Armini, A. Cascina, T. Oggionni, F.

Meloni, C. Cimaglia, A. Agresta, D. Serraino and E. Arbustini; Pavia, Italy;

Rome, Italy and Aviano (PN), Italy

> 16:30 O-285 PROTOCOL-DRIVEN RECIPROCAL OUTCOMES OF

MALIGNANCY AND CHRONIC REJECTION AFTER LUNG

TRANSPLANTATION

Barbara C. Wagemakers, Erik A.M. Verschuuren, Michiel E. Erasmus, Boukje

van Dijk, Albert J.H. Suurmeijer and Wim van der Bij; Groningen, The

Netherlands

100


16:10

18:00

101

SCIENTIFIC

PROGRAMME

> 16:40 O-286 STABILIZATION OF KIDNEY FUNCTION IN

A CALCINEURININHIBITOR-EVEROLIMUS BASED

IMMUNOSUPPRESSION AFTER LUNG TRANSPLANTATION

Barbara Zweytick, Bahil Ghanim, Max Winter, Lila Hatosch, Georg Boehmig,

Peter Jaksch and Walter Klepetko; Vienna, Austria

> 16:50 O-287 SUBLINGUAL TACROLIMUS AS AN ALTERNATIVE TO

INTRAVENOUS ROUTE IN THORACIC ORGAN TRANSPLANTATION

Romain Guillemain, Cedric Collin, Sandrine Lefeuvre, Catherine Amrein,

Anne-Sophie Glouzman, Patrick Chevalier, Véronique Boussaud, Laurent

Havard and Eliane M. Billaud; Paris, France

> 17:00 O-288 TRANSPLANTATION OF TISSUE-ENGINEERED TRACHEAS -

DECELLULARIZATION BY ULTRA-HIGH PRESSURE METHOD AND

SEEDING OF MESENCHYMAL STEM CELLS-

Michiharu Suga, Toshiya Fujisato, Seiichi Funamoto, Kenichi Yoshida and

Takeshi Nakatani; Suita, Osaka, Japan

PARALLEL SESSION 34

Room 252 AB

Pancreas transplantation: clinical aspects

Chairs: Paolo Rigotti, Padua, Italy

Alexander Schaapherder, Leiden, The Netherlands

> 16:10 O-289 A RANDOMIZED, PROSPECTIVE TRIAL OF ALEMTUZUMAB

VERSUS RABBIT ANTI-THYMOCYTE GLOBULIN INDUCTION IN KIDNEY-

PANCREAS TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Robert Stratta, Rajinder Singh, Alan Farney, Jeffrey Rogers, William Doares,

Erica Hartman, Amber Reeves-Daniel, Michael Gautreaux, Samy Iskandar

and Patricia Adams; Winston Salem, NC, United States

> 16:20 O-290 COMPARING RISK FACTORS AND INCIDENCE OF CANCER

IN KIDNEY-PANCREAS AND KIDNEY TRANSPLANT RECIPIENTS

REPORTED BY UNITED NETWORK FOR ORGAN SHARING (UNOS)

BETWEEN 1988-2006

Alireza Hamidian Jahromi, Ian MacPhee, Mohamed Morsy, Jiri Fronek and

Nicos Kessaris; London, United Kingdom

> 16:30 O-291 PATIENTS AGED 50 YEARS OR MORE AS RECIPIENTS FOR

PANCREAS TRANSPLANTATION

Fabio Vistoli, Gabriella Amorese, Marco Del Chiaro, Chiara Croce, Carlo

Moretto, Stefano Signori, Sabrina Gabbriellini, Nelide De Lio, Vittorio

Perrone, Simone D’Imporzano, Piero Marchetti, Franco Mosca and Ugo

Boggi; Pisa, Italy

> 16:40 O-292 IMPACT OF DONOR AGE IN PANCREAS TRANSPLANTATION.

A UK SINGLE CENTRE EXPERIENCE

Bence Forgacs, Sanjay Mehra, Abbas Ghazanfar, Sarah Heap, Otilia-Maria

Mitu-Pretorian, Deep Malde, Ravi Pararajasingam, Tunde Campbell, Hany

Riad, Neil Parrott, Titus Augustine and Afshin Tavakoli; Manchester, United

Kingdom

> 16:50 O-293 LONG FUNCTIONING PANCREAS AND/OR KIDNEY GRAFT

PREVENTS CARDIOVASCULAR DEATH IN SPKTX RECIPIENTS

Tadeusz Grochowiecki, Katarzyna Grygiel, Zbigniew Galazka, Slawomir

Nazarewski, Krzysztof Madej, Magdalena Durlik, Slawomir Frunze, Leczek

Paczek and Jacek Szmidt; Warsaw, Poland


16:10

18:00

> 17:00 O-294 THE IMPACT OF PANCREAS ONLY TRANSPLANTATION ON

EXISTING RENAL FUNCTION: DOES IT DETERIORATE?

Sarah Heap, Bence Forgacs, Hany Riad, Neil Parrott, Tunde Campbell,

Ravi Pararajasingam, Colin Short, Mike Picton, Titus Augustine and Afshin

Tavakoli; Manchester, United Kingdom

PARALLEL SESSION 35

Grand Amphitheatre

Clinical immunosuppression: renal function

Chairs: Jean Paul Squiffl et, Liege, Belgium

Eric Thervet, Paris, France

> 16:10 O-295 IMPROVEMENT IN RENAL FUNCTION FOLLOWING

CONVERSION FROM LOW-DOSE MYCOPHENOLATE ACID TO

HIGHER-DOSE ENTERIC-COATED MYCOPHENOLATE SODIUM

(EC-MPS) WITH CONCOMITANT TACROLIMUS REDUCTION IN

MAINTENANCE KIDNEY TRANSPLANT RECIPIENTS

Nassim Kamar, Christophe Mariat, Laetitia Albano, Florence Villemain, Marie-

Christine Moal, Marc Ladrière, Benoit Barrou, Didier Ducloux, Stéphane

Quere, Fabienne Di Giambattista, François Berthoux and Lionel Rostaing;

Toulouse, France; Saint Etienne, France; Nice, France; Angers, France; Brest,

France; Vandoeuvre les Nancy, France; Paris, France; Besançon, France and

Rueil-Malmaison, France

> 16:20 O-296 RENAL FUNCTION, EFFICACY AND SAFETY OF SIROLIMUS AND

MYCOPHENOLAT MOFETIL THERAPY AFTER EARLY CALCINEURIN-

INHIBITOR WITHDRAWAL IN DE NOVO RENAL TRANSPLANT PATIENTS:

ONE-YEAR ANALYSIS OF A RANDOMIZED MULTICENTER TRIAL

Markus Guba, Johann Pratschke, Christian Hugo, Bernhard Krämer,

Constanze Nohr-Westphal, Jens Brockmann and Karl-Walter Jauch; Münster,

Germany; Berlin, Germany; Erlangen, Germany; Bochum, Germany; Rostock,

Germany and Muenster, Germany

> 16:30 O-297 RENAL FUNCTION IN EVEROLIMUS/ENTERIC-COATED

MYCOPHENOLATE SODIUM TREATED DE NOVO RENAL TRANSPLANT

RECIPIENTS AFTER CALCINEURIN INHIBITOR WITHDRAWAL: THE

ZEUS STUDY

T. Becker, W. Arns, K. Budde, U. Eisenberger, W. Fischer, S. Kramer, P. Reinke,

C. Sommerer and F. Pietruck; Hannover, Germany; Cologne, Germany; Berlin,

Germany; Bern, Switzerland; Nuremberg, Germany; Heidelberg, Germany

and Essen, Germany

> 16:40 O-298 SLOW RECOVERY OF GRAFT FUNCTION IS ASSOCIATED

WITH POOR GRAFT AND PATIENTS SURVIVAL IN LIVING DONOR

TRANSPLANTION

Chul Woo Yang, So Young Lee, Hye Eun Yoon, Bum Soon Choi and In Sung

Moon; Seoul, Korea

> 16:50 O-299 COMPARISON OF HISTOLOGICAL LESIONS ON TEN YEAR

PROTOCOL BIOPSIES IN KIDNEY TRANSPLANT RECIPIENTS WITH OR

WITHOUT CYCLOSPORINE

Renaud Snanoudj, Virginie Royal, Marc-Olivier Timsit, Catherine Girardin,

Henri Kreis, Frank Martinez, Eric Thervet, Laure-Hélène Noel and Christophe

Legendre; Paris, France

102


16:10

18:00

103

SCIENTIFIC

PROGRAMME

> 17:00 O-300 INTERSTITIAL FIBROSIS AND FIBROUS INTIMAL THICKENING

IN DE NOVO RENAL ALLOGRAFTS UNDER SIROLIMUS OR

CYCLOSPORINE: RESULTS OF A RANDOMISED, CONTROLLED TRIAL

(FIBRASIC)

Annemie T. Woestenburg, Patrick Peeters, Jacques Sennesael, Daniel

Abramowicz, Karl M. Wissing, Caroline Geers, Eric A. Van Marck, Andre

Van Daele, Angelika Jürgens, Benedicte De Winter, Gert A. Verpooten and

Jean-Louis Bosmans; Wilrijk, Belgium; Gent, Belgium; Brussel, Belgium and

Brussels, Belgium

PARALLEL SESSION 36

Blue Amphitheatre

New immunosuppressive strategies in kidney

transplantation

Chairs: Alan Jardine, Glasgow, United Kingdom

Domingos Paulo Lopes Silveira Machado, Lisbon, Portugal

> 16:10 O-301 IMMEDIATE VERSUS DELAYED EVEROLIMUS: COMPARABLE

RENAL FUNCTION AND WOUND HEALING COMPLICATIONS IN

KIDNEY TRANSPLANT RECIPIENTS AT RISK OF DELAYED GRAFT

FUNCTION

J. Dantal, F. Berthoux, M.C. Moal, L. Rostaing, C. Legendre, A.S. Blanc, F. Di

Giambattista and E. Cassuto; France and Paris, France

> 16:20 O-302 EC-MPS IS ASSOCIATED WITH SUPERIOR EFFICACY OUTCOMES

COMPARED TO MMF IN DE NOVO KIDNEY TRANSPLANT PATIENTS:

A POOLED ANALYSIS

Maurizio Salvadori, Klemens Budde, Herwig Holzer, Giovanni Civati, Bjørn

Lien and Wolfgang Arns; Florence, Italy; Berlin, Germany; Graz, Austria;

Milan, Italy; Oslo, Norway and Cologne, Germany

> 16:30 O-303 EXCELLENT EFFICACY AND SAFETY WITH ONCE-DAILY

PROLONGED-RELEASE TACROLIMUS (ADVAGRAF®) IN KIDNEY

TRANSPLANT PATIENTS

G.A. Mondragón-Ramirez, B.K. Krämer and E. Cassuto-Viguier; Cuernavaca,

Mexico; Herne, Germany and Nice, France

> 16:40 O-304 BASILIXIMAB VERSUS DACLIZUMAB COMBINED WITH

TRIPLE IMMUNOSUPPRESSION IN DECEASED DONOR RENAL

TRANSPLANTATION: A PROSPECTIVE RANDOMIZED STUDY

Miha Arnol, Katarina Omahen, Manca Oblak, Andrej F. Bren and Aljoša

Kandus; Ljubljana, Slovenia

> 16:50 O-305 EFFECT OF DONOR BONE MARROW CELLS INFUSION ON

ALLOIMMUNIZATION IN KIDNEY ALLOGRAFT PATIENTS

Gholamreza Pourmand, Ghasem Solgi, Abdolrasoul Mehrsai, Mohsen

Taherimahmoodi, Amirabdas Asadpour, Mandana Moheiydin, Berouz Nikbin,

Ali Akbar Amirzargar, Hannaneh Wahhabaghai and Maedeh Rezaeidanesh;

Tehran, Islamic Republic of Iran

> 17:00 O-306 FACTORS ASSOCIATED WITH GRAFT LOSS IN CHRONIC

KIDNEY TRANSPLANT RECIPIENTS CONVERTED TO MMF (CELLCEPT®)

Pierre Merville, Uwe Heemann, Herwig-Ulf Meier-Kriesche, Leishi Li, Jaime

Sánchez-Plumed, Kazimeirz Ciechanowski, Christoph Georg Gahlemann and

Helio Tedesco da Silva; Bordeaux, France; München, Germany; Gainesville,

United States; Nanjing, China; Valencia, Spain; Szczecin, Poland; Basel,

Switzerland and São Paulo, Brazil


PROGRAMME OVERVIEW

8:00

8:15

8:30

8:45

9:00

9:15

9:30

9:45

10:00

10:15

10:30

10:45

11:00

11:15

11:30

11:45

12:00

12:15

12:30

12:50

13:00

13:15

13:30

13:45

14:00

Wednesday, September 2 nd

State-of-the-

Art

Thoracic

Transplantation

p 110

Parallel Sessions

37-42

104

State-ofthe-Art

Liver

Transplantation

p 110

Coffee Break

Presidential Session

What’s hot - What’s new

Best Abstracts Presentation

Awards & Grants Ceremony

Closing Address

p 105-109

State-ofthe-Art

Basic Science

252-AB Blue A. Maillot p 111

Blue Amphitheatre

p 111-119


08:00

09:00

08:00

09:00

PARALLEL SESSION 37

Room Maillot

Complications and outcome in liver transplantation

Chairs: Darius Mirza, Birmingham, United Kingdom

Michael Olausson, Gothenburg, Sweden

105

SCIENTIFIC

PROGRAMME

> 08:00 O-307 THE PREDICTIVE VALUE OF INITIAL GRAFT FUNCTION AFTER

LIVER TRANSPLANTATION

Martin Stockmann, Johan F. Lock, Eugen Schwabauer, Constantin Weber

and Peter Neuhaus; Berlin, Germany

> 08:10 O-308 EXTENDED RIGHT LIVER GRAFTS OBTAINED BY EX SITU

SPLIT CAN BE USED SAFELY FOR PRIMARY AND SECONDARY

TRANSPLANTATION IN ADULTS WITH ACCEPTABLE BILIARY

MORBIDITY

Thomas Becker, Atsushi Takabe, Harald Schrem, Bastian Ringe, Frank Lehner,

Christian Strassburg, Hueseyin Bektas and Jürgen Klempanuer; Hannover,

Germany and Hannover, Germany

> 08:20 O-309 LIVER STEATOSIS AND NAFLD AFTER LIVER TRANSPLANTATION:

A STUDY ON PREVALENCE AND RISK-FACTORS

Jérôme Dumortier, Emile Giostra, Olivier Guillaud, Soraya Belbouab, Isabelle

Morard, Laurent Spahr, Olivier Boillot, Laura Rubbia-Brandt, Jean-Yves

Scoazec and Antoine Hadengue; Lyon, France and Geneva, Switzerland

> 08:30 O-310 SECOND LIVER RETRANSPLANTATION: INDICATIONS,

PROGNOSTIC FACTORS AND OUTCOME

Frank Ulrich, Panagiotis Fikatas, Michael Hippler-Benscheidt, Andreas

Pascher, Maxim Nebrig, Sascha Weiss, Gero Puhl, Olaf Guckelberger, Ulf

Neumann, Peter Neuhaus and Johann Pratschke; Berlin, Germany

> 08:40 O-311 CARDIOVASCULAR RISK FACTOR PREVALENCE AMONG

ACUTE LIVER FAILURE PATIENTS 5-YEARS AFTER LIVER

TRANSPLANTATION

Fredrik Åberg, Antti Jula, Krister Höckerstedt and Helena Isoniemi; Helsinki,

Finland

> 08:50 O-312 LIVER TRANSPLANT AND PREGNANCY

Victoria Ardiles, Rodgrigo Sanchéz Clariá, José Iniesta, Alejandra Villamil,

Miguel A. Ciardullo and Eduardo de Santibañes; Buenos Aires, Argentina

PARALLEL SESSION 38

Room 252 AB

Clinical immunosuppression: the liver

Chairs: Gabriela Berlakovich, Vienna, Austria

Christophe Duvoux, Créteil, France

> 08:00 O-313 TACROLIMUS (TAC) MONOTHERAPY IN LIVER

TRANSPLANTATION (LT): ONE-YEAR RESULTS OF A PROSPECTIVE,

RANDOMIZED, DOUBLE-BLINDED PLACEBO-CONTROLLED STUDY

Jan Lerut, Olga Ciccarelli, Eliano Bonaccorsi-Riani, Jules Mathis, Catherine

Verbaandert, Stéphanie Talpe, Julien Lemaire, Vincent Vanthuyne, Francine

Roggen, Chantal De Reyck, Pierre Goffette, Dominique Latinne, Giuseppe

Orlando, Jacques Rahier, Christine Sempoux, Pierre Wallemacq and Pierre

Giancarlo; Brussels, Belgium


08:00

09:00

> 08:10 O-314 TACROLIMUS CONCENTRATIONS IN PERIPHERAL BLOOD

MONONUCLEAR CELLS ARE ASSOCIATED WITH HISTOLOGICAL

STAGING OF REJECTION IN THE EARLY PHASE AFTER LIVER

TRANSPLANTATION

Arnaud Capron, Jan Lerut, Michel Mourad, Eliano Bonaccorsi-Riani,

Dominique Latinne, Vincent Haufroid and Pierre Wallemacq; Brussels,

Belgium

> 08:20 O-315 THE SILVER STUDY: AN INVESTIGATOR-INITIATED TRIAL TO

DETERMINE IF SIROLIMUS USE IMPROVES HCC RECURRENCE-FREE

SURVIVAL IN AFFECTED LIVER TRANSPLANT RECIPIENTS

Andreas A. Schnitzbauer, Philipp E. Lamby, Ingrid Mutzbauer, Carl Zuelke,

Hans J. Schlitt and Edward K. Geissler; Regensburg, Bavaria, Germany

> 08:30 O-316 ARE TACROLIMUS CONCENTRATION PATTERNS IN LIVER AND

KIDNEY PARENCHYMA AND LYMPHOCYTES PARALLEL TO BLOOD

CONCENTRATION PATTERNS?

Michel Mourad, Arnaud Capron, Denis Dufrane, Martine De Meyer, Luc De

Pauw, Pierre Wallemacq and Pierre Gianello; Brussels, Belgium

> 08:40 O-317 A NOVEL CONCEPT FOR IMMUNOSUPPRESSIVE THERAPY

IN ABO-INCOMPATIBLE LIVER TRANSPLANTATION: TEMPORAL

DEPLETION OF B CELLS COMBINED WITH B-1 CELL DIFFERENTIATION

BLOCKADE

Toshimitsu Irei, Yuka Igarashi, Hirofumi Tazawa, Kentaro Ide, Yuka Tanaka,

Masahiro Ohira, Hiroyuki Tahara, Masataka Banshodani, Akihiko Oshita,

Hironobu Amano, Hirotaka Tashiro, Toshiyuki Itamoto, Toshimasa Asahara

and Hideki Ohdan; Hiroshima, Japan

> 08:50 O-318 EXCELLENT EFFICACY AND RENAL FUNCTION IN LIVER

RECIPIENTS WITH ONCE-DAILY PROLONGED-RELEASE TACROLIMUS

(ADVAGRAF®)

O. Boillot, P. Trunecka and U. Neumann; Lyon, France; Prague, Czech

Republic and Berlin, Germany

PARALLEL SESSION 39

Room 242-AB

Clinical immunosuppression: side effects & prevention

Chairs: Uwe Heemann, Münster, Germany

Federico Oppenheimer, Barcelona, Spain

> 08:00 O-319 INFLUENCE OF IMMUNOSUPPRESSION IN TRADITIONAL

CARDIOVASCULAR RISK FACTORS. A SPANISH, MULTICENTER,

CROSS-SECTIONAL STUDY

Roberto Marcén, Gema Fernandez-Fresnedo, Luis Capdevila, Domingo del

Castillo, Ana Fernández-Rodriguez, Carmen Cantarell, Alberto Rodríguez,

Emilio Rodrigo, Cristina Galeano, Pedro Aljama, Joaquín Camps and Manuel

Arias; Madrid, Spain; Santander, Spain; Barcelona, Spain and Córdoba,

Spain

> 08:10 O-320 POLYOMAVIRUS BK VIRURIA AND VIREMIA IN DE NOVO

RENAL TRANSPLANTATION COMPARING CYCLOSPORINE AND

TACROLIMUS: A MULTIVARIATE ANALYSIS FROM THE DIRECT STUDY

H.H. Hirsch, F. Vincenti, S. Friman, A. Wiecek, M.D. Pescovitz, T. Jenssen,

L. Rostaing, E.H. Scheuermann, F. Citterio, S. Chadban, K. Budde and H.

Prestele; Basel, Switzerland

106


08:00

09:00

107

SCIENTIFIC

PROGRAMME

> 08:20 O-321 RISK OF KAPOSI’S SARCOMA FOLLOWING SOLID ORGAN

TRANSPLANTATION. A MULTICENTER STUDY IN 4767 RECIPIENTS:

ITALY 1970-2006

P. Piselli, G. Busnach, F. Citterio, M. Frigerio, E. Arbustini, P. Burra, A.D. Pinna,

V. Bresadola, G.M. Ettorre, A Buda, U. Baccarani, A. Lauro, C. Cimaglia, G.

Spagnoletti, G. Zanus, A. Lenardon, M. Agozzino, M. Gambato, C. Zanfi , L.

Miglioresi, P. Di Gioia, E. Girardi and D. Serraino; Rome, Italy; Milan, Italy;

Pavia, Italy; Padua, Italy; Bologna, Italy; Udine, Italy and Aviano (PN), Italy

> 08:30 O-322 CONVERSION TO SIROLIMUS FROM CALCINEURIN INHIBITORS

TO PREVENT NON-MELANOMA SKIN CANCER (NMSC) IN

RENAL TRANSPLANT RECIPIENTS AT HIGH RISK FOR NMSC

Rowan Walker, Scott Campbell, Graeme Russ and Sandi See Tai; Melbourne,

VC, Australia; Brisbane, Australia; Woodville, Australia and Collegeville, PA,

United States

> 08:40 O-323 STEROID AVOIDANCE IMMUNOSUPPRESSIVE PROTOCOL:

LONG TERM EVALUATION OF PROSPECTIVE RANDOMIZED STUDY

AFTER LIVE DONOR RENAL ALLOTRANSPLANT

Ahmed H. Nematalla, Mohamed A. Bakr, Osama A. Gheith, Ahmed E. Akl

and Mohamed A. Ghoneim; Mansoura, DK, Egypt

> 08:50 O-324 GASTROINTESTINAL DISORDERS IN PATIENTS WHO

UNDERGONE TRASNPLANTATION: DO IMMUNOSUPPRESSIVE DRUGS

REALLY INFLUENCE THE SMALL OR LARGE BOWEL TRANSPORT AND

BARRIER FUNCTION?

Maciej Malinowski, Peter Martus, Bodil Engelmann, Johan F. Lock, Peter

Neuhaus and Martin Stockmann; Berlin, Germany

PARALLEL SESSION 40

Room 241

Pediatric transplantation

Chairs: Christophe Chardot, Birmingham, United Kingdom

Piotr Jerzy Kalicińsky, Krakow, Poland

> 08:00 O-325 IS THERE A NEED FOR LONG TERM PROTOCOL LIVER

BIOPSIES IN PEDIATRIC LIVER TRANSPLANTATION RECIPIENTS?

Dominique Debray, Monique Fabre, Dalila Habès, Frédéric Gauthier and

Olivier Bernard; Kremlin-Bicêtre, France

> 08:10 O-326 CONVERSION FROM PROGRAF TO ADVAGRAF IN

ADOLESCENTS WITH NORMAL GRAFT FUNCTION AFTER LIVER

TRANSPLANTATION

Loreto Hierro, Enrique Piñana, Esteban Frauca, Angela de la Vega, Carmen

Camarena, Gema Muñoz Bartolo, Carmen Díaz, Maria Dolores Lledín,

Francisco Hernandez, Nuria Leal, Manuel Gámez, Jose Luis Encinas, Manuel

López Santamaría, Antonio Carcas and Paloma Jara; Madrid, Spain

> 08:20 O-327 OPTIMAL LONG TERM GRAFT ACCEPTANCE FOLLOWING

PEDIATRIC LIVER TRANSPLANTATION WITH STEROID-FREE

TACROLIMUS-BASED IMMUNOSUPPRESSION

Aurore Pire, Magda Janssens, Andrea Brunati, Catherine deMagnée,

Francoise Smet, Etienne Sokal, Raymond Reding and Christophe Bourdeaux;

Brussels, Belgium

> 08:30 O-328 IMPROVED SURVIVAL FOLLOWING PEDIATRIC LIVER

TRANSPLANTATION, TOWARD A 100 % SURVIVAL PROSPECT?

Christophe Bourdeaux, Catherine deMagnée, Florence Dedobbeleer,

Andrea Brunati, Magda Janssen, Etienne Sokal and Raymond Reding;

Brussels, Belgium


08:00

09:00

> 08:40 O-329 FAVORABLE LONG-TERM EFFECTS OF MYCOPHENOLATE

MOFETIL (CELLCEPT®) INTRODUCTION IN PEDIATRIC RENAL

TRANSPLANT PATIENTS

Lars Pape, Burkhard Tönshoff, Jörg Dötsch, Alberto Holm, Sigrid Burkhalter

and Herwig-Ulf Meier-Kriesche; Hannover, Germany; Heidelberg, Germany;

Erlangen, Germany; Mexico City, Mexico; Basel, Switzerland and Gainesville,

United States

> 08:50 O-330 KIDNEY TRANSPLANTATION FROM PEDIATRIC DONORS

AFTER CARDIAC DEATH (DCD): 25 YEAR EXPERIENCE IN THE

NETHERLANDS

Eva E. de Vries, Maarten G. Snoeijs and Ernest van Heurn; Maastricht, The

Netherlands

PARALLEL SESSION 41

Blue Amphitheatre

Belatacept in kidney transplantation

Chairs: Anders Hartmann, Oslo, Norway

Raimund Margreiter, Innsbruck, Austria

> 08:00 O-331 PRIMARY OUTCOMES FROM A RANDOMIZED, PHASE III

STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT

RECIPIENTS (BENEFIT STUDY)

F. Vincenti, J.M. Grinyo, B. Charpentier, J.D. Medina-Pestana, L. Rostaing,

Y. Vanrenterghem, G.B. Di Russo, P. Garg, C.-S. Lin and C. Larsen; San

Francisco, CA, United States; Barcelona, Spain; Kremlin-Bicetre, France;

Sao Paulo, Brazil; Toulouse, France; Leuven, Belgium; Princeton, NJ, United

States and Atlanta, GA, United States

> 08:10 O-332 PRIMARY OUTCOMES FROM A RANDOMIZED, PHASE III STUDY

OF BELATACEPT VS CYCLOSPORINE IN ECD KIDNEY TRANSPLANTS

(BENEFIT-EXT STUDY)

FA. Durrbach, C. Larsen, J.D. Medina-Pestana, Y. Vanrenterghem, F. Vincenti,

S. Florman, A.J. Block, P. Garg, K. Sen and J.M. Grinyo; Kremlin Bicetre,

France; Atlanta, GA, United States; Sao Paulo, Brazil; Leuven, Belgium; San

Francisco, CA, United States; New Orleans, United States; Barcelona, Spain

and Princeton, NJ, United States

> 08:20 O-333 BELATACEPT IS ASSOCIATED WITH PRESERVATION OF

RENAL FUNCTION AND STRUCTURE AT 1 YEAR COMPARED TO

CYCLOSPORINE IN EXTENDED CRITERIA DONOR (ECD) KIDNEY

TRANSPLANT PATIENTS (BENEFIT-EXT STUDY)

J.D. Medina-Pestana, J.M. Campistol, M. del C. Rial, V.D. Garcia, T. Becker,

M. Agarwal, P. Garg and T. Duan; Sao Paulo, Brazil; Barcelona, Spain; Buenos

Aires, Argentina; Porto Alegre, RS, Brazil; Hanover, Germany and Princeton,

NJ, United States

> 08:30 O-334 BELATACEPT IS ASSOCIATED WITH IMPROVED

CARDIOVASCULAR AND METABOLIC RISK FACTORS COMPARED TO

CYCLOSPORINE IN KIDNEY TRANSPLANT PATIENTS (BENEFIT AND

BENEFIT-EXT STUDIES)

Y. Vanrenterghem, E. Mancilla-Urrea, P. Lang, M. Agarwal, A.J. Block and J.

Xing; Leuven, Belgium; Mexico City, Mexico; Creteil, France and Princeton,

NJ, United States

108


08:00

09:00

> 08:40 O-335 ONE YEAR SAFETY PROFILE OF BELATACEPT IN KIDNEY

TRANSPLANT PATIENTS FROM THE BENEFIT AND BENEFIT-EXT

STUDIES

C. Larsen, B. Charpentier, J.M. Grinyo, J.D. Medina-Pestana, Y.

Vanrenterghem, F. Vincenti, D. Thomas, G.B. Di Russo and R. Shi; Atlanta,

GA, United States; Kremlin Bicetre, France; Barcelona, Spain; Sao Paulo,

Brazil; Leuven, Belgium; San Francisco, CA, United States and Princeton,

NJ, United States

> 08:50 O-336 IMMUNOSUPPRESSION WITH BELATACEPT-BASED,

CNI-FREE, STEROID-AVOIDING REGIMENS IN KIDNEY TRANSPLANT

RECIPIENTS: 6 MONTH, INTERIM RESULTS

J.M. Grinyo, W. Marks, F. Vincenti, D. Kaufman, B. Marder, S. Woodle, F.

Citterio, M. Agarwal, P. Garg, C.-S. Lin and R. Ferguson; Barcelona, Spain;

Seattle, WA, United States; San Francisco, CA, United States; Chicago,

United States; Dever, United States; Cincinnati, United States; Rome, Italy;

Princeton, NJ, United States and Columbus, United States

PARALLEL SESSION 42

Room 251

Late Breaking

Chairs: Thierry Berney, Geneva, Switzerland

Dirk Van Raemdonck, Leuven, Belgium

SCIENTIFIC

PROGRAMME

> 08:00 LB-1 CYCLOSPORINE (CyA) VERY LOW DOSE WITH EVEROLIMUS

(E) HIGH DOSE IS ASSOCIATED WITH BETTER OUTCOMES IN

RENAL TRANSPLANT PATIENTS WITH RESPECT TO STANDARD

TREATMENT WITH EC-MPS (M)

Elisabetta Bertoni, Aida Larti, Silvia Farsetti, Giuseppina Rosso, Lorenzo Di

Maria, Maria Zanazzi and Maurizio Salvadori; Florence, Italy

> 08:10 LB-2 RANDOMISED CONTROLLED TRIAL OF ALEMTUZUMAB-

TACROLIMUS MONOTHERAPY WITH DACLIZUMAB-TACROLIMUS-

MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION

Adam McLean, Ka-Kit Chan, Jack Galliford, Dawn Goodall, Rawya Charif,

Anthony Dorling, Anthony Warrens, Thomas Cairns, Vassilios Papalois,

Nadey Hakim and David Taube; London, United Kingdom

> 08:20 LB-3 BORTEZOMIB THERAPY FOR ACUTE HUMORAL REJECTION

J.J. Everly, R.C. Walsh, P.A. Brailey, R.R. Alloway, A.H. Rike, L.J. Arend, G.

Mogilishetty, A. Govil, A. Tevar and E.S. Woodle; Cincinnati, OH, United

States

> 08:30 LB-4 FASTING PROTECTS AGAINST HEPATIC ISCHEMIA/

REPERFUSION INJURY VIA UPREGULATION OF HO-1 AND

ANTIOXIDANT DEFENCE

Marielle Verwey, Tessa van Ginhoven, James Mitchell, Sandra van den Engel,

Fred Bonthuis, Elham Torabi, Jan IJzermans, Jan Hoeijmakers and Ron de

Bruin; Rotterdam, Netherlands and Boston, United States

> 08:40 LB-5 PRELIMINARY RESULTS OF A STUDY FOR LIVER DONOR

QUALITY WITHIN THE EUROTRANSPLANT DATABASE: STRIKING

DIFFERENCES WITH THE UNOS LIVER DONOR QUALITY!

Andries E. Braat, Joris J. Blok, Nigel G. Kooreman, Jeroen Dubbeld, Hein

Putter, Axel O. Rahmel, Robert J. Porte, Xavier Rogiers and Jan Ringers;

Leiden, Netherlands; Groningen, Netherlands and Ghent, Belgium

109


09:00

10:30

09:00

10:30

> 08:50 LB-6 PANCREAS TRANSPLANTATION FROM NON-HEART BEATING

DONORS IN THE UNITED KINGDOM

Anand Sivaprakash Rathnasamy Muthusamy, Alexander Hudson, Lisa

Mumford and Peter J. Friend; Oxford, Oxfordshire, United Kingdom; Bristol,

United Kingdom and Oxford, United Kingdom

STATE OF THE ART

THORACIC TRANSPLANTATION

Room 252 AB

New concepts and modalities

Chairs: Ugolino Livi, Udine, Italy

Martin Strüber, Hannover, Germany

> 09:00 Current status of cellular therapy in cardiac repair

Alfred Kocher, Innsbruck, Austria

> 09:20 Role of mesenchymal stem cells in modulating rejection following

cardiac transplantation

Denis Angoulvant, Lyon, France

> 09:40 Artifi cial lung as bridge to lung transplantation

Martin Strüber, Hannover, Germany

> 10:00 Preserving renal function following thoracic transplantation

Maryvonne Hourmant, Nantes, France

> 10:20 Discussion

STATE OF THE ART

LIVER TRANSPLANTATION

Blue Amphitheatre

Life Style in liver transplantation

Chairs: René Adam, Paris, France

Andrew K. Burroughs, London, United Kingdom

> 09:00 Schooling and psycho-social adaptation after liver transplantation

Barbara Wildhaber, Geneva, Switzerland

> 09:20 Sexual and reproductive function in men and women after liver

transplantation

Patrizia Burra, Padua, Italy

> 09:40 Employment after liver transplantation

Pietro Majno, Geneva, Switzerland

> 10:00 Sporting and hobbies after organ transplantation

Jacques Pirenne, Leuven, Belgium

> 10:20 Discussion

110


09:00

10:30

11:00

13:30

STATE OF THE ART

BASIC SCIENCE

Room Maillot

Innate immunity in transplantation

Chairs: Michel Braun, Brussels, Belgium

Johann Pratschke, Berlin, Germany

> 09:00 Evolution of innate allorecognition

Fadi Lakkis, Pittsburg, United States

> 09:20 The role of dentritic cells

Francesca Fallarino, Perugia, Italy

> 09:40 Toll like Receptors: coming of age

Maria Luisa Alegre, Chicago, United States

> 10:00 New roles of complements in transplantation

Steven H. Sacks, London, United Kingdom

> 10:20 Discussion

PRESIDENTIAL & AWARDS SESSION

Blue Amphitheatre

Chairs: Ferdinand Mühlbacher, ESOT President

Rutger J. Ploeg, ESOT Secretary

> 11:00 Presidential address

ESOT President elect

> 11:15 Address of the President of World Transplant Games Federation

Olivier Coustère

> 11:25 What’s hot, what’s new - Clinical

Josep Grinyò, Barcelona, Spain

> 11:45 What’s hot, what’s new - Basic science

Michel Goldman, Brussels, Belgium

BIOTEST Awards for Best Oral Presentation

in Clinical Transplantation and in Basic Science

Chairs: Ferdinand Mühlbacher, Vienna, Austria

Rutger J. Ploeg, Groningen, The Netherlands

SCIENTIFIC

PROGRAMME

> 12:05 Biotest Clinical Award 1 - Alan Jardine

O-337 THE IMPACT STUDY: PROPHYLAXIS WITH VALGANCICLOVIR

FOR UP TO 200 DAYS POST-TRANSPLANT IN HIGH RISK KIDNEY

RECIPIENTS SIGNIFICANTLY REDUCES THE INCIDENCE OF

CMV DISEASE COMPARED TO 100 DAYS USE FOLLOWED BY

PLACEBO

Alan G. Jardine, Yvon Lebranchu, Flavio Vincenti, Ingeborg Hauser, Emily

Blumberg, Jeffrey Punch, Daniel Abramowicz, Jane Ives, Patrick Peeters,

Nigel Pluck and Atul Humar; Glasgow, United Kingdom; Tours, France; San

Francisco, CA, United States; Frankfurt, Germany; Philadelphia, PA, United

States; Ann Arbor, MI, United States; Brussels, Belgium; Welwyn Garden

City, United Kingdom; Gent, Belgium and Edmonton, AB, Canada

111


12:15 Biotest Clinical Award 2 - Annaick Pallier

O-338 OPERATIONALLY TOLERANT KIDNEY GRAFT RECIPIENTS

DISPLAY INCREASED NUMBERS OF PERIPHERAL B CELLS WITH

AN INHIBITORY PHENOTYPE

Annaick Pallier, Sophie Hillion, Richard Danger, Magali Giral, Nicolas

Degauque, Maud Racape, Emilie Dugast, Joanna Ashton-Chess, Segolene

Pettré, Cecile Braudeau, Jean-Paul Soulillou and Sophie Brouard; Nantes,

France, Metropolitan and Brest, France, Metropolitan

> 12:25 Biotest Clinical Award 3 - Michael H. Mengel

O-339 CAN MOLECULAR CHANGES IN PROTOCOL BIOPSIES

PREDICT THE FUTURE? CORRELATING MICROARRAY DATA TO

FUTURE SCARRING, DYSFUNCTION, AND REJECTION IN RENAL

ALLOGRAFTS

Michael H. Mengel, Daniel Kayser, Wilfried Gwinner, Anke Schwarz, Jeff

Reeve, Gunilla Einecke, Hermann Haller and Philip F. Halloran; Edmonton,

Canada and Hannover, Germany

> 12:35 Biotest Basic Science Award 1 - Thomas Conlon

O-340 ALLOSPECIFIC B CELLS CAN RECEIVE EFFECTIVE

HELP FROM CD4 T CELLS THAT RECOGNIZE AN UNRELATED

ALLOANTIGEN

Thomas Conlon, Kourosh Saeb-Parsy, Siva Sivaganesh, Reza Motallebzadeh,

Chris Callaghan, Eleanor Bolton, Andrew Bradley and Gavin Pettigrew;

Cambridge, United Kingdom

> 12:45 Biotest Basic Science Award 2 - Robert Sucher

O-341 INDOLEAMINE 2,3-DIOXYGENASE (IDO) AND Treg

SUPPORT ARE CRITICAL FOR CTLA4Ig MEDIATED TOLERANCE

INDUCTION TO SOLID ORGAN ALLOGRAFTS

Robert Sucher, Nikolaus Fischler, Rupert Oberhuber, Robert Oellinger, Stefan

Schneeberger, Irmgard Kronberger, Dietmar Fuchs, Ernst R. Werner, Bettina

Zelger, George Tellides, Nina Pilat, Thomas Wekerle, Raimund Margreiter

and Gerald Brandacher; Innsbruck, Austria; New Haven, United States and

Vienna, Austria

> 12:55 Biotest Basic Science Award 3 - Alexander H.K. Kroemer

O-342 ACTIVATION STATUS OF NK CELLS DRIVES DICHOTOMOUS

T CELL RESPONSE

Alexander H.K. Kroemer, Xiang Xiao, Karoline Edtinger, Gulcin Demirci and

Xian C. Li; Boston, MA, United States

Awarded by Dr. Georg Ebers, in representation of Biotest

> 13:05 - 13:30

Awards Ceremony & Grants Presentation

Chairs: Ferdinand Mühlbacher, Vienna, Austria

Rutger J. Ploeg, Groningen, The Netherlands

ESOT BEST POSTER AWARDS

3 posters selected during the congress from the top 10% of the highest

scoring posters

Awarded by Guido Persijn, ESOT Ambassador, in representation of ESOT

112


EUROLIVER FOUNDATION AWARDS

Willij Zuidema

> O 75 FOLLOW-UP STUDY AMONG SAMARITAN DONORS: MOTIVATION

TO DONATE

Willij Zuidema, Emma K. Massey, Leonieke W. Kranenburg, Gert Hak,

Ruud A.M. Erdman, Medard T. Hilhorst, Jan N.M. Ijzermans and Willem

Weimar. Internal Medicine, Erasmus MC, Rotterdam, Netherlands; Medical

Psychology and Psychotherpy, Erasmus MC, Rotterdam, Netherlands;

General Surgery, Erasmus MC, Rotterdam, Netherlands and Medical Ethics,

Erasmus MC, Rotterdam, Netherlands.

Elisabetta Bertoni

> O133 PREEMPTIVE CADAVERIC RENAL TRANSPLANTATION: FAIRNESS

AND UTILITY IN THE CASE OF HIGH DONATION RATE

Elisabetta Bertoni, Giuseppina Rosso, Aida Larti, Alberto Rosati, and

Maurizio Salvadori. Renal Unit, Careggi University Hospital, Florence, Italy

Yan G. Moysyuk

> O248 TRENDS IN ORGAN DONATION AND TRANSPLANTATION IN

RUSSIA. ANALYSIS OF 2006-2008 NATIONAL REGISTRY DATA

Sergey V. Gautier, Yan G. Moysyuk, Marina G. Minina, and Oleg N. Reznik.

Clinical Organ Transplantation, Shumakov State Scientifi c Center of

Transplantology and Artifi cial Organs, Moscow, Russian Federation; Moscow

Coordinating Center of Organ Donation, Moscow, Russian Federation

and Transplantation Department, Djanelidze State Research Institute for

Emergency, S.Petersburg, Russian Federation

Awarded by Herman Tob, EUROLIVER FOUNDATION

ESOT PARIS 2009 YOUNG INVESTIGATOR AWARDS

SCIENTIFIC

PROGRAMME

Elisenda Bañón-Maneus

> O-002 2D-DIGE ANALYSIS OF THE URINE PROTEOME IN CHRONIC

ALLOGRAPH DYSFUNCTION

Elisenda Bañón-Maneus, Fritz K. Diekmann, Daniel Moya-Rull, Luis F.

Quintana, María José Ramírez-Bajo, Jordi Rovira, Ignacio Revuelta, Alex

Gutierrez-Dalmau, Amanda Sole-Gonzalez and Josep M. Campistol;

Barcelona, Catalunya, Spain

Lidia Ghisdal

> O-003 TCF7L2 POLYMORPHISM IS AN INDEPENDENT RISK FACTOR FOR

NEW ONSET DIABETES MELLITUS AFTER TRANSPLANTATION: A

COHORT STUDY ON 1229 RENAL TRANSPLANT PATIENTS

Lidia Ghisdal, Christophe Baron, Yvon Lebranchu, Jean-Michel Halimi, Yann

Lemeur, Jean-Philippe Rerolle, Mireille Drouet, Arnaud Lionet, François

Glowacki, Christian Noël, Karl Martin Wissing, Daniel Abramowicz and Marc

Abramowicz; Brussels, Belgium; Tours, France; Limoges, Belgium and Lille,

France

Andrew Brett

> O-092 RISK FACTORS FOR POST-TRANSPLANTATION MALIGNANCY

IN HEART, LUNG AND HEART-LUNG TRANSPLANT RECIPIENTS

REPORTED BY UNOS 1988-2006

Andrew Brett, Cara R. Baker, Mohammed Morsy, Iain MacPhee, Jiri Fronek

and Nicos Kessaris; London, United Kingdom

Rebecca Roberts

> O-129 A UK REGISTRY STUDY OF THE INCIDENCE OF TRANSMISSION

OF INTRACRANIAL MALIGNANCY

Rebecca Roberts, Karen Wright, David Greenberg, Claire Hamilton, Dave

Collett and Christopher Watson; Cambridge, United Kingdom and Bristol,

United Kingdom

113


Toshihito Hirai

> O-138 THE EVALUATION OF TWO DIFFERENT PRECONDITIONING

REGIMENS FOR ABO-INCOMPATIBLE LIVING KIDNEY DONOR

TRANSPLANTATION. A COMPARISON OF SPLENECTOMY VS.

RITUXIMAB-TREATED NON-SPLENECTOMY PRECONDITIONING

REGIMENS

Toshihito Hirai, Hideki ishida, Yuuki Miyauchi, Tomokazu Shimizu, Hiroki

Shirakawa, Kazuya Omoto and Kazunari Tanabe; Shinjuku-ku, Tokyo, Japan

A. Loupy

> O-141 NATURAL HISTORY OF SUBCLINICAL ANTIBODY-MEDIATED

REJECTION (SAMR) IN KIDNEY TRANSPLANT RECIPIENTS WITH

DONOR SPECIFIC ANTIBODIES (DSA)

A. Loupy, C. Suberbielle, G. Hill, C. Lefaucheur, D. Anglicheau, J. Zuber,

Mo Timsit, F. Martinez, E. Thervet, P. Bruneval, C. Legendre and D. Nochy;

Paris, France

Ayyaz A. Ali

> P-172 THE RESUSCITATED DECEASED DONOR HEART IS FUNCTIONALLY

SUPERIOR TO THE BRAINSTEM DEAD DONOR HEART

Ayyaz A. Ali, Giovanni Fajardo, Shoichi Tsuda, Grant Budas, Ziad Ali, Thomas

Quertermous, Daniel Bernstein, Steven Tsui, Robert Robbins, Michael

Fischbein, Stephen Large and Euan Ashley; Palo Alto, CA, United States

and Papworth Everard, Cambridgeshire, United Kingdom

Wei Wang

> O-175 THE ROLE OF COMPLEMENT REGULATORY PROTEINS IN

CARDIOPROTECTION OF ISCHEMIC POSTCONDITIONING IN

HEART ISCHEMIC-REPERFUSION INJURY

Wei Wang, Yuchuan Huang, Huaiqiang Sun, Li Zhang and Hong Bu; Chengdu,

Sichuan, China and Chengdu, China

Olivier Thaunat

> O-267 INTRAGRAFT ECTOPIC LYMPHOID TISSUE DURING CHRONIC

REJECTION: HIJACKING OF AN EMBRYONIC DEVELOPMENTAL

PROGRAMME PROMOTES THE DEVELOPMENT OF A LOCAL

AGGRESSIVE ALLOIMMUNE RESPONSE

Olivier Thaunat, Natacha Patey, Chantal Gautreau, Emmanuel Morelon,

Stéphanie Graff-Dubois and Antonino Nicoletti; Lyon, France and Paris,

France

Dirk J. van der Windt

> O-280 TRANSPLANTATION OF hCD46 TRANSGENIC PORCINE ISLETS

INTO DIABETIC NONHUMAN PRIMATES RESULTS IN LONG-TERM

NORMOGLYCEMIA UNDER LIMITED IMMUNOSUPPRESSION

Dirk J. van der Windt, Rita Bottino, Anna Casu, Nathalie Campanile, Cynthia

Smetanka, Jing He, Noriko Murase, Hidetaka Hara, Suyapa Ball, Bruce E.

Loveland, David Ayares, Fadi G. Lakkis, David K.C. Cooper and Massimo

Trucco; Pittsburgh, PA, United States; Blacksburg, PA, United States and

Heidelberg, VC, Australia

Awarded by Bernard Charpentier and Yvon Lebranchu, ESOT 2009 Chairs.

114


EPITA European Pancreas & Islet Transplant Association AWARDS

Best abstract in the fi elds of Pancreas transplantation - Anand Sivaprakash

Rathnasamy Muthusamy

> LB-06 PANCREAS TRANSPLANTATION FROM NON-HEART BEATING

DONORS IN THE UNITED KINGDOM

Anand Sivaprakash Rathnasamy Muthusamy, Alexander Hudson, Lisa

Mumford and Peter J. Friend; Oxford, Oxfordshire, United Kingdom; Bristol,

United Kingdom and Oxford, United Kingdom.

Best abstract in the fi elds of Islet transplantation - Nadja Niclauss

> P-179 INFLUENCE OF DONOR AGE ON ISLET ISOLATION AND

TRANSPLANTATION OUTCOME

Nadja Niclauss, Domenico Bosco, Philippe Morel, Sandrine Demuylder-

Mischler, Coralie Brault, Antonino Sgroi, Géraldine Parnaud, Yannick Muller,

Laurianne Giovannoni, Pierre-Yves Benhamou and Thierry Berney; Geneva,

Switzerland; Lyon, France and Grenoble, France.

Awarded by Thierry Berney, EPITA Chair

� 2008 ASTELLAS Junior Basic Science Grant

Dr. S.F. Fichtner-Feigl

Dept. of Surgery, University of Regensburg

Regensburg, Germany

� 2009 ASTELLAS Junior Basic Science Grant

Dr. M. Hill

INSERM U643, CHU Nantes, ITERT,

Nantes, France

Awarded by Albert Groenewoud, in representation of Astellas

� 2009 ASTS-ESOT Exchange Grant

Dr. J. A. Hutchinson

Dept. of Experimental Surgery

Regensburg University

Regensburg, Germany

Awarded by Robert Merion, ASTS President

SCIENTIFIC

PROGRAMME

� 2008 BRISTOL-MEYERS SQUIBB Senior Clinical Research

Grant

Dr. M.W. Bodingbauer

Dept. of Transplantation,

Medical University Vienna

Vienna, Austria

115


� 2009 BRISTOL-MEYERS SQUIBB Senior Clinical Research

Grant

Dr. V. Papalois

Hammersmith Hospital,

the West London Renal and Transplant Centre,

Imperial College Healthcare NHS Trust

London, United Kingdom

Awarded by Simon Beck, in representation of Bristol-Meyers

Squibb

� 2008 NOVARTIS Short Stay-and-Study Grants

Dr. D. Pellicanò

Department of Surgical and Gastroenterological Sciences

University of Padua

Padua, Italy

Dr. L.M. Marinov

Transplantation Unit

Hopital Universitaire de Geneve

Geneva, Switzerland

Dr. F. Renyi-Vamos

Department of General and Thoracic Surgery

National Institute of Oncology

Budapest, Hungary

Dr. A. Celebic

Department of Surgery

Institute of Oncology and Radiology of Serbia

Belgrade, Serbia

� 2008 NOVARTIS ESOT- SLATC Travel Grant

Dr. E. Bonaccorsi Riani

Transplant Unit

Hospital Felicio Rocho

Belo Horizonte, Brazil

� 2009 NOVARTIS ESOT-STALYC Travel Grant

Dr. C.G. Moore

PhD student

Universidad de Chile

Santiago, Chile

� 2009 NOVARTIS Short Stay-and-Study Grants

Miss. K.R. Tang-Quan

Stanford School of Medicine,

Dept. of Cardiothoracic Surgery

Stanford, United States

Dr. C.A. Apestegui

Güemes 3594 (1425)

Buenos Aires, Argentina

116


Dr. A. Magoni Rossi

Dept. of General and Transplantation Surgery

S. Martino Hospital

Genova, Italy

Awarded by Yugo Takahashi, in representation of Novartis

� 2008 ESOT Junior Clinical Research Grant

Dr. A.G.N. Robertson

Dept. of Cardio-pulmonary Transplantation

Cardiothoracic Centre, Freeman Hospital

Newcastle upon Tyne, United Kingdom

� 2009 ESOT Junior Clinical Research Grant

Dr. M.-H. Dahlke

University Medical Centre Regensburg,

Department of Surgery,

Regensburg, Germany

Awarded by Ferdinand Mühlbacher, ESOT President

� 2008 ESOT Basic Science Travel Grants

Dr. Carla C. Baan

Department of Internal Medicine,

Transplantation Laboratory,

Erasmus Medical Center

Erasmus University Rotterdam, The Netherlands

� 2008 ESOT Senior Basic Science Grant

Dr. Xian-Liang Li

INSERM U 643

Nantes, France

� 2009 ESOT Senior Basic Science Grant

Dr. T. Wekerle,

Assoc. Prof. Group Leader,

University of Vienna Medical Center,

Division of Transplantation,

Dept. of Surgery,

Vienna, Austria

Awarded by Ignacio Anegon, in representation of EBSOT Basic

Science Committee

� 2007 ESOT Student Travel Grants

Dr. Mara Giovanelli

Ospedale Bolognini di Seriate

General Surgery

Seriate (BG),Italy

117

SCIENTIFIC

PROGRAMME


Long-term protection

in good hands

Proven short- and long-term efficacy1-4 More than 20 years experience in transplantation

Continuous evolution – Proven long-term benefit

1. Vincenti F et al. Am J Transplant 2007; 7: 1-9 2. Kaplan B et al. J Am Soc Nephrol 2003; 14: 2980-2984

3. Levy G et al. Liver Transplantation 2006; 12: 1464-1472 4. Levy G et al. Transplantation 2004; 77 (11): 1632-1638

SANDIMMUN NEORAL ® 100 mg/mL oral solution

SANDIMMUN NEORAL ® 10 mg, 25 mg, 50 mg, 100 mg soft gelatine capsules

SANDIMMUN ® 50 mg/mL concentrate for solution for infusion

Presentation: Oral solution containing 100 mg/mL ciclosporin. Soft gelatine capsules containing 10 mg, 25 mg, 50 mg and 100 mg ciclosporin. Concentrate

for solution for infusion containing 50 mg/mL ciclosporin (contains polyoxyethylated castor oil as excipients). Indications: Solid organ transplantation

(kidney, liver, heart, combined heart-lung, lung, pancreas); bone marrow transplantation; endogenous uveitis; nephrotic syndrome; severe active rheumatoid

arthritis; severe psoriasis; severe atopic dermatitis. Dosage: Depending upon indication and route of administration. Conversion from Sandimmun ® to

Sandimmun Neoral ® : the recommended dose ratio is 1:1. For specifi c safety measures in transplantation and autoimmune diseases see full prescribing

information. Contraindications: Known hypersensitivity to ciclosporin or any other component of the formulation. For Sandimmun concentrate for solution

for infusion, in addition: hypersensitivity to polyoxyethylated castor oil (e.g. Cremophor ® EL). Warnings/Precautions: Sandimmun Neoral should

only be prescribed by physicians experienced in immunosuppressive therapy after they have consulted the full prescribing information. Monitor closely

kidney and liver function, blood pressure, blood lipids and ciclosporin blood levels in transplant patients. Avoid excessive immunosuppression, as this

could lead to lymphoproliferative disorders, other malignancies and may result in an increased risk of infection. Avoid excess unprotected sun exposure

and UV light therapy. Do not use potassium-containing medication or potassium-sparing drugs, avoid high dietary potassium intake. Monitoring of serum

potassium and magnesium is recommended. Caution is required in treating patients with hyperuricaemia, when vaccinating (avoid live-attenuated

vaccines), when using concentrate for solution for infusion, and when co-administering with lercanidipine. For non-transplant indications, in addition:

impaired renal function (for nephrotic syndrome see full prescribing information), uncontrolled hypertension, uncontrolled infection, history or presence

of malignancy, elderly patients. Only limited experience in children. Should not be used during pregnancy unless clearly necessary. Mothers treated with

Sandimmun Neoral should not breast feed. Interactions: Aminoglycosides, amphotericin B, ciprofl oxacin, vancomycin, melphalan, trimethoprim (+

sulfamethoxazole), NSAIDs, histamine H2-receptor antagonists, tacrolimus; nifedipine; lercanidipine; HMG-CoA reductase inhibitors, colchicine, digoxin,

etoposide; everolimus, sirolimus; repaglinide; fi bric acid derivatives; ketoconazole, fl uconazole, itraconazole, voriconazole, erythromycin, azithromycin,

clarithromycin, oral contraceptives, diltiazem, nicardipine, verapamil; metoclopramide; danazol; methylprednisolone (high dose); allopurinol; amiodarone;

cholic acid and derivatives; protease inhibitors, imatinib, nefazodone ; barbiturates, carbamazepine, oxcarbazepine, phenytoin, rifampicin, nafcillin, sulfadimidine

i.v.; octreotide; probucol; orlistat, hypericum perforatum (St. John’s wort), ticlopidine, sulfi npyrazone, terbinafi ne, bosentan; potassium sparing

drugs and potassium containing drugs; methotrexate. Adverse reactions: Very common: impaired renal function, hypertension, tremor, headache, hyperlipidaemia;

Common: hepatic dysfunction, hypertrichosis, gingival hypertrophy, paraesthesia, fatigue, anorexia, nausea, vomiting, abdominal pain, diarrhoea;

hyperkalaemia, hyperuricaemia, hypomagnesaemia, muscle cramps, myalgia; Uncommon: Signs of encephalopathy such as convulsions, confusion,

disorientation, decreased responsiveness, agitation, insomnia, visual disturbances, cortical blindness, coma, paresis, cerebellar ataxia; weight increase,

oedema, allergic rash, anaemia, thrombocytopenia; Rare: pancreatitis, menstrual disturbances, gynecomastia, muscle weakness, myopathy, motor polyneuropathy,

micro-angiopathic haemolytic anaemia, haemolytic uraemic syndrome, hyperglycaemia; Very rare: Optic disc oedema including papilloedema,

with possible visual impairment secondary to benign intracranial hypertension. Anaphylactoid reactions have been observed following i.v. administration.

Packs and prices: Country specifi c. Legal classifi cation: Country specifi c.


Dr. Olga Ciccarelli

Université Catholique de Louvain

Dept. of Digestive Surgery and Liver Transplantation

Brussels, Belgium

Dr. Delphine Faugaret

Centre de Recherche du CHUQ, pavillon CHUL

Rhumatologie et Immunologie

Université Laval

Sainte Foy, Canada

Dr. Carlijn Buis

University Medical Center Groningen

Surgery Dpt.

Groningen, The Netherlands

Dr. Stefano Di Domenico

S. Martino University Hospital

Dept. of Transplantation and General Surgery

Univ. Genoa

Genova, Italy

� 2008 ESOT Student Travel Grants

Dr. Janos Kovacs

Semmelweis University

Transplantation and Surgery

Budapest, Hungary

Dr. Antal Petér

Semmelweis University Medical School

Transplantation and Surgican Clilnic

Budapest, Hungary

Dr. A. Avramovski

Clinic for Digestive Surgery Clinical Centar Skopje

Clinic for Digestive Surgery

St. Cyrilus et Methodius

Skopje, Macedonia

Dr. W. Blogowski

Clinical Research Fellow

SPSK nr. 2

Dept. of Laboratory Diagnostics and Molecular Medicine

Szczecin, Poland

Mrs. A.L. Kist

Dept. of Surgery

University Medical Center Groningen

Groningen, The Netherlands

� 2009 ESOT Student Travel Grant

Dr. E. Massey

Research Psychologist

Erasmus Medical Center Rotterdam

Rotterdam, The Netherlands

Awarded by John L.R. Forsythe, Chair Education Committee

119

SCIENTIFIC

PROGRAMME


� 2008 KÖHLER-CHEMIE Preservation Grant

Dr. J. Ma

Dept. of Surgery, University Hospital of Regensburg

Regensburg, Germany

� 2009 KÖHLER-CHEMIE Preservation Grant

Dr. H.G.D. Leuvenink

Surgical Research Laboratory,

University Medical Center Groningen,

Groningen, The Netherlands

Awarded by Dr. Ekkehard Schaffner, in representation of

Köhler-Chemie

� 2009 INSTITUT GEORGE LOPEZ

Organ Viability & Preservation Grant

Dr. M. Maglione

Trainee in Visceral, Transplant and Thoracic Surgery,

Center of Operative Medicine,

Innsbruck Medical University,

Innsbruck, Austria

Awarded by Silvina Ramella Virieux, in representation of Institut

Georges Lopez

120


POSTERS

The P # indicates poster board location and

abstract number before tittle in the Abstract Book.

Those posters identifi ed as ESOT Poster of Distinction

by this symbol have received review scores

that place them in the top 10% of their category.

The Scientifi c Programme Committee encourages

you to make them a priority when you visit

the poster session.


POSTER SESSION 1

P001 > P509

FROM SUNDAY, AUGUST 30 TO MONDAY, AUGUST 31

Cell transplant

P-1 TISSUE FLUID/LYMPH CYTOKINES AND GROWTH FACTORS

REGULATE HUMAN KERATINOCYTE PROLIFERATION AND

DIFFERENTIATION

Anna Domaszewska-Szostek, Marzanna Zaleska and Waldemar L. Olszewski;

Warsaw, Poland and Oslo, Norway

P-2 INDUCTION OF LETHAL GRAFT-VERSUS-HOST DISEASE (GVHD)

BY ANTI-CD137 MONOCLONAL ANTIBODY IN MICE WHICH ARE

PRONE TO CHRONIC GVHD

Hong R. Cho, Juyang Kim, Wonyoung Kim, Jong S. Lee, Yang W. Nah, Chang

W. Nam and Byungsuk Kwon; Ulsan, Republic of Korea

P-3 CHARACTERIZATION, CRYOPRESERVATION AND EXPERIMENTAL

TRANSPLANTATION OF THE HETEROGENOUS POOL OF STEM CELL

IN HUMAN FETAL LIVER

Alexander Yu Petrenko, Yuri A. Petrenko, Natalia G. Scorobogatova, Olga V.

Ochenashko, Victor A. Litovchenko, Andrei A. Pendela and Barry J. Fuller;

Kharkov, Ukraine and London, United Kingdom

P-4 NON-COMMERCIAL CLINICAL TRIALS IN ADVANCED THERAPIES

PROMOTED AND SPONSORED BY GOVERNMENT OF ANDALUSIA

(SPAIN)

Natividad Cuende, José L. Zugaza, Gloria Carmona, Ana Cardesa and Itziar

Ochotorena; Seville, Spain

P-5 CD4+CD25+ T REGULATORY CELL MOBILISATION FOR THERAPEUTIC

PURPOSES

Vladislav Rozenkov, Lanfeng Wang, Bik To and Ian D. Lewis; Melbourne, VC,

Australia and Adelaide, Australia

P-6 WITHDRAW

P-7 HUMAN UMBILICAL CORD BLOOD AND UMBILICAL CORD

MESENCHYMAL STEM CELLS CAN CONTRIBUTE TO LIVER

REGENERATION IN AN ANIMAL MODEL OF CHEMICAL-INDUCED

INJURY

Tatiana Chioato, Debora Bizzaro, Donatella Pellicanò, Diletta Arcidiacono,

Silvia Tomat, Patrizio Bo, Maria Teresa Conoconi, PierPaolo Parnigotto,

Francesco Paolo Russo and Patrizia Burra; Padua, Italy and Cittadella, Italy

P-8 STUDY OF THE USE OF ICG FOR RAPID ASSESSMENT OF ISOLATED

HUMAN HEPATOCYTE FUNCTION

Cheng-Maw Ho, Anil Dhawan, Robin Hughes, Sharon Lehec, Juliana Puppi,

Christina Philippeos, Rey-Heng Hu, Po-Huang Lee and Ragai Mitry; Taipei,

Taiwan and London, United Kingdom

P-9 AUTOLOGOUS BONE MARROW STEM CELLS IN THE TREATMENT

OF CIRRHOTIC PATIENTS

Saman Nikeghbalian, Naser Aghdami, Behzad Pournasr, Kazem Hosseiniasl,

Mohsen Namiri, Alireza Rasekhi, Mani Ramzi, E. Taghiabadi, H. Baharvand,

Seyed Mohammadreza Nejatollahi, Farzad Kakaei and Seyed Ali Malekhosseini;

Shiraz, Islamic Republic of Iran and Tehran, Islamic Republic of Iran

P-10 AN “IN VITRO” MODEL FOR EVALUATION OF ENGRAFTMENT

ENHANCERS IN LIVER CELL TRANSPLANTATION

Javier Alfaro, Elisa Ramírez, Mario Mellado, María Cevey, Juan C. Meneu,

Baltasar Pérez-Saborido, Cristina Camañas, Marcela Castillo, Estela Paz-Artal

and Antonio Serrano; Madrid, Spain

122


Composite tissues

123

POSTERS

P-11 INVESTIGATION OF THE ROLE OF ISCHEMIA AND REPERFUSION IN

LIMB TRANSPLANTATION

Robert Sucher, Andrey Kuznetsov, Rupert Oberhuber, Guido Rumberg,

Theresa Hautz, Bettina Zelger, Gerald Brandacher, W.P. Andrew Lee, Raimund

Margreiter and Stefan Schneeberger; Innsbruck, Austria and Pittsburgh, PA,

United States

P-12 ROLE OF ALLOTRANSPLANTATION IN REHABILITATION OF THE

PATIENTS WITH TRAUMATIC INJURY OF SKELETAL SYSTEM AND

ORTHOPEDIC DISORDERS

Meri Mshvidobadze, Nugzar Elizbarashvili and Gia Tomadze; Tbilisi,

Georgia

Donation & allocation

P-13 WEB BASED NATIONAL TRANSPLANT DATABASE & APPLICATION.

A COMPLETE SOFTWARE SOLUTION FOR ORGANS, CELLS AND

TISSUES

Roman R.B. Benedek; Bratislava, Slovakia (Slovak Republic)

P-14 WITHDRAW

P-15 MODULATION OF BRAIN-DEAD INDUCED INFLAMMATION BY

VAGUS NERVE STIMULATION

Simone Hoeger, Claudia Bergstraesser, Jochen Selhorst, Marc Seelen, Henri

Leuvenink, Peter Schnuelle and Benito Yard; Mannheim, Germany and

Groningen, The Netherlands

P-16 DECEASED DONOR MANAGEMENT AND DEMOGRAPHIC FACTORS

RELATED TO KIDNEY ALLOGRAFT REJECTION AND GRAFT

SURVIVAL

Douglas P. Slakey, Lauren M. Slakey, Christina M. Slakey and Lillian Yau; New

Orleans, LA, United States

P-17 THE ROLE OF THE TRANSPLANT NURSE CLINICAL COORDINATOR

FOR LIVER TRANSPLANTATION IN ITALY

Chiara Comuzzi, Marcello Castellese, Sandro Gelsomino, Giovanni Scianna,

Diana Malagoli, Monica Di Furia, Silvia Zivieri, Umberto Baccarani and Lucia

Rizzato; Udine, Italy; Palermo, Italy; Modena, Italy and Rome, Italy

P-18 IMPLEMENTING MINIMUM NOTIFICATION CRITERIA FOR ORGAN

DONATION IN AN ACUTE HOSPITALS CRITICAL CARE UNIT

Lee F. Alexander and Jane Monks; Manchester, United Kingdom

P-19 RELATIONSHIP BETWEEN CLINICAL AND CYTOKINES PROFILE OF

BRAIN-DEATH DONORS

Simone L. Mello, Rose M.F.L. Silva, Maria da Consolação V. Moreira, Andrea

Teixeira-Carvalho, Juciaria S. Matos and Marcus V.M. Andrade; Belo

Horizonte, Minas Gerais, Brazil

P-20 CRITICAL CARE STAFFS’ EDUCATIONAL NEEDS AND THEIR

ASSOCIATION WITH COUNTRIES’ DONATION PERFORMANCE: DATA

FROM THE DONOR ACTION DATABASE

Leo Roels, Caroline Spaight, Jacqueline Smits and Bernard Cohen; Linden,

Belgium and Leiden, Belgium


P-21 DETECTION OF BILIARY AND VASCULAR ANOMALIES IN LIVING

LIVER DONORS: VALUE OF GADOBENATE DIMEGLUMINE

ENHANCED MR AND MDCT ANGIOGRAPHY

Diana Artioli, Marianna Tagliabue, Paolo Aseni, Sandro Sironi and Angelo

Vanzulli; Milano, Italy and Monza, Italy

P-22 POSSIBLE ERRORS IN HBV AND HCV TESTING DUE TO FLUID

ABNORMALITIES IN DECEASED ORGAN DONORS

Jaroslaw Czerwinski, Anna Pszenny, Marta Laba, Krzysztof Ostrowski, Marek

Pacholczyk, Dariusz Wasiak, Maciej Kosieradzki, Andrzej Chmura and Piotr

Malkowski; Warsaw, Poland

P-23 DISEASED DONOR WITH THE SUSPICION OF BRAIN TUMOR – CASE

REPORT

Anna Milecka, Alicja Debska-Slizien, Marzena Lawicka, Zadrozny Dariusz,

Zbigniew Sledzinski and Boleslaw Rutkowski; Gdansk, Poland and Wejherowo,

Poland

P-24 MELD-BASED ORGAN ALLOCATION INCREASES TOTAL COSTS OF

LIVER TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE

Peter Schemmer, Helge Bruns, Norbert Hillebrand, Tobias Schneider, Ulf

Hinz, Jan Schmidt and Markus W. Büchler; Heidelberg, Germany

P-25 EDUCATION FOR HEALTH IN SCHOOLS PROMOTING BONE

MARROW DONATION

Helena Alves; Porto, Portugal

P-26 RESULTS OF THE IMPLEMENTATION OF A MELD SCORE-BASED

ALLOCATION SYSTEM IN A EUROPEAN CENTER

Claire Francoz, Daniele Sommacale, Federica Dondero, Hamza Boudjema,

Catherine Paugam, Dominique Valla, Jacques Belghiti and Francois Durand;

Clichy, France

P-27 A PROPOSAL FOR A PORTUGUESE KIDNEY PAIRED DONATION

PROGRAM

Bruno A. Lima, Leonídio Dias, António C. Henriques and Helena Alves;

Porto, Portugal

P-28 WASTING KIDNEY GRAFTS

Daniel B. Foltys, Michael Heise, Maria Hoppe-Lotichius, Ana Paula Barreiros,

Nathalia Peixoto and Gerd Otto; Mainz, Germany and Fairfax, United

States

P-29 AN EXPERIENCE IN THE HEALTH AUTHORITY IMPLEMENTATION OF

A QUALITY ASSURANCE PROGRAM OF THE DONATION PROCESS

Alba Ribalta and Rosa Deulofeu; Barcelona, Spain

P-30 DONOR ACTION PROGRAM IN THE EMILIA-ROMAGNA REGION

(ERR)

Lorenza Ridolfi , Nicola Alvaro, Maria Bonanno and Tiziana Campione;

Bologna, BO, Italy

P-31 RECENT EXPERIENCE WITH ORGAN DONATION AFTER CARDIAC

DEATH(DCD) IN ONE REGION OF AUSTRALIA

Carol Adams, Carrie Alvaro, Deepak Bhonagiri, Amy Davis, Lee McKay,

Nicola Seifert, Julie Letts and Deborah Verran; Sydney, NSW, Australia

P-32 A SINGLE CENTER EXPERIENCE USING EXTRACORPOREAL

SUPPORT IN DONATION AFTER CARDIAC DEATH DONORS

Robert Stratta, Rajinder Singh, Michael Hines, Alan Farney, Jeffrey Rogers,

Erica Hartman, Amber Reeves-Daniel, Michael Gautreaux, David Kiger, Samy

Iskandar and Patricia Adams; Winston Salem, NC, United States

P-33 TELEMEDICINE IN TRANSPLANTATION PROCESS

Francesco Gabbrielli, Renzo Pretagostini, Davide Stabile, Pamela Fiaschetti,

Alessandra Oliveti, Daniela Peritore and Benedetta D’Ercole; Rome, Italy

and Matera, Italy

124


125

POSTERS

P-34 ANALYSIS OF PROCUREMENT AND UTILIZATION OF DECEASED

CARDIAC DONORS IN MICHIGAN

Raymond J. Lynch, David Gee, Richard E. Pietroski, Burton J. Mattice,

Michael J. Englesbe and Jeffrey D. Punch; Ann Arbor, MI, United States

P-35 HEPATOCELLLULAR CARCINOMA ON CIRRHOSIS: LIVER RESECTION,

LIVER TRANSPLANTATION OR BOTH SURGICAL TREATMENTS? AN

INTENTION TO TREAT ANALYSIS

Massimo Del Gaudio, Giorgio Ercolani, Matteo Ravaioli, Matteo Cescon,

Augusto Lauro, Marco Vivarelli, Alessandro Cucchetti, Matteo Zanello,

Gaetano Vetrone, Chiara Zanfi , Cristina Morelli, Gian Luca Grazi and Antonio

Daniele Pinna; Bologna, Italy

P-36 NON TRANSPLANTABLE LIVER OBTAINMET FOR CELL ISOLATION

FOR THERAPEUTIC USE

Marti Manyalich, Wolfgang Rüdinger, Maria P. Gomez, Evelin Lara, MARC

Net and Hernan Pinto; Barcelona, Spain and Weinheim, Germany

P-37 A MODIFICATION TO HEART TRANSPLANT ALLOCATION TO

SAVE MORE CRITICAL PATIENTS: TIME FOR ALLOCATION SYSTEM

CHANGE?

E. Benazzi, R. Fiocchi, M. Frigerio, G. Guzzi, A. Forni, A. Gambino, M. Viganò,

A. Gamba, L. Martinelli, U. Livi, G. Faggian, G. Gerosa, A.M. D’Armini, O.

Barozzi, N. De Fazio and M. Scalamogna; Milan, Italy; Bergamo, Italy; Udine,

Italy; Verona, Italy; Padua, Italy; Pavia, Italy and Brescia, Italy

P-38 TRAINING OF HEALTH CARE STUDENTS AND PROFESSIONALS: A

PIVOTAL ELEMENT IN THE PROCESS OF OPTIMAL ORGAN

DONATION AWARENESS AND PROFESSIONALIZATION

Gloria Páez, Martí Manyalich and Ricard Valero; Barcelona, Spain

P-39 ORGAN DONATION IN MOSCOW

Marina Minina; Moscow, Russian Federation

P-40 INFLUENCE OF CERTAIN DONOR FACTORS ON THE FUNCTION OF

TRANSPLANTED LIVER

Marina Minina; Moscow, Russian Federation

P-41 RENAL FUNCTION OUTCOMES IN LIVING KIDNEY DONORS

Domniki Economidou, Panagiotis Pateinakis, Grigorios Myserlis, Georgios

Arsos, Spyros Dovas and Dimitrios Memmos; Thessaloniki, Greece

P-42 INTERNATIONAL ORGAN EXCHANGE OR HOW CAN WE INCREASE

THE NUMBER OF HEART TRANSPLANTATIONS IN SWITZERLAND

Stephanie Schneider, Dagmar Vernet, Hans P. Marti and Franz F. Immer;

Bern, Switzerland

P-43 EDUCATIONAL SYSTEM FOR TRANSPLANT COORDINATORS IN

POLAND. POSTGRADUATE STUDIES IN WARSAW MEDICAL

UNIVERSITY; 2 YEARS OF EXPERIENCE

Jaroslaw Czerwinski, Wojciech Rowinski, Anna Jakubowska-Winecka, Tomasz

Kubik, Robert Becler, Anna Milecka, Sylwia Sekta, Krzysztof Pabisiak and

Piotr Malanowski; Warsaw, Poland; Gdansk, Poland; Katowice, Poland and

Szczecin, Poland

P-44 A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED

ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY

Martina Gambato, Alessandro Vitale, Alberto Brolese, Giacomo Zanus,

Francesco D’Amico, Enrico Gringeri, Marco Senzolo, Francesco P. Russo,

Francesco Grigoletto, Elena Saracino, Francesco E. D’Amico, Eleonora De

Martin, Umberto Cillo and Patrizia Burra; Padua, Italy


P-45 TPM ON-LINE COURSES: THE E-LEARNING PLATFORM ON

PROFESSIONAL TRAINING AND EDUCATION FOR HEALTH

PROFESSIONALS TAKING PART IN THE ORGAN DONATION

PROCESS

Gloria Páez, Martí Manyalich and Ricard Valero; Barcelona, Spain

P-46 CORTICOSTEROID TREATMENT OF DECEASED DONORS IN THE

EUROPEAN SENIOR PROGRAM

Anja Reutzel-Selke, Johannes Schuller, Marion Marksteiner, Andreas Pascher,

Frank Ulrich, Ali Yahazadeh, Petra Reinke, Ulrich Frei, Peter Neuhaus, Katja

Kotsch and Johann Pratschke; Berlin, Germany

P-47 WITHDRAW

P-48 EUROPEAN TRAINING PROGRAM ON ORGAN DONATIO (ETPOD):

A NEW COLLABORATIVE EUROPEAN FORMATIVE STRATEGY ON

ORGAN DONATION (PROJECT FUNDED BY DG SANCO (2005205)

Martí Manyalich, Gloria Páez, Xavier Guasch, Ricard Valero, Maria del Río

and ETPOD Partners Consortium; Barcelona, Spain

P-49 AN AUDIT OF SUDDEN DEATHS IN ACCIDENT AND EMERGENCY

UNIT AS AN ON-GOING REVIEW OF POTENTIAL NHBD DONORS

Christopher Ray, Aditya Kanwar, Lynn Robson, Soroush Sohrabi, Alex

Navarro, Susan Stamp, Mohamed-Saleem Noormohamed, Brian Shenton,

Noel Carter, Anne Cunningham and David Talbot; Newcastle Upon Tyne,

United Kingdom and Sunderland, United Kingdom

P-50 TWO YEARS OF MELD ALLOCATION SYSTEM IN SÃO PAULO –

BRAZIL

Rogerio C. Afonso, Maria Paula V.C. Zurstrassen, Luis A. Pereira, Sergio P.

Meira-Filho, Marcelo B. Rezende, Andre I. David, Renato Hidalgo and Ben-

Hur Ferraz-Neto; Sao Paulo, SP, Brazil

P-51 A REVIEW OF RENAL TRANSPLANT LIVING DONORS ATTENDING

INKOSI ALBERT LUTHULI CENTRAL HOSPITAL, DURBAN, SOUTH

AFRICA

Kevin Nankissor, I. Naidoo and Alain G. Assounga; Durban, KwaZulu-Natal,

South Africa

P-52 LONG TERM OUTCOME OF LIVING KIDNEY DONORS.

RETROSPECTIVE ANALYSIS

Taieb Ben Abdallah, Amel Salah, Mohamed Salah Ben Ammar, Jamil

Hachicha, Habib Skhiri, Ezzedine Abderrahim, Jalel Hmida and Adel Kheder;

Tunis, Tunisia

P-53 ACTIVE SEARCH IN ORGAN DONATION: INCREASING RESULTS

THROUGH EDUCATION PROGRAMS

Nilza Hilário, Helder Zambelli, Wilma Aparecida Nunes and Bartira de Aguiar

Roza; Campinas, SP, Brazil and São Paulo, SP, Brazil

P-54 KNOWLEDGE AND ATTITUDES OF MOROCCAN MEDICAL

STUDENTS TOWARDS ORGAN DONATION AND TRANSPLANTATION:

A PILOT STUDY

Inass Laouad; Marrakech, Morocco

P-55 WITHDRAWAL OF THERAPEUTIC EFFORTS CAN BE A CONDITIONING

FACTOR FOR DECEASED ORGAN DONATION?

David Paredes, Camino Rodriguez-Villar, Angel Ruiz, Marta Alberola and

Blanca Miranda; Barcelona, Catalunya, Spain

126


127

POSTERS

P-56 ORGAN PROCUREMENT AND TRANSPLANT IN VIRAL RISK DONORS

IN ITALY – GRAFT AND RECIPIENT SURVIVAL

Carlo De Cillia, Sante Venettoni, Lucia Rizzato, Andrea Ricci, Dino A. Mattucci,

Paolo A. Grossi and Alessandro Nanni Costa; Rome, Italy and Varese, Italy

P-57 MELD ALLOCATION SYSTEM IN BELGIUM-ET AND OUTCOME

Mauricio Sainz Barriga, Ivo Hantjens, Eva Line Decoster, Luc Colenbie, Bert

Van den Bossche, Frederik Berrevoet, Anja M. Geerts, Isabel Colle, Hans Van

Vlierberghe, Xavier Rogiers and Bernard de Hemptinne; Ghent, Belgium

Clinical immunosuppression I

P-58 PREFERENTIAL INCREASE IN MEMORY AND REGULATORY

SUBSETS DURING CD4+ T-CELL IMMUNE RECONSTITUTION AFTER

THYMOGLOBULIN INDUCTION THERAPY IN RENAL TRANSPLANT

PATIENTS RECEIVING SIROLIMUS VS CYCLOSPORINE

Emmanuel Morelon, Nicole Lefrançois, Caroline Besson, Julie Prévautel,

Marie Nathalie Kollop-Sarda, Maria Brunet, Jean-Louis Touraine, Lionel

Badet, Françoise Touraine-Moulin, Olivier Thaunat and Christophe Malcus;

Lyon, France

P-59 EFFECT OF TRIPTERYGIUM ON PROTEINURIA ASSOCIATED WITH

SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS

Shu-ming Ji, Lei-shi Li, Ji-Qiu Wen, Guo-zhu Sha, Dong-rui Cheng, Jin-Song

Chen and Zhi-hong Liu; Nanjing, China and Nannjing, China

P-60 CLINICAL STUDY OF THE CONVERSION TREATMENT WITH

SIROLIMUS AND MYCOPHENOLATE MOFETIL IN THE RENAL

TRANSPLANT RECIPIENTS

Shu-ming Ji, Lei-shi Li, Ji Qiu Wen, Guo-zhu Sha, Dong-rui Cheng, Qi-quan

Sun, Jin-Song Chen and Zhi-hong Liu; Nanjing, China

P-61 THE MAXIMUM TOLERATED DOSE OF MYCOPHENOLIC ACID (MPA)

IS HIGHER WITH ENTERIC-COATED MYCOPHENOLATE SODIUM

(EC-MPS) COMPARED TO MYCOPHENOLATE MOFETIL (MMF) IN

KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF A RANDOMIZED,

MULTICENTER TRIAL

Magdi Shehata, Sunil Bhandari, Gopalakrishnan Venkat-Raman, Richard

Moore and Richard D’Souza; Nottingham, United Kingdom; Hull, United

Kingdom; Portsmouth, United Kingdom; Cardiff, United Kingdom and

Exeter, United Kingdom

P-62 HEALTH-RELATED QUALITY OF LIFE MAINTAINED DESPITE INCREASE

IN MYCOPHENOLIC ACID (MPA) DOSE FOLLOWING CONVERSION

FROM MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC-COATED

MYCOPHENOLATE SODIUM (EC-MPS): A RANDOMIZED,

MULTICENTER TRIAL IN KIDNEY TRANSPLANT RECIPIENTS

Magdi Shehata, Sunil Bhandari, Gopalakrishnan Venkat-Raman, Richard

Moore and Richard D’Souza; Nottingham, United Kingdom; Hull, United

Kingdom; Portsmouth, United Kingdom; Cardiff, United Kingdom and

Exeter, United Kingdom

P-63 CAMPATH INDUCTION AND SIROLIMUS MAINTENANCE THERAPY,

A STEROID FREE AND CALCINEURIN FREE PROTOCOL IN LIVE-

DONOR RENAL TRANSPLANT RECIPIENTS: PILOT STUDY

Khaled Mahmoud, Aymn Refaie, Hussein Attia, Amany Ismaeil and Mohamed

Ghoneim; Mansoura, DK, Egypt


P-64 IMPROVED LONG-TERM SURVIVAL AFTER AN INTRA-OPERATIVE

SINGLE HIGH-DOSE ATG-FRESENIUS INDUCTION IN CADAVERIC

RENAL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE

Jürgen Kaden, Gottfried May, Andreas Völp and Claus Wesslau; Berlin,

Germany and Frankfurt, Germany

P-65 EXTENDED RELEASE TACROLIMUS IN DE NOVO KIDNEY TRANSPLANT

RECIPIENTS. CLINICAL EXPERIENCE OF A SHORT-TERM USE

Pascual Núñez P, Sanz Ballesteros, Herrero A. Mendiluce and J. Bustamante;

Valladolid, Spain

P-66 SERIAL SOLUBLE CD30 MEASUREMENT AS A PREDICTOR OF

KIDNEY GRAFT OUTCOME

M.A. Halim, T. Al-Otaibi, I. Al-Muzairai, M. Mansour, H. Hasaneen, W.H.

Awadain, K.A. Tawab, T. Said, P. Nair and M.R.N. Nampoory; Kuwait, Kuwait

P-67 ACTIVE MANAGEMENT OF POST-RENAL TRANSPLANTATION BK

VIRUS NEPHROPATHY – A PRELIMINARY REPORT

M.A. Halim, T. Al-Otaibi, O. El-Kholy, S. Al-Waheeb, G. Szucs, A. Pacsa, T.

Said, M.A. Balaha, O. Gheith and M.R.N. Nampoory; Kuwait, Kuwait

P-68 DOSAGE REDUCTION OF CICLOSPORIN A IN COMBINATION WITH

EVEROLIMUS IN HEART TRANSPLANT RECIPIENTS WITH CHRONIC

RENAL FAILURE: A TWO-YEAR FOLLOW UP

Fuchs Uwe, Schulz Uwe, Armin Zittermann, Hakim-Meibodi Kavous and Jan

Gummert; Bad Oeynhausen, Germany

P-69 NONCOMPLIANCE TO TACROLIMUS AND SIROLIMUS IN RENAL

TRANSPLANTATION

Clara Sequeira, Odete Isabel, Alfredo Mota and Carlos Fontes Ribeiro;

Coimbra, Portugal

P-70 SUBCLINICAL TOXICITY OF CALCINEURIN INHIBITORS IN

REPEATED PROTOCOL BIOPSIES OF TRANSPLANTED KIDNEYS:

AN INDEPENDENT RISK FACTOR FOR THE DEVELOPMENT OF

INTERSTITIAL FIBROSIS AND TUBULAR ATROPHY

Karel Krejčí, Tomáš Tichý, Miroslav Hrubý, Hana Ciferská, Vladko Horcicka,

Pavel Štrebl, Sadek Al-Jabry, Petr Bachleda and Josef Zadrazil; Olomouc,

Czech Republic

P-71 MONITORING THE IMMUNOSUPPRESSIVE EFFECT OF CSA BY NFAT

REGULATED GENE EXPRESSION

Uta Herden, Arno Kromminga, Lutz Fischer, Frauke Kohl, Björn Nashan and

Martina Sterneck; Hamburg, Germany

P-72 THE COST OF SIROLIMUS THERAPY IN KIDNEY TRANSPLANTATION:

IS THERE A HIGH PRICE TO PAY?

Mark Reza Laftavi, Rezvan Rostami, Sunil Patel, Romesh Kohli, Feng Lin,

Meriem Said, Merill Dayton and Oleh Pankewycz; Buffalo, NY, United States

P-73 OPTIMIZATION OF TACROLIMUS FOR RENAL TRANSPLANTATION –

AN HISTORICAL RETROSPECTIVE FOR 10 YEARS

Hyunchul Kim, Eunah Hwang, Seungyeup Han, Sungbae Park, Hyoungtae

Kim, Wonhyun Cho, Jungeun Kim and Mihyun Chang; Daegu, Korea

P-74 ASSESSMENT OF THE NEW TACROLIMUS CMIA ASSAY IN HEART,

KIDNEY AND LIVER TRANSPLANTATION

Christophe Bazin, Caroline Barau, Amelie Guinedor, Claire Gozalo, Helene

Marty, Valerie Furlan, Laurent Massias and Anne Hulin; Créteil, France;

Bicêtre, France; Paris, France and Reims, France

128


129

POSTERS

P-75 MPA EXPOSURE IN PATIENTS WITH EARLY STEROID WITHDRAWAL:

COMPARISON BETWEEN TWO MMF BASED IMMUNOSUPPRESSIVE

REGIMENS, CONCENTRATION-CONTROLLED VERSUS FIXED DOSE

Y. Le Meur, N. Kamar, E. Rondeau, L. Tricot, Y. Lebranchu, M. Kessler, D.

Glotz, C. Mousson, F. Vrtovsnik, F. Bayle, J. Dantal, E. Thervet, S. Rouanet,

N. Tagieva and P. Marquet; Brest, France; Toulouse, France; Paris, France;

Suresnes, France; Tours, France; Nancy, France; Dijon, France; Grenoble,

France; Nantes, France; Neuilly, France and Limoges, France

P-76 RELATIONSHIP OF CLINICAL MARKERS OF SYSTEMIC ENDOTHELIAL

DYSFUNCTION TO THE CALCINEURIN INHIBITOR NEPHROTOXICITY

Vladko Horcicka, Josef Zadrazil, David Karasek, Karel Krejci, Pavel Strebl,

Milan Halenka, Tomas Tichy and Sadeq Al-Jabry; Olomouc, Czech Republic

P-77 TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION WITH

THE COMPLEMENT INHIBITOR ECULIZUMAB

Rizwan Hamer, Nithya Krishnan, Daniel Zehnder, Dave Lowe, David Briggs,

Simon Fletcher, For T. Lam, Habib Kashi, Lam Chin Tan, Chris Imray and Rob

Higgins; Coventry, United Kingdom and Birmingham, United Kingdom

P-78 EFFICACY AND SAFETY OF SINGLE AND MULTIPLE DOSE

ANTITHYMOCYTE GLOBULIN INDUCTION TREATMENT IN LIVING

RELATED RENAL TRANSPLANTATION

Radmila N. Blagojevic Lazic, Dragana M. Radivojevic Djokic, Stojanka B.

Ristic and Visnja D. Lezaic; Beograd, Serbia

P-79 ANGIOTENSINOGEN (AGT) M235T GENOTYPE BUT NOT INSERTION/

DELETION (I/D) POLYMORPHISM OF ANGIOTENSIN-CONVERTING

ENZYME (ACE) GENE AFFECTS GLUCOSE METABOLISM IN

TACROLIMUS TREATED KIDNEY TRANSPLANT RECIPIENTS

Barbara Grandtnerova and Olga Krizanova; Martin, Slovakia (Slovak Republic)

and Bratislava, Slovakia (Slovak Republic)

P-80 RESULTS OF CONVERSION TO EVEROLIMUS IN PATIENTS

PRESENTING WITH CALCINEURIN INHIBITOR NEPHROTOXICITY

E.S. Stolyarevich, R.N. Vedernikova, N.D. Fedorova and N.A. Tomilina;

Moscow, Russian Federation

P-81 THE POSITIVE EFFECT OF MYCOPHENOLATE MOFETIL ON THE

HISTOLOGY COURSE OF HEPATITIS C AFTER LIVER TRANSPLANTATION

Tommaso Maria Manzia, Luca Toti, Ilaria Lenci, Roberta Angelico, Andrea

Monaco, Matteo Manuelli, Linda de Luca, Laura Tariciotti and Giuseppe

Tisone; Rome, Italy

P-82 THE EFFECTS OF CONVERSION FROM CNI (CALCINUERIN

INHIBITORS) TO SIROLIMUS IN RENAL TRANSPLANT RECIPIENTS

Natalie L. Borman and Gopalakrishnan Venkat-Raman; Portsmouth, United

Kingdom

P-83 EVEROLIMUS AS BASE-THERAPY IN KIDNEY TRANSPLANTATION

(KTX)

Donato Donati, Andrea Ambrosini and Fiorella Dossi; Varese, Italy

P-84 A 6-MONTH, MULTI-CENTER, SINGLE-ARM, PILOT STUDY TO

EVALUATE THE EFFICACY AND SAFETY OF GENERIC TACROLIMUS

(TACROBELL®) AFTER PRIMARY RENAL TRANSPLANTATION

Soo Jin Kim, Duck Jong Han and Yu Seun Kim; Seoul, Korea

P-85 EXRERIENCE WITH MYFORTIC APPLICATION IN RENAL TRANSPLANT

RECIPIENTS

Irina G. Kim, Ekaterina S. Stolyarevich and Natalya A. Tomilina; Moscow,

Russian Federation


P-86 A PHASE 2B, OPEN-LABEL, MULTI-CENTER, PROSPECTIVE,

RANDOMIZED STUDY TO COMPARE THE PHARMACOKINETICS AND

SAFETY OF LCP-TACRO TABLETS ONCE-A-DAY TO PROGRAF®

CAPSULES TWICE-A-DAY IN DE NOVO LIVER TRANSPLANT

PATIENTS

Derek A. DuBay, Rita R. Alloway, Angel E. Alsina, William C. Chapman, Sandy

Feng, Andreas G. Tzakis, Lewis W. Teperman, Eliezer Katz, H. Eugene Griffi n,

Robert D. Gordon, Karin J. Hamberg and Lawrence Chodoff; Birmingham,

AL, United States; Cincinnati, United States; Tampa, FL, United States; St.

Louis, United States; San Francisco, CA, United States; Miami, United States

and New York, United States

P-87 A PHASE 2, OPEN-LABEL, MULTI-CENTER, PROSPECTIVE

CONVERSION STUDY TO COMPARE THE PHARMACOKINETICS AND

SAFETY OF LCP-TACRO TABLETS ONCE-A-DAY TO PROGRAF®

CAPSULES TWICE-A-DAY IN STABLE LIVER TRANSPLANT PATIENTS:

RESULTS AT 12 MONTHS

Rita R. Alloway, Devin E. Eckhoff, Lewis W. Teperman, W. Kenneth Washburn,

Andreas G. Tzakis, A. Osama Gaber, Russell H. Wiesner, Richard B. Freeman,

Juan V. del Rio Martin, Robyn E. Chudzinski, John R. Lake, Eliezer Katz, H.

Eugene Griffi n, Robert D. Gordon, Karin J. Hamberg and Lawrence Chodoff;

Cincinnati, United States; Birmingham, United States; New York, United

States; San Antonio, TX, United States; Miami, United States; Houston,

United States; Rochester, MN, United States; Boston, MA, United States and

Minneapolis, United States

P-88 SOTRASTAURIN, A NOVEL PROTEIN KINASE C-INHIBITOR, IN

COMBINATION WITH TACROLIMUS: PHARMACOKINETIC

INTERACTION IN RENAL TRANSPLANT RECIPIENTS

J.U. Steiger, K. Budde, J.M. Grinyo, L. Rostaing, W. Arns, J. Dantal, A. Slade,

M.J. Barten and J.M. Kovarik; Basel, Switzerland

P-89 TOLERABILITY OF MYCOPHENOLATE MOFETIL IN MAINTENANCE

LIVER TRANSPLANT RECIPIENTS: A 10-YEAR SINGLE CENTRE

EXPERIENCE

Jérôme Dumortier, Olivier Guillaud, Janine Salandre, Mustapha Adham and

Olivier Boillot; Lyon, France

P-90 PREOPERATIVE ANTILYMPHOCYTE THERAPY: EFFECT ON DAMP’S

AND RENAL TRANSPLANT OUTCOME

Dietmar K. Abendroth, Michael Marzinzig and Jürgen Kaden; Ulm, Germany

and Berlin, Germany

P-91 SAFETY OF RITUXIMAB THERAPY FOR PREVENTION OR

TREATMENT OF ACUTE HUMORAL REJECTION AFTER RENAL

TRANSPLANTATION

Anne Scemla, Eric Thervet, Alexandre Loupy, Frank Martinez, Sophie Candon,

Marie France Mamzer, Julien Zuber, Dany Anglicheau and Christophe

Legendre; Paris, France

P-92 EVEROLIMUS(EVL)-INDUCED PNEUMONITIS IN PATIENTS WITH A

PAST HISTORY OF SIROLIMUS (SRL) PNEUMONITIS

Marion Rabant, Julien Zuber, Dany Anglicheau, Frank Martinez, Marie-France

Mamzer, Renaud Snanoudj, Arnaud Mejean, Christophe Legendre and Eric

Thervet; Paris, France

P-93 HISTOLOGICAL RECURRENCE OF HENOCH-SCHONLEIN PURPURA

AFTER RENAL TRANSPLANTATION IS FREQUENT BUT NOT

ASSOCIATED WITH NEGATIVE CLINICAL OUTCOME

Jessie Aouizerate, Laure Helene Noel, Isabelle Brocheriou, Frank Martinez,

Marie-France Mamzer, Marc Olivier Timsit, Christophe Legendre and Eric

Thervet; Paris, France

130


131

POSTERS

P-94 MANAGEMENT OF LATE RISING CREATININES IN KIDNEY

TRANSPLANT RECIPIENTS: THE BENEFITS OF A PROACTIVE

APPROACH

Leonard M. Ebah, Durga Kanigicherla and John Anderton; Manchester,

United Kingdom and Preston, United Kingdom

P-95 OSELTAMIVIR PROPHYLAXIS REDUCES THE OCCURRENCE OF

INFLUENZA INFECTION IN TRANSPLANT RECIPIENTS

Michael G. Ison, Peter Szakaly, Michael Y. Shapira, Gergely Kriván, Ann Nist

and Regina Dutkowski; Chicago, IL, United States; Pécs, Hungary; Jerusalem,

Israel; Budapest, Hungary and Nutley, NJ, United States

P-96 THE SUCCESSFUL TREATMENT OF ASPERGILLOSIS BY MONITORING

INTRACELLULAR CYCLOSPORINE CONCENTRATION IN RENAL

TRANSPLANT

Seok-Ju Park, Young-Chul Yoon, Yang-Wook Kim, Sun-Woo Kang, Im-Sook

Song, Jae-Gook Shin and Yeong-Hoon Kim; Busan, Korea

P-97 THE EFFECT OF HIGH DOSE METHYLPREDNISOLONE THERAPY

ON IN VIVO CYP3A4/5 ACTIVITY AND CALCINEURIN INHIBITOR

PHARMACOKINETICS IN RENAL TRANSPLANT RECIPIENTS: A PILOT

STUDY

Hylke de Jonge, Henriette de Loor, Kristin Verbeke, Yves Vanrenterghem

and Dirk R. Kuypers; Leuven, Belgium

P-98 IN VIVO CYP3A4/5 ACTIVITY IS SIGNIFICANTLY HIGHER IN TACROLIMUS

TREATED VS. CYCLOSPORINE TREATED RENAL TRANSPLANT

RECIPIENTS THREE MONTHS AFTER TRANSPLANTATION

Hylke de Jonge, Henriette de Loor, Kristin Verbeke, Yves Vanrenterghem

and Dirk R. Kuypers; Leuven, Belgium

P-99 IMMEDIATE VERSUS DELAYED EVEROLIMUS TREATMENT IN DE

NOVO RENAL TRANSPLANT RECIPIENTS AT RISK OF DELAYED

GRAFT FUNCTION: 1-YEAR RESULTS OF THE CALLISTO STUDY

L. Albano, F. Berthoux, M. C. Moal, L. Rostaing, C. Legendre, A.S. Blanc, F.

Di Giambattista and J. Dantal; France and Paris, France

P-100 THE CLEAR STUDY: A PROSPECTIVE, RANDOMIZED, CONTROLLED,

OPEN-LABEL MULTICENTRE 6-MONTH STUDY COMPARING THE

EFFICACY AND SAFETY OF A 5-DAY 3-G DAILY MMF LOADING DOSE

VERSUS STANDARD 2-G MMF DAILY DOSING IN RENAL TRANSPLANT

RECIPIENTS

Bryce A. Kiberd, Sita Gourishankar, Isabelle Houde, Paul Keown, David

Landsberg, Carl Cardella, Azemi Barama, Raymond Dandavino, Ahmed

Shoker, Lidia Pirc and Michelle Wrobel; Halifax, NS, Canada; Edmonton, AB,

Canada; Québec City, QC, Canada; Vancouver, BC, Canada; Toronto, ON,

Canada; Montreal, QC, Canada; Saskatoon, SK, Canada and Mississauga,

ON, Canada

P-101 CONVERSION TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN

MAINTENANCE LIVER TRANSPLANT PATIENTS: RESULTS FROM 94

PATIENTS

Mélanie Vallin, Olivier Guillaud, Isabelle Morard, Marie-Claude Gagnieu,

Gilles Mentha, Mustapha Adham, Emmanuel Morelon, Emile Giostra, Olivier

Boillot and Jérôme Dumortier; Lyon, France and Geneva, Switzerland

P-102 GLUCOSE METABOLISM FOLLOWING CONVERSION FROM CNI

TO SIROLIMUS BASED IMMUNOSUPRESSION IN STABLE RENAL

TRANSPLANT RECIPIENTS

Kam Kamaraj and Keshwar Baboolal; Cardiff, Wales, United Kingdom


P-103 RAPAMYCIN AS A THERAPY OF CHOICE AFTER RENAL

TRANSPLANTATION IN A PATIENT WITH TUBEROUS SCLEROSIS

COMPLEX

Agnieszka Tarasewicz, Alicja Debska-Slizien, Joanna Konopa, Zbigniew

Zdrojewski and Boleslaw Rutkowski; Gdansk, Poland

P-104 THE IMPACT OF SIMULECT VERSUS LOW DOSE THYMOGLOBULIN

INDUCTION ON BK VIRUS VIREMIA

Michael Casey, Aaron Eagan, Michael Bucci, Jamie Pack, Shehzad Rehman,

Jesse D. Schold and Herwig-Ulf Meier-Kriesche; Gainesville, FL, United

States

P-105 INCIDENCE OF DELAYED GRAFT FUNCTION (DGF) IN SIROLIMUS

(SRL)–BASED REGIMENS COMPARED WITH CALCINEURIN

INHIBITORS (CNIS) AND MYCOPHENOLATE MOFETIL (MMF) IN DE

NOVO RENAL ALLOGRAFT RECIPIENTS

Josep M. Campistol, Maciej Glyda, Alihan Gurkan, Stuart M. Flechner, Seth

Schulman and Sandi See Tai; Barcelona, Spain; Poznan, Poland; Antalya,

Turkey; Cleveland, OH, United States and Collegeville, PA, United States

P-106 EVALUATION OF MYCOPHENOLIC ACID EXPOSURE DURING

MYCOPHENOLATE MOFETIL THERAPEUTIC DRUG MONITORING IN

KIDNEY TRANSPLANTATION

Thierry Basset, Bertrand Pons, Xavier Delavenne, Michel Ollagnier and

Christophe Mariat; Saint-Etienne, France

P-107 DE NOVO MALIGNANCIES OF KIDNEY TRANSPLANTED PATIENTS

TREATED WITH THE PROLIFERATION SIGNAL INHIBITORS (PSI)

Eva Toronyi, Adam Remport, Katalin Földes, Rita Chmel, Marina Varga,

Gyula Végso, Szilárd Török, Miklós Z.S. Molnár, Zsolt Máthé and Jeno Járay;

Budapest, Hungary

P-108 EVEROLIMUS-INDUCED DELAYED HEALING OF EXPERIMENTAL

COLONIC ANASTOMOSES IS ASSOCIATED WITH PROLONGED

INFLAMMATION

Markus A. Küper, Nadja Schölzl, Frank Traub, Petra Mayer, Jürgen Weinreich,

Stephan Coerper, Wolfgang Steurer, Alfred Königsrainer and Stefan Beckert;

Tübingen, Germany

P-109 B-CELL DEPLETION DURING ALLOGENEIC SENSITIZATION LESSENS

SECOND-SET REJECTION

Meng-Kun Tsai, Hsiung-Fei Chien, Mei-Ching Tzeng and Po-Huang Lee;

Taipei, Taiwan

P-110 IMMUNIZATION OF RECIPIENT WITH DONOR IMMOBILIZED NON-

DIVIDING SPLENOCYTES SIGNIFICANTLY PROLONGS ALLOGENEIC

HEART SURVIVAL

Waldemar L. Olszewski, Maria Moscicka and Hubert Dolezyczek; Warsaw,

Poland and Oslo, Norway

P-111 THE EXPRESSION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO), HEME

OXYGENASE-1 (HO-1), IL-7 MRNAS IN MESANGIAL CELLS WITH

CYTOSKELETON DAMAGE AND IMPACT OF DIFFERENT

IMMUNOSUPPRESSIVE AGENTS ON THEIR EXPRESSIONS

Guo Biao Liang, Yi Ping Lu, Guang Heng Luo, Jun Song and You Ping Li;

Chengdu, China

P-112 THE MINIMAL DOSE OF FK506 IS SUFFICIENT TO INHIBIT

REJECTION OF VENOUS ALLOGRAFT AFTER ITS TRANSPLANTATION

TO ARTERIAL SYSTEM IN RATS

Martin Varga, Ivan Matia, Alena Lodererova and Milos Adamec; Prague,

Czech Republic

P-113 IN VITRO EVALUATION OF THE ROLE OF IMMUNOSUPPRESSIVE

THERAPY ON LIVER FIBROGENESIS

Alcindo Jr. Passaia, Lynda Aoudjehane, Olivier Scatton, Sandrine Chouzenoux,

Olivier Soubrane, Yvon Calmus and Filomena Conti; Paris, France

132


133

POSTERS

P-114 A NOVEL APPROACH TO DEPLETE ANTIGEN-SPECIFIC T CELLS

Hong R. Cho, Sang C. Lee, Jong S. Lee, Yang W. Nah, Chang W. Nam and

Byungsuk Kwon; Ulsan, Republic of Korea

P-115 ANGIOTENSIN II BLOCKADE DECREASES AGING PROCESS BY

UPREGULATING KLOTHO, AN ANTI-AGING GENE, IN EXPERIMENTAL

MODEL OF CHRONIC CYCLOSPORINE NEPHROPATHY

Chul Woo Yang, Hye Eun Yoon, Donghe Han, Jung Yeon Ghee, Ji Hyun Song,

ShangGuo Park, Jin Kim and So Young Lee; Seoul, Korea

P-116 IMPDH-ACTIVITY MEASUREMENT AND ITS POSSIBLE CLINICAL

BENEFIT

Matthias C. Raggi, Stephanie Siebert, Stefan Thorban, Manfred J. Stangl and

Dietmar Abendroth; Münster, Bavaria, Germany and Ulm, Germany

P-117 IN VIVO EXPANSION OF CD4+CD25+FOXP3+ T CELLS AFTER ATG

INDUCTION THERAPY IS REFLECTED AT THE EPIGENETIC LEVEL

Katja Kotsch, Diana Stauch, Ali Yayahzadeh, Uwe Baron, Sven Olek, Hans-

Dieter Volk, Andreas Pascher, Peter Neuhaus and Johann Pratschke; Berlin,

Germany

P-118 PHYTOHEMAGGLUTININ-INDUCED IL2 AND TNFSF2 MRNA AS A

MARKER OF IMMUNOSUPPRESSIVE DRUGS

Kazuo Mizutani, Ryouhei Hattori, Masashi Kato, Tsuneo Kinukawa, Kazuhiko

Obara, Tetsuya Ueda, Hiroshi Izutsu, Masato Mitsuhashi and Momokazu

Gotho; Nagoya, Aichi, Japan; Hitachi, Japan and Irvine, CA, United States

P-119 TACROLIMUS INHIBITION OF CALCINEURIN ACTIVITY IN WHOLE

BLOOD AND IN ISOLATED T-LYMPHOCYTES

Dorthe M. Mortensen, Pernille B. Kofoed-Nielsen, Holger J. Møller and Kaj

A. Jørgensen; Aarhus N, Denmark and Aarhus C, Denmark

P-120 ALEMTUZUMAB (CAMPATH-1H) FOR LYMPHOCYTE DEPLETION IN

CYNOMOLGUS MONKEYS

Dirk J. van der Windt, Cynthia Smetanka, Camila Macedo, Rita Bottino, Jan

N.M. Ijzermans, Massimo Trucco, Fadi G. Lakkis and David K.C. Cooper;

Pittsburgh, PA, United States and Rotterdam, The Netherlands

P-121 IMMUNOSUPPRESSIVE DRUGS INHIBIT RAT ISLET CELL

PROLIFERATION IN VITRO

Geraldine Parnaud, Domenico Bosco and Thierry Berney; Geneva,

Switzerland

P-122 IMPAIRING EFFECTS OF CYCLOSPORINE AND TACROLIMUS ON

TRANSCRIPTIONAL REGULATION AND SECRETION OF INSULIN IN

RAT -CELLS

Lara Aygen Oezbay, Jan Carstens, Kaj Anker Joergensen, Ole Schmitz and

Jørgen Rungby; Aarhus, Denmark

P-123 CYCLOSPORIN A INHIBITS PROFIBROTIC EFFECTS OF INTERLEUKIN-4

AND TGF- IN HUMAN INTRAHEPATIC FIBROBLASTS IN VITRO

Alcindo Jr. Pissaia, Lynda Aoudjehane, Samia Ben Othman, Olivier Scatton,

Sandrine Chouzenoux, Olivier Soubrane, Yvon Calmus and Filomena Conti;

Paris, France

P-124 SUNITINIB PREVENTS CHRONIC REJECTION IN EXPERIMENTAL

KIDNEY TRANSPLANTATION

Jukka M. Rintala, Johanna Savikko, Niina Malmström, Sini E. Rintala and Petri

Koskinen; Helsinki, Finland

P-125 THE EFFECT OF INHIBITION OF INDIRECT T-CELL ACTIVATION ON

CHRONIC REJECTION OF KIDNEY ALLOGRAFTS IN RATS

Jan Frese, Holger Hackstein, Stefan Menzler, Winfried Padberg, Joren C.

Madsen and Ruediger Hoerbelt; Giessen, Germany and Boston, MA, United

States


P-126 HUMAN MITOMYCIN C-TREATED DENDRITIC CELLS SUPPRESS

ALLOGENEIC T-CELL RESPONSE IN-VITRO. AN EFFECT MEDIATED

BY INDUCTION OF CD4+CD25+FOXP3+ TREGS

Janina Jiga, Lucian P. Jiga, Bogdan Hoinoiu, George Dindelegan, Alexandru

Blidisel, Calin Tatu, Mihai Ionac and Virgil Paunescu; Timisoara, Romania and

Cluj-Napoca, Romania

P-127 HEPATITIS C VIRUS INFECTION INFLUENCE ON REGULATORY T

CELLS (TREGS) LEVELS IN KIDNEY TRANSPLANTED PATIENTS

Elisa Ramírez, Jose M. Morales, David Lora, Mario Mellado, Francisco J.

Alfaro, María Cevey, Estela Paz-Artal and Antonio Serrano; Madrid, Spain

P-128 EFFECT OF CALCINEURIN ANTAGONISTS ON HCV-ANTIGEN

SPECIFIC PBMC RESPONSE IN LIVER TRANSPLANTED PATIENTS

WITH VIRAL RECURRENCE

Alessandro Perrella, Giuseppe Arenga, Donatella Pisaniello and Oreste

Cuomo; Naples, Italy

P-129 TACROLIMUS AND DIABETES MELLITUS: ONLY OVERDOSEAGE

LEADS TO AN IMPAIRED INSULIN PRODUCTION IN THE RAT

PANKREAS

Maciej Malinowski, Johann Pratschke, Anke Jurisch, Peter Neuhaus and

Martin Stockmann; Berlin, Germany

P-130 HUMAN MACROPHAGES DRIVEN TO A NOVEL STATE OF ACTIVATION

HAVE TOLEROGENIC PROPERTIES IN RENAL TRANSPLANT

RECIPIENTS

James A. Hutchinson, Paloma Riquelme, Birgit Sawitzki, Fred Fändrich and

Edward K. Geissler; Regensburg, Bavaria, Germany; Berlin, Germany and

Kiel, Schleswig-Holstein, Germany

P-131 DOES TACROLIMUS INFLUENCE THE ABILITY OF POSTOPERATIVE

WOUND HEALING IN A RODENT MODEL?

Martine C.M. Willems, Adam J. van der Vliet, Roger M.L.M. Lomme, Ben M.

de Man and Thijs Hendriks; Nijmegen, The Netherlands

P-132 ROUTINE USE OF EARLY INTRAVENOUS TACROLIMUS IN INTESTINAL

TRANSPLANTATION MAINTAINS MORE CONSISTENT BLOOD LEVELS

WITHOUT NEGATIVELY IMPACTING RENAL FUNCTION

Lindsey Pote, Jeanne Chen, Richard S. Mangus, A. Joseph Tector, Jonathan

A. Fridell and Rodrigo M. Vianna; Indianapolis, IN, United States

P-133 RABBIT ANTITHYMOCYTE GLOBULIN (RATG) IMMUNOSUPPRESSION

INDUCTION IN 1000 CONSECUTIVE ADULT, DECEASED DONOR

LIVER TRANSPLANTS

Jeanne M. Chen, Lindsey Pote, Richard S. Mangus, Jonathan A. Fridell,

Rodrigo M. Vianna and A. Joseph Tector; Indianapolis, IN, United States

P-134 PATHOPHYSIOLOGICAL MECHANISMS UNDERLYING THE

CARDIOVASCULAR SIDE-EFFECTS OF SIROLIMUS VERSUS

CYCLOSPORIN

Flávio Reis, Belmiro Parada, Patrícia Garrido, José Sereno, Pedro Nunes,

Pedro Eufrásio, Nuno Piloto, Sofi a Batista, Edite Teixeira-Lemos, Arnaldo

Figueiredo, Alfredo Mota and Frederico Teixeira; Coimbra, Portugal

P-135 WITHDRAW

P-136 INHIBITION OF BLADDER TUMOR GROWTH BY

IMMUNOSUPPRESSION AGENTS: EXPERIMENTAL STUDY

Belmiro Parada, Flávio Reis, Arnaldo Figueiredo, José Sereno, Edite Teixeira-

Lemos, Pedro Nunes, Alfredo Mota and Frederico Teixeira; Coimbra,

Portugal

134


Histocompatibility

135

POSTERS

P-137 LATE ACUTE ANTIBODY MEDIATED REJECTION ON TOP OF

DENOVO MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

AFTER 9 YEARS OF RENAL TRANSPLANTATION

M.A. Halim, T. Al-Otaibi, S. Al-Waheeb, O. El-Kholy, P. Nair, T. Said and

M.R.N. Nampoory; Kuwait, Kuwait

P-138 ANALYSIS OF DONOR SPECIFIC ANTIBODIES THE DAY OF THE GRAFT

TO AVOID ACUTE REJECTION IN KIDNEY TRANSPLANTATIONS

PERFORMED ACROSS A POSITIVE FLOW CYTOMETRIC CROSS

MATCH

Lionel Couzi, Caroline Araujo, Thomas Bachelet, Gwendaline Guidicelli, Jean-

Francois Moreau, Pierre Merville and Jean-Luc Taupin; Bordeaux, France

P-139 REJECTION AFTER HLA ANTIBODY INCOMPATIBLE KIDNEY

TRANSPLANTATION; ASSOCIATION WITH ANTIBODY LEVELS AND

SPECIFICITIES

Robert Higgins, Dave Lowe, David Briggs, Rizwan Hamer, Nithya Krishnan

and Daniel Zehnder; Coventry, United Kingdom and Birmingham, United

Kingdom

P-140 KIR AND CYTOKINE GENE POLYMORPHISMS IN HEART TRANSPLANT

RECIPIENTS

Libor Kolesar, Yelena Pavlova, Ivan Malek, Eva Honsova, Alena Lodererova,

Ilja Striz and Antonij Slavcev; Prague, Czech Republic

P-141 HOW USEFUL IS THE SCREENING ON THE CDC VERSUS FLOW

CYTOMETRY CROSSMATCH (FCXM)?

Paula Xavier, Manuela Monteiro, Cecília Mendes, Ermelinda Osório, Paula

Aires and Helena Alves; Porto, Portugal

P-142 HLA CLASS I ANTIBODY FREQUENCIES IN THE SOUTHERN PORTUGAL

KIDNEY CANDIDATE IN WAITING LIST

Luis Ramalhete, M. Rosario Sancho and Helder Trindade; Lisbon, Portugal

P-143 DETECTION AND IDENTIFICATION OF HLA ANTIBODIES.

COMPARISON OF COMPLEMENT DEPENDENT CITOTOXICITY (CDC)

AND ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA)

Maria J. Moreno, Sara R. Teper and Marcela M. Quintana; Buenos Aires,

Argentina

P-144 CLINICAL RELEVANCE OF LUMINEX DONOR-SPECIFIC

CROSSMATCHES: DATA FROM 165 RENAL TRANSPLANTS

Evy V.A. Billen, Maarten H.L. Christiaans and Ella M. van den Berg-Loonen;

Maastricht, The Netherlands

P-145 DE NOVO PRODUCTION OF ANTI-HLA DONOR-

SPECIFIC ANTIBODIES IN KIDNEY ALLOGRAFT RECIPIENTS: CLINICAL

SIGNIFICANCE

Antonina Piazza, Elvira Poggi, Giuseppina Ozzella, Daniela Caputo, Manuela

Catalano, Valentina Imbroglini, Rosanna Cremona and Domenico Adorno;

Rome, Italy

P-146 QUANTIFICATION BY QUANTIPLEX OF HLA DONOR SPECIFIC

ANTIBODIES: CASE REPORT

António C. Henriques, Manuela S. Monteiro, José F. Teixeira, Cecília Mendes,

Ermelinda Osório, Helena Alves, Susana Pereira, Paulo Santos, Leonídio Dias

and La Salete Martins; Porto, Portugal

P-147 RESULTS OF PREEMPTIVE KIDNEY RETRANSPLANTATION VERSUS

RETURN TO DIALYSIS PROGRAM AFTER GRAFT LOST. IMPACT OF

IMMUNOLOGICAL SENSITIZATION IN KIDNEY GRAFT LOST

Ignacio Revuelta, Miguel Blasco, Vanesa de la Fuente-Fernández, Nuria

Esforzado, Frederic Cofán, María José Ricart, Vicente Torregrosa, Rafael

Gutiérrez del Pozo, Jaume Martorell, Antonio Alcaraz, Josep M. Campistol

and Federico Oppenheimer; Barcelona, Spain


Heart

P-148 ASSOCIATION OF NT-PRO BRAIN NATRIURETIC PEPTIDE LEVELS

AND ECHOCARDIOGRAPHIC VARIABLES IN LONGTERM HEART

TRANSPLANT RECIPIENTS

J. Renoldner, R. Berger, S. Roedler, A. Aliabadi, A. Zuckermann and B.

Stanek; Vienna, Austria

P-149 PSYCHOSOCIAL PARAMETERS OF COMPLIANCE AND SURVIVAL OF

PATIENTS WITH ADVANCED HEART FAILURE

Pavla Notova, Eva Goncalvesova, Sona Wimmerova, Milan Luknar, Peter

Lesny, Ivan Varga, Ivana Soosova and Juraj Fabian; Bratislava, Slovakia

(Slovak Republic)

P-150 HYPOMAGNESEMIA AFTER HEART TRANSPLANTATION:

SURPRISINGLY REMAINS A PROBLEM

Milan Luknar, Peter Lesny and Eva Goncalvesova; Bratislava, Slovakia (Slovak

Republic)

P-151 IMMUNOSUPPRESSION WITH TACROLIMUS MONOTHERAPY IN

RENAL TRANSPLANTATION: A 6 YEARS ANALYSIS

Florence Villemain, Jean Francois Augusto, Celine Onno, Virginie Besson,

Maud Cousin and Jean Francois Subra; Angers, France

P-152 POST-TRANSPLANT OUTCOME OF DILATED CARDIOMYOPATHY

CAUSED BY DYSTROPHIN GENE DEFECTS

Michele Pasotti, Alessandra Serio, Fabiana Isabella Gambarin, Marta Diegoli,

Nicola Marziliano, Maurizia Grasso, Carlo Campana, Stefano Ghio, Carlo

Pellegrini, Mario Viganò, Oreste Febo and Eloisa Arbustini; Pavia, Italy and

Montescano, Italy

P-153 RELATIONSHIP BETWEEN BNP LEVEL DYNAMICS AND MYOCARDIAL

REVERSE REMODELING IN PATIENTS REFERRED AS HEART

TRANSPLANT CANDIDATES WITH SHORT HISTORY OF NON-

ISCHEMIC HEART FAILURE

Markéta Hegarová, Petr Lupínek, Antonín Jabor, Blanka Dufková and Ivan

Málek; Prague, Czech Republic

P-154 SEEKING TRANSLATIONAL EVIDENCE FOR A NEW INDICATION

OF INTRAVENOUS IMMUNOGLOBULIN IN SOLID ORGAN

TRANSPLANTATION

Elizabeth Sarmiento, Juan-Jose Rodriguez-Molina, Joaquin Navarro, Nallibe

Lanio, Antonio Gallego, Juan Fernandez-Yanez, Jesus Palomo, Patricia

Munoz, Manuel Ruiz, Cesar Rodriguez and Javier Carbone; Madrid, Spain

P-155 MONITORING OF LYMPHOPROLIFERATIVE RESPONSES USING CFSE

AND CLINICAL FINDINGS AFTER HEART TRANSPLANTATION

Larisa Valor, Elizabeth Sarmiento, Joaquin Navarro, Nallibe Lanio, Antonio

Gallego, Juan Fernandez-Yanez, Eduardo Fernandez-Cruz and Javier

Carbone; Madrid, Spain

P-156 PLASMAPHERESIS AND IMMUNE GLOBULIN: TOGETHER THEY

ARE STRONG AGAINST HUMORAL REJECTION IN CARDIAC

TRANSPLANTATION

Karin Janssen van Doorn, Tom Vermeulen, Gert A. Verpooten and Viviane M.

Conraads; Edegem, Belgium and Edegem (Antwerpen), Belgium

P-157 PRETRANSPLANT PREGNANCY- ASSOCIATED PLASMA PROTEIN A

(PAPP-A) AS A PREDICTOR OF CHRONIC GRAFT VASCULOPHATY

AND POSTTRANSPLANT CARDIOVASCULAR EVENTS

O.P. Shevchenko, O.V. Orlova, A.O. Shevchenko, E.N. Kazakov and A. Ja.

Kormer; Moscow, Saint Kitts and Nevis and Moscow, Russian Federation

P-158 PLASMA LEVELS OF SOLUBLE CD40 LIGAND IN HEART TRANSPLANT

RECIPIENTS

O.V. Orlova, O.P. Shevchenko, E.N. Kazakov, A. Ya. Kormer and A.O.

Shevchenko; Moscow, Russian Federation

136


137

POSTERS

P-159 EFFICACY AND SAFETY OF COMBINED THERAPY OF TACROLIMUS

AND ATORVASTATIN IN HEART TRANSPLANT RECIPIENTS

Blanka Skalicka, Yevheniya Vymetalova and Ivan Malek; Prague, Czech

Republic

P-160 THE ROLE OF THE LEVITRONIX CENTRIMAG DEVICE IN THE

THERAPY OF POSTTRANSPLANT HEART FAILURE

Nils Reiss, Lukasz Kizner, Latif Arusoglu, Uwe Schulz, Kavous Hakim-Meibodi,

Reiner Koerfer and Jan Gummert; Bad Oeynhausen, Germany

P-161 FP15 A NOVEL PEROXYNITRITE DECOMPOSITION CATALYST

PROTECTS AGAINST MYOCARDIAL AND ENDOTHELIAL

REPERFUSION INJURY AFTER ORTHOTOPIC HEART

TRANSPLANTATION

Gábor Szabó, Nicole Stumpf, Christiane Miesel-Gröschel, Ulrike Heger and

Matthias Karck; Heidelberg, Germany

P-162 MECHANICAL CIRCULATORY SUPPORT IN END-STAGE HEART

FAILURE AS BRIDGE TO HEART TRANSPLANTATION

Antonino Loforte, Andrea Montalto, Federico Ranocchi, Giovanni Casali,

Giampaolo Luzi, Paola Lilla Della Monica, Fabio Sbaraglia, Vincenzo Polizzi,

Giada Distefano and Francesco Musumeci; Rome, Italy

P-163 CMV INFECTION IN THE NEW MILLENIUM

Arezu Z. Aliabadi, Claudia Bauer, Heidrun Kerschner, Daniela Dunkler,

Martina Groemmer, Stephane L. Mahr, Daniel Zimpfer, Michael Grimm,

Theresia Popow-Kraupp and Andreas O. Zuckermann; Vienna, Austria

P-164 ROLE OF MARGINAL DONORS IN HEART TRANSPLANTATION

Alberto Forni, Giuseppe Faggian, Bartolomeo Chiominto, Vincenzo

Giambruno and Alessamdro Mazzucco; Verona, Italy

P-165 NON-INVASIVE ASSESSMENT OF MYOCARDIAL FUNCTION

AND STRAIN RATE IMAGING BY DOPPLER MYOCARDIAL

ULTRASONOGRAPHY IN KIDNEY TRANSPLANTED PATIENTS

Maria Dudziak, Alicja Debska-Slizien, Dorota Rawicz-Zegrzda and Boleslaw

Rutkowski; Gdansk, Poland

P-166 VALGANCICLOVIR UNIVERSAL PROPHYLAXIS OF

CYTOMEGALOVIRUS INFECTION IN HEART TRANSPLANTATION

Jevgenija Vymetalova, Blanka Skalicka, Tomaš Gazdic, Jana Vrbska and Ivan

Malek; Prague, Czech Republic

P-167 IODINE MANAGEMENT IN HEART TRANSPLANT RECIPIENTS

Anita Cichoracka, Elzbieta Wozniak-Grygiel, Slawomir Zeglen, Michal

Zakliczynski, Marta Szewczyk and Marian Zembala; Katowice, Poland and

Zabrze, Poland

P-168 EARLY ACTIVATION OF WNT-PATHWAY IN HEART OF BRAIN DEATH

RATS. A POSSIBLE LINK TO TRANSPLANT VASCULOPATHY (TVP)?

Markus Richter, Thomas Schröter, Volker Adams, Hartmut Bittner and Martin

Kostelka; Leipzig, Germany

P-169 PROTEINURIA AND KIDNEY FUNCTION AFTER CONVERSION TO AN

EVEROLIMUS BASED IMMUNOSUPPRESSIVE REGIME AFTER OHTX

Martin Schweiger, Philipp Stiegler, Andre Wasler, Günter Prenner and

Karlheinz Tscheliessnigg; Graz, Austria

P-170 WHAT ELSE DIFFERS CELLULAR REJECTION GRADE 1A FROM 0?

ANNEXIN V AND BCL EXPRESSIONS IN ELECTIVE BIOPSIES RECEIVED

FROM HEART TRANSPLANT RECIPIENTS

Slawomir Zeglen, Elzbieta Wozniak-Grygiel, Jerzy Nozynski, Michal

Zakliczynski, Anna Laszewska, Andrzej Fabry and Marian Zembala; Zabrze,

Poland

P-171 FIRST DOCUMENTED CASE OF PARACOCCUS YEEI INFECTION IN A

TRANSPLANTED HEART

Martin Schweiger, Philipp Stiegler, Michael Scarpatetti, Andre Wasler, Günter

Prenner and Karlheinz Tscheliessnigg; Graz, Austria


P-172 THE RESUSCITATED DECEASED DONOR HEART IS FUNCTIONALLY

SUPERIOR TO THE BRAINSTEM DEAD DONOR HEART

Ayyaz A. Ali, Giovanni Fajardo, Shoichi Tsuda, Grant Budas, Ziad Ali, Thomas

Quertermous, Daniel Bernstein, Steven Tsui, Robert Robbins, Michael

Fischbein, Stephen Large and Euan Ashley; Palo Alto, CA, United States and

Papworth Everard, Cambridgeshire, United Kingdom

P-173 CMV THERAPY WITH IMMUNOGLOBULIN (CYTOTECT)

MONOTHERAPY IN NEUTROPENIC PATIENTS AFTER HEART

TRANSPLANTATION -REPORT OF 4 CASES-

Uwe Schulz, Sebastian Schulte-Eistrup, Stefanie SchulzeSchleithoff and Jan

Gummert; Bad Oeynhausen, Germany

P-174 THERE IS NO RELATION BETWEEN CYTOMEGALOVIRUS INFECTION

AND MICROVASCULOPATHY DEVELOPMENT IN HEART TRANSPLANT

RECIPIENTS

Michael Zakliczynski, Anna Krynicka-Mazurek, Dominika Konecka-Mrowka,

Jerzy Nozynski, Slawomir Zeglen, Roman Przybylski and Marian Zembala;

Zabrze, Poland and Rybnik, Poland

Islets

P-175 IMPACTS OF TOLL-LIKE RECEPTORS (TLRS) IN ALLOGENEIC ISLET

TRANSPLANTATION

Han Ro, Eun-Won Lee, Jaeseok Yang and Curie Ahn; Seoul, Republic of

Korea and Seoul, Republic of Korea

P-176 GRAVES’ HYPERTHYROIDISM AFTER STOPPING IMMUNE

SUPPRESSIVE TREATMENT IN TYPE 1 DIABETIC ISLET CELL

RECIPIENTS WITH PRETRANSPLANT TPO AUTOANTIBODIES

Pieter Gillard, Volkert Huurman, Bart Van der Auwera, Brigitte Decallonne,

Kris Poppe, Bart Roep, Frans Gorus, Chantal Mathieu, Daniel Pipeleers

and Bart Keymeulen; Brussels, Belgium; Leuven, Belgium and Leiden, The

Netherlands

P-177 IMPROVED YIELD AND FUNCTIONAL PARAMETERS OF RAT

PANCREAS ISLETS ISOLATED UNDER INTRAMUSCULAR ANESTHESIA

Yu Seun Kim, Jeong-Ik Lee, Joon Ye Kim, Won Hyun Cho, Byung-Jun So, Jin

Ho Jeong, Soon Il Kim and Hee Chul Yu; Seoul, Korea; Daegu, Korea; Iksan,

Korea and Jeonju, Korea

P-178 RESULTS OF ISLET AUTOTRANSPLANTATION AFTER EXTENDED

PANCREATECTOMY FOR BENIGN DISEASE OF THE PANCREAS AND

THEIR SIGNIFICANCE FOR LIVE DONATION

Frederic Ris, Nadja Niclauss, Philippe Morel, Sandrine Demuylder-Mischler,

Leo Buhler, Domenico Bosco and Thierry Berney; Geneva, Switzerland

P-179 INFLUENCE OF DONOR AGE ON ISLET ISOLATION AND

TRANSPLANTATION OUTCOME

Nadja Niclauss, Domenico Bosco, Philippe Morel, Sandrine Demuylder-

Mischler, Coralie Brault, Antonino Sgroi, Géraldine Parnaud, Yannick Muller,

Laurianne Giovannoni, Pierre-Yves Benhamou and Thierry Berney; Geneva,

Switzerland; Lyon, France and Grenoble, France

P-180 ISLET AFTER KIDNEY TRANSPLANTATION FROM THE COLLABORATIVE

ISLET TRANSPLANT REGISTRY: 1999-2008

Thierry Berney, Rodolfo Alejandro, François Pattou, Franca B. Barton, Steve

Wease, Bernhard Hering and CITR Investigators; Geneva, Switzerland;

Miami, FL, United States; Lille, France; Rockville, MD, United States and

Minneapolis, MN, United States

138


139

POSTERS

P-181 HUMAN ALLOGENIC BONE MARROW AND CORD BLOOD DERIVED

MESENCHYMAL STEM CELL SECRETING TROPHIC FACTORS

INFLUENCE ON ADP/ATP RATIO AND INSULIN SECRETARY FUNCTION

OF ISOLATED HUMAN ISLETS FROM CADAVERIC DONOR

Ki-Soo Park, Young-Seok Kim, Jae-Hyun Kim, Bongkum Choi, Sa-Hyun Kim,

Seung-Hoon Oh, You-Ran Ahn, Myung-Shik Lee, Moon-Kyu Lee, Gwan

Chul Lee, Eun Young Kim, Mil Jae Shin, Choon-Hyuck Kwon, Jae-Won Joh,

Kwang-Won Kim and Sung-Joo Kim; Seoul, Republic of Korea

P-182 PORTAL VENOUS OXYGEN PERSUFFLATION FOR THE PRESERVATION

OF NON HEART-BEATING-DONOR PANCREASES PRIOR TO ISLET

ISOLATION

Mettu Reddy, Aimee Kibondo, Ali Aldibbiat, Susan Stamp, Brian Shenton,

James Shaw, Noel Carter, Anne Cunningham and David Talbot; Newcastle

Upon Tyne, United Kingdom and Sunderland, United Kingdom

P-183 COMPARATIVE IMPACT ON ISLET ISOLATION AND

TRANSPLANTATION OUTCOME OF THE NEW PRESERVATION

SOLUTION IGL-1 VERSUS UW AND CELSIOR

Nadja Niclauss, Anne Wojtusciszyn, Philippe Morel, Sandrine Demuylder-

Mischler, Coralie Brault, Domenico Bosco, Pierre-Yves Benhamou and

Thierry Berney; Geneva, Switzerland; Montpellier, France; Lyon, France and

Grenoble, France

P-184 MECHANISMS OF RAPAMYCIN TOXICITY IN PANCREATIC BETA

CELLS

Adam D. Barlow, Michael L. Nicholson and Terry P Herbert; Leicester, United

Kingdom

Kidney I

P-185 RESCUE IMMUNOSUPPRESSIVE THERAPIES IN LIVE RELATED RENAL

ALLO-TRANSPLANTS: LONG TERM PROSPECTIVE RANDOMIZED

EVALUATION

Mohamed Adel Bakr, Osama Gheith, Amani Mostafa, Mahmoud El Baz and

Mohamed Ghoneim; Mansoura, DK, Egypt

P-186 A NEW TECHNIQUE FOR URETERIC STENTING DURING KIDNEY

TRANSPLANTATION

Uta Herden, Stefan W. Schmid, Christian A. Seiler and Daniel Candinas;

Bern, Switzerland

P-187 KIDNEY GRAFTS WITH MULTIPLE ARTERIES AND ARTERIAL

RECONSTRUCTION – ANALYSIS OF A 10 YEAR PERIOD

Uta Herden, Christian A. Seiler, Daniel Candinas and Stefan W. Schmid; Bern,

Switzerland

P-188 PREDICTION OF GRAFT SURVIVAL OF LIVING DONOR KIDNEY

TRANSPLANTATION: NOMOGRAMS OR ARTIFICIAL NEURAL

NETWORKS?

Ahmed I. Akl, Amani I. Mostafa and Mohamed A. Ghoneim; Mansoura, DK,

Egypt

P-189 KIDNEY TRANSPLANTATION IN PATIENTS WITH AUGMENTATION

CYSTOPLASTY: EARLY AND LONG TERM RESULTS

Reza Mahdavi Zafarghandi, Rahim Taghavi, Mohammad Reza Darabi,

Meysam Mahdavi Zafarghandi and Mohammad Hadi Shakibi; Mashhahd,

Khorasan Razavi, Islamic Republic of Iran

P-190 PREOPERATIVE EVALUATION OF LIVING DONORS USING COMPUTED

TOMOGRAPHY ANGIOGRAPHY (CTA) AND FORMAL ANGIOGRAPHY:

COMPARISON WITH INTRAOPERATIVE FINDINGS

Taghavi Rahim, Mahdavi Reza and Darabi Mohammad Reza; Mashhad,

Khorasan Razavi, Islamic Republic of Iran


P-191 INCISIONAL HERNIA OF SURGICAL SITE AFTER KIDNEY

TRANSPLANTATION AND ITS REPAIR WITH PROPYLENE MESH

Reza Mahdavi Zafarghandi, Mostafa Mehrabi, Ali Ghaior and Meysam

Mahdavi Zafarghandi; Mashhad, Khorasan Razavi, Islamic Republic of Iran

P-192 CLINICAL SIGNIFICANCE OF 25-HYDROXYVITAMIN D (25-OHD)

INSUFFICIENCY IN RENAL TRANSPLANT RECIPIENTS

Dong Ryeol Lee and Jin Min Kong; Pusan, Korea

P-193 PREVALENCE AND CORRELATES OF INFLUENZA VACCINATION

AMONG RENAL TRANSPLANT PATIENTS

Lut Berben, Kris Denhaerynck, Stefan Schaub and Sabina De Geest; Basel,

Switzerland

P-194 MONITORING OF POLYOMA VIRUS BK AND JC VIRURIA AND

VIREMIA IN KIDNEY TRANSPLANT PATIENTS: TWO YEARS

PROSPECTIVE STUDY

Veronica Lopez, Cristina Gutierrez, Isabel Garcia, Dolores Burgos, Eugenia

Sola, Mercedes Cabello, Jose Lopez, Miguel Gonzalez and Domingo

Hernandez; Malaga, Spain

P-195 CINACALCET FOR THE TREATMENT OF HYPERCALCEMIA

IN 29 RENAL TRANSPLANTED PATIENTS WITH PERSISTENT

HYPERPARATHIROIDISM

Veronica V. Lopez, Cristina C. Gutierrez, Eugenia E. Sola, Remedios R. Toledo,

Seema S. Sujan, Manuel M. Rodriguez, Mercedes M. Cabello, Dolores D.

Burgos, Miguel M. Gonzalez Molina and Domingo D. Hernandez; Malaga,

Spain and Almeria, Spain

P-196 THE EFFECTIVENESS OF A 5-DAY EXTERNAL STENTING

PROTOCOL ON UROLOGICAL COMPLICATIONS AFTER RENAL

TRANSPLANTATION

Robert C. Minnee, Frederike J. Bemelman, Karlijn A. Donselaar van der Pant,

Pilar P. Laguna Pes, Ineke J. ten Berge, Dink A. Legemate and Mirza M. Idu;

Amsterdam, The Netherlands

P-197 RISK FACTORS FOR DELAYED GRAFT FUNCTION AFTER HAND

ASSISTED LAPAROSCOPIC DONOR NEPHRECTOMY

Robert C. Minnee, Willem A. Bemelman, Karlijn A. Donselaar van der Pant,

Jan Booij, Sylvia ter Meulen, Ineke J. ten Berge, Dink A. Legemate, Frederike

J. Bemelman and Mirza M. Idu; Amsterdam, The Netherlands

P-198 KIDNEY TRANSPLANTATION FROM SPOUNITED STATESL DONORS:

A REPORT OF 11 CASES

He Fan, Wang Li, Lin Tao, Lu Yi Ping and Yang Yu Ru; Chengdu, Sichuan,

China

P-199 POSTURAL EPIGASTRIC PAIN AS A SIGN OF CMV GASTRITIS IN

RENAL TRANSPLANT RECIPIENTS: A CASE-BASED REVIEW

Li Wang, Fan He and Lu Yiping; Chengdu, Sichuan, China

P-200 NONINVASIVE PRE-TRANSPLANT CARDIAC RISK ASSESSMENT WITH

CALCIUM SCORING AND ANGIOGRAPHY BY HIGH RESOLUTION

COMPUTED TOMOGRAPHY

Hector Carbajal, Nabi Faisal, John Mahmarian and Osama A. Gaber;

Houston, TX, United States

P-201 RENAL TRANSPLANTATION IN MALAYSIA: INFLUENCE ON LONG-

TERM SURVIVAL OF NON IMMUNOLOGICAL FACTORS

Bak-Leong Goh, Morad Zaki, Lai-Seong Hooi and Teck-Onn Lim; Kajang,

Selangor, Malaysia; Kuala Lumpur, Malaysia and Johor Bharu, Johor,

Malaysia

P-202 CYTOMETRIC ANALYSIS OF TH1/TH2 CYTOKINES IN THE URINE OF

PATIENTS PRIOR TO THE KIDENY TRANSPLANTATION

Jacek Karczewski, Marek Karczewski, Krzysztof Wiktorowicz and Maciej

Glyda; Poznan, Poland

140


141

POSTERS

P-203 IMMUNOLOGIC INTOLERANCE TO THE RENAL ALLOGRAFTS.

ANALYSIS OF THE THERAPEUTIC ATTITUDE AND MAGNITUDE OF

THE INFLAMMATORY STATE IN A SERIES OF 199 PATIENTS

I. Agraz, J. Fort, J. De la Torre, J. Gorro, L.L. Capdevila, C. Cantarell, M.

Perelló, I. Gil, M. Azancot, R. Ramos and J. Camps; Barcelona, Spain

P-204 TWENTY YEAR EXPERIENCE IN A TRANSPLANT CENTRE. ANALYSIS

OF FIRST KIDNEY TRANSPLANTATION RESULTS

Georgios Vergoulas, Georgia Mahia, Maria Tsalidou, Gregory Miserlis,

Andreas Papagiannis, Vasilios Papanikolaou, Dimitrios Takoudas and

Georgios Efstratiadis; Thessaloniki, Greece

P-205 STUDY OF RISK FACTORS AND LONG TERM PROGNOSIS OF POST

KIDNEY TRANSPLANT DIABETES MELLITUS (PTDM): A SINGLE

CENTER EXPERIENCE

Ayman Maher, Ayman Refaie, Ehab Wafa, Ahmed Akl, Ahmed Shokeir,

ElMetwally ElShehawy, Sameh Hana and Mohamed Ghoneim; Mansoura,

DK, Egypt and Benha, Egypt

P-206 EVALUATION OF THE EFFICACY AND SAFETY OF CONVERSION TO

SIROLIMUS IN 85 RENAL TRANSPLANT RECIPIENTS

Veronica Lopez, Eugenia Sola, Cristina Gutierrez, Mercedes Cabello, Dolores

Burgos, Miguel Gonzalez Molina and Domingo Hernandez; Malaga, Spain

P-207 THE IMPACT OF DONOR: RECIPIENT SIZE DISCREPANCY IN

PAEDIATRIC RENAL TRANSPLANTATION ON SHORT AND LONG-

TERM OUTCOMES

Paul J. Goldsmith, Dan Ridgway, Sonal Asthana, Maggie Fitzpatrick, Eric

Finley, Magdy Attia, Stephen G. Pollard and Niaz Ahmad; Leeds, United

Kingdom

P-208 EFFECT OF TEMOCAPRIL AND CANDESARTAN ON PAI-1 AND TGF-

BETA EXPRESSION IN CYCLOSPORINE-TREATED NEPHROTOXIC

RATS

Akira Ishikawa, Masamitsu Tanaka and Yukio Homma; Bunkyo-ku, Tokyo,

Japan and Chuo-ku, Tokyo, Japan

P-209 HEAD AND NECK MALIGNANCIES IN RENAL TRANSPLANT

RECIPIENTS

Nikolina Basic-Jukic, Ljubica Bubic-Filipi, Ana Djanic-Hadzibegovic and Petar

Kes; Zagreb, Croatia

P-210 RENAL TRANSPLANTATION IN CROATIA AFTER JOINING

EUROTRANSPLANT

Nikolina Basic-Jukic, Petar Kes, Ljubica Bubic-Filipi, Josip Pasini, Vesna Furic-

Cunko and Zeljka Mustapic; Zagreb, Croatia

P-211 THE IMPACT OF VERY PROLONGED COLD ISCHAEMIA TIME ON

SHORT AND LONG-TERM OUTCOMES IN RENAL

TRANSPLANTATION

Paul J. Goldsmith, Dan Ridgway, Sheila M. Fraser, Magdy Attia, J. Peter A.

Lodge and Niaz Ahmad; Leeds, United Kingdom

P-212 THE VALUE OF RESISTIVE INDICES AS A PREDICTOR OF SHORT

AND LONG-TERM OUTCOMES IN NON-HEARTBEATING RENAL

TRANSPLANT DONORS

Paul J. Goldsmith, Dan Ridgway, Sheila M. Fraser, Charles Newstead, Krishna

V. Menon, K. Rajendra Prasad and Niaz Ahmad; Leeds, United Kingdom

P-213 METABOLIC BONE DISEASE IN AFTER RENAL TRANSPLANTATION IN

PATIENTS WITH BALKAN ENDEMIC NEPHROPATHY

Nikolina Basic-Jukic, Ruzica Smalcelj, Petar Kes, Djanic Davor and Ana Djanic;

Zagreb, Croatia and Slavonski Brod, Croatia

P-214 EARLY POST-TRANSPLANT INFLAMMATORY RESPONSE PREDICTS

LATER ANEMIA IN KIDNEY TRANSPLANT RECIPIENTS

Goran Imamovic, Enver Zerem, Senaid Trnacevic, Enisa Mesic and Alma

Imamovic; Tuzla, Bosnia and Herzegowina


P-215 MAIN CHARACTERISTICS OF CADAVERIC KIDNEY TRANSPLANT AT

10 YEARS AFTER TRANSPLANTATION

Elisabetta Bertoni, Aida Larti, Lorenzo Di Maria, Maria Zanazzi and Maurizio

Salvadori; Florence, Italy

P-216 KIDNEY GRAFT SURVIVAL RATES DO NOT IMPROVE BY ERA: THE

IMPACT OF FACTOR AGE

Elisabetta Bertoni, Aida Larti, Giuseppina Rosso and Maurizio Salvadori;

Florence, Italy

P-217 SUBCLINICAL ACUTE REJECTIONS IN PROTOCOL BIOPSIES

PERFORMED AT 3 MONTHS AFTER KIDNEY TRANSPLANTATION

Ivo Matl, Petra Hribová, Eva Honsová, Irena Brabcová, Alena Lodererová and

Ondrej Viklický; Prague, Czech Republic

P-218 LOW DOSE THYMOGLOBULIN THERAPY FAILS TO DEPLETE CD8

AND TOTAL B CELLS: A NEW APPROACH TO REDUCE SIDE EFFECTS

WHILE MAINTAINING EFFICACY

Oleh Pankewycz, Paul Wallace, Romesh Kohli, Feng Lin, Meriem Said and

Mark R. Laftavi; Buffalo, NY, United States

P-219 LOW HDL LEVELS IN RENAL TRANSPLANT RECIPIENTS IS ASSOCIATED

WITH A GREATER RISK OF ADVERSE CARDIOVASCULAR EVENTS

Oleh Pankewycz, Kulpreet Barn, Drew Pierce, Mark R. Laftavi, Romesh Kohli

and William E. Boden; Buffalo, NY, United States

P-220 IS PERIOPERATIVE PROPHYLACTIC ANTIBIOTIC THERAPY NESESSARY

IN THE NEW ERA OF KIDNEY TRANSPLANTATION?

Mark R. Laftavi, Resvan Rostami, Sunil Patel, Romesh Kohli, Lin Feng, Meriem

Said, Merril Dayton and Oleh Pankewycz; Buffalo, NY, United States

P-221 MAINTENANCE OF LARGE TRIPTERYGIUM WILFORDII HOOK F FOR

RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER

RENAL TRANSPLANTATION: TWO CASES CLINICAL OBSERVATION

AND IN VITRO EXPERIENCE

Jiqiu Wen, Zhihong Liu, Chunxia Zheng, Chaohong Chen, Caihong Zeng,

Jinsong Chen, Dongrui Cheng, Qiquan Sun and Leishi Li; Nanjing, China

P-222 EVALUATION OF VASCULAR LESIONS USING CIRCULATING

ENDOTHELIAL CELLS IN PATIENT WITH RENAL TRANSPLANTATION

Jiqiu Wen, Zhihong Liu, Jinsong Chen, Chunxia Zheng, Cihong Zeng, Qiquan

Sun and Leishi Li; Nanjing, Jiangsu, China

P-223 OCCURRENCE OF LYMPHOCELE AFTER KIDNEY TRANSPLANTATION:

IS THERE A ROLE OF HIGH MYCOPHENOLATE MOFETIL

DOSING REGIMEN?

Elie Zagdoun, Maxence Ficheux, Thierry Lobbedez, Valerie Chatelet,

Angelique Lecouf, Henri Bensadoun and Bruno Hurault de Ligny; Caen,

France

P-224 THE ROLE OF SEX STEROIDS IN THE MAINTENANCE OF BONE

DENSITY IN MALE KIDNEY RECIPIENTS

Ruzica Smalcelj, Vesna Kusec and Petar Kes; Zagreb, Croatia

P-225 DESENSITIZATION AND RENAL TRANSPLANT. PLASMAPHERESIS/

IVIG STANDARD DOSES IN PATIENTS WITH HIGH IMMUNOLOGICAL

RISK

Francisco Flores, Guillermo A. Mondragon and Tommaso Bochicchio;

Cuernavaca, Morelos, Mexico

P-226 COMPARING AORTIC STIFFNESS IN KIDNEY TRANSPLANT

RECIPIENTS AND PATIENTS WITH RESIDUAL RENAL FUNCTION

Marcus Baumann, Chengrui Pan, Marcel Roos, Maximilian von Eynatten,

Daniel Sollinger, Jens Lutz and Uwe Heemann; Münster, Germany

142


143

POSTERS

P-227 LIVING KIDNEY DONATION FOR RE-TRANSPLANTATION: OUTCOME

AND RISK FACTORS

Matthias C. Raggi, Edouard Matevossian, Norbert Hueser, Alice Schwarznau,

Manfred Stangl and Stefan Thorban; Münster, Bavaria, Germany

P-228 INDICATIONS AND RESULTS IN HIGH URGENCY KIDNEY

TRANSPLANTATION

Edouard Matevossian, Matthias Raggi, Norbert Hüser, Manfred Stangl and

Stefan Thorban; Münster, Bavaria, Germany

P-229 LONG-TERM FOLLOW-UP OF KIDNEY DONORS: QUALITY OF LIFE

AFTER DONATION

Nino Maglakelidze, Tinatin Pantsulaia and Archil Chkhotua; Tbilisi, Georgia

P-230 A CASE OF DIFFUSE C4D DEPOSITION WITHOUT MORPHOLOIC

ACTIVE HUMORAL REJECTION IN RENAL TRANSPLANTATION

Woo-Hyung Kwun, Bo-Yang Suh and Yong-Jin Kim; Daegu, Korea

P-231 MINIMAL INCISION LIVING DONOR NEPHRECTOMY ASSISTED

BY LAPAROSCOPIC INSTRUMENTS VIA THE RETROPERITONEAL

APPROACH

Zhilian Min, Liming Wang, Li Zeng and Lei Zhang; Shanghai, China

P-232 A NATION-WIDE PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP)

EPIDEMIC IN GERMAN RENAL TRANSPLANT PATIENTS

Frank Eitner, Ingeborg Hauser, Olaf Rettkowski, Thomas Rath, Kai Lopau,

Rainer Pliquett, Markus Guba and Michael Fischereder; Aachen, Germany;

Frankfurt, Germany; Halle, Germany; Kaiserslautern, Germany; Würzburg,

Germany and Münster, Germany

P-233 TRANSPLANTATION OF ORGANS FROM EXPANDED CRITERIA

DONORS ABOVE 75 YEARS OF AGE – MADNESS OR NOT?

Aksel Foss, Kristian Heldal, Helge Scott, Stein Foss, Torbjørn Leivestad, Pål

F. Jørgensen, Tim Scholz and Karsten Midtvedt; Oslo, Norway and Skien,

Norway

P-234 IS ABO-INCOMPATIBLE RENAL TRANSPLANTATION A RISK FACTOR

FOR BK VIRUS INFECTION OR NEPHROPATHY?

Tsuneo Ueki, Akio Katayama, Norihiko Goto, Takaharu Nagasaka, Yoshihiko

Watarai, Takaaki Kobayashi and Kazuharu Uchida; Nagoya, Aichi, Japan

P-235 IMPACT OF POST-TRANSPLANTATION GLOMERULONEPHRITIS

ON LONG-TERM OUTCOME IN CHINESE KIDNEY TRANSPLANT

PATIENTS: A SINGLE-CENTER KIDNEY BIOPSY REPORT

Tung-Min Yu, Kuo-Hsiung Shu, Chi-Hung Cheng, Ming-Ju Wu and Cheng-

Hsu Chen; Taichung, Taiwan

P-236 WITHDRAW

P-237 EFFECT OF DIFFERENT CALCINEURIN INHIBITORS ON OXIDATIVE

STRESS 6 MONTHS AFTER KIDNEY TRANSPLANTATION

Josef Zadrazil, Pavel Štrebl, Vladko Horcicka, Karel Krej í, Pavel Horák, Jitka

Vostálová, Adéla Zdarilová, Markéta Kajabová, Jarmila Dedochová and Ivo

Valkovský; Olomouc, Czech Republic and Ostrava, Czech Republic

P-238 EXCHANGE DONOR PROGRAM IN KIDNEY TRANSPLANTATION AS

A BETTER OPTION FOR EXPANDING DONOR POOL

Min Soo Kim, Oh Jung Kwon and Chong Myung Kang; Seoul, Korea

P-239 HIGH IMMUNOLOGICAL RENAL TRANSPLANT RECIPIENTS HAVE

GOOD EVOLUTION WITH POTENT IMMUNOSUPPRESSION

Antonio Franco, Eva Cotilla, Susana Roca, Luis Jimenez and Jesus Olivares;

Alicante, Alicante, Spain

P-240 THE ROLE OF FOXP3+ REGULATORY T CELLS IN KIDNEY

TRANSPLANTATION

Marek Karczewski, Jacek Karczewski, Artur Kostrzewa, Krzysztof Wiktorowicz

and Maciej Glyda; Poznan, Poland


P-241 DETECTION OF CITRATE SYNTHASE AUTOANTIBODIES IN RATS

WITH CHRONIC ALLOGRAFT NEPHROPATHY

Li Yuan Zhang, Yi Ping Lu, Li Yang, Guang Heng Luo and You Ping Li;

Chengdu, Sichuan, China

P-242 TACROLIMUS AND ANGIOTENSIN RECEPTOR BLOCKERS

ASSOCIATED WITH CHANGES IN SERUM ADIPONECTIN LEVEL IN

NEW ONSET DIABETES AFTER RENAL TRANSPLANTATION: SINGLE-

CENTER CROSS-SECTIONAL ANALYSIS

Kenji Nishimura, Hidefumi Kishikawa, Taigo Kato, Yasuyuki Kobayashi,

Naohiko Fujii, Shiro Takahara and Yasuji Ichikawa; Nishinomiya, Hyogo,

Japan and Suita, Osaka, Japan

P-243 DOES RELATIONSHIP EXIST BETWEEN CORONARY ARTERY

CALCIFICATION AND SERUM CALCIUM, PHOSPHORUS, PTH LEVELS,

AND CALCIUM-PHOSPHORUS PRODUCT IN RENAL TRANSPLANT

RECIPIENTS?

Zbigniew Serafi n, Pawel Strózecki, Andrzej Adamowicz, Fabian Przygonski,

Grazyna Dymek, Zbigniew Wlodarczyk, Jacek Manitius and Wladyslaw Lasek;

Bydgoszcz, Poland

P-244 THE RELATIONSHIP BETWEEN CORONARY ARTERY CALCIFICATION

AND PULSE WAVE VELOCITY IN RENAL TRANSPLANT RECIPIENTS

Andrzej Adamowicz, Pawel Strózecki, Zbigniew Serafi n, Zbigniew Wlodarczyk,

Jacek Manitius and Wladyslaw Laesk; Bydgoszcz, Poland

P-245 RESULTS OF SIMULTANEOUS AND SEQUENTIAL LIVER AND KIDNEY

FROM LIVING DONORS: RENAL PERSPECTIVES

Kwan Tae Park, Sang Kyoung Cho, Jae Berm Park, Young Hoon Kim, Song

Chul Kim and Duck Jong Han; Seoul, Korea

P-246 MUCORMYCOSIS FOLLOWING KIDNEY TRANSPLANTATION: A

MULTICENTER STUDY

Behzad Einollahi, Mahboob Lessan-Pezeshki, Eghlim Nemati, Mohammad

Hassan Ghadiani, Fatemeh Pour-Reza-Gholi, Mohsen Nafar, Fariba

Samadian, Pedram Ahmadpoor, Heshmatollah Shahbazian, Mohammad

Reza Ghanji, Ammir Hossein Miladipour and Nader Nouri-Majalan; Tehran,

Islamic Republic of Iran; Ahvaz, Islamic Republic of Iran and Yazd, Islamic

Republic of Iran

P-247 THE OUTCOME OF PATIENTS WHO DEVELOP CLOSTRIDIUM DIFFICILE

INFECTION FOLLOWING SOLID ORGAN TRANSPLANTATION: A

SINGLE CENTRE EXPERIENCE

Otilia-Maria Mitu-Pretorian, Bence Forgacs, Afshin Tavakoli, Ahmed

Qamruddin and Ravi Pararajasingam; Manchester, United Kingdom

P-248 ABO-INCOMPTIBALE KIDNEY TRANSPLANTATION IN TAIWAN — A

SINGLE INSTITUTION EXPERIENCE

Chi-Chuan Yeh, Ching-Yao Yang, Ming-Hsiou Wu, Shyh-Chyl Lo and Meng-

Kun Tsai; Taipei, Taiwan

P-249 AUGMENTATION CYSTOPLASTY AND PYELOPLASTY WITH

ENCRUSTED PYELITIS IN TRANSPLANTED KIDNEY

Hyun Hee Na, Haeng Il Koh, Sang Hyun Park, Seong Woo Hong and Mun

Cheol Kim; Seoul, Korea

P-250 SELF-EXPANDING METALLIC URETERAL STENT INSERTION

FOR TREATMENT OF URETERAL STENOSIS AFTER

URETEROURETEROSTOMY

Hyun Hee Na, Haeng Il Koh, Sang Hyun Park, Mun Cheol Kim, Young Chul

Yoon and Young Kwon Cho; Seoul, Korea and Busan, Korea

P-251 COMPARISON OF NEW ONSET DIABETES ACCORDING TO THE

TIME OF ONSET AFTER KIDNEY TRANSPLANTATION IN KOREA

Samuel Lee, Jieun Oh, Jooseop Kim, Kyujong Yoon and Kiwon Jeon; Seoul,

Republic of Korea

144


145

POSTERS

P-252 NEWFOUND RISK-FACTORS FOR CMV-INFECTION IN KIDNEY

TRANSPLANT PATIENTS

Marina Varga, Ádám Remport, Katalin Rajczy, Éva Toronyi, Antal Péter, Eniko

Sárváry, János Fazakas, Zsuzsanna Gálffy, Imre Fehérvári and Jeno Járay;

Budapest, Hungary

P-253 SERUM TISSUE INHIBITOR OF METALLOPROTEINASES 1 (TIMP-1)

PREDICTS ORGAN RECOVERY FROM DELAYED GRAFT FUNCTION

AFTRE KIDNEY TRANSPLANTATION FROM DONORS AFTER

CARDIAC DEATH

Mamoru Kusaka, Yoko Kuroyanagi, Manabu Ichino, Hitomi Sasaki, Takahiro

Maruyama, Kunihiro Hayakawa, Ryoichi Shiroki, Atsushi Sugitani, Hiroki

Kurahashi and Kiyotaka Hoshinaga; Toyoake, Aichi, Japan

P-254 HIGH FREQUENCY OF GASTRIC ULCER IN THE FIRST THREE

POSTTRANSPLANT MONTHS

Gabor Telkes, Antal Peter, Zsolt Tulassay and Argiris Asderakis; Budapest,

Hungary and Cardiff, United Kingdom

P-255 RHABDOMYOLYSIS IN KIDNEY TRANSPLANTATION INDUCED BY

EXTREMELY HIGH LEVEL OF SERUM CYCLOSPORINE DUE TO THE

DISORDER IN METABOLIC ENZYME AND TRANSPORTERS

Taigo Kato, Masatomo Miura, Hidefumi Kishikawa, Kenji Nishimura, Yasuyuki

Kobayashi, Shigeru Sato and Yasuji Ichikawa; Nishinomiya, Hyogo, Japan

and Akita, Akita, Japan

P-256 TRANSPLANT GLOMERULOPATHY AFTER HLA ANTIBODY

INCOMPATIBLE TRANSPLANTATION, REMISSION AND

PROGRESSION

Rob Higgins, Klaus Chen, Daniel Zehnder, Dave Lowe, David Briggs, For

T. Lam, Lam Chin Tan, Chris Imray, Habib Kashi, Rizwan Hamer and Nithya

Krishnan; Coventry, United Kingdom and Birmingham, United Kingdom

P-257 EFFECTIVENESS OF ULTRASONOGRAPHY SCREENING FOR RENAL

CELL CARCINOMA IN RENAL TRANSPLANT RECIPIENTS

Man Fai Lam, Wai Kuen Tso, Sai Man Chu, Tak Mao Chan and Kar Neng Lai;

Hong Kong, HKSAR, Hong Kong

P-258 THE LOW DOSE OF RITUXIMAB IN ABO-INCOMPATIBLE KIDNEY

TRANSPLANTATION WITHOUT SPLENECTOMY

Hroki Shirakawa, Hideki Ishida, Kazuya Omoto, Tomokazu Shimizu, Shoichi

Iida, Daisuke Tokita and Kazunari Tanabe; Shinjuku, Tokyo, Japan

P-259 IMPAIRED RENAL FUNCTION IS ASSOCIATED WITH REDUCED

ABILITY TO WORK IN KIDNEY TRANSPLANT RECIPIENTS

Luca Neri, Daniel Brennan, Paolo Salvalaggio, Paola Buchannan, Jonathan

Dukes and Mark Schnitzler; Saint Louis, MO, United States; Milano, Italy and

Seattle, WA, United States

P-260 A LONG TERM EXPERIENCE, OF A PROGRAM DEVOTED TO RENAL

RE-TRANSPLANTATION

Andrea Buscaroli, Giorgia Comai, Olga Baraldi, Francesco Gozzetti, Vittorio

Dalmastri, Giovanni Liviano d’Arcangelo, Giorgio Feliciangeli, Gaetano La

Manna, Maria Piera Scolari and Sergio Stefoni; Bologna, BO, Italy

P-261 EFFECT OF MYCOPHENOLIC ACID MEDIATED APOPTOSIS IN

HUMAN JURKAT CELLS VIA REGULATION OF HEME OXYGENASE-1

EXPRESSION

Ho Kyun Lee, Sang Young Chung, Hea Sook You and Soo Jin Na Choi;

Gwangju, Korea

P-262 TACROLIMUS(FK506) INDUCED APOPTOTIC SIGNALLING WITH

ENDOPLASMIC RETICULUM STRESS PATHWAY PROTEINS

Soo Jin Na Choi, Hae Sook Tou, Ho Kyun Lee and Sang Young Chung;

Gwangju, Korea


P-263 PREDOMINANT TH1 AND CYTOTOXIC PHENOTYPE IN BIOPSIES

FROM RENAL TRANSPLANT RECIPIENTS WITH TRANSPLANT

GLOMERULOPATHY

Sebastien Homs, Hicham Mansour, Dominique Desvaux, Marc Hazan,

Mathias Buchler, Yvon Lebranchu, Philippe Lang and Philippe Grimbert;

Creteil, France; Lille, France and Tours, France

P-264 IMPACT OF HAND-ASSISTED LAPAROSCOPIC NEPHRECTOMY FOR

LIVING DONOR TRANSPLANTATION ON DONOR’S QUALITY OF LIFE

AND SOCIAL STATE

Andre Schumann, Amir M. Hamza, Rashid Hoda, Olaf Rettkowski and Paolo

Fornara; Halle, Sachsen-Anhalt, Germany

P-265 EARLY AND LATE GRAFT FUNCTION AFTER LAPAROSCOPIC

HAND-ASSISTED DONOR NEPHRECTOMY FOR LIVING KIDNEY

TRANSPLANTATION: COMPARISON WITH OPEN DONOR

NEPHRECTOMY

Amir M. Hamza, Andre Schumann, Rashid Hoda, Kerstin Fischer and Paolo

Fornara.; Halle, Sachsen-Anhalt, Germany

P-266 A COMPARISON OF EFFECTS OF SHORT-TERM MAINTENANCE

EXPOSURE OF ADVAGRAF AND NEORAL ON RENAL PERFUSION

AND FUNCTION IN HEALTHY VOLUNTEERS

Jeffrey S. Zaltzman and Ralph A. Ferguson; Toronto, ON, Canada and

Markham, ON, Canada

P-267 PROTEINURIA AMONG EGYPTIAN RENAL TRANSPLANT PATIENTS:

ITS RELATION TO HCV AND GRAFT OUTCOME

Rashad H. Rashad, Alaa A. Sabry, Ihab M. Hassan, Magdy A. Hamed and

Mohamed A. Sobh; Mansoura, DK, Egypt

P-268 ALTITUDE AND LONG-TERM OUTCOMES OF KIDNEY

TRANSPLANTATION

Wolfgang C. Winkelmayer, Jun Liu and M. Alan Brookhart; Boston, MA,

United States

P-269 DGF AFFECTS REJECTION AND SURVIVAL OF HB BUT NOT OF NHB

DONOR KIDNEYS

Judith A. Kal-van Gestel, Joke I. Roodnat, Jan N. Ijzermans and WIllem

Weimar; Rotterdam, The Netherlands

P-270 EMPOWERING NEW TRANSPLANT REGISTRY STUDIES: DESIGN,

METHODS AND CENTER-SPECIFIC INFORMATION OF THE

MYCOPHENOLIC ACID OBSERVATIONAL RENAL TRANSPLANT

STUDY (MORE) REGISTRY

William Irish, Cataldo Doria, Stuart Greenstein, Laurence Chan, Mohanram

Narayanan, Kimi Ueda and Anthony Langone; Cincinnati, United States;

Philadelphia, United States; New York, United States; Denver, United States;

Temple, United States; San Francisco, CA, United States and Nashville,

United States

P-271 POST RENAL TRANSPLANTATION UROLOGICAL COMPLICATIONS

Salwa M. Buresley, Mahmoud S. Samhan, Said N. Moniri, Jhone Codaj and

Mustafa Al-Mosawi; Kuwait City, Kuwait

P-272 RENAL FIBRINOGEN-ALPHA AMYLOIDOSIS

Sanjeev Sethi, Dylan Miller and Nelson Leung; Rochester, MN, United

States

P-273 THE ROLE OF THE MALNUTRITION-INFLAMMATION COMPLEX

SYNDROME IN POST-TRANSPLANT ANEMIA: RESULTS OF THE

MALNUTRITION-INFLAMMATION COMPLEX SYNDROME IN

TRANSPLANTATION-HUNGARY (MICSIT-HU) STUDY

Miklos Z. Molnar, Adam Remport, Maria E. Czira, Eniko Sarvary, Gabriella

Beko, Anna Rudas, Akos Ujszaszi, Marta Novak and Istvan Mucsi; Budapest,

Hungary

146


147

POSTERS

P-274 ASSOCIATION BETWEEN THE MALNUTRITION AND INFLAMMATION

COMPLEX SYNDROME SCORE AND MORTALITY IN KIDNEY

TRANSPLANTED PATIENTS

Adam Remport, Maria E. Czira, Anna Rudas, Akos Ujszaszi, Eniko Sarvary,

Gabriella Beko, Istvan Mucsi, Marta Novak and Miklos Z. Molnar; Budapest,

Hungary

P-275 ASSOCIATION OF TIME ON DIALYSIS PRIOR TO TRANSPLANTATION

WITH LONG-TERM MORTALITY IN A PREVALENT COHORT OF

KIDNEY TRANSPLANTED PATIENTS

Adam Remport, Istvan Mucsi, Anna Rudas, Akos Ujszaszi, Maria E. Czira,

Szilard Torok, Rita Chmel, Katalin Foldes, Eva Toronyi, Jeno Jaray and Miklos

Z. Molnar; Budapest, Hungary

P-276 ISCHEMIA-INDUCED COLLAPSING GLOMERULOPATHY IN RENAL

TRANSPLANTS

Guillaume Canaud, Patrick Bruneval, Laure Helene Noel, Jean Michel

Correas, Lara Zafrani, Marion Rabant, Marc Olivier Timsit, Frank Martinez,

Dany Anglicheau, Eric Thervet, Natacha Patey, Christophe Legendre and

Julien Zuber; Paris, France

P-277 INTENSIVE AND PROLONGED TREATMENT OF FOCAL AND

SEGMENTAL GLOMERULOSCLEROSIS RECURRENCE IN ADULT

KIDNEY TRANSPLANT RECIPIENTS: A PILOT STUDY

Guillaume Canaud, Julien Zuber, Rebecca Sberro, Virginie Royale, Dany

Anglicheau, Renaud Snanoudj, Khaled Gaha, Eric Thervet, François Lefrere,

Marina Cavazzana Calvo, Laure Helene Noel, Arnaud Mejean, Christophe

Legendre and Frank Martinez; Paris, France

P-278 COLUMBIA CLASSIFICATION OF HISTOLOGICAL VARIANTS OF

FOCAL AND SEGMENTAL GLOMERULOSCLEROSIS (FSGS) AND RISK

OF RECURRENCE AFTER TRANSPLANTATION

Guillaume Canaud, Daniel Dion, Julien Zuber, Marie-Claire Gubler, Rebecca

Sberro, Eric Thervet, Renaud Snanoudj, Marina Charbit, Rémi Salomon, Frank

Martinez, Christophe Legendre, Laure-Helene Noel and Patrick Niaudet;

Paris, France

P-279 PREVALENCE AND RISK FACTORS OF POST-TRANSPLANT ANEMIA.

A LONGITUDINAL STUDY

Roberto Marcen Letosa, Belen Ponte Martinez, Ana M. Fernandez Rodriguez,

Cristina Galeano Alvarez, Nuria Rodriguez Mendiola, Jose L. Teruel Briones,

Francisco J. Burgos Revilla and Joaquin Ortuño Mirete; Madrid, Spain

P-280 MALIGNANCIES IN KIDNEY TRANSPLANT RECIPIENTS. INFLUENCE

OF THE NEW IMMUNOSUPPRESSIVE THERAPIES

Roberto Marcen Letosa, Ana M. Fernandez Rodriguez, Cristina Galeano

Alvarez, Nuria Rodriguez Mendiola, Belen Ponte Martinez, Jose L. Teruel

Briones, Francisco J. Burgos Revilla and Joaquin Ortuño Mirete; Madrid,

Spain

P-281 INCIDENCE OF ACUTE REJECTION AND GRAFT OUTCOME. AN

HISTORICAL ANALYSIS

Roberto Marcen Letosa, Cristina Galeano Alvarez, Ana M. Fernandez

Rodriguez, Nuria Rodriguez Mendiola, Belen Ponte Martinez, Juan J.

Villafruela Sanz, Jose L. Teruel Briones, Francisco J. Burgos Revilla and

Joaquin Ortuño Mirete; Madrid, Spain

P-282 STUDY OF OPPORTUNISTIC INFECTIONS FOLLOWING

RENAL TRANSPLANTATION AND THEIR CO-RELATION WITH

IMMUNOSUPPRESSION PROTOCOLS

Krishan L. Gupta, Kiran Joshi, Mukut Minz, Manish Rathi, Harbir Kohli,

Vivekanand Jha and Vinay Sakhuja; Ch, India and Chandigarh, India

P-283 URINARY INTERLEUKINE PATTERN AND URINARY TRACT INFECTION

AFTER KIDNEY TRANSPLANTATION

Kersten Fischer, Amir Hamza, Rashid Hoda and Paolo Fornara; Halle/Saale,

Germany


P-284 IMMUNOLOGICAL MONITORING AFTER KIDNEY

TRANSPLANTATION: RESEARCH TO IMPROVE DIAGNOSIS OF

REJECTION AND TO ESTIMATE RISK OF INFECTION

Kersten Fischer, Amir Hamza, Rashid Hoda and Paolo Fornara; Halle/Saale,

Germany

P-285 PREVALENCE OF ANEMIA AND ITS CORRELATION WITH THE

OUTCOMES OF KIDNEY TRANSPLANTATION

Viktor K. Denisov and Ann S. Ksenofontova; Donetsk, United States

P-286 PREVALENCE OF ARTERIAL HYPERTENSION AND ITS CORRELATION

WITH THE OUTCOMES OF KIDNEY TRANSPLANTATION

Viktor K. Denisov and Ann S. Ksenofontova; Donetsk, Ukraine

P-287 CHANGES OF OXIDATIVE STRESS ON SKIN CANCER-SCREENED

PATIENTS FOLLOWING SOLID ORGAN TRANSPLANTATION

Tamas Fekecs, Zsolt Kadar, Bela Csete, Zita Battyani, Karoly Kalmar-Nagy,

Peter Szakaly, Peter Ors Horvath, Erzsebet Roth, Gyorgy Weber and Andrea

Ferencz; Pecs, Baranya, Hungary

P-288 EFFECT OF THYMOGLOBULIN ON THE VARIOUS GRADES OF

VASCULAR LESION IN ACUTE CORTICOSTEROID-RESISTANT

REJECTION OF RENAL ALLOGRAFTS

Ana A.A.G. Almoguera Gonzalez, Rosa R.O.S. Ortega Salas, Maria Molo

Lopez Oliva, Domingo Del Castillo Caba and Pedro P.A.G. Aljama Garcia;

Cordoba, Spain

P-289 RELATIONSHIP BETWEEN SERUM PARAOXONASE ACTIVITY,

ADIPOKINES AND ASYMMETRIC DIMETHYLARGININE LEVELS IN

OBESE RENAL TRANSPLANTED PATIENTS

Lajos Locsey, Laszlo Szabo, Ferenc Sztanek, Ildiko Seres, Laszlo Asztalos and

Gyorgy Paragh; Debrecen, Hungary

P-290 TRENDS OF WEB BROWSING IN TRANSPLANT PATIENTS - A

CAMBRIDGE SURVEY

Faisal Hanif, Janet C. Read, John A. Goodacre, Afzal Chaudhry and Paul

Gibbs; Cambridge, United Kingdom and Preston, United Kingdom

P-291 POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN KIDNEY

TRANSPLANT PATIENTS: REPORT FROM A SINGLE-CENTER OVER 25

YEARS

Soo Jin Kim, Won Hyun Cho, Hee Chul Yu, Byung-Jun So, Soon Il Kim and Yu

Seun Kim; Seoul, Korea; Daegu, Korea; Jeonju, Korea and Iksan, Korea

P-292 A FRAMEWORK OF TRANSPLANT ONLINE SERVICES FOR PATIENT

CENTRED CARE

Faisal Hanif, Janet C. Read, John A. Goodacre, Afzal Chaudhry and Paul

Gibbs; Cambridge, United Kingdom and Preston, United Kingdom

P-293 CLINICAL OUTCOMES OF SPOUNITED STATESL DONOR KIDNEY

TRANSPLANTATION: SINGLE CENTER EXPERIENCE

Soo Jin Kim, Byung-Jun So, Won Hyun Cho, Yu Seun Kim and Soon Il Kim;

Seoul, Korea; Iksan, Korea; Daegu, Korea and Jeonju, Korea

P-294 THE EFFECTS OF GENDER ON HEALTH-RELATED QUALITY OF LIFE

IN PEDIATRIC LIVE-DONOR KIDNEY TRANSPLANTATION: A SINGLE-

CENTER EXPERIENCE

Rashad H. Rashad, Amr A. El-Husseini, Mohamed A. Sobh and Mohamed A.

Ghoneim; Mansoura, DK, Egypt

148


149

POSTERS

P-295 SKIN CANCER AFTER KIDNEY TRANSPLANTATION: A LARGE

MULTICENTER STUDY

Eghlim Nemati, Behzad Einollahi, Naser Simforoosh, Mahboob Lessan-

Pezeshki, Mohammad Hossein Hossein, Vahid Pourfarziani, Abas Basiri,

Mojtaba Sharafi , Mohsen Nafar, Farshid Oliaei, Atieh Makhlogh, Hamid Reza

Samimagham, Jalal Azmandian, Fatemeh Pour-Reza Gholi, Ahmad Firoozan,

Pedram Ahmadpour, Khadidheh Makhdomi, Ali Ghafari, Shahrzad Shahidi,

Mitra Mahdavi Mahdavi Mazdeh, Mojgan Jalalzadeh, Hassan Arghani,

Mohammad Reza Ardalan, Taiebi Khosroshahi and Heshmatollah Shahbazian;

Tehran, Islamic Republic of Iran; Babel, Islamic Republic of Iran; Sari, Islamic

Republic of Iran; Kerman, Islamic Republic of Iran; Uromieh, Islamic Republic

of Iran; Esfahan, Islamic Republic of Iran; Semnan, Islamic Republic of Iran;

Tabriz, Islamic Republic of Iran; Yazd, Islamic Republic of Iran and Ahvaz,

Islamic Republic of Iran

P-296 STUDY OF CYTOKINE GENE POLYMORPHISM AND GRAFT

OUTCOME IN EGYPTIAN LIVE-DONOR KIDNEY TRANSPLANTATION

Rashad H. Rashad, Ahmed F. Hamdy, Amgad E. El-Agroudy, Amani M. Ismail,

Nagy A. Said Ahmad and Mohamed A. Sobh; Mansoura, DK, Egypt

P-297 MORPHOLOGY OF FOCAL AND DIFFUSE C4D-POSITIVE ACUTE

ANTIBODY-MEDIATED (AAMR) KIDNEY ALLOGRAFT REJECTION (AR)

Andrei V. Trailin, Tamara N. Nikonenko, Tatiana I. Ostapenko, Nikolai N.

Polyakov and Alexander S. Nikonenko; Zaporizhzhya, Ukraine

P-298 RENAL TRANSPLANTATION IN PATIENTS TREATED WITH

CINACALCET

Luisa Benozzi, Giovanni Gaffi , Domenica Taruscia, AnnaMaria Ricciatti, Sibilla

Sagripanti, Paolo Freddi, Emilio Balestra and Giovanni M. Frascà; Ancona,

AN, Italy

P-299 MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL

MANIFESTATIONS OF KIDNEY ALLOGRAFT ACUTE REJECTION (AR)

VARIANTS

Andrei V. Trailin, Tamara N. Nikonenko, Tatiana I. Ostapenko, Nikolai N.

Polyakov and Alexander S. Nikonenko; Zaporizhzhya, Ukraine

P-300 PNEUMOCYSTIS PNEUMONIA (PCP) AND PNEUMOCYSTIS JIROVECII

CARRIAGE IN RENAL TRANSPLANT PATIENTS

Diana Riebold, Matthias Maruschke, Martha Holtfreter, Martina Sombetzki,

Gero Korten, Steffen Mitzner, Andreas Fuehrer, Micha Loebermann, Oliver

W. Hakenberg and Emil C. Reisinger; Rostock, Germany

P-301 HYPERGLYCEMIA AFTER TRANSPLANTATION IN CALCINEURIN

INHIBITOR TREATED INDIAN RENAL TRANSPLANT RECIPIENTS:

INCIDENCE AND RISK FACTORS

Vinay Sakhuja, Z. Jabbar, H.S. Kohli, V. Jha and K.L. Gupta; Chandigarh,

India

P-302 AN IDEA OF URETER RECONSTRUCTION OF RENAL

TRANSPLANTATION IN LONG-TERM DIALYSIS PATIENTS

Nobuji Ogawa, Hiroshi Asano, Yasuhiro Ohara, Eri Umeki, Kastuya Okada,

Yasuko Toshimistu, Kimiyasu Aikawa, Mistuo Miyazawa, Nozomi Shinozuka

and Isamu Koyama; Hidaka, Saitama, Japan

P-303 OUTCOME OF RENAL TRANSPLANT RECIPIENTS WITH POST-

TRANSPLANT LYMPHOPROLIFERATIVE DISORDER – 20 YEAR

EXPERIENCE AT NOTTINGAM RENAL TRANSPLANT UNIT

Sunil Daga, Faiz Rahman, Gavin Mchaffi e, Catherine Byrne and Linda Evans;

Nottingham, Nottinghamshire, United Kingdom

P-304 WITHDRAW


P-305 GASTROINTESTINAL CYTOMEGALOVIRUS INFECTION IN KIDNEY

TRANSPLANTATION PATIENTS, PATIENTS WITH END-STAGE KIDNEY

DISEASE AND IMMUNOCOMPETENT PATIENTS

Marko Lempinen, Leena Halme, Johanna Arola, Eero Honkanen, Kaija

Salmela and Irmeli Lautenschlager; Helsinki, Finland

P-306 ANTIBODY-MEDIATED ACUTE REJECTION (AMAR): AN

IMMUNOLOGICAL AND CLINICAL STUDY FROM 14 FRENCH KIDNEY

TRANSPLANTATION CENTRES IN 2007-2008

Antoine Thierry, Isabelle Jollet, Ramzi Abou Ayache, Frank Bridoux, Fabien

Duthe, Jean-Luc Taupin and Guy Touchard; Poitiers, France and Bordeaux,

France

P-307 PER OPERATIVE FLUID MANAGEMENT IN PREEMPTIVE RENAL

TRANSPLANTATION:A CASE-CONTROL STUDY

Julie Badin, Christelle Barbet, Anne Bretagnol, Azmi Al Najjar, Jean Michel

Halimi, Jean Michel Boutin, Wassim Jaber, Mohamed Bensenouci, Yvon

Lebranchu and Matthias Büchler; Tours, France

P-308 INTERFERON- ( -IF),INTERLEUKINE 10 (IL-10), TRANSFORMING

GROWTH FACTOR- (TGF- ) BLOOD LEVELS IN DIAGNOSIS OF

CHRONIC RENAL ALLOGRAFT DYSFUNCTION

Ruben Ovakimovitch Zograbian, Victoria Yevgenivna Driyanska, Georgiy

Nikolayevitch Drannik and Vladislav Philippovitch Zakordonetz; Kiev,

Ukraine

P-309 EVEROLIMUS IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS:

THE ASCERTAIN STUDY

Hallvard Holdaas, Karsten Midtvedt, Daniel Seron, Philip O’Connell, C.M.

Thiagarajan, Robert Fassett, Jacques Dantal, Raj K. Sharma, Edward Cole,

Jeremy Chapman, Helen Pilmore, Isabelle Binet, Kearkiat Praditpornsipa,

Piergiorgio Messa, Shankaran Sunder and Lionel Rostaing; Oslo, Norway;

Barcelona, Spain; Westmead, Australia; Chennai, India; Launceston,

Australia; Nantes, France; Lucknow, India; Toronto, ON, Canada; Grafton,

Auckland, New Zealand; St. Gallen, Switzerland; Bangkok, Thailand; Milano,

Italy; Bangalore, Karnataka, India and Toulouse, France

P-310 ROLE OF RESISTIVE INDEX MEASUREMENT IN DIAGNOSIS OF

ACUTE REJECTION EPISODES FOLLOWING SUCCESSFUL KIDNEY

TRANSPLANTATION

Abdolrasoul Mehrsai, Sepehr Salem, Mohsen Taherimahmoodi, Hamed

Ahmadi, Nima Baradaran, Mohammadreza Nikoobakht, Hannaneh

Wahhabaghai, Maedeh Rezaeidanesh, Dariush Mansouri and Gholamreza

Pourmand; Tehran, Islamic Republic of Iran

P-311 COULD PROPHYLACTIC MONOCLONAL ANTIBODY BLOCKER

INJECTION HELP KIDNEY GRAFT SURVIVAL?

Gholamreza Pourmand, Ali Saraji, Ali Asadpour, Abdolrasoul Mehrsai, Sepehr

Salem, Mohammadreza Nikoobakht and Mohsen Taherimahmoodi; Tehran,

Islamic Republic of Iran

P-312 ADIPONECTIN AND INSULIN RESISTANCE: COMPARISON OF

HEALTHY SUBJECTS,UREMIC PATIENTS AND KIDNEY TRANSPLANT

RECIPIENTS

Mohsen Taherimahmoodi, Hamed Ahmadi, Abdolrasoul Mehrsai,

Ebrahim Kalantar, Alireza Esteghamati, Hannaneh Wahhabaghai, Maedeh

Rezaeidanesh and Gholamreza Pourmand; Tehran, Islamic Republic of Iran

P-313 CYTOMEGALOVIRUS INFECTION AND DISEASE FOLLOWING RENAL

TRANSPLANTATION: PRELIMINARY REPORT OF INCIDENCE AND

POTENTIAL RISK FACTORS

Mohsen Taherimahmoodi, Hamed Ahmadi, Nima Baradaran, Sepehr Salam,

Laleh Montaser Kouhsari, Abdolrasoul Mehrsai, Ebrahim Kalantar, Yunes

Jahani, Maedeh Rezaeidanesh, Hannaneh Wahhabaghai and Gholamreza

Pourmand; Tehran, Islamic Republic of Iran

150


151

POSTERS

P-314 -174 G/C INTERLEUKIN 6 GENOTYPE IS RELATED TO HIGHER RISK

OF GRAFT LOSS AND GFR DECLINE IN 5-YEAR OBSERVATION IN

KIDNEY GRAFT RECIPIENTS

Urszula Siekiera, Jerzy Chudek, Magdalena Szotowska, Henryk Karkoszka,

Aureliusz Kolonko, Lech Cierpka and Andrzej Wiecek; Katowice, Poland

P-315 RENAL VASCULAR RESISTANCE MEASURED BY DOPPLER

SONOGRAPHY IN THE EARLY PERIOD AFTER KIDNEY

TRANSPLANTATION AS A PREDICTOR OF GRAFT LOSS AND

CHRONIC GRAFT DYSFUNCTION – A 5 YEARS FOLLOW-UP STUDY

Aureliusz Kolonko, Jerzy Chudek and Andrzej Wiecek; Katowice, Poland

P-316 INFLUENCE OF HEPATITIS C VIRUS IN THE DEVELOPMENT OF

INFECTIONS IN KIDNEY TRANSPLANT RECIPIENTS. A PROSPECTIVE

MULTICENTER STUDY

Francisco López-Medrano, José María Morales, Carlos Cervera, Antonio

Ramos, Jordi Carratalá, Julián de la Torre-Cisneros, Rafael San Juan, Manuel

Lizasoain, Joan Gavaldá, Yolanda Meije, Ana García-Reyne, Patricia Muñoz,

Albert Pahissa and José María Aguado; Madrid, Spain; Barcelona, Spain and

Córdoba, Spain

P-317 IMPACT OF INTERSTITIAL FIBROSIS (IF) BY AUTOMATIC

QUANTIFICATION AT ONE YEAR ON THE EVOLUTION OF RENAL

FUNCTION IN TRANSPLANT RECIPIENTS WITH CYCLOSPORINE

(CSA) DISCONTINUATION AND SIROLIMUS (SRL) INTRODUCTION

Aude Servais, Vannary Meas-Yedid, Olivier Toupance, Yvon Lebranchu, Guy

Touchard, Pierre Francois Westeel, Isabelle Etienne, Bruno Moulin, Bruno

Hurault de Ligny, Patrick Le Pogamp, Cecile Hayem, Jean Christophe Olivo

Marin and Eric Thervet; Paris, France; Reims, France; Tours, France; Poitiers,

France; Amiens, France; Rouen, France; Strasbourg, France; Caen, France;

Rennes, France and Neuilly/Seine, France

P-318 LONGITUDINAL ANALYSIS OF INTERSTITIAL FIBROSIS (IF) BY

AUTOMATIC QUANTIFICATION IN SEQUENTIAL ROUTINE RENAL

BIOPSIES (RB) AFTER RENAL TRANSPLANTATION (RT)

Aude Servais, Vannary Meas-Yedid, Frank Martinez, Clarisse Panterne, Laure

Helene Noel, Henri Kreis, Marc Olivier Timsit, Christophe Legendre, Jean

Christophe Olivo Marin and Eric Thervet; Paris, France

P-319 INFLUENCE OF CYP3A5 POLYMORPHISM IN DONOR AND RECIPIENT

ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME

AFTER RENAL TRANSPLANTATION

Christelle Cauffi ez, François Glowacki, Arnaud Lionet, François Provot, Marc

Hazzan, Christian Noël and Franck Broly; Lille, France

P-320 KIDNEY TRANSPLANTATION IN POLICYSTIC KIDNEY DISEASE. IS

NATIVE NEPHRECTOMY A RISK FACTOR FOR PATIENT AND GRAFT

SURVIVAL?

Stefano Soldano, Cinzia Poli, Matteo Tripepi, Ornella M. Rossetti and Cosimo

V. Sansalone; Milan, Italy

P-321 RISK FACTORS IN KIDNEY RE-TRANSPLANTATION. A 30-YEAR

NIGUARDA HOSPITAL EXPERIENCE

Cinzia Poli, Matteo Tripepi, Stefano Soldano, Ornella M. Rossetti and Cosimo

V. Sansalone; Milan, Italy

P-322 ABO INCOMPATIBLE(ABO-I) KIDNEY TRANSPLANTATION

WITHOUT SPLENECTOMY: POSTTRANSPLANT PLASMAPHERESIS

IS NOT A ROUTINE BUT ON DEMAND PROCEDURE FOR SAFE

ENGRAFTMENT

Jin M. Kong, Joon H. Jeong, Byung C. Kim, Mi Y. Jeon, Wha L. Lee, Jung O.

Lee and Jae H. Choi; Busan, Korea

P-323 ASSOCIATION OF KIR GENOTYPES AND ACUTE REJECTION IN

KIDNEY TRANSPLANT

Serena Corsini, Gaetano La Manna, Maria L. Cappuccilli, Diletta Conte, Elena

Matteucci, Sandra Iannelli, Katia Nisi, Elena Della Bella, Maria P. Scolari,

Andrea Bontadini and Sergio Stefoni; Bologna, BO, Italy


P-324 NATIVE KIDNEY FUNCTION AFTER COMBINED SOLID ORGAN

TRANSPLANT (LIVER/KIDNEY, HEART/KIDNEY)

Giovanni Mosconi, Laura Panicali, Marco Veronesi, Maria L. Cappuccilli, Diletta

Conte, Nicole Lanci, Giovanni Liviano D’Arcangelo, Giorgio Feliciangeli and

Sergio Stefoni; Bologna, BO, Italy

P-325 PHYSICAL ACTIVITY IN SOLID ORGAN TRANSPLANT RECIPIENTS

Giovanni Mosconi, Laura Panicali, Serena Corsini, Matteo Parigino, Davide

Pisoni, Manuela Trerotola, Daniela Storani, Giulio S. Roi, Alessandro Nanni

Costa and Sergio Stefoni; Bologna, BO, Italy and Rome, RM, Italy

P-326 RENAL TRANSPLANT PROGRAMMES AND PREVIOUS BONE-GRAFT

TRANSPLANTATION. IMMUNOLOGICAL IMPLICATIONS

Giovanni Mosconi, Olga Baraldi, Concetta Fantinati, Maria L. Cappuccilli,

Diletta Conte, Nicole Lanci, Paola Zanelli, Giorgio Feliciangeli and Sergio

Stefoni; Bologna, BO, Italy and Parma, PR, Italy

P-327 KIDNEY TRANSPLANTATION (KT) FOR PATIENTS AFFECTED BY

VON HIPPEL-LINDAU (VHL) DISEASE: EXPERIENCE OF AN MTOR

INHIBITOR-BASED PROTOCOL

Federica N. Vigotti, Maria Messina, Giuliana Tognarelli, Antonio Lavacca,

Elisabetta Mezza, Roberta Giraudi, Ana M. Manzione, Vincenzo Cantaluppi

and Giuseppe P. Segoloni; Turin, Italy

P-328 ARE ABO-IGA LEVELS IMPORTANT IN HLA INCOMPATIBLE RENAL

TRANSPLANTS?

Nithya Krishnan, Robert Higgins, Dave Lowe, Hamer Rizwan, Zehnder Daniel

and David Briggs; Coventry, United Kingdom and Birmingham, United

Kingdom

P-329 VIRAL AND BLOODGROUP ANTIBODIES DO NOT FOLLOW DSA’S IN

HLAI KIDNEY TRANSPLANTATION

Nithya S. Krishnan, Robert M. Higgins, Dave Lowe, Hamer Rizwan, Zehnder

Daniel and David Briggs; Coventry, United Kingdom and Birmingham, United

Kingdom

P-330 PROGNOSTIC FACTORS IN ACUTE HUMORAL REJECTION OF

RENAL ALLOGRAFTS AND THERAPEUIC DECISIONS BASED ON

HISTOPATHOLOGIC FINDINGS

Ana A.A.G. Almoguera Gonzalez, Maria Molo Lopez Oliva, Rosa R.O.S.

Ortega Salas, Domingo Del Castillo Caba and Pedro P.A.G. Aljama Garcia;

Cordoba, Spain

P-331 INCIDENCE OF NON-MELANOMA SKIN CANCER FOLLOWING

HUMAN SOLID ORGAN TRANSPLANTATION

Tamas Fekecs, Zsolt Kadar, Bela Csete, Zita Battyani, Karoly Kalmar-Nagy,

Peter Szakaly, Peter Ors Horvath, Gyorgy Weber and Andrea Ferencz; Pecs,

Baranya, Hungary

P-332 A NEW APPROACH FOR THE TRANSPLANTATION OF SENSITIZED

KIDNEY GRAFT RECIPIENTS AT A HIGH RISK OF ANTIBODY-MEDIATED

GRAFT LOSS

Christian Morath, Jorg Beimler, Jorg Ovens, Vedat Schwenger, Gerhard

Opelz, Martin Zeier and Caner Susal; Heidelberg, Germany

P-333 VALIDITY OF TWO SLEEP QUALITY ITEMS USED IN THE SWISS

TRANSPLANT COHORT STUDY IN RENAL TRANSPLANT RECIPIENTS

Hanna Burkhalter, Anna Wirz-Justice, Susan Sereika, Sandra Engberg, Jürg

Steiger and Sabina De Geest; Basel, Switzerland and Pittsburgh, PA, United

States

P-334 THE ROLE OF SPOUNITED STATESL DONORS IN LIVING DONOR KIDNEY

TRANSPLANTATION FOR DONOR POOL EXPANSION: SINGLE CENTER

EXPERIENCE

Jin Kyu Lim, Min Soo Kim, Oh Jung Kwon and Jin Young Kwak; Seoul,

Korea

152


153

POSTERS

P-335 CYTOMEGALOVIRUS INFECTION INFLUENCE ON THE KIDNEY

GRAFT SURVIVAL

Igor Codreanu, Petru Cepoida, Adrian Tanase, Larisa Evdochimov, Grigore

Romanciuc and Dorin Visterniceanu; Chisinau, Republic of Moldova

P-336 PREDICTION OF KIDNEY TRANSPLANT OUTCOME BY DONOR

QUALITY SCORING SYSTEMS: EXPANDED CRITERIA DONOR AND

DECEASED DONOR SCORE

Emilio Rodrigo, Eduardo Miñambres, Juan C. Ruiz, Ana Vallejo, Celestino

Piñera, Javier Llorca, Rosa Palomar, Julio Gonzalez-Cotorruelo and Manuel

Arias; Santander, Spain

P-337 TLR7 AND 9 EXPRESSION IN HUMAN KIDNEY TRANSPLANT

BIOPSIES

Miriam C. Banas, Bettina Jung, Charles E. Alpers, Kelly L. Hudkins, Tobias

Bergler and Bernhard Banas; Regensburg, Germany and Seattle, United

States

P-338 RISK OF INFECTIOUS AGENT TRANSMISSION BETWEEN

DONOR AND RECIPIENT: WHAT IS THE VALUE OF PRETRANSPLANT

MICROBIOLOGICAL SAMPLES?

Claire Billault, Christophe Vaessen, Emmanuel Van Glabeke, Culty Thibaut,

Arzouk Nadia, Laura Dumitru, Ourahma Saida, Robert Jérome, Richard

François and Barrou Benoit; Paris, France and Montreuil, France

P-339 PTH SUPPRESSION TEST PREDICTS PERSISTENT

HYPERPARATHYROIDISM AFTER KIDNEY TRANSPLANTATION

Peggy Perrin, Sophie Caillard, Thierry Krummel, Rose Marie Javier and Bruno

Moulin; Strasbourg, France

P-340 INCIDENCE AND RISK FACTORS OF GLUCOSE METABOLISM

DISORDERS AFTER KIDNEY TRANSPLANTATION: ROLE OF

SYSTEMATIC SCREENING BY OGTT BEFORE TRANSPLANTATION

Laure Eprinchard, Sophie Caillard and Bruno Moulin; Strasbourg, France

P-341 DE NOVO SIROLIMUS-BASED REGIMEN IN ASIAN RENAL

TRANSPLANTATION RECIPIENTS: A TWO-YEARS FOLLOW UP

Natavudh Townamchai, Yingyos Avihingsanon, Kearkiat Praditpornsilpa,

Kriang Tungsanga and Somchai Eiam-Ong; Bangkok, Thailand

P-342 TRANSPLANTATION IN ADULTS WITH PRIMARY HYPEROXALURIA:

EXPERIENCE WITH 5 CASES

Deep J. Malde, Afshin Tavakoli, Ravi Pararajasingam, Babatunde Campbell,

Hany Riad, Neil Parrott and Titus Augustine; Manchester, United Kingdom

P-343 ASSOCIATION BETWEEN TWO POLYMORPHISMS IN IMMUNITY

GENES AND CYTOMEGALOVIRUS REACTIVATION AFTER KIDNEY

TRANSPLANTATION

Thomas W. Hoffmann, Jean-Michel Halimi, Mathias Büchler, Florence

Velge-Roussel, Azmi Al-Najjar, Jean-Frédéric Marliere, Yvon Lebranchu and

Christophe Baron; Tours, France

P-344 EVOLUTION OF BONE DISEASE IN 2 YEARS AFTER

TRANSPLANTATION; A PROSPECTIVE SINGLE CENTER STUDY

Krzysztof Falkiewicz, Maria Boratynska, Slawomir C. Zmonarski, Andrzej

Milewicz, Dariusz Patrzalek, Przemyslaw Biecek and Marian Klinger; Wroclaw,

Poland

P-345 WITHDRAW

P-346 VERY HIGH PREDITIVE VALUE OF BLOOD MIG LEVEL IN KIDNEY

TRANSPLANT PATIENTS

Paula Xavier, Paula Aires, Cecília Meireles, Helena Alves and José G. Oliveira;

Porto, Portugal


P-347 A MULTICENTER RCT OF DECEASED ORGAN DONOR PRE-

TREATMENT WITH CORTICOSTEROIDS: RISK FACTORS FOR ARF IN

STEROID PRE-TREADED DONORS

Julia Wilfl ingseder, Alexander Kainz, Christa Mitterbauer, Georg Györi, Paul

Perco, Timothy Meyer, Bernd Mayer, Robert Langer and Rainer Oberbauer;

Linz, Austria; Vienna, Austria; Palo Alto, United States and Budapest,

Hungary

P-348 INCIDENCE AND CLINICAL CHARACTERISTICS OF

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDER DURING

38 YEARS OF KIDNEY TRANSPLANTATION AT THE SINGAPORE

GENERAL HOSPITAL

Choo Gee Lim, Colin Phipps Diong, Daryl Tan and Terence Kee; Singapore,

Singapore

P-349 IS DEFICIENCY OF 1,25-DIHYDROXYVITAMIN D3 A PREDICTIVE

FACTOR OF POORER OUTCOME IN RENAL TRANSPLANTATION

Krzysztof Falkiewicz, Bozena Bidzinska-Speichert, Maria Boratynska,

Slawomir C. Zmonarski, Urszula Tworowska, Dariusz Patrzalek and Marian

Marian; Wroclaw, Lower Silesia, Poland

P-350 OUTBREAK OF DISEASE OF SEVEN PNEUMOCYSTIS PNEUMONIA AT

AROUND JUST SAME TIME AFTER RENAL TRANSPLANTATION

Katsunori Yoshida, Shinji Fukui, Tatsuo Yoneda, Kunihiko Arai, Kiyohide

Fujimoto, Syoki Kimura and Yoshihiko Hirao; Kashihara, Nara, Japan

P-351 MANAGEMENT OF LOCALIZED PROSTATE CANCER BY RETROPUBIC

RADICAL PROSTATECTOMY IN PATIENTS AFTER RENAL

TRANSPLANTATION

M. Raschid Hoda, Amir Hamza, Sigrid Wagner, Andre Schumann and Paolo

Fornara; Halle, Germany

P-352 IMMUNE FACTORS THAT INCREASE A CHANCE OF ACCEPTANCE

OF ALLOGENEIC KIDNEY IN ELDERLY RECIPIENTS

Piotr Trzonkowski, Alicja Debska-Slizien, Magdalena M. Jankowska, Lukasz

Hak, Grazyna Moszkowska, Anita Dobyszuk, Beata Bzoma and Boleslaw

Rutkowski; Gdansk, Poland

P-353 THE ROLE OF ISOTOPE DIFFERENTIAL RENAL FUNCTION IN

ASSESSING POTENTIAL LIVING KIDNEY DONORS

Jacob A. Akoh, Tahawar A. Rana and Sarah L. Stacey; Plymouth, Devon,

United Kingdom

P-354 DONOR PERSPECTIVES IN LIVING KIDNEY DONATION

Tahawar A. Rana, Sarah L. Stacey and Jacob A. Akoh; Plymouth, Devon,

United Kingdom

P-355 PHARMACOKINETICS OF TACROLIMUS IN RENAL TRANSPLANT

PATIENTS WITH PREVIOUS GASTRIC BYPASS SURGERY

Paul J. Goldsmith, Fung Foo and Niaz Ahmad; Leeds, United Kingdom

P-356 FRENCH REGISTRY OF PTLD AFTER KIDNEY TRANSPLANTATION:

ANALYSIS OF GRAFT, BRAIN AND GASTRO-INTESTINAL TRACT

LYMPHOMAS

Sophie Caillard, Jerome Olagne, François Xavier Lamy, Fabienne Pessione

and Bruno Moulin; Strasbourg, France and Saint Denis, France

P-357 CLOSURE OF HIGH-VOLUME ARTERIOVENOUS FISTULAS RESCUES

RENAL ALLOGRAFT FUNCTION IN PATIENTS WITH RIGHT HEART

FAILURE. A RETROSPECTIVE ANALYSIS OF 6 PATIENTS

Markus Meier, Lutz Fricke, Waichi Wong, Juergen Steinhoff, Hendrik Lehnert,

Jan Kramer and Martin Nitschke; Luebeck, Germany and Boston, MA, United

States

P-358 CARDIOPULMONARY EXERCISE TESTING COULD BE USEFUL FOR

ASSESSING FITNESS FOR RENAL TRANSPLANTATION

Joanna McKinnell, Rob Higgins, Chris Imray, Duncan Watson, Prithwish

Bannerjee, David Parr, Simon Fletcher and Daniel Zehnder; Coventry, United

Kingdom

154


155

POSTERS

P-359 BETTER RENAL FUNCTION IN RENAL-TRANSPLANT RECIPIENTS

TREATED WITH EVEROLIMUS PLUS CSA ELIMINATION COMPARED

WITH CSA REDUCTION

Josep Maria Grinyó, Javier Paul, Pablo Novoa, Pedro Errasti, Antonio Franco,

Guillermo Aldana, Jaqueline Pefaur and Federic Oppenheimer; Barcelona,

Spain; Zaragoza, Spain; Córdoba, Argentina; Pamplona, Spain; Alicante,

Spain; Bogotá, Colombia and Santiago, Chile

P-360 THE EFFECT OF HEMODIALYSIS AND DIALYSIS ANTICOAGULATION

BEFORE TRANSPLANT SURGERY ON EARLY RENAL ALLOGRAFT

FUNCTION – A PAIR OF RANDOMIZED CONTROLLED TRIALS

Zeljko Kikic, Matthias Lorenz, Sunder-Plassmann Gere, Schillinger Martin,

Regele Heinz, Györi Georg, Mühlbacher Ferdinand, Wolfgang C. Winkelmayer

and Böhmig A. Georg; Vienna, Austria and Boston, MA, United States

P-361 RENAL GRAFT MASS AND TRANSPLANT OUTCOME

Lionel Badet, Ricardo Codas, Fabrice Danjou, William Hanf, Celine Dagot,

Araz Bayramov, Maria Brunet, Emmanuel Morelon, Palmina Petruzzo and

Xavier Martin; Lyon, France and Cagliari, Italy

P-362 EARLY RENAL ISCHEMIA-REPERFUSION INJURY IS PREVENTED BY

IL-6 RELEASE FROM THE ALLOGRAFT

Dorottya K. de Vries, Jan H.N. Lindeman, Dimitrios Tsikas, Anja Roos,

Johan W. de Fijter, Andrzej G. Baranski, Emile de Heer, Johannes van Pelt

and Alexander F.M. Schaapherder; Leiden, The Netherlands and Hannover,

Germany

P-363 INFLUENCE OF A MODIFIED PRESERVATION SOLUTION IN

PROLONGING THE COLD ISCHEMIC PERIOD – A COMPARATIVE STUDY

IN A PORCINE MODEL OF ALLOGRAFT KIDNEY TRANSPLANTATION

Mohammad Golriz, Hamidreza Fonouni, Arianeb Mehrabi, Gani

Kuttymuratov, Thomas Longerich, Majid Esmaeilzadeh, Morva Tahmasbi Rad,

Pravin Jarahian, Markus W. Büchler, Martha M. Gebhard and Jan Schmidt;

Heidelberg, Germany

P-364 MEASUREMENT OF MACULAR ANATOMIC ABNORMALITIES BY

OPTICAL COHERENCE TOMOGRAPHY IN KIDNEY TRANSPLANTED

PATIENTS

Eva Toronyi, Zsuzsa Récsán, Orsolya Fiedler, Belema Boyle, Kata Szinyei

Merse, Adam Remport, Katalin Földes, Rita Chmel, Miklós Z.S. Molnár,

Szilárd Török and János Németh; Budapest, Hungary

P-365 KIDNEY PAIRED EXCHANGE PROGRAMS AROUND THE WORLD

Bruno A. Lima and Helena Alves; Porto, Portugal

P-366 C4D-POSITIVITY AND OUTCOME FOLLOWING RENAL

TRANSPLANTATION

Bayanne Olabi, Houlberg Kristian, Christopher Bellamy and Marson Lorna;

Edinburgh, United Kingdom

P-367 OVERWEIGHT-ASSOCIATED HYPERFILTRATION DOES NOT AFFECT

RECIPIENT RENAL FUNCTION

Michel R.M. San Giorgi, Hilde Tent, Mieneke Rook, Willem J. van Son, Sijbrand

H. Hofker, Rutger J. Ploeg, Jaap J. Homan van der Heide and Gerjan Navis;

Groningen, The Netherlands

P-368 RIGHT KIDNEYS AND MULTIPLE VESSELS ARE NOT CONTRA-

INDICATIONS TO LAPAROSCOPIC LIVE DONOR NEPHRECTOMY

Yutaro Higashi, Adam D. Barlow, Jenny Moorhouse, Peter S. Veitch and

Michael L. Nicholson; Leicester, United Kingdom

P-369 SAFETY PROFILE OF A CONSECUTIVE SERIES OF 235 LAPAROSCOPIC

LIVE DONOR NEPHRECTOMIES

Adam D. Barlow, Yutaro Higashi, Rosemary Elwell, Jenny Moorhouse, Peter

S. Veitch and Michael L. Nicholson; Leicester, United Kingdom


P-370 THE RETURN OF BIOSYNSORB ANTIGEN-SPECIFIC

IMMUNOADSORPTION IN ABO-INCOMPATIBLE KIDNEY

TRANSPLANTATION

Yuki Nakagawa, Kazuhide Saito and Kota Takahashi; Niigata, Japan

P-371 EVEROLIMUS WITH REDUCED-DOSE CYCLOSPORINE AS A

STRATEGY FOR OPTIMIZING LONG-TERM RENAL FUNCTION:

RESULTS FROM A RANDOMIZED STUDY IN 833 DE-NOVO RENAL-

TRANSPLANT RECIPIENTS

H. Tedesco, Y.S. Kim, E. Lackova, T. Johnston, G. Zibari, C. Panis, K. Mange

and D. Cibrik; São Paulo, Brazil; Seoul, Korea; Banská Bystrica, Slovakia

(Slovak Republic); Lexington, KT, United States; Shreveport, LA, United

States; East Hanover, NJ, United States and Ann Arbor, MI, United States

P-372 DETERMINANTS OF PLASMA OXALATE IN NON-HYPEROXALURIA

KIDNEY TRANSPLANT PATIENTS

Linda F. Johnsen, Katja B.P. Elgstøen, Berit Woldseth, Lars Mørkrid and

Anders Hartmann; Oslo, Norway

P-373 SIROLIMUS INHIBITS LYMPHANGIOGENESIS IN RENAL ALLOGRAFTS

– A NOVEL MECHANISM TO PREVENT CHRONIC REJECTION

Niina K. Malmström, Johanna Savikko, Jukka M. Rintala, Sini E. Rintala and

Petri K. Koskinen; Helsinki, Finland

P-374 PREOPERATIVE EVALUATION, MANAGEMENT AND SURGICAL

APPROACH IN NON CONVENTIONAL KIDNEY TRANSPLANTATION

DUE TO GRAFT VASCULAR ANOMALIES – 12 YEARS SINGLE CENTER

EXPERIENCE

Ioanel Sinescu, Mihai Harza, Marcian Antonio Manu, Bogdan Serbanescu,

Bogdan Stefan, Catalin Baston, Vasile Cerempei, Dorina Tacu, Eminee

Kerezsy, Cristina Bucsa, Liliana Domnisor, Denise Daia, Ovidiu Palea, Eliza

Burchiu and Ileana Constantinescu; Bucharest, Romania

P-375 RECURRENT IGA NEPHROPATHY (IGAN) AFTER RENAL

TRANSPLANTATION (RTX): A SINGLE CENTRE EXPERIENCE

Roberta Giraudi, Maria Messina, Elisabetta Mezza, Federica Neve Vigotti,

Giuliana Tognarelli, Vincenzo Cantaluppi, Olga Randone, Ester Gallo, Maria

Cristina Di Vico, Luigi Biancone and Giuseppe Paolo Segoloni; Torino, Italy

P-376 THE IMPACT OF SLOW AND DELAYED GRAFT FUNCTION VS.

IMMEDIATE GRAFT FUNCTION ON CADAVER RENAL TRANSPLANT

OUTCOMES

Ioanel Sinescu, Marcian Antonio Manu, Mihai Harza, Bogdan Serbanescu,

Bogdan Stefan, Catalin Baston, Vasile Cerempei, Dorina Tacu, Eminee

Kerezsy, Cristina Bucsa, Liliana Domnisor, Denise Daia, Ovidiu Palea, Eliza

Burchiu and Ileana Constantinescu; Bucharest, Romania

P-377 CALCINEURIN INHIBITORS (CNI) RELATED OPTIC NEUROPATHY

AFTER KIDNEY TRANSPLANTATION (KT): RESULTS OF CONVERSION

TO AN M-TOR REGIMEN IN THREE CASES

Elisabetta Mezza, Maria Messina, Maura Rossetti, Ana Maria Manzione,

Roberta Giraudi, Michela Tamagnone, Federica Neve Vigotti, Caterina Dolla

and Giuseppe Paolo Segoloni; Turin, Italy

P-378 “SILENT” REJECTION DURING DELAYED KIDNEY GRAFT FUNCTION

Vadim Suhorukov, Tatjana Tihomirova, Janis Jushinskis, Ieva Ziedina and

Rafail Rozental; Riga, Latvia

P-379 A SIX MONTHS STEROID BASED THERAPY FOR RECURRENT

OR DE NOVO IGA GLOMERULONEPHRITIS (IGAGN) IN KIDNEY

TRANSPLANTATION (KT): PRELIMINARY EXPERIENCE IN 3 PATIENTS

(PTS)

Elisabetta Mezza, Maria Messina, Roberta Giraudi, Maura Rossetti, Luigi

Biancone, Maria Cristina Di Vico, Ester Gallo, Federica Neve Vigotti, Olga

Randone and Giuseppe Paolo Segoloni; Turin, Italy

156


157

POSTERS

P-380 COMPARATIVE QUALITY OF LIFE ASSESSED BY SF-36 HEALTH

SURVEY IN DIALYSIS PATIENTS, ANEPHRIC PATIENTS FOR RENAL

MALIGNANCIES, RENAL TRANSPLANT PATIENTS AND PATIENTS

WITH MALIGNANT UROLITHIASIS

Ioanel Sinescu, Marcian Antonio Manu, Mihai Harza, Bogdan Serbanescu,

Bogdan Stefan, Catalin Baston, Vasile Cerempei, Dorina Tacu, Eminee

Kerezsy, Cristina Bucsa, Liliana Domnisor, Denise Daia, Ovidiu Palea, Eliza

Burchiu and Ileana Constantinescu; Bucharest, Romania

P-381 COMPARATIVE STUDY REGARDING QUALITY OF LIFE ASSESSED BY

SF-36 HEALTH SURVEY IN OLDER VERSUS YOUNGER AND RELATED

VERSUS NON-RELATED LIVE KIDNEY DONORS

Ioanel I. Sinescu, Marcian Antonio M. Manu, Mihai M. Harza, Bogdan B.

Serbanescu, Bogdan B. Stefan, Catalin C. Baston, Vasile V. Cerempei, Dorina

D. Tacu, Eminee E. Kerezsy, Cristina C. Bucsa, Liliana L. Domnisor, Denise

D. Daia, Ovidiu O. Palea, Eliza E. Burchiu and Ileana I. Constantinescu;

Bucharest, Romania

P-382 OUTCOME OF RENAL TRANSPLANT RECIPIENTS WITH HEPATITIS B

INFECTION AND PREEMPTIVE TREATMENT WITH LAMIVUDINE

Cristina A. Bucsa, Dorina B. Tacu, Eminee C. Kerezsy, Marcian Manu, Mihai

Hirza, Liliana Domnisor, Denise Daia, Bogdan Serbanescu, Bogdan Stefan,

Eliza Burchiu and Ioanel Sinescu; Bucharest, Romania

P-383 EARLY GRAFT DYSFUNCTION DUE TO VASCULAR ANOMALIES,

VESSELS RECONSTRUCTION AND SPECIAL ANASTOMOTIC

TECHNIQUES IN KIDNEY TRANSPLANTATION

Ioanel I. Sinescu, Mihai M. Harza, Marcian Antonio M. Manu, Bogdan B.

Serbanescu, Bogdan S. Stefan, Catalin C. Baston, Vasile V. Cerempei, Dorina

D. Tacu, Eminee E. Kerezsy, Cristina C. Bucsa, Liliana L. Domnisor, Denise

D. Daia, Ovidiu O. Palea, Eliza E. Burchiu and Ileana I. Constantinescu;

Bucharest, Romania

P-384 LOW DOSE IMMUNOSUPPRESSION IS NOT SUFFICIENT TO AVOID

ACUTE REJECTIONS IN OLD FOR OLD KIDNEY TRANSPLANT

RECIPIENTS: A ONE YEAR PROSPECTIVE MULTICENTER RANDOMIZED

CONTROLLED TRIAL

Lutz Fricke, Markus Meier, Wibke Bode, Waichi Wong, Hendrik Lehnert,

Juergen Steinhoff and Markus Meier; Luebeck, Germany and Boston, MA,

United States

P-385 WITHDRAW

P-386 INFLUENCE OF PERIOPERATIONAL ACID-BASE BALANCE

DISORDERS ON 1-YEAR GRAFT FUNCTION IN KIDNEY

TRANSPLANTATION

Karol Tejchman, Leszek Domanski, Tadeusz Sulikowski, Maciej Romanowski

and Marek Ostrowski; Szczecin, Zachodniopomorskie, Poland

P-387 WITHDRAW

P-388 A SINGLE CENTER EXPERIENCE UTILIZING KIDNEYS FROM

DECEASED DONORS WITH TERMINAL ACUTE RENAL FAILURE

Robert Stratta, Rajinder Singh, Jack Zuckerman, Alan Farney and Jeffrey

Rogers; Winston Salem, NC, United States

P-389 A SEVEN YEAR EXPERIENCE WITH 222 EXPANDED CRITERIA DONOR

KIDNEY TRANSPLANTS AT A SINGLE CENTER

Robert Stratta, Rajinder Singh, Jack Zuckerman, Alan Farney, Jeffrey Rogers,

Erica Hartman, Amber Reeves-Daniel, Michael Gautreaux, Samy Iskandar,

Gloria Hairston and Patricia Adams; Winston Salem, NC, United States


P-390 HISTOMORPHOLOGICAL AND IMMUNOHISTOCHEMICAL

EVALUATION OF PERFUSED AND PRESERVED KIDNEY WITH EC OR

UW SOLUTION STUDIED WITH AN EXPERIMENTAL MODEL OF THE

PRE-TRANSPLANTATION PERIOD

Tadeusz Sulikowski, Leszek Domanski, Zbigniew Zietek, Karol Tejchman,

Maciej Romanowski, Mariola Marchlewicz, Marek Ostrowski, Kazimierz

Ciechanowski, Maciej Zukowski and Andrzej Ciechanowicz; Szczecin,

Zachodniopomorskie, Poland

P-391 IS ABO-INCOMPATIBLE RENAL TRANSPLANTATION A RISK FACTOR

FOR MALIGNANCY?

Takayuki Yamamoto, Takehiro Hachisuka, Yoshimasa Hashimoto, Akio

Katayama and Kazuharu Uchida; Yokkaichi, Japan and Nagoya, Japan

P-392 AREA UNDER THE CURVE SERUM CREATININE 7 DAYS POST

TRANSPLANT DETERMINES GRAFT OUTCOME IN LIVE DONOR

KIDNEY TRANSPLANTATION

Sarah A. Hosgood, Adam D. Barlow, Yasha Johari, Joshua Elias and Michael

L. Nicholson; Leicester, Leicestershire, United Kingdom

P-393 IMPACT OF OXIDATIVE STRESS AND INFLAMMATORY CYTOKINES

ON SHORT TERM KIDNEY TRANSPLANT OUTCOME

Nicole Lanci, Gaetano La Manna, Maria L. Cappuccilli, Diletta Conte, Serena

Corsini, Anna M. Ferri, Laura Panicali, Elisa Carretta, Maria P. Scolari and

Sergio Stefoni; Bologna, BO, Italy

P-394 TRANSIENT DISAPPEARANCE OF DONOR-SPECIFIC ANTIBODY

ON POST-TRANSPLANT DAY 1 MAY INDICATE HIGH RISK FOR

ANTIBODY MEDIATED ACUTE REJECTION FOLLOWING KIDNEY

TRANSPLANTATION IN SENSITIZED RECIPIENTS

Yasuo Ueda, Michio Nojima, Mitsuo Hashimoto, Yoshihide Higuchi, Tomoko

Kinoshita, Hiroyuki Hao, Masahiro Kyo, Yasuji Ichikawa, Seiichi Hirota, Shingo

Yamamoto and Hiroki Shima; Nishinomiya, Japan and Osaka, Japan

P-395 BELATACEPT DEMONSTRATES SUPERIOR COMPOSITE PATIENT/

GRAFT SURVIVAL IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS VS

CSA: RESULTS FROM THE BENEFIT AND BENEFIT-EXT STUDIES

L. Rostaing, F. Vincenti, H.H. Neumayer, R. Reyes-Acevedo, A.J. Block, G.B.

Di Russo and C.-S. Lin; Toulouse, France; San Francisco, CA, United States;

Berlin, Germany; Aguascalients, Zona Centro, Mexico and Princeton, NJ,

United States

P-396 BELATACEPT IS ASSOCIATED WITH PRESERVATION OF RENAL

FUNCTION AND STRUCTURE AT 1 YEAR COMPARED TO

CYCLOSPORINE IN KIDNEY TRANSPLANT PATIENTS (BENEFIT

STUDY)

J.M. Grinyo, G. Mondragon-Ramirez, P. Darji, B. Bresnahan, T. Pearson,

G.B. Di Russo, P. Garg and J. Xing; Barcelona, Spain; Morelos, Mexico;

Ahmedabad, India; Milwaukee, United States; Atlanta, GA, United States

and Princeton, NJ, United States

P-397 LIMITED IMPACT OF ACUTE REJECTION ON GRAFT OUTCOMES IN

BELATACEPT-TREATED KIDNEY TRANSPLANT RECIPIENTS (BENEFIT/

BENEFIT-EXT)

C. Larsen, F. Vincenti, J.M. Grinyo, B. Charpentier, G.B. Di Russo, P. Garg

and Y. Dong; Atlanta, GA, United States; San Francisco, CA, United States;

Barcelona, Spain; Kremlin Bicetre, France and Princeton, NJ, United States

P-398 NON-SKIN MALIGNANCIES AFTER RENAL TRANSPLANTATION: ONE

CENTRE EXPERIENCE

Slawomir Lizakowski, Alicja Debska-Slizien, Beata Imko-Walczuk, Janusz

Jaskiewicz and Boleslaw Rutkowski; Gdansk, Poland

P-399 SEMI-QUANTITATIVE ANALYSIS OF FOXP3

Hayato Iwase, Takaaki Kobayashi, Kenta Iwasaki, Masataka Haneda, Takahumi

Kuzuya, Akio Katayama, Kazuharu Uchida, Yasuhiro Kodera and Akimasa

Nakao; Nagoya City, Aichi Prefecture, Japan

158


159

POSTERS

P-400 SKIN AND SOLID ORGAN CANCERS IN KIDNEY TRANSPLANT

RECIPIENTS: WHEN SHOULD CANCER SCREENING BE CLOSER?

Anne-Claire Du Besset, Emmanuel Villar, Rémi Cahen, Sylvie Euvrard and

Claire Pouteil-Noble; Pierre-Bénite, France and Lyon, France

P-401 DEVELOPMENT OF MARGINAL DONOR SCORING SYSTEM IN

KOREA

Soo Jin Kim, Yeong Hoon Kim, Chan Duck Kim, In-Sung Moon, Hee Chul Yu,

Hyoung Tae Kim, Myoung Soo Kim, Sun Cheol Park and Seok Ju Park; Seoul,

Korea; Busan, Korea; Daegu, Korea and Jeonju, Korea

P-402 MULTIPLE SEQUENTIAL NEOPLASM IN KIDNEY ALLOGRAFT

RECIPIENTS

Francesca Fior, Francesco Nacchia and Luigi Boschiero; Verona, Italy

P-403 CLINICAL SIGNIFICANCE OF 25-HYDROXYVITAMIN D (25-OHD)

DEFICIENCY IN RENAL TRANSPLANT RECIPIENTS

Dong Ryeol Lee, JIN MIN Kong, Byung Chang Kim, Jung Oh Lee, Mi Young

Jeon and Hwa Lim Lee; Busan, Republic of Korea

P-404 ANEURYSM SCREENING IN LONG TERM TRANSPLANT RECIPIENTS

MAY PREVENT LETHAL COMPLICATIONS

A.O. Mahendran, M. Elvey, M. Mahendran, M. Behnam, P. Dupont, P.S. Veitch

and P. Sweny; London, United Kingdom

P-405 ROUTINE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS IN RENAL

TRANSPLANTATION: IT MAKES NO DIFFERENCES IN BACTERIAL

INFECTIONS

Seong-Uk Choi, Chang-Kwon Oh, Ji-Hye Kim, Gyu-Tae Shin and Se-Jung

Kim; Suwon, Gyeonggi-do, Korea

P-406 RENAL FUNCTION AND SAFETY ARE WELL-MAINTAINED AFTER

CONVERSION FROM TWICE-DAILY PROGRAF® TO ONCE-DAILY

ADVAGRAF® IN STABLE KIDNEY TRANSPLANT PATIENTS: A PHASE

IIIB STUDY

M. Ostrowski, R. Lauzurica, J. Morales and J. van Hooff; Szczecin, Poland;

Barcelona, Spain; Madrid, Spain and Maastricht, The Netherlands

P-407 VACUUM-ASSISTED CLOSURE THERAPY (VACT) IN THE MANAGEMENT

OF WOUND INFECTION AFTER RENAL TRANSPLANTATION: A

SINGLE CENTRE EXPERIENCE

I. Butt, M.S. Delbridge, A.T. Raftery and B.M. Shrestha; Sheffi eld, United

Kingdom

P-408 THE ANSWER IS IN MACHINE PERFUSION: ANALYSIS OF MACHINE

PERFUSION ON DONORS AFTER CARDIAC ARREST

Nader Vaziri, Raphael Thuillier, Frederic Favreau, Olivier Celhay, Emilie

Manguy, Ludivine Rossard, Thierry Hauet and Benoit Barrou; Poitiers, France

and France

Liver intestine I

P-409 DEVELOPMENT AND VALIDATION OF A SURGICAL CHALLENGE

SCORE WITH SIGNIFICANT IMPACT ON RESULTS AFTER LIVER

TRANSPLANTATION

Harald Schrem, Nina Till, Ludwig Hoy, Moritz Kleine, Hüseyin Bektas, Thomas

Becker and Jürgen Klempnauer; Hannover, Germany

P-410 NONPERSISTENT EFFECT OF BISPHOSPHONATE TREATMENT

FOR PREVENTING FRACTURES THREE YEARS AFTER LIVER

TRANSPLANTATION

Martin Bodingbauer, Julian Marschalek, Klaus Klaushofer, Georg Gyoeri,

Christopher Burghuber, Ferdinand Muehlbacher and Rainer Oberbauer;

Vienna, Austria and Linz, Austria


P-411 EXCELLENT OUTCOME AFTER LATE RETRANSPLANTATION OF THE

LIVER DURING THE LAST DECADE

Wojciech G. Polak, Paul M.J. Peeters, Koert P. de Jong, Marieke T. de Boer,

Aad P. Van Den Berg, Henkjan J. Verkade, Rene Scheenstra, Elizabeth B.

Haagsma, Herman G.D. Hendriks, Maarten J.H. Slooff and Robert J. Porte;

Groningen, The Netherlands

P-412 LIVER FAILURE AND THE NEED FOR TRANSPLANTATION IN THREE

PATIENTS WITH HEPATOPORTAL SCLEROSIS

Bita Geramizadeh, Seyed Ali Malek-hosseini, Heshmatollah Salahi, Ali

Bahador and Saman Nikeghbalian; Shiraz, Fars, Islamic Republic of Iran

P-413 LIVER TRANSPLANTATION FROM A DECEASED DONOR WITH

SEVERE RHABDOMYOLYSIS

Seong-Hwan Chang, Ik Jin Yun and Hae Won Lee; Seoul, Republic of Korea

P-414 HEALTH-RELATED QUALITY OF LIFE IN ADULT TRANSPLANT

RECIPIENTS MORE THAN 15 YEARS AFTER ORTHOTOPIC LIVER

TRANSPLANTATION

Lampros Kousoulas, Michael Neipp, Hannelore Barg-Hock, Steffan Jackobs,

Christian P. Strassburg, Juergen Klempnauer and Thomas Becker; Hannover,

Germany

P-415 DE NOVO AUTOIMMUNE HEPATITIS AFTER LIVER

TRANSPLANTATION

Barra Valencia Vanessa, Gimeno Calvo Alberto, Pérez Saborido Baltasar,

Fundora Suárez Yilliam, Juan Carlos Meneu Díaz, Colina Francisco, Abradelo

de Usera Manuel, Carlos Jiménez Romero and Enrique Moreno González;

Madrid, Spain

P-416 OUTCOME OF LIVING DONOR LIVER TRANSPLANTATION FOR

INCIDENTALLY FOUND HEPATOCELLULAR CARCINOMA

Mohamed Said, Ayman Yosry, Gamal Esmat, Magdy El-Serafy, Ashraf Omar,

Waheed Doss, Adel Hosny, Yaser Hatata, Ebrahem Marawan, Refat Refat

Kamel, Ahmad El-Taweel, Ayman Dosoky, Ahmad Ghaly and Hatem El-

Gabaly; Cairo, Egypt and Menofi a, Egypt

P-417 EVALUATION OF THE APACHE III SCORE IN COMPARISON TO MELD

SCORE AND KING’S COLLEGE HOSPITAL CRITERIA FOR FULMINANT

HEPATIC FAILURE

Panagiotis Fikatas, Ji Eun Lee, Frank Ulrich, Sascha Chopra, Andreas Pascher,

Olaf Guckelberger, Gero Puhl, Ulf Neumann, Peter Neuhaus and Johann

Pratschke; Berlin, Germany

P-418 130 LIVER TRANSPLANTATIONS FOR FULMINANT HEPATIC FAILURE:

RESULTS OF A HIGH VOLUME CENTER

Panagiotis Fikatas, Ji Eun Lee, Frank Ulrich, Sascha Chopra, Andreas Pascher,

Olaf Guckelberger, Gero Puhl, Ulf Neumann, Peter Neuhaus and Johann

Pratschke; Berlin, Germany

P-419 A SINGLE CENTER EXPERIENCE OF 50 LIVING DONOR LIVER

TRANSPLANTATIONS FOR ACUTE LIVER FAILURE

Toru Ikegami, Akinobu Taketomi, Yuji Soejima, Hideaki Uchiyama, Tomoharu

Yoshizumi, Keishi Sugimachi, Tomoharu Gion and Yoshihiko Maehara;

Fukuoka, Japan

P-420 THE EFFECTS OF ULTRASONOGRAPHY EXAMINATION ON THE

MICROSURGICAL RECONSTRUCTION OF THE HEPATIC ARTERY IN

LIVER TRANSPLANTATION

Shigehito Miyagi, Yoshitaka Enomoto, Satoshi Sekiguchi, Naoki Kawagishi,

Yorihiro Akamatsu, Kazushige Sato, Ikuo Takeda, Keisei Fujimori and Susumu

Satomi; Sendai, Japan

160


161

POSTERS

P-421 ACUTE GRAFT FAILURE AFTER LIVING-DONOR LIVER

TRANSPLANTATION SUGGESTING THE INVOLVEMENT OF

APOPTOSIS BY ACTIVATION OF FAS/FAS-L

Hideshi Yamamoto, Taiji Tohyama, Taro Nakamura, Jota Watanabe, Masahide

Hatano, Makoto Shirai, Fumiki Kushihata, Kazuo Honda and Nobuaki

Kobayashi, Yoshito Ono and Masamitsu Monimoto; Toon, Ehime, Japan and

Nagoya, Aichi, Japan

P-422 ELDERLY VS YOUNG LIVER TRANSPLANT RECIPIENTS: PATIENT AND

GRAFT SURVIVAL

Gian Luigi Adani, Umberto Baccarani, Dario Lorenzin, Vittorio Bresadola,

Paolo Garelli, Daniele Nicolini and Andrea Risaliti; Udine, Italy and Ancona,

Italy

P-423 HUMORAL REJECTION AFTER LIVER TRANSPLANTATION; DELAYED

ONSET AND PROGNOSIS

Marek J. Pacholczyk, Beata Lagiewska, Tomasz Cieciura, Wojciech Lisik,

Leszek Adadynski, Agnieszka Perkowska-Ptasinska and Andrzej Chmura;

Warsaw, Poland

P-424 EFFICACY OF NUCLEOSIDE ANALOGUE MONOTHERAPY

FOLLOWING ONE-YEAR COURSE OF HEPATITIS B IMMUNOGLOBULIN

PLUS NUCLEOSIDE ANALOGUE IN PREVENTING HEPATITIS B VIRUS

RECURRENCE AFTER LIVING DONOR LIVER TRANSPLANTATION

Naoki Kawagishi, Atsushi Nakamura, Takeru Iwane, Ikuo Takeda, Shigehito

Miyagi, Kazushige Satoh, Yorihiro Akamatsu, Satoru Sekiguchi and Susumu

Satomi; Sendai, Miyagi, Japan

P-425 SINGLE CENTER EXPERIENCE IN LIVER TRANSPLANT FOR HIGH

MELD RECIPIENTS

Ben-Hur Ferraz-Neto, Andre I. David, Maria Paula V.C. Zurstrassen, Sergio P.

Meira Filho, Marcio D. De Almeida, Bianca Della-Guardia, Paulo Henrique F.

Barros, Marcelo B. Rezende and Rogerio C. Afonso; Sao Paulo, SP, Brazil

P-426 BRAZILIAN SINGLE CENTER SURVIVAL RATES AFTER LIVER

TRANSPLANT DUE TO FULMINANT HEPATIC FAILURE

Andre I. David, Maria Paula V.C. Zurstrassen, Sergio P. Meira Filho, Marcio

D. De Almeida, Bianca Della-Guardia, Itágores H. Coutinho, Marcelo B.

Rezende, Rogerio C. Afonso and Ben-Hur Ferraz-Neto; Sao Paulo, SP, Brazil

P-427 TESTING OF POST-TRANSPLANT LIVER FUNCTION AND VIABILITY

BASED ON PORTAL FLOW

Beata J. Lagiewska, Marek Pacholczyk, Maciej Kosieradzki, Wojciech Lisik,

Gajusz Gontarczyk, Leszek Adadynski, Janusz Trzebicki and Andrzej Chmura;

Warsaw, Poland

P-428 INTENT-TO-TREAT SURVIVAL ANALYSIS OF CANDIDATES FOR LIVER

TRANSPLANTATION IN ISRAEL

Daniel Erez, Ziv Ben-Ari, Rachel Michowiz and Eytan Mor; Petah-Tiqwa,

Israel

P-429 THE VENOUS RECONSTRUCTION AT LIVING DONOR LIVER

TRANSPLANTATION IN CHILDREN AND ADULTS

Oleg Gen. Kotenko, Denis Alex. Fedorov, Alexander Val. Grinenko, Andrey

Vit. Gusev, Alexander Alex. Korshak and Alexey Oleg. Popov; Kiev, Ukraine

P-430 THE VENOUS OUTFLOW RECONSTRUCTION IN ADULT LIVING

DONOR LIVER TRANSPLANTATION USING THE RIGHT HEPATIC LOBE

WITHOUT THE MIDDLE HEPATIC VEIN

Maria Ghizzoni, Paolo Aseni, Abdallah O. Slim, Alessandro Giacomoni,

Andrea Lauterio, Iacopo Mangoni, Plamen Mihaylov, Vincenzo Pirotta, Luca

Lamperti, Stefano Di Sandro, Mohamed Al Kofahi and Luciano G. De Carlis;

Milan, Italy


P-431 BACTERIAL AND FUNGAL INFECTIONS IN LIVING DONOR LIVER

TRANSPLANTATION

Hirotaka Tashiro, Kohei Ishiyama, Masahiro Ohira, Hironobu Amano, Akihiko

Oshita, Toshimitsu Irei, Hiroyuki Tahara, Tsuyoshi Kobayashi, Masataka

Banshodani, Yoshisato Tanimoto, Shintaro Kuroda, Hirofumi Tazawa,

Toshimasa Asahara and Hideki Ohdan; Hiroshima, Japan

P-432 LIVING DONOR LIVER TRANSPLANTATION: EFFECT OF THE TYPE OF

LIVER GRAFT DONATION ON DONOR MORTALITY AND MORBIDITY

Lampros Kousoulas, Harald Schrem, Nicolas Richter, Thomas Becker, Juergen

Klempnauer and Frank Lehner; Hanover, Germany

P-433 THE EFFECTS OF DESFLURANE AND SEVOFLURANE ON

POSTOPERATIVEHEPATIC AND RENAL FUNCTIONS AFTER RIGHT

HEPATECTOMY IN LIVER DONORS

Gaab Soo Kim, Mi Sook Gwak, Justin Sangwook Ko, Jin Young Lee, Hee

Kyung Kim and Jae Won Joh; Seoul, Korea

P-434 MAGNESIUM DEPLETION AFTER LIVER TRANSPLANTATION UNDER

CYCLOSPORINE A OR TACROLIMUS IMMUNOSUPPRESSION

Mirja Tervo, Päivi Valta, Krister Höckerstedt and Leena Lindgren; Tampere,

Finland; Espoo, Finland and Helsinki, Finland

P-435 CMV-REACTIVATIONS IN ADULT LIVER TRANSPLANT RECIPIENTS

MONITORED BY QUANTITATIVE PCR

Irmeli Lautenschlager, Raisa Loginov, Heikki Mäkisalo and Krister Höckerstedt;

Helsinki, Finland

P-436 INCIDENCE OF HEPATIC VENOUS OUTFLOW OBSTRUCTION IN

“PIGGY-BACK” LIVER TRANSPLANTATION: COMPARISON OF THREE

KINDS OF GRAFT’S OUTFLOW RECONSTRUCTION

Qi-Fa Ye, Ying Niu, Ying-zi Ming, Ke Chen, Xing-guo She and Zu-hai Ren;

Changsha, Hunan, China

P-437 FEASIBILITY OF USING GRAFTS FROM MARGINAL DONORS IN LIVER

RETRANSPLANTATION. A SINGLE-CENTER ANALYSIS

Josep Marti, Constantino Fondevila, Maria Marta Modolo, David Calatayud,

Santiago Sanchez, Joana Ferrer, Raquel Garcia-Roca, Josep Fuster and Juan

Carlos Garcia-Valdecasas; Barcelona, Spain

P-438 PREVENTION OF BILIARY STENOSIS AFTER DUCT-TO-DUCT

RECONSTRUCTION IN LIVING DONOR LIVER TRANSPLANTATION

WITH A BIOABSORBABLE POLYMER STENT

Masayasu Aikawa, Mitsuo Miyazawa, Yasuko Tshimitsu, Katsuya Okada,

Isamu Koyama and Yoshito Ikada; Hidaka, Saitama, Japan and Nara, Japan

P-439 THE SURVIVAL BENEFIT OF LIVER TRANSPLANTATION IN PATIENTS

WITH HEPATOCELLULAR CARCINOMA

Alessandro Vitale, Michael Volk, Anna Chiara Frigo, Francesco Grigoletto,

Alberto Brolese, Giacomo Zanus, Fabio Farinati, Ptrizia Burra, Davide F.

D’Amico and Umberto Cillo; Padua, Italy and Ann Arbor, MI, United States

P-440 CONGESTION OF REMNANT LIVER AFTER PROCUREMENT OF AN

EXTENDED LEFT LOBE GRAFT IN LIVE DONORS

Mitsuo Shimada, Masaki Nishi, Mami Kanamoto, Jun Hanaoka, Hirofumi

Kanemura, Satoru Imura, Yuji Morine, Hideaki Uchiyama and Tohru

Utsunomiya; Tokushima, Tokushima, Japan

P-441 PREVENTION OF HBV INFECTION AFTER LIVER TRANSPLANTATION

IN PATIENTS WITH HBV OR HBV+HDV CIRRHOSIS

Anastasiya A. Salienko, Olga I. Andreytseva and Alexey V. Zhao; Moscow,

Russian Federation

P-442 LONG TERM OUTCOME OF LIVER TRANSPLANTATION VS RESECTION

FOR ADVANCED HCC

Anna Rossetto, Dario Lorenzin, Gian Luigi Adani, Chiara Comuzzi, Alessandro

Uzzau, Claudio Avellini, Vittorio Bresadola and Umberto Baccarani; Udine,

Italy

162


163

POSTERS

P-443 SOTRASTAURIN: PHARMACOKINETICS AND CLEARANCE IN LIVER

TRANSPLANTION

J. Pratschke, J.M. Kovarik, U. Cillo, S. Stitah, A. Slade and P. Neuhaus; Berlin,

Germany; Basel, Switzerland and Padua, Italy

P-444 ADULT CIRRHOTIC LIVER EXPLANTS: DIAGNOSIS OF UNDETECTED

CHOLANGIOCARCINOMA

Mélanie Vallin, Jérôme Dumortier, Olivier Guillaud, Mustapha Adham, Olivier

Boillot and Jean-Yves Scoazec; Lyon, France

P-445 LONG TERM RESULTS OF LIVER TRANSPLANTATION FOR WILSON’S

DISEASE

Valeria Pabon, Jérôme Dumortier, Olivier Guillaud, Jacques Baulieux,

Christian Ducerf, Christian Trépo, Jean-Christophe Souquet, Fabien Zoulim,

Olivier Boillot, Muriel Bost and Alain Lachaux; Lyon, France

P-446 STUDY ON COMPLEMENT ACTIVATION DURING LIVER REPERFUSION

IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME OR

OTHER INDICATIONS FOR LIVER TRANSPLANTATION

Eija M. Tukiainen, Aino Koskinen, Arno Nordin, Heikki Mäkisalo, Krister

Höckerstedt, Helena Isoniemi and Sakari Jokiranta; Helsinki, Finland

P-447 ALBUMIN DIALYSIS MARS IN ACUTE LIVER FAILURE: PREDICTIVA

CRITERIA FOR OUTCOME

G. Novelli, M. Rossi, V. Morabito, R. Haiberger, S. Novelli and P. Berloco;

Rome, Italy and Rome, Italy

P-448 DEVELOPMENT OF AN ARTIFICIAL BILE DUCT MADE OF

BIOABSORBABLE POLYMER TO BE USED FOR TREATMENT OF BILIARY

STENOSIS AFTER LIVING-DONOR LIVER TRANSPLANTATION

Mitsuo Miyazawa, Asayasu Aikawa, Katsuya Okada, Yasuko Toshimitsu, Kojun

Okamoto and Isamu Koyama; Saitama, Japan

P-449 DEVELOPMENT OF A NEW TREATMENT FOR BILE DUCT STENOSIS

USING TISSUE ENGINEERING TECHNIQUES – DEVELOPMENT OF A

BILE DUCT PATCH MADE OF BIOABSORPABLE POLYMER –

Katsuya Okada, Mitsuo Miyazawa, Masayasu Aikawa, Yasuko Toshimitsu,

Isamu Koyama and Kojun Okamoto; Saitama, Japan

P-450 CLINICOPATHOLOGICAL STUDY OF EXPLANTED LIVERS IN

TRANSPLANTATION FOR ADULT POST-KASAI BILIARY ATRESIA

Kwang-Jong Lee, Yukihiro Inomata, Katsuhiro Asonuma, Hideaki Okajima,

Hidekazu Yamamoto, Yasumasa Shirouzu, Yukika Tsukamoto and Taiki Yoshii;

Kumamoto, Japan

P-451 ARE THE PROTECTIVE FACTORS OF PRECONDITIONING

TRANSFERRABLE?

Ersin Ates and Sezgin Yilmaz; Eskisehir, Turkey and Afyon, Turkey

P-452 ALCOHOL-METABOLIZING ENZYME GENE POLYMORPHISMS IN

ALCOHOL LIVER CIRRHOSIS AMONG POLISH INDIVIDUALS

Halina Cichoz-Lach, Emilia Lis, Krzysztof Celinski and Maria Slomka; Lublin,

Poland

P-453 GRAFT PRECONDITIONING WITH LOW-DOSE TACROLIMUS

(FK506) AND NITRIC OXIDE INHIBITOR (AGH) REDUCES ISCHEMIA/

REPERFUSION INJURY AFTER LIVER TRANSPLANTATION IN THE RAT

Edouard A. Matevossian, Volker Assfalg, Helmut Friess, Joerg Naehrig,

Manfred Stangl and Norbert Hüser; Münster, Bavaria, Germany

P-454 HEPATIC ARTERY RECONSTRUCTION WITHOUT MICROSCOPE IN

LIVING DONOR LIVER TRANSPLANTATION. TECHNICAL ASPECTS

Abdallah Slim, Andrea Lauterio, Alessandro Giacomoni, Stefano Di Sandro,

Paolo Aseni, Iacopo Mangoni, Plamen Mihaylov, Mohamed Al Kofahi and

Luciano De Carlis; Milan, Italy


P-455 LIVER TRANSPLANTATION FOR HCC. A COMPARATIVE ANALYSIS OF

PATIENTS TRANSPLANTED WITH GRAFT COMING FROM DECEASED

OR LIVING DONORS

Alessandro Giacomoni, Abdallah Slim, Andrea Lauterio, Stefano Di Sandro,

Vincenzo Pirotta, Plamen Mihaylov and Luciano De Carlis; Milan, Italy

P-456 LIVER RESECTION FOR HCC PRIOR TO LIVER TRANSPLANTATION

DOES NOT AFFECT PATIENTS OUTCOME

Alessandro Giacomoni, Abdallah Slim, Stefano Di Sandro, Andrea Lauterio,

Iacopo Mangoni, Plamen Mihaylov, Luca Lamperti and Luciano De Carlis;

Milan, Italy

P-457 HCC RADIOLOGICAL PROGRESSION AFTER DOWNSTAGING ALSO

IN PATIENTS INSIDE MILAN CRITERIA CORRELATE WITH A HIGH HCC

RECURRENCE RATE AFTER TRANSPLANTATION

Alessandro Giacomoni, Stefano Di Sandro, Abdallah Slim, Andrea Lauterio,

Paolo Aseni, Iacopo Mangoni and Luciano De Carlis; Milan, Italy

P-458 LARGE-FOR-SIZE STEATOTIC LIVER GRAFTS CAN BE SAFELY

REDUCED

Guido Liddo, Ganesh Nagarajan, Federica Dondero, Safi Dokmak, Daniele

Sommacale, Claire Francoz, Francois Durand and Jacques Belghiti; Clichy,

France

P-459 HEPATIC SURGERY IN TRANSPLANTED PATIENTS: IS IT DIFFERENT

FROM ROUTINE LIVER SURGERY?

Daniele Sommacale, Ganesh Nagarajan, Safi Dokmak, Federica Dondero,

Catherine Paugam and Jacques Belghiti; Clichy, France

P-460 FIBRINOLYSIS AFTER LIVER GRAFT REPERFUSION: INCIDENCE

ANALYSED WITH ROTEM

Catherine Boucaud, Berangere Sagniat, Yves Bouffard, Nelly Gaillac, Helene

Counioux and Olivier Boillot; Lyon, France

P-461 RISK FACTORS FOR POST-TRANSPLANTATION MALIGNANCY IN

LIVER AND SMALL INTESTINE TRANSPLANT RECIPIENTS REPORTED

BY UNOS 1988-2006

Cara R. Baker, Mei Nortley, Mohammed Morsy, Iain MacPhee, Jiri Fronek

and Nicos Kessaris; London, United Kingdom

P-462 HEPARINOIDS DETECTION AFTER LIVER GRAFT REPERFUSION WITH

ROTEM ANALYSIS

Catherine Boucaud, Nelly Gaillac, Berangere Sagniat, Yves Bouffard, Marie

Christine Graber and Olivier Boillot; Lyon, France

P-463 INCIDENCE OF ABNORMAL FIBRINOLYSIS IN PATIENTS UNDERGOING

LIVER TRANSPLANTATION- ROTEM ANALYSIS

Catherine Boucaud, Nelly Gaillac, Yves Bouffard, Berangere Sagniat, Pierre

Sagnard and Olivier Boillot; Lyon, France

P-464 NK-CELL CHIMERISM IS A UNIQUE FEATURE OF LIVER

TRANSPLANTATION AND MAY MODULATE THE RECIPIENT’S

IMMUNE RESPONSE AGAINST THE GRAFT

Viviana Moroso, Herold J. Metselaar, Brenda M. Bosma, Shanta Mancham, Luc

J.W. van der Laan, Nicole M. van Besouw, Hugo W. Tilanus, Ernst J. Kuipers,

Diana Eissen, Arnold van der Meer, Irma Joosten and Jaap Kwekkeboom;

Rotterdam, The Netherlands and Nijmegen, The Netherlands

P-465 EARLY PREDICTION OF ACUTE OR CHRONIC ALLOGRAFT

REJECTION IN FK506 TREATED RAT INTESTINE TRANSPLANT

RECIPIENTS

Maren Kloepfel, Sven Kohler, Anja Reutzel-Selke, Christoph Loddenkemper,

Katrin Vogt, Peter Neuhaus, Johann Pratschke, Birgit Sawitzki and Andreas

Pascher; Berlin, Germany

164


165

POSTERS

P-466 A SIMPLIFIED FUNCTIONAL VENOPLASTY OF MIDDLE HEPATIC VEIN

IN RIGHT LOBE GRAFT LIVER TRANSPLANTATION

Koichi Tanaka, Takako Yamada, Hitoshi Iwamoto, Yasser Hatata, Kenji

Uryuhara, Satoshi Kaihara, Taiji Toyama, Nobuaki Kobayashi and Shinji

Uemoto; Kobe, Japan; Tokyo, Japan; Cairo, Egypt; Matsuyama, Japan and

Kyoto, Japan

P-467 RESULTS OF LIVER TRANSPLANTATION IN ALCOHOLIC CIRRHOSIS:

ARE THE SAME THAN WITH OTHER ETIOLOGIES?

Vanessa Barra-Valencia, Baltasar Pérez-Saborido, Laura Peláez Berdullas, Sara

Piris Borregas, Yilliam Fundora Suárez, Alberto Gimeno Calvo, Juan Carlos

Meneu Díaz, Manuel Abradelo de Usera, Santos Jiménez de los Galanes,

Sergio Pedro Olivares Pizarro, Edurne Alvaro, Carlos Jiménez Romero and

Enrique Moreno González; Madrid, Spain

P-468 CONVERSION FROM TWICE-DAILY PROGRAF TO ONCE-DAILY

ADVAGRAF IS STRAIGHTFORWARD IN STABLE LIVER TRANSPLANT

RECIPIENTS

D. Thorburn, L. Paczek, P. Wolf and O. Boillot; Birmingham, United Kingdom;

Warsaw, Poland; Strasbourg, France and Lyon, France

P-469 ADULT LIVING-DONOR LIVER TRANSPLANTATION WITHOUT GRAFT

COLD PRESERVATION; NON-RANDOMIZED PROSPECTIVE STUDY

Young Kyoung You, Sang Kuon Lee, Tae Ho Hong, Jung Hyeon Park, Kyeong

Keun Lee, Young Cheol Yoon, Say Joon Kim and Dong Goo Kim; Seoul,

Korea; Bucheon, Korea and Daejon, Korea

P-470 ROLE OF LIPOCALIN 2/LCN2 IN LIVER REGENERATION

Katrin Kienzl, Alexander R. Moschen, Geiger Sabine, Gerald Brandacher,

Felix Aigner, Raimund Margreiter and Herbert Tilg; Innsbruck, Austria

P-471 IMPACT OF LEFT LOBE GRAFT ON ADULT-TO-ADULT LIVING DONOR

LIVER TRANSPLANTATION

Satoru Imura, Mitsuo Shimada, Yusuke Arakawa, Mami Kanamoto, Jun

Hanaoka, Hirofumi Kanemura, Yuji Morine, Hideaki Uchiyama, Nobuhiro

Kurita, Toru Utsunomiya and Hidenori Miyake; Tokushima, Japan

P-472 STRATEGIES FOR PREVENTING THE SMALL-FOR-SIZE SYNDROME IN

LIVING DONOR LIVER TRANSPLANTATION: A CLINICAL STUDY OF 39

CASES

Bai-Yong Shen, Chen-Hong Peng, Xia-Xing Deng, Qian Zhan and Hong-Wei

Li; Shanghai, China

P-473 MARGINAL ORGANS DO NOT IMPAIR LIVER ALLOGRAFT RECIPIENT

ONE YEAR OVERALL AND ORGAN SURVIVAL

Andreas A. Schnitzbauer, Axel Doenecke, Wijdan Abu Ajaj, Martin Loss,

Stefan A. Farkas, Carl Zuelke, Marcus N. Scherer and Hans J. Schlitt;

Regensburg, Bavaria, Germany

P-474 TRANSARTERIAL CHEMOEMBOLIZATION UTILITY AS A BRIDGE

TO LIVER TRANSPLANT FOR PATIENTS WITH HEPATOCELLULAR

CARCINOMA DURING THE WAITING LIST

Baltasar Pérez-Saborido, Vanessa Barra-Valencia, María Donat-Garrido,

Alberto Gimeno-Calvo, Santos Jiménez de los Galánnes-Marchán, Yillian

Fundora-Suárez, Vanesa López-Jara, Juan Carlos Menéu-Díaz, Manuel

Adradelo de Usera and Enrique Moreno-González; Madrid, Spain and

Vallecas, Madrid, Spain

P-475 FIRST CASE OF MALIGNANT TRANSFORMATION IN LIVER

ADENOMATOSIS TREATED BY LIVING DONOR LIVER

TRANSPLANTATION

Stefano Di Sandro, Abdallah Slim, Alessandro Giacomoni, Andrea Lauterio,

Iacopo Mangoni, Plamen Mihaylov, Vincenzo Pirotta and Luciano De Carlis;

Milan, Italy


P-476 SMALL DIFFERENCE IN INR MAY YIELD A SIGNIFICANT IMPACT ON

PRIORITIES OF PATIENTS LISTED FOR LIVER TRANSPLANTATION

Eniko Sarvary, Zsolt Seregely, Janos Fazakas, Ibolya Gaal, Jozsef Varga,

Ferenc Kovacs, Gabriella Beko, Denes Gorog, Laszlo Kobori, Balazs Nemes,

Marina Varga, Katalin Monostory, Jeno Jaray and Zsuzsa Gerlei; Budapest,

Pest, Hungary and Kanizsa, Zala, Hungary

P-477 MORPHOLOGICAL FEATURES OF ADVANCED HEPATOCELLULAR

CARCINOMA AS A PREDICTOR OF SUCCESSFUL DOWNSTAGING

AND LIVER TRANSPLANTATION: AN INTENTION-TO-TREAT

ANALYSIS

Omar Barakat, Patrick R. Wood, Claire F. Ozaki, Victor Ankoma-say, Mark

Skolkin, Warren Moore and Luis A. Mieles; Houston, TX, United States

P-478 GRADE AND TYPE OF DECEASED DONOR LIVER STEATOSIS

VARIABLY IMPACTS ON GRAFT AND RECIPIENT OUTCOMES

Esther De Graaf, James Kench, Pamela Dilworth, Patrick Tang, Nicholas

Shackel, Simone Strasser, James Gallagher, Henry Pleass, Michael Crawford,

Geoff McCaughan and Deborah Verran; Groningen, The Netherlands and

Sydney, NSW, Australia

P-479 PRE AND INTRA-OPERATIVE PREDICTORS OF THE NEED FOR RENAL

REPLACEMENT THERAPY AFTER LIVER TRANSPLANTATION

Man Ki Ju, Gi Hong Choi, Soo Jin Kim, Kyung Ock Jeon, Jong Hoon Lee, Kiil

Park, Jinsub Choi, Soon Il Kim and Yu Seun Kim; Seoul, Korea and Goyang,

Korea

P-480 CAN WE APPLY UCSF CRITERIA BY PRE-TRANSPLANT RADIOLOGIC

IMAGING AS SELECTION CRITERIA FOR LIVER TRANSPLANTATION

IN HEPATOCELLULAR CARCINOMA?

Soo Jin Kim, Gi Hong Choi, Jinsub Choi, Kyung Ock Jeon, Jong Hoon Lee,

Kiil Park, Soon Il Kim and Yu Seun Kim; Seoul, Korea and Goyang, Korea

P-481 DOES VENOUS RECONSTRUCTION OF THE ANTERIOR SECTOR

AFFECT ON GRAFT REGENERATION IN LIVING DONOR RIGHT LOBE

LIVER TRANSPLANTATION?

Gi Hong Choi, Soo Jin Kim, Jinsub Choi, Kyung Ock Jeon, Jong Hoon Lee,

Kiil Park, Soon Il Kim and Yu Seun Kim; Seoul, Korea and Goyang, Korea

P-482 THE OUTCOME OF LIVER TRANSPLANT RECIPIENTS WITHOUT

RENAL SUPPORT DURING LIVER TRANSPLANTATION

Hee Kyung Kim, Jin Young Lee, Young Hee Shin, Sang Wook Ko, Mi Sook

Gwak, Suk-Koo Lee and Gaab-Soo Kim; Seoul, Korea

P-483 RESULTS OF LIVER TRANSPLANTATION (LT) FROM CONTROLLED

DONATION AFTER CARDIAC DEATH (DCD) DONORS: A SINGLE

CENTER EXPERIENCE

Olivier Detry, Benoît Seydel, Emmanuel Decker, Arnaud De Roover, Jean

Delwaide, Boris Bastens, Christian Brixko, Anne Lamproye, Sévrine Lauwick,

Jean Joris, Michel Meurisse and Pierre Honoré; Liège, Belgium

P-484 QUICK LINKER DEVICE PROVES EFFECTIVE TO AVOID WARM

ISCHEMIA DAMAGE DURING ORTHOTOPIC LIVER

TRANSPLANTATION IN RAT

Graziano Oldani, Giacomo Angelastri, Marcello Maestri and Annalisa

Gaspari; London, United Kingdom and Pavia, Italy

P-485 DUAL GRAFT LIVER TRANSPLANTATION USING ABO-COMPATIBLE

AND ABO-INCOMPATIBLE GRAFTS COMBINATION TO OVERCOME

SMALL-FOR-SIZE GRAFT SYNDROME AND ABO BLOOD BARRIER

Gi-Won Song, Sung-Gyu Lee, Shin Hwang, Chuk-Soo Ahn, Ki-Hun Kim,

Deok-Bog Moon and Nam-Gyu Choi; Seoul, Korea

P-486 EARLY PREDICTORS FOR THE DEVELOPMENT OF HEPATITIS-C-

ASSOCIATED LIVER GRAFT FIBROSIS

Dennis Eurich, Marcus Bahra, Fabian Spies, Jan M. Langrehr, Ruth Neuhaus,

Peter Neuhaus and Ulf P. Neumann; Berlin, Germany

166


167

POSTERS

P-487 SPLIT LIVER TRANSPLANTATION IN ADULT AND PEDIATRIC

RECIPIENTS: A 16 YEAR EXPERIENCE IN A SINGLE CENTER

Olivier Boillot, Gabriella Pittau, Thomas Gelas, Mustapha Adham, Jerome

Dumortier, Olivier Guillaud, Yves Bouffard, Catherine Boucaud, Pierre

Sagnard and Charles Ber; Lyon, France

P-488 IS THERE RELATION BETWEEN THE GRADE OF TUMOR NECROSIS

AND THE RADIOLOGICAL RESPONSE AFTER PREOPERATIVE TAC

AND THE TUMOR RECURRENCE BETWEEN PATIENTS WITH LIVER

TRANSPLANT DUE TO HEPATOCELLULAR CARCINOMA

Baltasar Pérez-Saborido, Santos Jiménez de los Galánes-Marchán, Juan

Carlos Menéu-Díaz, Vanessa Barra-Valencia, María Donat-Garrido, Yillian

Fundora-Suárez, Alberto Giméno-Calvo, Manuel Octavio Salinas and Enrique

Moreno-González; Madrid, Spain and Vallecas, Madrid, Spain

P-489 TUMOR RECURRENCE AFTER LIVER TRANSPLANTATION FOR

HEPATOCELLULAR CARCINOMA. RECURRENCE PATHWAYS AND

TREATMENT

Baltasar Pérez-Saborido, María Donat-Garrido, Vanessa Barra-Valencia,

Alberto Gimeno-Calvo, Santos Jiménez de los Galánes-Marchán, Almudena

Moreno Elola-Olaso, Yillian Fundora-Suárez, Juan Carlos Menéu-Díaz,

Manuel Abradelo de Usera, Vanesa López-Jara and Enrique Moreno-

González; Madrid, Spain

P-490 LAPAROSCOPIC TREATMENT OF BILIARY PERITONITIS AFTER T

TUBE REMOVAL IN PATIENTS UNDERGOING ORTHOTOPIC LIVER

TRANSPLANTATION

Pedro Cascales, Pablo Ramirez, Ricardo Robles, Francisco Sanchez Bueno,

Antonio Capel, Jose Antonio Pons, Manuel Miras, Antonio Rios, Rocio

Gonzalez SAnchez and Pascual Parrilla; Murcia, Spain

P-491 EFFECT OF KAMPO MEDICINE “DAI-KENCHU-TO” ON PORTAL

BLOOD FLOW IN LIVING DONOR LIVER TRANSPLANT RECIPIENTS

Yuko Kawata, Mitsuo Shimada, Mami Kanamoto, Jun Hanaoka, Yusuke

Arakawa, Hirofumi Kanemura, Yuji Morine, Satoru Imura, Hideaki Uchiyama,

Nobuhiro Kurita, Toru Utsunomiya and Hidenori Miyake; Tokushima, Japan

Lung

P-492 ASPIRATION SECONDARY TO GASTRO-OESOPHAGEAL REFLUX BUT

NOT DUODENAL REFLUX OCCURS IN THE IMMEDIATE POST LUNG

TRANSPLANTATION PERIOD

Andrew G.N. Robertson, Chris Ward, Jeff P. Pearson, Albert J. Bredenoord,

Andrew J. Fisher, James Lordan, Paul A. Corris, John H. Dark and S. Michael

Griffi n; Newcastle Upon Tyne, United Kingdom and Nieuwegein, The

Netherlands

P-493 KIDNEY FUNCTION DURING AND AFTER LUNG TRANSPLANTATION

SHOULD BE MONITORED BY CYSTATIN C RATHER THAN CREATININE

BASED GFR

Slawomir Zeglen, Jacek Wojarski, Elzbieta Wozniak-Grygiel, Marta Szewczyk,

Rafal Buldak, Piotr Rozentryt, Ewa Kucewicz-Czech and Marian Zembala;

Zabrze, Poland

P-494 AGGRESSIVE SKIN CANCERS ASSOCIATED WITH PROLONGED

VORICONAZOLE THERAPY IN 4 LUNG TRANSPLANT PATIENTS

Sébastien Quétant, Christel Saint-Raymond, Amélie Hugon, Pierrick

Bedouch, Olivier Epaulard, Christophe Pison and Marie-Thérèse Leccia;

Grenoble, France

P-495 VALGANCICLOVIR (VGCV) PROPHYLAXIS FOR CMV INFECTION IN

CARDIAC AND LUNG TRANSPLANT PATIENTS

Patrick Chevalier, Sandrine Lefeuvre, Rokkia Zekkour, Catherine Amrein,

Veronique Boussaud, Laurent Havard, Charlotte Charpentier, Romain

Guillemain and Eliane M. Billaud; Paris, France


P-496 LEFLUNOMIDE (A77-1726) AS IMMUNOSUPPRESSIVE(IS) ALTERNATIVE

IN THORACIC TRANSPLANTATION

Romain Guillemain, Sandrine Lefeuvre, Ismail Faiz, Patrick Chevalier, Maud

Berge, Veronique Boussaud, Catherine Amrein, Christine Le Beller and Eliane

M. Billaud; Paris, France

P-497 HOW TO INVESTIGATE THE IMPACT OF DONOR BRAIN DEATH

FOR LUNG TRANSPLANTATION? A SYSTEMATIC REVIEW OF

EXPERIMENTAL ANIMAL MODELS

Shana Wauters, Caroline Meers, Geert Verleden, Toni Lerut and Dirk Van

Raemdonck; Leuven, Belgium

P-498 OSTEOPOROSIS AND VERTEBRAL FRACTURES ARE A MAJOR

PROBLEM IN CYSTIC FIBROSIS PATIENTS AFTER LUNG

TRANSPLANTATION

Barbara Zweytick, Bahil Ghanim, Lila Hatosch, Peter Jaksch, Janina Patsch,

Franz Kainberger and Walter Klepetko; Vienna, Austria

P-499 CONSENSUS PHARMACOLOGICAL PROTOCOL IN LUNG

TRANSPLANTATION

Catarina Coelho, Maria José Guimarães, Emília Sola, Manuel J. Antunes and

Odete Isabel; Coimbra, Portugal

P-500 COMBINED LUNG LIVER TRANSPLANTATION IN CYSTIC FIBROSIS:

THE FRENCH EXPERIENCE

Redha Souilamas, Veronique Boussaud, Catherine Amrein, Patrick Chevalier,

Romain Guillemain, Olivier Scatton, Yvan Calmus, Philippe Sogni, Reem

Kanaan, Daniel Dusser and Olivier Soubrane; Paris, France

P-501 RENAL FUNCTION DECLINE BEYOND ONE MONTH AFTER LUNG

TRANSPLANTATION DEPENDS ON CNI TYPE

M.E. Hellemons, S.J.L. Bakker, E.A.M. Verschuuren, M.E. Erasmus, G.J. Navis

and W. v.d. Bij; Groningen, The Netherlands

P-502 LUNG EMBOLISM IN LONG TERM FOLLOW UP AFTER

THORACIC ORGAN TRANSPLANTATION – AN UNDERESTIMATED

COMPLICATION

Tim Sandhaus, Constanze Strüning, Torsten Bossert, Christina Malessa, Kosro

Hekmat, Martin Breuer and Artur Lichtenberg; Jena, Germany

P-503 IS THERE AN ASSOCIATION BETWEEN CYCLOSPORINE

CONCENTRATION AT 2 HOURS POST-DOSE AND CLINICAL

OUTCOMES IN DE NOVO LUNG TRANSPLANT RECIPIENTS?

N. Mazier, J. Jamart, P. Bulpa, L. Delaunois, Ph Eucher and P. Evrard; Yvoir,

Belgium

P-504 SIDE EFFECTS OF A CALCINEURIN-EVEROLIMUS BASED

IMMUNOSUPPRESSIVE REGIME IN LUNG TRANSPLANTED

RECIPIENTS

Barbara Zweytick, Bahil Ghanim, Max Winter, Peter Jaksch and Walter

Klepteko; Vienna, Austria

Xenotransplantation

P-505 PERITONEAL IMPLANTATION OF CRYOPRESERVED ENCAPSULATED

PORCINE HEPATOCYTES IN RATS WITHOUT IMMUNOSUPPRESSION:

VIABILITY AND FUNCTION

Raffaele Cursio, Edoardo Baldini, Georges DeSousa, Andrea Margara, Jiri

Honiger, Marie-Christine Saint-Paul, Pascal Bayer, Vincent Raimondi, Roger

Rahmani, Jean Mouiel and Jean Gugenheim; Nice, France; Antibes, France

and Paris, France

168


169

POSTERS

P-506 CREATION OF A PREVASCULARIZED SITE FOR PANCREATIC ISLET

CELL TRANSPLANTATION USING A V.A.C.®- GRANUFOAMTM AND

HYPERBARIC OXYGENATION IN RATS

Philipp Stiegler, Martin Schweiger, Vanessa Stadlbauer, Eve Pierer, Veronika

Matzi, Silvia Schaffellner, Heiko Renner, Alfred Maier, Joachim Greilberger,

Carolin Lackner, Freyja-Maria Smolle-Jüttner, Florian Iberer and Karlheinz

Tscheliessnigg; Graz, Austria

P-507 XENOTRANSPLANTATION OF MICROENCAPSULATED PORCINE

ISLET CELLS IN DIABETIC RATS

Philipp Stiegler, Vanessa Stadlbauer, Silvia Schaffellner, Florian Hackl, Carolin

Lackner, Florian Iberer and Karlheinz Tscheliessnigg; Graz, Austria

P-508 DEVELOPMENT OF REGENERATED CHIMERIC LIVER GRAFTS AND

LONG-TERM EVALUATION OF THEIR POTENTIAL AFTER AUXILIARY

TRANSPLANTATION IN MOUSE AND RAT COMBINATION

Toshiyuki Hata, Junji Iwasaki, Eiji Kobayashi and Shinji Uemoto; Kyoto, Japan

and Shimotsuke, Tochigi, Japan

P-509 MICROARRAY ANALYSIS OF CHANGES IN PORCINE ORTHOTOPIC

CARDIAC GENE EXPRESSION

Guerard W. Byrne, Zeji Du, John S. Logan and Christopher G.A. McGregor;

Rochester, MN, United States

POSTER SESSION 2

P510 > P1035 & LBP1 > LBP67

FROM TUESDAY, SEPTEMBER 1 TO WEDNESDAY, SEPTEMBER 2

Ethics, law, psychosocial & public policy

P-510 EDUCATION AND ORGAN SHORTAGE, A PROMISING CHALLENGE

Félix Cantarovich; Buenos Aires, Argentina and Paris, France

P-511 NON-ADHERENCE TO IMMUNOSUPPRESSIVE MEDICATION IN

RENAL TRANSPLANT RECIPIENTS WITHIN THE SCOPE OF THE

INTEGRATIVE MODEL OF BEHAVIOURAL PREDICTION: A CROSS-

SECTIONAL STUDY

Gabriela Schmid-Mohler, Martina Pechula Thut, Rudolf Peter Wüthrich, Kris

Denhaerynck and Sabina De Geest; Zurich, Zurich, Switzerland and Basel,

Basel Stadt, Switzerland

P-512 OBSERVATIONAL STUDY ON COMPLIANCE AFTER RENAL

TRANSPLANTATION IN PATIENTS WITH ACCESS TO OTIS SOFTWARE

(ORGAN TRANSPLANT INFORMATION SYSTEM): INTERIM RESULTS

AT 3 MONTHS

Lionel Couzi, Marie Pierre Morin, Elisabeth Cassuto, David Misdrahi, Bruno

Moulin, Stéphane Barbier, Eric Alamartine, Benoit Barrou, Emmanuel

Morelon, Gilles Sinasse-Raymond, Laurence Mendes and Pierre Merville;

Bordeaux, France; Rennes, France; Nice, France; Strasbourg, France; Rouen,

France; Saint-Etienne, France; Paris, France and Lyon, France

P-513 PSYCHOLOGICAL FACTORS ASSOCIATED WITH NON-COMPLIANCE

AFTER KIDNEY TRANSPLANTATION IN DIFFERENT AGE GROUPS OF

PATIENTS

Lucia Prihodova, Jaroslav Rosenberger, Jitse P. van Dijk, Iveta Nagyova,

Robert Roland and Johann W. Groothoff; Kosice, Slovakia (Slovak Republic)

and Groningen, The Netherlands


P-514 QUALITY OF LIFE (QOL) AFTER LIVER TRANSPLANTATION IN HIV+

SUBJECTS

Chiara Comuzzi, Angela Londero, Francesco Bragantini, Gian Luigi Adani,

Dario Lorenzin, Isabella Garlatti, Umberto Baccarani and Marcello Tavio;

Udine, Italy

P-515 SELF-RATED HEALTH OF PATIENTS AFTER TRANSPLANTATION IS

DEPENDENT ON A CHANGE IN GLOMERULAR FUNCTION

Maria Majernikova, Jaroslav Rosenberger, Lucia Prihodova, Iveta Nagyova,

Robert Roland, Jitse P. van Dijk and Johan W. Groothoff; Kosice, Slovakia

(Slovak Republic) and Groningen, The Netherlands

P-516 “OUT-OF-THE-NORM” EXPERIENCES OF TRANSPLANTED

PERSONS IN THE INTENSIVE CARE UNIT: PATHOLOGICAL OR NORMAL

REACTIONS?

Chantal Piot-Ziegler; Lausanne, Vaud, Switzerland

P-517 THE ETHICAL EQUIPOISE IN LIVING AND DECEASED DONOR LIVER

TRANSPLANTATION: TOWARDS DECISION PROCESSES BASED ON

MATHEMATICAL MODELS

Alessandro Vitale, Michael Volk, Enrico Gringeri, Francesco D’Amico, Michele

Valmasoni, Patrizia Burra, Paolo Angeli and Umberto Cillo; Padua, Italy and

Ann Arbor, MI, United States

P-518 ANXIETIES AND DOUBTS ABOUT LIVING KIDNEY DONATION FROM

THE RECIPIENT’S VIEWPOINT

Uwe Wutzler, Margit Venner, Kathrin Therolf-Henke, Undine Ott, Thomas

Villmann, Thomas Steiner, Heide Sperschneider and Antje Gumz; Stadtroda,

Germany; Jena, Germany; Leipzig, Germany and Mittweida, Germany

P-519 CORRELATES OF WILLINGNESS TO PAY FOR A KIDNEY

TRANSPLANT

Nick Kontodimopoulos, Dimitris Niakas, Georgios Skoutelis and John N.

Boletis; Patras, Greece and Athens, Greece

P-520 DEVELOPMENT OF THE ESSEN COMPLIANCE SCORE – MEASUREMENT

OF ADHERENCE IN KIDNEY TRANSPLANT PATIENTS

Tobias R. Türk, Gabriele H. Franke, Leif Haferkamp, Melanie Jagla, Jens

Reimer, Andreas Kribben and Oliver Witzke; Essen, Germany; Stendal,

Germany and Hamburg, Germany

P-521 WITHDRAW

P-522 CHARACTERISTICS OF THE REGIONAL TRANSPLANT COORDINATOR

IN POLAND

Anna Milecka, Aleksandra W. Woderska, Iwona Skóra, Alicja Debska-Slizien,

Zbigniew Sledzinski and Boleslaw Rutkowski; Gdansk, Poland and Bydgoszcz,

Poland

P-523 WITHDRAW

P-524 WITHDRAW

P-525 DONOR’S AND ORGAN REPRESENTATIONS IN LIVER, KIDNEY, HEART

AND LUNG TRANSPLANTATION: A QUALITATIVE LONGITUDINAL

STUDY

Francesca Bosisio, Christine Bridy, Laetitia Pralong, Jennifer Szymanski,

Manuel Pascual and Chantal Piot-Ziegler; Lausanne, Vaud, Switzerland

170


171

POSTERS

P-526 ETHICAL CONCERNS SURROUNDING LIVING DONOR LIVER

TRANSPLANTATION IN EGYPT

Hesham M. Abdeldayem, Naglaa A. Allam, Essam M. Salah, Amr M. Aziz,

Samy Kashkoush, Nermin Adawy, Hisham Gad and Amr Helmy; Shibin El

Kom, Menoufeyia, Egypt

P-527 DONORS/RECIPIENTS REPRESENTATIONS ABOUT LIVING-KIDNEY

DONATION

Laetitia Pralong, Manuel Pascual, Marie Santiago, Jean-Pierre Venetz and

Chantal Piot-Ziegler; Lausanne, Vaud, Switzerland

P-528 FUTURE VISION FOR THE TRANSPLANTS: QUALITY OF

CONTEMPORANY LIFE

Marli Elisa Nascimento Fernandes, Nilza Hilario, Nelson Adami Andreollo,

Ilka de Fátima Santana Boin, Helder Zambelli and Eliete Bachega; Campinas,

SP, Brazil

P-529 ANTHROPOLOGY OF THE DONATION: ALTRUISTIC EGOISM AND

SUSPENSION OF THE EXCHANGE

Filippo Buscemi, Giovanni Correnti, Francesca Paola Puleo and Salvino

Leone; Palermo, PA, Italy and Palermo, Italy

P-530 TRANSPLANT TOURISM FROM THE UK. WHAT IS THE OUTCOME

Nishani Jayasooriya, Chandni Ondhia, Heather Lumgair, Trevor Gaunt,

Raj Thuraisingham, Carmelo Puliatti, Nicos Kessaris, Nizam Mamode and

Roberto Cacciola; London, United Kingdom

P-531 INTRODUCTION OF DONOR ACTION PROGRAM IN JAPAN. AN

ANALYSIS OF SURVEY RESULTS USING MRR AND HAS DATA

Kanako Seto, Kunichika Matsumoto, Mika Kigawa, Naoshi Shinozaki, Shinichi

Oshima and Tomonori Hasegawa; Ota-ku, Tokyo, Japan; Ichikawa-shi, Chiba,

Japan and Obu-shi, Aichi, Japan

P-532 ORGAN TRANSPLANTATION AND KNOWLEDGE TRANSLATION:

ETHICAL ISSUES

Carlo Petrini; Rome, Italy

P-533 ETHICAL CHALLENGES AND DEBATES OF THE ROMANIAN LAW OF

TRANSPLANTATION

Mihaela-Cornelia Frunza, Sandu Frunza and Iulia Grad; Cluj-Napoca, Cluj,

Romania

P-534 EVALUATION OF THE 3 YEAR POST TRANSPLANT RESULTS OF

THORACIC TEAMS IN FRANCE (2000-2004)

Christelle Cantrelle, François Xavier Lamy, Emilie Savoye, Fabienne Pessione,

Sabrina Di Costanzo, Marie Thuong, Transplant Teams and Bernard Loty;

Saint Denis La Plaine, France

P-535 INCREASED DEATH FROM CARDIOVASCULAR AND INFECTIOUS

CAUSES IN FAR LIVING RENAL TRANSPLANT (RTX) PATIENTS

Amin R. Soliman, Usama A. Sharafeldin, Amin Soliman, Amin Soliman and

Amin Soliman; Cairo, Egypt

P-536 EVALUATION OF ACCESSIBILITY AND USE OF WEB BASED

INFORMATION TECHNOLOGIES IN PATIENTS ON THE WAITING LIST

FOR RENAL TRANSPLANTATION

Susanne H. Hoischen, Petra Vollmer, Jan Goßmann, Helmut Geiger and

Ernst-Heinrich Scheuermann; Neckargemünd, Germany and Frankfurt am

Main, Germany

P-537 ASSESSMENT OF ANXIETY AND/OR DEPRESSION DISORDERS IN A

HOSPITAL WARD FOR TRANSPLANT PATIENTS

Daniel Merino, Cecilia Buljevich, Luciana Merkt, Cecilia Tordó and Ruben

Schiavelli; Buenos Aires, Capital Federal, Argentina


P-538 LIVE DONOR KIDNEY TRANSPLANTATION (LDKT): ATITUDES OF

HEALTHCARE PROFESSIONALS AND PATIENTS TOWARDS ELDERLY

AND MARGINAL DONORS

Evangelos M. Mazaris, Anthony W. Warrens, Glenn Smith, Paris Tekkis and

Vassilios E. Papalois; London, United Kingdom

P-539 WITHDRAW

P-540 LIVE DONOR KIDNEY TRANSPLANTATION (LDKT): ATTITUDES

TOWARDS THE PATHWAY TO SURGERY AND POST-OPERATIVE

FOLLOW-UP

Evangelos M. Mazaris, Anthony W. Warrens, Glenn Smith, Paris Tekkis and

Vassilios E. Papalois; London, United Kingdom

P-541 SOCIAL ASPECTS IN KIDNEY TRANSPLANT RECIPIENTS WHO WENT

THROUGH TRANSITION FROM PEDIATRIC TO ADULT MEDICAL

CARE

Graciela V. Gambina, Rubén Schiavelli, Merino O. Daniel, Fernanda Avella,

Geraldine Gahan, Estebán Alvarenga and Carlos Cuevas; Ciudad Autónoma

de Buenos Aires, Argentina

P-542 COMPARISON OF MEDICAL ECONOMICS ASPECT BETWEEN

CADAVER RENAL TRANSPLANTATION AND DIALYSIS IN JAPAN

Masae Ikeda, Kazunari Yoshida, Yasuo Takeuchi, Kyoko Yaguchi, Haruki

Wakai, Tadao Endo, Fumino Noguchi, Toru Hyodo, Fimiya Obata and Shiro

Baba; Sagamihara, Kanagawa, Japan; Sagamihra, Kanagawa, Japan and

Msashimurayama, Tokyo, Japan

P-543 ETHICAL LAW AND PROCUREMENT IN FRANCE: EVALUATION AND

COMMENT

Béatrice Bodet; Lyon, France, Metropolitan

P-544 SHIRAZ TRANSPLANT CENTER IS SURPASSING THE LIVING

UNRELATED DONORS

Ali Bahador, Saman Nikeghbalian, Heshmatollah Salahi, Mehdi Slehipour,

Ghanbarali RaeisJalali, Jamshid Roozbeh, Kourosh Kazemi, Farzad Kakaei

and Seyed Ali Malek-hosseini; Shiraz, Islamic Republic of Iran

P-545 RELATIONSHIP BETWEEN SOCIAL AND PSYCHOLOGICAL DIAGNOSES

IN ASSESSMENTS FOR INTRATHORACIC TRANSPLANTATION

Liliana Martinez, Silvia Moscoloni, Juan M. Osses, Mirta Diez, Alejandro M.

Bertolotti and Roberto R. Favaloro; Buenos Aires, Argentina

P-546 EULID PROJECT. EUROPEAN LIVING DONATION AND PUBLIC

HEALTH

Martí Manyalich, Assumpta Ricart, David Paredes, Chloë Balleste, Irene

Martínez, Danica Avsec, Carlo De Cillia, Leonidio Dias, Ingela Fehrman-

Eckholm, Frank Van Gelder, Christian Hiesse, George Kyriakides, Pål-Dag

Line, Andy Maxwell, Alessandro Nanni Costa, Rosana Turcu and Janusz

Walaszewski; Barcelona, Spain; Liubliana, Slovenia; Rome, Italy; Porto,

Portugal; Göteborg, Sweden; Paris, France; Nicosia, Cyprus; Oslo, Norway;

Bristol, United Kingdom; Rome, Italy; Bucharest, Romania and Warsaw,

Poland

P-547 EXPERIENCE OF DONATION AND QUALITY OF LIFE IN RELATED

AND UNRELATED LIVING DONORS

Alessandra Feltrin, Sara Pasquato, Veronica Buizza, Marilena Moretti, Paola

Frasson, Renzo Pegoraro, Claudio Rago, Paolo Benciolini, Mario Ermani and

Giampietro Rupolo; Padua, Italy

P-548 HUNGARIAN LEGAL ACTIONS ON ORGAN DONATION AND

TRANSPLANTATION CONSIDERING OF EUROPEAN UNION

RESOLUTION

Andrea Ferencz and Szilard Bankuti; Pecs, Baranya, Hungary

P-549 DETERMINING BRAIN DEATH: ARE THEORY AND PRACTICE IN

HARMONY?

Michael Bos; The Hague, The Netherlands

172


173

POSTERS

P-550 ADVERSE OUTCOMES IN RECIPIENTS AND DONORS INVOLVED IN

COMMERCIAL KIDNEY TRANSPLANTS

Michael Bos; The Hague, The Netherlands

P-551 PIERDUB PROJECT: INTERNACIONAL PROJECT ON EDUCATION

AND RESEARCH IN DONATION AT UNIVERSITY OF BARCELONA:

TRAINING UNIVERSITY STUDENTS ABOUT DONATION AND

TRANSPLANTATION

Marti Manyalich, David Paredes and Chloe Balleste; Barcelona, Spain

Clinical immunosuppression II

P-552 UNITED STATESBILITY OF THE HELPING HANDTM: A NEW ELECTRONIC

MONITORING TOOL TO ASSESS MEDICATION NON-ADHERENCE

Leentje De Bleser, Birgit Vincke, Fabienne Dobbels, Mary Beth Happ, Bart

Maes and Sabina De Geest; Leuven, Belgium; Pittsburgh, PA, United States;

Roeselare, Belgium and Basel, Switzerland

P-553 COMPUTER ASSISTED CYCLOSPORINE DOSING IN RENAL

TRANSPLANT RECIPIENTS

Anders Åsberg, Liv H. Undset, Pål Falck, Christina Dørje, Hallvard Holdaas,

Anders Hartmann and Karsten Midtvedt; Oslo, Norway

P-554 RITUXIMAB USE FOR DESENSITIZATION OF IMMUNOLOGICALLY

HIGH-RISKY RENAL TRANSPLANTATION WITHOUT SPLENECTOMY

Masashi Takeda, Yoji Hyodo, Takeshi Ishimura, Atsushi Takenaka and Masato

Fujisawa; Kobe, Japan

P-555 EVALUATING THE EFFICACY AND SAFETY OF DACLIZUMAB,

TACROLIMUS, MYCOPHENOLATE AND CORTICOSTEROIDS

IMMUNOSUPPRESSIVE REGIMEN IN COMPARISON TO

CURRENT STANDART IMMUNOSUPPRESSION (TACROLIMUS,

MYCOPHENOLATE AND CORTICOSTEROIDS) IN RENAL

TRANSPLANTATION

Milan Kuman, Pavel Studenik, Vladimir Mejzlik, Jiri Ondrasek and Petr

Nemec; Brno, Pekarska 53, Czech Republic

P-556 ADVANTAGES OF PSI + LOW-DOSE CNI VS PSI ALONE IN DUAL

KIDNEY TRANSPLANTATION (DKT) FROM ELDERLY DONORS

Lucrezia Furian, Cristina Silvestre, Alessandro Broggiato, Nicola Baldan,

Burcin Ekser, Francesco Marchini, Luciana Bonfante, Barbara Rossi and Paolo

Rigotti; Padua, Italy

P-557 INTENSIFIED DOSE OF ENTERIC-COATED MYCOPHENOLATE

SODIUM (EC-MPS) FOR STEROIDS AVOIDANCE, IN COMBINATION

WITH CICLOSPORINE MICRO-EMULSION (CSA-ME): MULTICENTER,

RANDOMIZED, OPEN LABEL, COMPARATIVE STUDY IN DE NOVO

KIDNEY TRANSPLANTATION (DOMINOS)

Guy Touchard, Georges Mourad, Yvon Lebranchu, Lionel Rostaing, Florence

Villemain, Anne-Elisabeth Heng, Yann Le Meur, Gabriel Choukroun, Olivier

Toupance, Christophe Legendre, Patrick Le Pogamp, Michelle Kessler, Pierre

Merville, Bruno Moulin, Stéphane Quere and Kamel Chaouche-Teyara;

Poitiers, France; Montpellier, France; Tours, France; Toulouse, France;

Angers, France; Clermont Ferrand, France; Brest, France; Amiens, France;

Reims, France; Paris, France; Rennes, France; Vandoeuvre les Nancy, France;

Bordeaux, France; Strasbourg, France and Rueil Malmaison, France

P-558 STUDY PROTOCOL: A THERAPEUTIC EXPLORATORY STUDY TO

DETERMINE THE EFFICACY AND SAFETY OF CALCINEURIN-

INHIBITOR-FREE DE-NOVO IMMUNOSUPPRESSION AFTER LIVER

TRANSPLANTATION: CILT

Armin D. Goralczyk, Andreas Schnitzbauer, Hans J. Schlitt, Thomas Lorf and

Aiman Obed; Göttingen, Germany and Regensburg, Germany


P-559 CONVERSION FROM SIROLIMUS TO EVEROLIMUS IN KIDNEY

TRANSPLANT RECIPIENTS

Luís Coentrão, Catarina Carvalho, Susana Sampaio, Joana Santos, Manuela

Bustorff, Jose G. Oliveira and Manuel Pestana; Porto, Portugal

P-560 DOSE CONTROL STRATEGY OF MMF EMPLOYING MPA-TDM IN

RENAL TRANSPLANTATION

Kazunari Yoshida, Akihiro Kobayashi, Keita Umemoto, Takahiro Hirayama,

Daisuke Ishii, Tatsuya Chikaraishi, Hideo Sasaki, Kazuo Yago, Tadao Endo

and Shiro Baba; Sagamihara, Kanagawa, Japan and Kawasaki, Kanagawa,

Japan

P-561 THE NUMBER OF HLA MISMATCHES BETWEEN DONOR AND RENAL

ALLOGRAFT RECIPIENTS CAN AFFECT THE EXPRESSION OF CD11B

AND CD57 WITHIN CD8+CD28- POPULATION

Anna Korecka-Polak, Anna Duszota, Piotr Wierzbicki, Danuta Klosowska,

Mariusz Niemczyk, Janusz Wyzgal and Grazyna Korczak-Kowalska; Warsaw,

Poland

P-562 EFFECTS OF MYCOPHENOLIC ACID, CYCLOSPORINE A AND

EVEROLIMUS ON CELLULAR AND HUMORAL RESPONSES AFTER

VACCINATION

Geertrude H. Struijk, Robert C. Minnee, Sven D. Koch, Ineke J.M. ten Berge

and Frederike J. Bemelman; Amsterdam, The Netherlands

P-563 PREVENTION OF CYTOMEGALOVIRUS INFECTION BY

VALGANCICLOVIR IN SOLID ORGAN TRANSPLANT RECIPIENTS:

INTERIM RESULTS FROM THE ORVAL OBSERVATIONAL STUDY

C. Legendre, R. Guillemain, A. Fourrier-Réglat, L. Nguyen, N. Tagieva and F.

Saliba; Paris, France; Bordeaux, France; Neuilly, France and Villejuif, France

P-564 BENIGN SKIN LESIONS AFTER RENAL TRANSPLANTATION

Aleksandra Okuniewska, Beata Imko-Walczuk, Agata Predota, Janusz

Jaskiewicz, Waldemar Placek, Boleslaw Rutkowski, Alicja Debska-Slizien,

Maria Czubek and Zbigniew Wlodarczyk; Gdansk, Poland and Bydgoszcz,

Poland

P-565 TACROLIMUS DOSING IN THE EARLY POST-TRANSPLANT PERIOD:

THE OXFORD EXPERIENCE

Niten Vig, Aron Chakera and Edward Sharples; Oxford, United Kingdom

P-566 DO WOUND COMPLICATIONS OR LYMPHOCELES OCCUR MORE

OFTEN IN PATIENTS RECEIVING MTOR INHIBITORS? A SYSTEMATIC

REVIEW

Liset H.M. Pengel and Peter J. Morris; London, United Kingdom

P-567 MYCOPHENOLATE ACID MAY REDUCE DONOR SPECIFIC HLA

ANTIBODY STRENGTH IN KIDNEY TRANSPLANT RECIPIENTS

Lorita M. Rebellato, Sousan Zadeh, Mikki Ozawa, Karen R. Parker, Kimberly P.

Briley, Paul Catrou, Paul Bolin, Carl E. Haisch and Paul I. Terasaki; Greenville,

NC, United States and Los Angeles, CA, United States

P-568 THE EFFECTS OF BISHOSPHONATES TO PREVENT GIOP IN

KIDNEY TRANSPLANTATION RECIPIENTS. THE TENTATIVE REPORT OF

SINGLE-BLIND RANDOMIZED PROSPECTIVE CLINICAL STUDY

Nobuyuki Nakamura, Satoru Ogahara, Hiroshi Mikami, Takumi Matsubara,

Kazuna Higuchi, Ryuzaburou Furuya, Shigerou Miyajima, Tomotarou Adachi,

Shinichirou Irie, Hirofumi Matsuoka, Yoshie Sasatomi, Toshiaki Murata, Takao

Saitou and Masatoshi Tanaka; Fukuoka, Fukuoka, Japan

P-569 SWITCHING LONGTERM RENAL TRANSPLANT RECIPIENTS TO

MTOR-BASED IMMUNOSUPPRESSION MAY REDUCE DE NOVO SKIN

CANCER INCIDENCE

M. Tufail Hanel, P. Itin, J. Steiger and A. Bock; Aarau, Switzerland and Basel,

Switzerland

174


175

POSTERS

P-570 CNI-FREE DE NOVO “BOTTOM-UP, ON DEMAND”-

IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS WITH

PREEXISTING RENAL IMPAIRMENT: AN INITIAL EXPERIENCE

Andreas A. Schnitzbauer, Axel Doenecke, Johannes Sothmann, Martin

Loss, Stefan A. Farkas, Carl Zuelke, Marcus N. Scherer and Hans J. Schlitt;

Regensburg, Bavaria, Germany

P-571 OPTIMAL MPA, MPAG LEVELS AT THE EARLY PERIOD AFTER KIDNEY

TRANSPLANTATION AS THE KEY CONTRIBUTORS TO IMPROVING

LONG-TERM OUTCOMES

Teresa Baczkowska, Anna Sadowska, Jadwiga Majchrzak, Agnieszka

Perkowska-Ptasinska, Zbigniew Lewandowski, Joanna Pazik, Andrzej Chmura,

Zbigniew Galazka, Tomasz Pawinski and Magdalena Durlik; Warsaw, Poland

P-572 IMPACT OF EVEROLIMUS MONOTHERAPY VERSUS CYCLOSPORINE

AFTER LIVER TRANSPLANTATION IN HCV PATIENTS: RESULTS OF A

PROSPECTIVE, RANDOMIZED TRIAL

Gianluca Rompianesi, Roberto Montalti, Nicola Cautero, Michele Masetti,

Fabrizio Di Benedetto, Nazareno Smerieri, Gian Piero Guerrini, Nicola De

Ruvo, Monica Di Furia, Silvia Zivieri and Giorgio E. Gerunda; Modena, Italy

P-573 LONG TERM RESULTS IN A COHORT OF LOW RISK RENAL

TRANSPLANT RECIPIENTS INDUCED WITH BASILIXIMAB

Jorge Morales, Alberto Fierro, Carlos Zehnder, Mariana Elberg, Sylvia

Araneda, Cristina Herzog, Lorena Calabran, Carmen Cao and Erwin Buckel;

Santiago, Chile

P-574 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY IN A KIDNEY

TRANSPLANT RECIPIENT – CASE REPORT

Magdalena Pempkowiak, Alicja Debska-Slizien and Boleslaw Rutkowski;

Gdansk, Poland

P-575 META-ANALYSIS OF THE SAFETY AND EFFICACY OF CALCINEURIN

INHIBITORS FOR DE-NOVO IMMUNOSUPPRESSION AFTER LIVER

TRANSPLANTATION

Armin D. Goralczyk, Thomas Lorf and Aiman Obed; Göttingen, Germany

P-576 IMPACT OF FOXP3+CD4+CD25+T CELLS IN THE RECIPIENTS

ACQUIRING ALMOST TOLERANCE AFTER LIVING DONOR

LIVER TRANSPLANTATION WITH INTRA-PORTAL DONOR SPECIFIC

ANTIGEN TRANSFUSION

Yoshinobu Sato, Chikako Tomiyama, Satoshi Yamamoto, Hiroshi Oya, Takashi

Kobayashi and Katsuyoshi Hatakeyama; Niigata, Niigata, Japan

P-577 A PHASE III, RANDOMIZED, OPEN-LABEL, COMPARATIVE,

MULTI-CENTER STUDY TO ASSESS THE SAFETY AND EFFICACY OF

PROGRAF (TACROLIMUS) AND MODIFIED RELEASE TACROLIMUS

(MR4) IN DE NOVO LIVER LIVING DONOR LIVER TRANSPLANTATION

Gi-Won Song, Sung-Gyu Lee, Suk-Koo Lee, Dong-Koo Kim, Kyung-Suk Suh,

Kwan-Woo Kim and Gil-Chun Park; Seoul, Korea

P-578 AN OPTIMAL SETTING OF PLASMAPHERESIS FOR REMOVAL OF

PREEXISTING ANTIBODY BEFORE RENAL TRANSPLANTATION

Masayoshi Miura, Hiroshi Harada, Naohiko Shimoda, Nobuyuki Fukuzawa,

Tatsu Tanabe, Kiyohiko Hotta, Daiki Iwami and Katsuya Nonomura; Sapporo,

Japan

P-579 HCV AND LIVER TRANSPLANTATION: THE ROLE OF MINIMAL

IMMUNOSUPRESSION ON PATIENT, GRAFT AND HISTOLOGICAL

OUTCOME

Eliano Bonaccorsi-Riani, Christophe Bourdeaux, Nicolas Piette, Benoit

Kabamba, Olga Ciccarelli, Francine Roggen, Chantal De Reyck, Jacques

Rahier, Jeremie Gras, Christine Sempoux, Pierre Walemacq, Pierre-François

Laterre, Ziad Hassoun and Jan Lerut; Brussels, Belgium


P-580 EARLY RESULTS FROM A TRIAL COMPARING SIROLIMUS WITH

TACROLIMUS AS PRIMARY IMMUNOSUPPRESSION FOR RECIPIENTS

OF NON HEART BEATING DONOR (NHBD) KIDNEYS AFTER ANTI-IL2

MONOCLONAL ANTIBODY

Hugh Wyrley-Birch, Aditya Kanwar, Dhakshinamoorthy Vijayanand, Chris Ray,

John Moir, Alex Navarro, Soroush Sohrabi, Mettu Reddy, John Asher, Colin

Wilson, Ajay Gupta, Naeem Soomro, David Rix, Bryon Jaques, Steven White,

Jeremy French, Derek Manas, Nicholas Torpey and David Talbot; Newcastle

Upon Tyne, Tyne and Wear, United Kingdom

P-581 DACLIZUMAB VERSUS ANTI-THYMOCYTE GLOBULIN-FRESENIUS

(ATG-F) AS INDUCTION THERAPY IN LOW RISK KIDNEY TRANSPLANT

PATIENTS

Maroun M. Abou-Jaoude, Walid J. Abou-Jaoude, Naji F. Nawfal, Robert

Najm and Joseph A. Shaheen; Beirut, Lebanon

P-582 THE IMPACT OF EVEROLIMUS ON RENAL FUNCTION IN

MAINTENANCE LIVER TRANSPLANTATION

Paolo De Simone, Arianna Precisi, Stefania Petruccelli, Gabriele Catalano,

Paola Carrai, Marco Lorusso, Jessica Fruzzetti, Alice Alvares and Franco

Filipponi; Pisa, Italy

P-583 LOW DOSE CYCLOSPORINE AND SIROLIMUS REGIMEN IN RENAL

TRANSPLANT PATIENTS – SINGLE CENTER EXPERIENCE

Mihai M. Lucan, Alina Partiu, Adriana Muntean, Ciprian V. Lucan, Florin Elec,

Gheorghita Iacob and Adrian Barbos; Cluj-Napoca, Cluj, Romania

P-584 SINGLE PRETRANSPLANT PEAK LEVEL OF TACROLIMUS PREDICTS

POST TRANSPLANT TACROLIMUS DOSE IN RENAL TRANSPLANTAT

PATIENTS

Ashish Sharma, Mukut Minz, Sarabpreet Singh and V. Shetty; Chandigarh,

India and Bangalore, Karnataka, India

P-585 MEASURING ADHERENCE IN ADULT LIVER TRANSPLANT PATIENTS:

RESULT OF THE EAST STUDY

Paolo De Simone, Juri Ducci, Gabriela Schmid-Moehler, Lidiana Baldoni,

Paola Carrai, Stefania Petruccelli, Fabienne Dobbels and Sabina De Geest;

Pisa, Italy; Basel, Switzerland and Leuven, Belgium

P-586 SYMPTOMS PREVALENCE AND BELIEFS IN MAINTENANCE LIVER

TRANSPLANT PATIENTS

Paolo De Simone, Juri Ducci, Gabriela Schmid-Moehler, Lidiana Baldoni,

Paola Carrai, Stefania Petruccelli, Fabienne Dobbels, Sabina De Geest and

Franco Filipponi; Pisa, Italy; Basel, Switzerland and Leuven, Belgium

P-587 MINIMIZATION OF IMMUNOSUPPRESSION IN PRIMARY ADULT

LIVER TRANSPLANTATION WITH STEROID-FREE REGIMEN USING

LOW DOSE OF TACROLIMUS WITH MYCOPHENOLATE MOFETIL

AFTER DACLIZUMAB INDUCTION

Olivier Boillot, Gabriella Pittau, Jerome Dumortier, Thomas Gelas, Olivier

Guillaud, Yves Bouffard and Catherine Boucaud; Lyon, France

P-588 THE IMPACT OF SIROLIMUS ON WEIGHT CHANGE IN LIVER

TRANSPLANTATION: A CLINICAL PICTURE OF A COMPLEX

INTERACTION

Greg J. McKenna, James Trotter, Edmund Q. Sanchez, Srinath Chinnakotla,

Henry B. Randall, Richard Ruiz, Nicholas Onaca, Robert M. Goldstein, Marlon

F. Levy and Goran B. Klintmalm; Dallas, TX, United States

P-589 A PROSPECTIVE CLINICAL TRIAL COMPARING TACROLIMUS-MMF

TO CYCLOSPORINE-EVEROLIMUS IN DE NOVO RENAL TRANSPLANT

RECIPIENTS: 2 YEARS RESULTS

Evaldo Favi, Franco Citterio, Gionata Spagnoletti, Antonio Gargiulo, Jacopo

Romagnoli and Marco Castagneto; Rome, Italy

176


177

POSTERS

P-590 CLINICAL OUTCOME IN TWO GROUPS OF KIDNEY RECIPIENTS

TREATED WITH DIFFERENT CYCLOSPORINE FORMULATIONS

Michal Ciszek, Mariusz Niemczyk, Leszek Paczek, Andrzej Chmura and Jacek

Szmidt; Warsaw, Poland

P-591 A NOVEL RISK ASSESSMENT TOOL FOR REJECTION AND

INFECTION TO INDIVIDUALLY TAILOR IMMUNOSUPPRESSION IN

RENAL TRANSPLANTATION

Thomas Fehr, Henrik Ekberg, Teun van Gelder, Corrado Bernasconi, Claude

Cao and Marc Schiesser; Zurich, Switzerland; Malmö, Sweden; Rotterdam,

The Netherlands; Vacallo, Switzerland and Reinach, Switzerland

P-592 INITIAL EXPERIENCE WITH ADVAGRAF IN RENAL

TRANSPLANTATION

Irum Amin, Bridget Featherstone, Leona Edge and Chris Watson; Cambridge,

United Kingdom

P-593 PHARMACODYNAMIC MONITORING IN KIDNEY ALLOGRAFT

RECIPIENTS WITH AND WITHOUT CALCINEURIN INHIBITORS

Teresa Baczkowska, Piotr Wierzbicki, Agnieszka Perkowska-Ptasinska,

Danuta Klosowska, Maria Nowaczyk, Grazyna Korczak Kowalska, Zbigniew

Lewandowski, Joanna Pazik, Ewa Wazna, Tomasz Cieciura and Magdalena

Durlik; Warsaw, Poland

P-594 PERFORATED SIGMOID DIVERTICULITIS AFTER ORGAN

TRANSPLANTATION IS A RARE, BUT LIFE-THREATENING EVENT

Alexander Perathoner, Manuel Maglione, Christian Margreiter, Walter Mark

and Raimund Margreiter; Innsbruck, Austria

P-595 PHA STIMULATION OF PERIPHERAL BLOOD MONONUCLEAR

CELLS FROM KIDNEY TRANSPLANT RECIPIENTS PRODUCES LESS

ATP THAN FROM NORMAL CONTROL

Alain G. Assounga and Saleha Omarjee; Durban, KwaZulu-Natal, South

Africa

P-596 USE OF MYCOPHENOLATE MOFETIL IN LIVER TRANSPLANT

PATIENTS. ANDALUSIAN LIVER REGISTRY

Lydia Barrera-Pulido, Manuel de la Mata, David Marín, Flor Nogueras,

Miguel Ángel Goméz-Bravo, Francisca Nuñez, Miguel Jiménez and Maria

Dolores López-Garrido; Sevilla, Spain; Córdoba, Spain; Málaga, Spain and

Granada, Spain

P-597 LONG TERM FOLLOW-UP OF DE NOVO MALIGNANCIES AFTER 1300

LIVER TRANSPLANTATION: A CASE-CONTROL STUDY

Massimo Del Gaudio, Giampaolo Bianchi, Chiara Zanfi , Giorgio Ercolani,

Matteo Cescon, Matteo Ravaioli, Augusto Lauro, Marco Vivarelli, Paolo

Di Gioia, Maria Rosa Tame, Cristina Morelli, Gian Luca Grazi and Antonio

Daniele Pinna; Bologna, BO, Italy

P-598 MYCOPHENOLATE MOFETIL AND LOW DOSES OF CALCINEURIN

INHIBITORS IN PATIENTS WITH RENAL DYSFUCTION AFTER LIVER

TRANSPLANTATION. A TEN YEAR SINGLE-CENTER PROSPECTIC

STUDY

Alfonso W. Avolio, Raffaella Barbarino, Nicola Panocchia, Carmen Lirosi,

Lucrezia Vargiu, Francesco Frongillo, Antonio Grieco and Salvatore Agnes;

Rome, Italy

P-599 CNI AVOIDANCE AND STEROID WITHDRAWAL IN RENAL

TRANSPLANTATION. RESULTS AT THREE YEARS OF A PROSPECTIVE

MULTICENTER RANDOMIZED TRIAL COMPARING SIROLIMUS (SRL)

AND CYCLOSPORINE (CSA): THE SPIESSER STUDY

Yvon Lebranchu, Isabelle Etienne, Olivier Toupance, Pierre François Westeel,

Bruno Hurault de Ligny, Jean Philippe Rerolle, Eric Thervet, Guy Touchard,

Bruno Moulin, Florence Villemain, Patrick Le Pogamp and Patrice Deteix;

Tours, France; Rouen, France; Reims, France; Amiens, France; Caen, France;

Limoges, France; Paris, France; Poitiers, France; Strasbourg, France; Angers,

France; Rennes, France and Clermont Ferrand, France


P-600 EVOLUTION OF PROTEINURIA UNDER SIROLIMUS IN 62

MAINTENANCE KIDNEY TRANSPLANT PATIENTS A SINGLE CENTER

ANALYSIS

Michael Duerr, Petra Glander, Fritz Diekmann, Lutz Liefeldt, Hans H.

Neumayer and Budde Klemens; Berlin, Germany

P-601 DO PATIENTS KNOW WHAT DOCTORS TOLD THEM TO DO?

Petra Glander, Anke Godemann, Lutz Liefeldt, Hans H. Neumayer and

Klemens Budde; Berlin, Germany

Immunobiology & basic science

P-602 RENAL TRANSPLANTATION IN PATIENTS WITH NEGATIVE CDC

CROSSMATCHES: VALUE OF DONOR SPECIFIC ANTIBODIES

DETECTION ON FIRST GRAFT

Khaled Mahmoud, Amani Ismail, Hussein Sheashaa, Osama Gheith, Mohamed

Kamal and Mohamed Ghoneim; Mansoura, DK, Egypt

P-603 SEROEPIDEMIOLOGY OF INFECTION WITH EPSTEIN- BARR VIRUS

AMONG ASYMPTOMATIC STUDENTS ATTENDING ISLAMIC AZAD

UNIVERSITY OF KAZEROUN, SOUTHWEST OF IRAN

Daryoush Tayyebi and Marjan Rahsaz; Kazeroun, Fars, Islamic Republic of

Iran and Shiraz, Fars, Islamic Republic of Iran

P-604 (+1057) G/A POLYMORPHISM OF THE CD86 GENE IN ACUTE RENAL

ALLOGRAFT REJECTION

Henda Krichen, Imen Sfar, Saloua Jendoubi-Ayed, Mouna Makhlouf, Thouraya

Ben Rhomdhane, Rafi ka Bardi, Ezzedine Abderrahim, Houda Aouadi, Taieb

Ben Abdallah, Khaled Ayed and Gorgi Yousr; Tunis, Tunisia

P-605 FORENSIC MEDICINE METHODS ALLOW TO DETECT DONOR DNA IN

RECIPIENT BLOOD FOR YEARS AFTER KIDNEY TRANSPLANTATION

Joanna Rutkowska, Malgorzata Zagozda, Renata Ginak, Andrzej Rydzewski,

Marta Swietek, Marek Durlik and Waldemar L. Olszewski; Warsaw, Poland

and Oslo, Norway

P-606 IS DONOR DNA INCORPORATED INTO RECIPIENT LYMPHOID

CELLS?

Malgorzata Zagozda, Joanna Tyszka, Joanna Rutkowska and Waldemar L.

Olszewski; Warsaw, Poland and Oslo, Norway

P-607 NON-INVASIVE BIOMARKERS FOR ACUTE REJECTION IN RENAL

TRANSPLANTATION USING 1H-NMR SPECTROMETRY

Paul J. Goldsmith, Hayley Fenton, Elizabeth Turner, Julie Fisher, Niaz Ahmad

and K. Rajendra Prasad; Leeds, United Kingdom

P-608 POST-TRANSPLANT PROTEINURIA ASSOCIATED WITH EVEROLIMUS.

DEFINITION OF MAIN FEATURES BASED ON AN INTEGRATED

PROTEOMIC APPROACH

Elisabetta Bertoni, Giovanni Candiano, Gianmarco Ghiggeri, Rosanna

Gusmano, Aida Larti and Maurizio Salvadori; Florence, Italy and Genova,

Italy

P-609 VALIDATION OF TCR V SPECTRATYPING FOR MONITORING T-CELL

RECEPTOR COMPLEXITY

Clare F. Grant, Susan Harris, Deborah Richardson, Kim Orchard, Anthony

Williams and Elizabeth Hodges; Southampton, Hampshire, United Kingdom

P-610 A NOVEL METHOD TO ASSESS THE LEVEL OF IN VIVO

IMMUNOSUPPRESSION IN TRANSPLANT PATIENTS USING AMNIS

IMAGESTREAM TECHNOLOGY

Oleh Pankewycz, Hans Minderman, Paul Wallace, Lin Feng and Mark R.

Laftavi; Buffalo, NY, United States

178


179

POSTERS

P-611 ROLE OF THE INTEGRATED STRESS RESPONSE IN EPITHELIAL

PHENOTYPIC CHANGES INDUCED BY ISCHEMIA

Nicolas Bouvier, Philippe Beaune, Christophe Legendre, Eric Thervet, Dany

Anglicheau and Nicolas Pallet; Paris, France

P-612 HIGH EXPRESSION OF CD16 BY GAMMA DELTA T CELLS DURING

CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT

RECIPIENTS: IMPLICATION IN THEIR ANTI-VIRAL AND ANTI-TUMOR

FUNCTION

Lionel Couzi, Vincent Pitard, Xavier Sicard, Pierre Merville, Jean-Francois

Moreau and Julie Dechanet-Merville; Bordeaux, France

P-613 LIPOCALIN-2 FORMS A COMPLEX WITH MATRIX METALLO

PROTEINASE 9 AND PROTECTS IT FROM DEGRADATION DURING

ISCHEMIA AND REPERFUSION OF THE TRANSPLANTED HEART

Herbert T. Maier, Albert Muigg, Evelyn A. Wallnoefer, Hubert Schwelberger,

Stephan Sickinger, Stefan Schneeberger, Jakob Troppmair, Raimund

Margreiter and Felix Aigner; Innsbruck, Austria

P-614 TCR-INDEPENDENT EXPANSION OF FOXP3+CD4+ REGULATORY T

CELLS BY CD137 STIMULATION

Hong R. Cho, Juyang Kim, Jong S. Lee, Yang W. Nah, Chang W. Nam and

Byungsuk Kwon; Ulsan, Republic of Korea

P-615 PROCALCITONIN AND C-REACTIVE PROTEIN SERUM LEVELS

FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

Negar Azarpira, Mani Ramzi, Mahdokht H. Aghdai, Bita Geramizadeh,

Mahdokht Aghdai, Marjan Rahsaz, Zahra Malekpour, Mehrzad Banihashemy

and Tahere Heidari; Shiraz, Islamic Republic of Iran

P-616 IS THE EFFECT OF HYPERBARIC OXYGEN THERAPY ON P-SELECTIN

EXPRESSION DURING COLD ORGAN PRESERVATION TISSUE

DEPENDENT?

Dawit G. Worku, Sebastian Laluf, Jennifer McGee, Keith VanMeter and

Douglas P. Slakey; New Orleans, LA, United States

P-617 THE INTERLEUKIN-6 AND VASCULAR ENDOTHELIAL GROWTH

FACTOR IN HEMATOPOIETIC STEM CELL TRANSPLANTATION

Negar Azarpira, Mani Ramzi, Masumeh Darai, Marjan Rahsaz, Mahdokht

Aghdai, Bita Geramizadeh, Ramin Yaghubi and Maryam Ayatollahi; Shiraz,

Islamic Republic of Iran

P-618 INVARIANT NKT CELLS ARE ESSENTIAL IN LIVER SINUSOIDAL

ENDOTHELIAL CELL-INDUCED IMMUNOSUPPRESSION OF T CELLS

WITH INDIRECT ALLOSPECIFICITY

Masayuki Shishida, Takashi Onoe, Yuka Tanaka, Yuka Igarashi, Masataka

Banshodani, Toshimasa Asahara and Hideki Ohdan; Hiroshima, Japan

P-619 CALCULATED WITHDRAWAL OF LOW-DOSE IMMUNOSUPPRESSION

BASED ON A DETAILED IMMUNOLOGICAL MONITORING AFTER

KIDNEY TRANSPLANTATION BETWEEN MONOCYGOTIC TWINS

Norbert Hüser, Volker Aßfalg, Patricia Schmidbauer, Edouard Matevossian,

Manfred Stangl and Melanie Laschinger; Münster, Germany

P-620 SKEWED INTRAGRAFT TH17/REGULATORY T CELL RESPONSES

DURING REJECTION IN TRANSPLANT PATIENTS

Carla C. Baan, Annemiek A.M. Peeters, Esme Dijke, Kadir Caliskan, Aggie

H.M.M. Balk and Willem Weimar; Rotterdam, The Netherlands

P-621 MURINE STROMAL CELL LINE, AFT024 ENHANCED IN VIVO

ENGRAFTMENT POTENTIAL THROUGH EPIGENETIC MODIFICATION

Yun Shin Chung, Bong Kum Choi, Guo Hua Ding, Eun Young Kim, Mil Jae

Shin and Sung Joo Kim; Seoul, Korea

P-622 APE1/REF-1 GENE OVER-EXPRESSION IN HUMAN HCC IS ASSOCIATED

TO CANCER ETHIOLOGY

Vittorio Di Maso, Umberto Baccarani, Lory Crocè, Francesco Lupo, Claudio

Avellini, Gian Luigi Adani, Dario Lorenzin, Gianluca Tell and Claudio Tiribelli;

Trieste, Italy; Udine, Italy and Torino, Italy


P-623 DONOR PRE-TREATMENT WITH SIMVASTATIN REDUCES GRAFT

IMMUNOGENICITY FOLLOWING PROLONGED COLD ISCHEMIA IN

THE LONG-TERM

Katja Kotsch, Manije Sabet, Maja Frankuski, Anja Reutzel-Selke, Andreas

Pascher, Peter Neuhaus and Johann Pratschke; Berlin, Germany

P-624 FGF2 AND TGFB PLAY DISTINCTIVE ROLES IN MYOFIBROBLAST

DIFFERENTIATION FROM CD45+ BONE MARROW FIBROBLAST-LIKE

CELLS

Gordon D. Wu and Andrew S. Klein; Los Angeles, CA, United States

P-625 NATRIURETIC PEPTIDE B PRE-OPERATORY LEVELS IN LIVER

TRANSPLANT RECIPIENTS

Maria-Dolores Espinosa, Carmen Olmedo, Ana-Maria Comino, Karim

Muffak-Granero, Javier Martin-Cano, Maria-Angeles Lopez-Garrido, Jesus-

Mª Villar del Moral, Maria-Flor Nogueras, Daniel Garrote, Pablo Bueno and

Jose-Antonio Ferron; Granada, Spain

P-626 MICROARRAY STUDY OF GENE EXPRESSION PROFILE IN STEATOTIC

HEPATOCYTES

Carmen Olmedo, Javier Martin-Cano, Fernando Garcia-Alcalde, Ana-Maria

Comino, Krasimira Alexandrova, Karim Muffak, Lubomir Arseniev, Daniel

Garrote, Armando Blanco, Pablo Bueno and Jose-Antonio Ferrón; Granada,

Spain; Weinheim, Germany and Hannover, Germany

P-627 PLASMA INDOLEAMINE 2,3-DIOXYGENASE ACTIVITY IN RENAL

TRANSPLANT RECIPIENTS PREDICTS ACUTE REJECTION

Imad Lahdou, Mahmoud Sadeghi, Volker Daniel, Fabrice Renner, Rolf

Weimer, Jan Schmidt, Arianeb Mehrabi, Martin Schenk, Stefan Löb, Alfred

Königsrainer, Gerhard Opelz and Peter Terness; Heidelberg, Germany;

Giessen, Germany and Tuebingen, Germany

P-628 EFFECTS OF TACROLIMUS ON SYNAPTIC TRANSMISSION BETWEEN

PARALLEL FIBRES AND PYRAMIDAL CELLS IN THE DORSAL

COCHLEAR NUCLEUS OF THE RAT

Laszlo Szabo, Zoltan Rusznak, Geza Szucs, Laszlo Asztalos and Balazs Pal;

Debrecen, Hungary

P-629 EFFECT OF ENDOGENOUS AND VECTOR DELIVERED A20 ON

ENDOTHELIAL CELL ACTIVATION AND APOPTOSIS

Jing Zhao, Eleanor M. Bolton, John A. Bradley and Andrew M.L. Lever;

Cambridge, United Kingdom

P-630 INCREASED EXPRESSION OF TRANSGLUTAMINASE TYPE 2, A

PROTEIN CROSS-LINKING ENZYME, IN THE FISHER-TO-LEWIS RAT

MODEL OF CHRONIC ALLOGRAFT NEPHROPATHY

Badri M. Shrestha, Imran Butt, John Shortland, B. Wagener, A.M. El-Nahas,

Andrew T. Raftery, T. Johnson and J.L. Haylor; Sheffi eld, United Kingdom

P-631 AMELIORATION OF TRANSPLANT ASSOCIATED INJURY BY THE

NOVEL HEME OXYGENASE-1 INDUCER HEME ARGINATE

Matthew F. Beesley, David A. Ferenbach, Stephen J. McNally, David C. Kluth

and Lorna P. Marson; Edinburgh, Midlothian, United Kingdom

P-632 DETERMINATION OF DENDRITIC CELLS EXPRESSING INHIBITORY

RECEPTORS ILT3 AND ILT4 IN KIDNEY TRANSPLANTED PATIENTS

WITH DIFFERENT OUTCOMES AND HEALTHY CONTROLS

Jhon F. Arboleda, Luis F. Garcia and Cristiam M. Alvarez; Medellin, Antioquia,

Colombia

P-633 TRANSPLANT VASCULOPATHY: A PROPHYLAXIC ROLE FOR

RAPAMYCIN?

Marie-Christine Guilbert, Patrick Laplante and Marie-Josée Hébert; Montreal,

QC, Canada

180


181

POSTERS

P-634 CONJOINT IMMUNOSUPPRESSION AND ANTIBIOSIS IMPROVE

SURVIVAL OF POLYMICROBIAL ABDOMINAL SEPSIS

Volker Assfalg, Norbert Hueser, Daniel Reim, Manfred J. Stangl, Bernhard

Holzmann and Klaus L. Emmanuel; Münster, Germany and Salzburg, Austria

P-635 EVALUATION OF CMV SPECIFIC T-CELL RESPONSE IN HEART

TRANSPLANT RECIPIENTS

Simona Cofano Simona, Alda Saldan, Marta Fiscon, Angela Bozza, Alice

Bianchin, Carlo Mengoli, Dino Sgarabotto, Mariangela Biasolo, Gianluca

Torregrossa, Giuseppe Feltrin, Chiara D’Agostino, Giuseppe Toscano, Luisa

Barzon, Antonio Gambino, Gino Gerosa, Giorgio Palu and Davide Abate;

Padua, Italy

P-636 P-GLYCOPROTEIN AS A POTENTIAL NOVEL THERAPEUTIC

TARGET IN ALLOTRANSPLANTATION. ROLE ON DENDRITIC CELL

MATURATION AND LYMPHOCYTE PROLIFERATION

Nuria Lloberas, Ines Rama, Linda Cassis, Ines Llaudo, Marcel la Franquesa,

Joan Torras, Josep M. Cruzado, Oriol Bestard, Daniel Benitez and Josep M.

Grinyo; Barcelona, Spain

P-637 A RAPID DECELLULARIZATION TECHNIQUE FOR ORGAN STORAGE

AND RECELLULARIZATION

Giuseppe Orlando, Sayed-Hadi Mirmalek-Sani, Pedro M. Baptista, Yuanyuan

Zhang, Anthony Atala and Shay Soker; Winston Salem, NC, United States

and Oxford, United Kingdom

P-638 THE ROLE OF ISCHEMIA REPERFUSION INJURY IN ALLOGRAFT

VASCULOPATHY

Chelsey L. King, Jennifer J. Devitt, Tim D.G. Lee and Camille L. Hancock

Friesen; Halifax, NS, Canada

P-639 THE RELATIONSHIP BETWEEN RECIPIENT CYTOKINE TNF AND

IL-10 GENE POLYMORPHISM AND ACUTE BIOLOGICAL REJECTION

AFTER LIVER TRANSPLANTATION

Xia-Xing Deng, Bai-Yong Shen, Chen-Hong Peng, Qian Zhan and Hong-Wei

Li; Shanghai, China

P-640 TRANSCRIPTIONAL PATHWAYS ACTIVATED IN THE DONOR HEART

DURING BRAIN DEATH INDUCTION

Markus Richter, Schröter Thomas, Volker Adams, Hartmut Bittner and Martin

Kostelka; Leipzig, Germany

P-641 INCIDENCE OF HEPATITIS B VIRUS REINFECTION AFTER LIVER

TRANSPLANTATION

X.J. Shi, J.H. Dong and B.W. Ji; Beijing, China

P-642 GRAFT TREATMENT WITH BILIRUBIN AMELIORATES ISCHEMIA

REPERFUSION INJURY

Florian Bösch, Michael Thomas, Andreas Kaiser, Dominik Wiedemann,

Pamela Kogler, Felix Aigner, Robert Sucher, Jakob Troppmair, Raimund

Margreiter and Robert Öllinger; Innsbruck, Austria and Münster, Germany

P-643 ANTI-IL-2 CHAIN RECEPTOR ANTIBODY SIGNIFICANTLY DOWN-

REGULATES THE EXPRESSION OF TLR-4 PRIMED BY LPS

Paula Xavier, Paula Aires, Helena Alves and Gerardo Oliveira; Porto,

Portugal

P-644 THE CD52 GENE POLYMORPHISM AND ITS POTENTIAL SIGNIFICANCE

FOR RESPONSE TO ALEMTUZUMAB IN RENAL TRANSPLANT

RECIPIENTS

Andrzej Oko, Lucjan S. Wyrwicz, Maciej Glyda, Ilona Idasiak-Piechocka,

Andrzej Ciechanowicz and Stanislaw Czekalski; Poznan, Poland and Szczecin,

Poland


P-645 EPITHELIAL-MESENCHYMAL TRANSITION (EMT) AND FIBROSIS ARE

RAPIDLY INDUCED DURING ACUTE REJECTION (AR) OF HUMAN

RENAL ALLOGRAFTS

Dany Anglicheau, Thangamani Muthukumar, Aurélie Hummel, Catherine

Snopkowski, Ruchuang Ding, Vijay K. Sharma, Darchana Dadhania, Surya

Seshan and Manikkam Suthanthiran; New York, NY, United States

P-646 REDUCED EXPRESSION OF THE ACTIVATING RECEPTOR NKG2D IN

NK CELLS FROM END-STAGE RENAL DISEASE PATIENTS

Marie-noelle Peraldi, Jeannig Berrou, Nicolas Dulphy, Denis Glotz and

Antoine Toubert; Paris, France

P-647 EFFECT OF ISCHEMIA-REPERFUSION AND ANTI-THYMOCYTE

GLOBULIN ON THE PERIOPERATIVE CYTOKINE PROFILE IN CLINICAL

RENAL TRANSPLANTATION

Manimaran Ranganathan, Edward Frances, Edvardo Chavez, Robert Walker,

Argiris Asderakis and Rafael Chavez; Cardiff, United Kingdom and Pontyclun,

United Kingdom

P-648 DETERMINATION OF CYTOTOXIC T LYMPHOCYTE ACTIVITY AGAINST

DONOR SPLEEN CELLS AND ESTIMATION OF MICROCHIMERISM

FOR TOLERANCE MEASUREMENT

Martin Schenk, Kaur Gill Prabjhot, Christian Thiel, Karolin Thiel, Silvio Nadalin

and Alfred Koenigsrainer; Tuebingen, Germany

P-649 INJECTION OF DONOR-DERIVED OX62+-SPLENIC DENDRITIC CELLS

AND ANTI-CD4 MONOCLONAL ANTIBODY INTO A FISCHER TO LEWIS

RAT COMBINATION INDUCES INDEFINITE SKIN GRAFT SURVIVAL

VIA THE GENERATION OF DONOR-SPECIFIC CD4+CD25+FOXP3+

T CELLS AND INHIBITS DONOR-SPECIFIC ALLOANTIBODIES

PRODUCTION

Mohamad Alawieh, Gerard Rifl e, Olivier Bouchot, Ghislain Malapert,

Christiane Mousson and Laurent Martin; Dijon, France

P-650 A NOVEL ENDOGENOUS MURINE ADULT CARDIAC STEM CELL

POPULATION AND ITS FLUX AFTER ISCHAEMIC INJURY

Ishtiaq M. Ahmed, Vashe Chandrakanthan, Munira Xaymardan, Owen W.J.

Prall, Sumayeh Nasr-Esfahani and Richard Harvey; Sydney, NSW, Australia

P-651 CHARACTERISATION OF EPITHELIAL AND MESENCHYMAL STEM

CELLS IN ADULT HUMAN LIVER

Federico Colombo, Alessandra Cattaneo, Silvia Mazzucchelli, Francesca

Baldan, Giorgio Rossi, Gianluca Svegliati-Baroni, Daniele Prati and Laura

Porretti; Milan, Italy; Ancona, Italy and Lecco, Italy

P-652 CD4+CD25+FOXP3+ REGULATORY T-CELLS IN THE PERIPHERY OF

STABLE RENAL TRANSPLANT RECIPIENTS RECEIVING DIFFERENT

COMBINATIONS OF IMMUNOSUPPRESSIVE DRUGS

Costas Fourtounas, Athanasia Mouzaki, Panagiota Sakellaraki and Jannis

Vlachojannis; Patras, Greece

P-653 PLASMA FROM KIDNEY TRANSPLANT RECIPIENTS HAS A LESSER

INHIBITORY EFFECT ON T CELL ACTIVATION THAN PLASMA FROM

HEALTHY CONTROLS

Alain G. Assounga and Saleha Omarjee; Durban, KwaZulu-Natal, South

Africa

P-654 ROLE OF IMMUNOSUPPRESSION IN DEVELOPMENT OF COLON

ADENOCARCINOMA. A COMPARATIVE IMMUNOHISTOCHEMICAL

STUDY OF RENAL TRANSPLANT PATIENTS AND GENERAL

POPULATION

Ignacio Revuelta, Flavia Guzman, Daniel Moya, Freddy Rojo, Álex Gutiérrez-

Dalmau, Jordi Rovira, Astrid Hernández, María José Rodríguez-Bajo, Elisenda

Bañón-Maneus, Amanda Solé, Luis F. Quintana, Federico Oppenheimer, Joan

Albanell and Josep M. Campistol; Barcelona, Spain and Zaragoza, Spain

182


183

POSTERS

P-655 A NOVEL ASSAY TO QUANTIFY DIRECT PATHWAY ALLOREACTIVE

T-CELLS LONGITUDINALLY AFTER LIVER TRANSPLANTATION

Özlem Tapirdamaz, Herold J. Metselaar, Shanta Mancham, Luc J.W. van der

Laan, Kris Thielemans and Jaap Kwekkeboom; Rotterdam, The Netherlands

and Brussels, Belgium

Kidney II

P-656 HYPOTHERMIC MACHINE PERFUSION OF DCD KIDNEYS: THE ROLE

OF OXYGEN IN RECOVERY FROM IR-INJURY

Jerome Cau, Raphael Thuillier, Arjan Van der Plaats, William Hebrard, Henri

Leuvenink, Gerhard Rakhorst and Thierry Hauet; Poitiers, France; Groningen,

The Netherlands; Surgeres, France and France

P-657 THE OUTCOMES OF ABO-INCOMPATIBLE LIVING UNRELATED

KIDNEY TRANSPLANTATION

Tomoaki Iwai, Junji Uchida, Yuichi Machida, Koichiro Kitamoto, Taro Iguchi,

Toshihide Naganuma, Katsuyuki Kuratsukuri, Hidenori Kawashima, Taku Kim

and Tatsuya Nakatani; Osaka, Japan and Yao, Osaka, Japan

P-658 CA19.9 IS A DIAGNOSTIC MARKER FOR HEPATIC CYST INFECTION

IN ADPKD KIDNEY TRANSPLANT PATIENTS

Nada Kanaan, Eric Goffi n, Yves Pirson, Olivier Devuyst and Ziad Hassoun;

Brussels, Belgium

P-659 TACROLIMUS ONCE-DAILY PROLONGED RELEASE (ADVAGRAF®) IN

KIDNEY, LIVER AND HEART RECIPIENTS: 4-YEAR RESULTS

R.R. Alloway, J.P. van Hooff and P. Trunecka; Cincinnati, United States;

Maastricht, The Netherlands and Prague, Czech Republic

P-660 LONG TERM OUTCOME OF THE EARLY STEROID WITHDRAWAL

AND SUBSEQUENT STEROID FREE MAINTENANCE THERAPY IN THE

KIDNEY TRANSPLANTATION

Kazuhiro Iwadoh, Shohei Fuchinoue, Kotaro Kai, Yasuo Ishii, Akihito

Sannomiya, Toru Murakami, Ichiro Koyama, Ichiro Nakajima and Satoshi

Teraoka; Shinjuku ward, Tokyo, Japan

P-661 SERUM NGAL IS SUPERIOR TO URINE NGAL AS A PREDICTOR OF

DGF IN DECEASED DONOR KIDNEY TRANSPLANTATIONS

Maria Hollmén, Lauri Kyllönen, Jussi Merenmies and Kaija Salmela; Helsinki,

Finland

P-662 A PROSPECTIVE STUDY FOR PREVENTION OF POST

TRANSPLANTATION BONE LOSS IN RENAL TRANSPLANT

RECIPIENTS

Spyros Dovas, Domniki Economidou, Aikaterini Papagianni, Eirini

Kazantzidou, Panagiotis Pateinakis, Georgios Efstratiadis, Dimitrios Takoudas

and Dimitrios Memmos; Thessaloniki, Greece

P-663 OCCLUSION OF ACCESSORY VESSELS IN MULTIPLE RENAL ARTERY

ALLOGRAFTS MAY PRESENT AS GRAFT DYSFUNCTION

A.O. Mahendran, M. Elvey, P. Dupont, P.S. Veitch and P. Sweny; London,

United Kingdom

P-664 AN INCREMENTAL INCREASE IN CHRONIC ALLOGRAFT DAMAGE

DETECTED ON PROTOCOL BIOPSIES DURING THE FIRST YEAR

POST-TRANSPLANTATION

A.O. Mahendran, S. Haroon, P.J. Dupont, A. Howie and P.S. Veitch; London,

United Kingdom


P-665 BASILIXIMAB INDUCTION NOT ONLY REDUCES REJECTION RATES

IN THE FIRST YEAR POST RENAL TRANSPLANTATION BUT ALSO

REDUCES THE DECLINE IN EGFR OVER TWO YEARS: A SINGLE

CENTRE RETROSPECTIVE ANALYSIS OF BIOPSY RESULTS AND RENAL

FUNCTION

Yasha Johari, David Bryson and Michael L. Nicholson; Leicester, Leicestershire,

United Kingdom

P-666 A MATCHED COMPARISON OF CHRONIC KIDNEY DISEASE (CKD)

COMPLICATIONS BETWEEN NON-TRANSPLANT AND TRANSPLANT

PATIENTS

Vincent Li, Christopher Gurban, Simon Ball, Paul Cockwell, Nicholas Inston,

Richard Borrows and Jason Moore; Birmingham, West Midlands, United

Kingdom

P-667 SERUM PHOSPHATE AND CALCIUM CONCENTRATIONS ARE

ASSOCIATED WITH REDUCED PATIENT SURVIVAL FOLLOWING

KIDNEY TRANSPLANTATION

Jason Moore, Charles Tomson, Tessa Savage, Richard Borrows and Charles

Ferro; Birmingham, United Kingdom and Bristol, United Kingdom

P-668 A COMPARISON OF TRANSPLANT OUTCOMES IN PERITONEAL AND

HEMODIALYSIS PATIENTS- A PAIRED KIDNEY ANALYSIS

Alicja Debska-Slizien, Wojciech Wolyniec, Grazyna Moszkowska, Dariusz

Zadrozny, Anna Milecka and Boleslaw Rutkowski; Gdansk, Poland

P-669 PULSATILE PERFUSION KIDNEY MACHINE IMPROVES KIDNEY

PRESERVATION AND PROVIDES INFORMATION ABOUT ORGAN

VIABILITY IN KIDNEYS FROM EXPANDED CRITERIA DONORS

V. de la Fuente-Fernandez, L. Peri, D. Paredes, A. Ruiz, I. Revuelta, M.

Manyalich, B. Miranda, A. Alcaraz, F. Oppenheimer and J.M. Campistol;

Barcelona, Spain

P-670 MAXIMISING THE UTILISATION OF EXPANDED CRITERIA DONOR

(ECD) KIDNEYS: AVOIDING BIOPSY RESULTS IN ACCEPTABLE

OUTCOMES

Farhina Sayyed, Jason Moore, Hari Krishnan, Ahmed Hamsho, Steve Mellor,

Desley Neil, Andrew Ready and Nicholas Inston; Birmingham, West Midlands,

United Kingdom

P-671 THE STORY OF POLYETHYLENE GLYCOL PART 1: PEG DURING COLD

PRESERVATION PRESERVES GRAFT FUNCTION

Emilie Manguy, Raphael Thuillier, Thibeau Desurmont, Michel Eugene,

Benoit Barrou and Thierry Hauet; Poitiers, France and France

P-672 THE STORY OF POLYETHYLENE GLYCOL PART 2: PEG DURING COLD

PRESERVATION PROTECTS AGAINST CHRONIC GRAFT FIBROSIS

Emilie Manguy, Raphael Thuillier, Thibeau Desurmont, Michel Eugene,

Benoit Barrou and Thierry Hauet; Poitiers, France and France

P-673 MOLECULAR EXPRESSION OF MTOR PATHWAY IN SKIN KAPOSI’S

SARCOMA AFTER RENAL TRANSPLANTATION

Astrid Hernández Sierra, Anna Petit, Daniel Moya, Ignacio Revuelta, Maria

Auxiliadora Mazuecos, Ana Isabel Sánchez Fructuoso, Pedro Errasti, Josep

María Cruzado, Federic Oppenheimer and Josep María Campistol; Barcelona,

Spain; Cadiz, Spain; Madrid, Spain and Pamplona, Spain

P-674 DONOR-GIFTED RENAL STONE DISEASE AND THE ROLE OF

URETEROSCOPY AT LIVE DONOR NEPHRECTOMY

John Moir, Pukar Shrestha, Naeem Soomro, David Talbot and David Rix;

Newcastle Upon Tyne, United Kingdom

184


185

POSTERS

P-675 EGFR EVOLUTION BETWEEN 6 AND 24 MONTH PREDICTS LONG-

TERM KIDNEY TRANSPLANT SURVIVAL IN PATIENTS WITH INFERIOR

GRAFT FUNCTION

Maria Magott, Maria Boratynska, Dariusz Patrzalek, Dariusz Janczak, Pawel

Chudoba and Marian Klinger; Wroclaw, Poland

P-676 THE EFFECT OF MYCOPHENOLATE MOFETIL ON LONG-TERM

GRAFT SURVIVAL IN RENAL TRANSPLANTATION: A SINGLE-CENTER

RETROSPECTIVE ANALYSIS

Kotaro Kai, Kazuhiro Iwadoh, Ichro Nakajima, Shouhei Fuchinoue, Hideki

Ishida, Kazunari Tanabe and Satoshi Teraoka; Tokyo, Japan

P-677 PRETRANSPLANT PBMC IDO ACTIVITY IS LOWER IN RENAL

TRANSPLANT RECIPIENTS THAN IN HEALTHY CONTROLS AND IS

NOT PREDICTIVE OF ACUTE GRAFT REJECTION

Mahmoud Sadeghi, Imad Lahdou, Volker Daniel, Jan Schmidt, Arianeb

Mehrabi, Gerhard Opelz and Peter Terness; Heidelberg, Germany

P-678 LYMPHOCYTES FROM STABLE RENAL TRANSPLANT PATIENTS WHO

HAVE HAD CMV VIRAEMIA SHOW A DIFFERENT IL-2 RESPONSE TO

CALCINEURIN INHIBITORS COMPARED TO PATIENTS WITHOUT

INFECTION

Hemali Kanji, Chandrasekar Vijayasekar, Alan G. Morris, For T. Lam and

Robert M. Higgins; Coventry, United Kingdom

P-679 PULSATILE PERFUSION PRESERVATION OF EXPANDED-CRITERIA

DONORS KIDNEYS: A FRENCH ACADEMIC HOSPITAL EXPERIENCE

ON GRAFT FUNCTION

Imad Abboud, Corinne Antoine, Carmen Lefaucheur, Evangéline Pillebout,

Tomas Serrato, Marie-Noelle Peraldi and Denis Glotz; Paris, France

P-680 WITHDRAW

P-681 WITHDRAW

P-682 WITHDRAW

P-683 COMPARISON OF PANCREATIC ISLETS PRESERVATION CONDITIONS

IN A MODEL OF MOUSE PANCREAS DONOR AFTER CARDIAC

ARREST

Sebastien Giraud, Thierry Hauet, Michel Eugene, P.M. Levillain and Benoit

Barrou; Poitiers, France; Paris, France and France

P-684 MULTIVARIATE ANALYSIS OF RISK FACTORS FOR LEFT VENTRICULAR

HYPERTROPHY PERSISTENCE AFTER SUCCESSFUL RENAL

TRANSPLANTATION

Domenico Montanaro, Maria Groppuzzo, Patrizia Tulissi, Clotilde Vallone,

Umberto Baccarani, Gian Luigi Adani, Dario Lorenzin and Fabrizio Bresadola;

Udine, Italy

P-685 TREATMENT OF CHRONIC HEPATITIS C IN RENAL TRANSPLANT

RECIPIENTS WITH ULTRALOW-DOSE PEGINTERFERON-ALFA2B PLUS

RIBAVIRIN

Yoshiaki Inui, Tsukasa Nishioka, Norio Yoshimura, Shiro Takahara, Yasuji

Ichikawa and Takahiro Akiyama; Nishinomiya, Hyogo, Japan; Sakai, Osaka,

Japan; Kyoto, Japan and Suita, Osaka, Japan

P-686 DELAYED CALCINEURINE INHIBITOR INDUCTION CAN SHORTEN

DELAYED GRAFT FUNCTION PERIOD OF KIDNEY ALLOGRAFTS

FROM EXTENDED CRITERIA DONORS

Hiroshi Harada, Masayoshi Miura, Michiko Nakamura, Naohiko Shimoda,

Jyunichi Iida, Toshimori Seki, Masaki Togashi, Tohru Tamaki, Katusya

Nonomura and Tetsuo Hirano; Sapporo, Hokkaido, Japan


P-687 TESTICULAR PAIN AND SWELLING FOLLOWING LAPAROSCOPIC

DONOR NEPHRECTOMY (LDN) FOR LIVING DONOR RENAL

TRANSPLANT

Morteza Jalali, Samir Rahmani, Georgina Speak, Jonathan Cartledge and

Niaz Ahmad; Leeds, United Kingdom

P-688 THE VALUE OF CXCR3 AND CXCR4 AS TOOLS FOR MONITORING

HUMAN KIDNEY TRANSPLANTS

Paula Xavier, Paula Aires, Helena Alves and Gerardo Oliveira; Porto,

Portugal

P-689 ADULT PRE-EMPTIVE KIDNEY TRANSPLANTATION: A PAIRED KIDNEY

ANALYSIS

Alicja Debska-Slizien, Beata Bzoma, Grazyna Moszkowska, Iwona Skora,

Andrzej Chamienia, Dariusz Zadrozny, Zbigniew Sledzinski and Boleslaw

Rutkowski; Gdansk, Poland

P-690 LOW PRETRANSPLANT ADIPONECTIN LEVELS INDEPENDENTLY

PREDICT RENAL TRANSPLANTATION OUTCOMES

Maximilian von Eynatten, Marcus Baumann, Dan Liu, Peter A. Horn, Falko

M. Heinemann, Oliver Witzke and Uwe Heemann; Münster, Germany and

Essen, Germany

P-691 HYDROGEN SULFIDE (H2S) INDUCED HYPOMETABOLISM IS

PROTECTIVE DURING HEPATIC ISCHEMIA/REPERFUSION

Eelke M. Bos, Harry van Goor and Henri G.D. Leuvenink; Groningen, The

Netherlands

P-692 DESENSITIZATION PROTOCOL FOR ABO-INCOMPATIBLE HIGH-

TITER KIDNEY TRANSPLANTATION

Junji Uchida, Koichiro Kitamoto, Taro Iguchi, Tomoaki Iwai, Yuichi Machida,

Kazuya Morimoto, Shintaro Shibano, Noriaki Nishikawa, Toshihide Naganuma,

Katsuyuki Kuratsukuri, Norihiko Kumada, Taku Kim, Hidenori Kawashima and

Tatsuya Nakatani; Osaka, Japan

P-693 INFLUENCE OF THE AGE ON GLUCOSE TOLERANCE IN RENAL

TRANSPLANT RECIPIENTS

Yuichi Machida, Junji Uchida, Koichiro Kitamoto, Taro Iguchi, Tomoaki

Iwai, Nobuyuki Kuwahara, Kazuya Morimoto, Noriaki Nishikawa, Toshihide

Naganuma, Katsuyuki Kuratsukuri, Taku Kim, Hidenori Kawashima and

Tatsuya Nakatani; Osaka, Japan

P-694 ARA290 PROTECTS AGAINST RENAL ISCHEMIA/REPERFUSION

INJURY IN PIGS

Henri G.D. Leuvenink, Petra J. Ottens, Willem G. van Rijt, Harry van Goor

and Rutger J. Ploeg; Groningen, The Netherlands

P-695 LOW-GRADE ALBUMINURIA REDUCTION WITH ANGIOTENSIN

II TYPE 1 RECEPTOR ANTAGONIST IN RENAL TRANSPLANT

RECIPIENTS

Junji Uchida, Kochiro Kitamoto, Yuichi Machida, Tomoaki Iwai, Kazuya

Morimoto, Noriaki Nishikawa, Shintaro Shibano, Taro Iguchi, Toshihide

Naganuma, Katsuyuki Kuratsukuri, Hidenori Kawashima and Tatsuya

Nakatani; Osaka, Japan

P-696 DOUBLE-J VERSUS EXTERNAL URETERAL STENTS IN KIDNEY

TRANSPLANTATION: A RETROSPECTIVE ANALYSIS

Markus Utech, Wiebke Hölscher-Keplin, Ricarda Diller, Jens Brockmann and

Heiner H. Wolters; Muenster, Germany; Paderborn, Germany and Oxford,

United Kingdom

P-697 END THE WAIT! OFFERS COMPREHENSIVE SOLUTION TO KIDNEY

TRANSPLANT WAITING LIST IN THE U.S.

John Davis; New York, NY, United States

186


187

POSTERS

P-698 SPONTANEOUS REGRESSION OF ASYMPTOMATIC TRANSPLANT

RENAL ARTERY STENOSIS DIAGNOSED BY SERIAL DOPPLER

ULTRASOUND

Knut Brabrand, Hallvard Holdaas, Anne Günther and Karsten Midtvedt;

Oslo, Norway

P-699 KIDNEY TRANSPLANTATION WITH A VIRTUAL CROSSMATCH

Anna Rizzello, Paul Sinnott, Arun Gupta, Raj Thuraisingham, Carmelo Puliatti

and Roberto Cacciola; London, United Kingdom

P-700 COMPARATIVE ANALYSIS OF IGL1 AND MPS IN MACHINE

PERFUSION, A WATERS RM3 STUDY

Ricardo Codas, Raphael Thuillier, Thierry Hauet and Lionel Badet; Lyon,

France; Poitiers, France and France

P-701 ARE BMP7 AND HSP70 EARLY MARKERS OF CHRONIC KIDNEY

GRAFT FUNCTION? PROTEOMIC AND GENOMIC ANALYSIS OF

ISCHEMIA REPERFUSION INJURY

Ludivine Rossard, Frederic Favreau, Raphael Thuillier, Olivier Page, Sandrine

Joffrion, Jean-Michel Goujon and Thierry Hauet; Poitiers, France and

France

P-702 IMPROVING DCAD GRAFTS: DIRECT THROMBIN INHIBITION

PREVENTS DELAYED GRAFT FUNCTION AND ACUTE INJURY

Sebastien Giraud, Raphael Thuillier, Aude Belliard, Jean-Michel Goujon,

Cedric Nadeau, Thierry Hauet and Laurent Macchi; Poitiers, France and

France

P-703 HOW FREQUENTLY SHOULD ONE SEE A NEPHROLOGIST IN THE

OUTPATIENT CLINIC AFTER A KIDNEY TRANSPLANT?

Ajay K. Israni, Jon J. Snyder, Melissa A. Skeans and Bertram L. Kasiske;

Minneapolis, MN, United States

P-704 CARDIOVASCULAR MEDICATION USE FOLLOWING KIDNEY

TRANSPLANT: DATA FROM THE PORT INTERNATIONAL DATA

COLLABORATION

Helen L. Pilmore, Bertram L. Kasiske, Ajay K. Israni, Melissa A. Skeans and

Jon J. Snyder; Auckland, New Zealand and Minneapolis, MN, United States

P-705 POST KIDNEY TRANSPLANT ESTIMATED GLOMERULAR

FILTRATION RATE BY CENTER: THE PORT INTERNATIONAL DATA

COLLABORATION

Jon J. Snyder, Melissa A. Skeans, Ajay K. Israni and Bertram L. Kasiske;

Minneapolis, MN, United States

P-706 PREDICTION OF SLOW AND DELAYED ALLOGRAFT FUNCTION

USING PERIOPERATIVE MEASUREMENTS OF ARACHIDONIC ACID’S

METABOLITES

Wojciech Blogowski and Barbara Dolegowska; Szczecin, Poland

P-707 POST RENAL TRANSPLANTATION ERYTHROCYTOSIS

Sabra Aloui, Najla Mokni, Faouzi Hawala, Chokri Maktouf, Imene Gorsane,

Frih Ameur, Nasr Ben Dhia, Mezri ElMay and Hbib Skhiri; Monastir, Tunisia

and Tunis, Tunisia

P-708 MINIMALLY INVASIVE TREATMENT OF POSTTRANSPLANT RENAL

TUMORS

Mihai M. Lucan, Gheorghita Iacob, Ciprian V. Lucan and Florin Elec; Cluj-

Napoca, Cluj, Romania

P-709 ENZYMATIC ACTIVITY IN THE POSTTRANSPLANT LYMPHOCELE

CONTENT AS AN INSTRUMENT FOR ESTIMATION OF ITS ORIGIN

Jaroslav Pacovsky, Radomir Hyspler, Pavel Navratil, Milos Brodak, Alena

Ticha, Petr Fixa and Lukas Holub; Hradec Kralove, Czech Republic


P-710 RECIPIENT GENETIC DETERMINANTS OF INFLAMMATORY PROCESS

AND NON-STANDARD ATHEROSCLEROSIS RISK FACTORS AND THEIR

PRODUCT CONCENTRATIONS AT EARLY POST TRANSPLANTATION

PERIOD AFFECT KIDNEY GRAFT FUNCTION

Magdalena Krajewska, Katarzyna Koscielska-Kasprzak, Dominika Drulis-

Fajdasz, Waclaw Weyde, Katarzyna Madziarska, Oktawia Mazanowska,

Mariusz Kusztal and Marian Klinger; Wroclaw, Poland

P-711 PITFALLS OF C2 MONITORING OF CYCLOSPORINE-

MICROEMULSION ADMINISTRARION IN STABLE RENAL TRANSPLANT

RECIPIENTS – CONDITIONS THAT ARE ABSOLUTELY NECESSARY IN

C2 MONITORING

Satoki Otsuka, Kazuharu Uchida, Takaharu Nagasaka, Yoshihiko Watarai,

Akio Katayama and Akimasa Nakao; Toyohashi, Aichi, Japan and Nagoya,

Aichi, Japan

P-712 BLADDER CANCER AFTER KIDNEY TRANSPLANTATION. SINGLE

CENTRE EXPERIENCE

Lukas Holub, Pavel Navratil, Milos Brodak, Jaroslav Pacovsky and Josef

Kosina; Hradec Kralove, Czech Republic

P-713 IMPORTANCE OF ROUTINE CANCER SURVEILLANCE TO IMPROVE

LONG-TERM RESULTS AFTER KIDNEY TRANSPLANTATION

Akio Katayama, Tsuneo Ueki, Takaharu Nagasaka, Yoshihiko Watarai,

Kazuharu Uchida, Takaaki Kobayashi and Akimasa Nakao; Nagoya, Aichi,

Japan

P-714 SUPERFICIAL FUNGAL INFECTIONS IN 222 CONSECUTIVE RENAL

TRANSPLANT RECIPIENTS

Agata Predota, Beata Imko-Walczuk, Aleksandra Okuniewska, Barbara

Zegarska, Wioletta Budna, Janusz Jaskiewicz, Waldemar Placek, Boleslaw

Rutkowski, Alicja Debska-Slizien, Maria Czubek and Zbigniew Wlodarczyk;

Gdansk, Poland and Bydgoszcz, Poland

P-715 GENETIC PREDISPOSITION TO NEW ONSET DIABETES AFTER

RENAL TRANSPLANTATION WITH CYCLOSPORINE AND TACROLIMUS

IN SOUTHEAST ASIA AND ITS ASSOCIATION WITH LIPID LEVELS AND

DRUG DOSAGE

Yogesh N.V. Reddy, Georgi Abraham, Yuvaram N.V. Reddy, Milly Mathew,

Varun Sundaram and Asik Ali Mohamed Ali; Chennai, India

P-716 VITAMIN D METABOLITE-MEDIATED HYPERCALCEMIA WITH

SUPPRESSED PARATHORMONE LEVELS IN PNEUMOCYSTIS JIROVECI

PNEUMONIA AFTER KIDNEY TRANSPLANTATION

Christiane Mousson, Kais Hajji, Frédéric Dalle, Amel Harzallah, Yves Tanter

and Gérard Rifl e; Dijon, France

P-717 LONG TERM GRAFT SURVIVAL IN LIVING UNRELATED/ABO-

INCOMPATIBLE RENAL TRANSPLANTS: A SINGLE CENTER

RETROSPECTIVE ANALYSIS

Mitsuhiro Sekijima, Kazuhiro Iwadou, Koutaro Kai, Hiroyuki Shirai, Yasuo Ishii,

Akihito Sannomiya, Ichiro Koyama, Ichiro Nakajima, Shouhei Fuchinoue and

Satoshi Teraoka; Tokyo, Japan

P-718 WITHDRAW

P-719 THE USE OF EXTENDED CRITERIA DONORS: A SINGLE CENTRE

EXPERIENCE

Susana Fernandez-Diaz, Shah Jalal Sarker, John Taylor, Geoff Koffman and

Nizam Mamode; London, United Kingdom

188


189

POSTERS

P-720 ENDOTHELIAL AND THROMBOCYTE ACTIVATION ARE NO

INITIATORS OF EARLY ISCHEMIA-REPERFUSION INJURY IN HUMAN

KIDNEY TRANSPLANTATION

Dorottya K. de Vries, Mark Roest, Jan H.N. Lindeman, Jan Ringers, Ton J.

Rabelink, Philip G. de Groot and Alexander F.M. Schaapherder; Leiden, The

Netherlands and Utrecht, The Netherlands

P-721 AN INNOVATIVE APPROACH TO ASSOCIATE OUTCOMES RELATED

TO ADHERENCE WITH PATIENT BEHAVIORS AND TREATMENT

CHARACTERISTICS

Ross J. Maclean, Marc Pfi ster, Zexun Zhou, Amit Roy, Vickie V. Tuomari and

Michael Heifets; Plainsboro, NJ, United States and Princeton, NJ, United

States

P-722 THE EFFECTS OF DONOR FACTORS ON GRAFT OUTCOMES IN

LIVING DONOR KIDNEY TRANSPLANTATION: SINGLE CENTER

EXPERIENCE

Min Soo Kim, Oh Jung Kwon, Chong Myung Kang and Jin Young Kwak;

Seoul, Korea

P-723 OUTCOME OF KIDNEY TRANSPLANTATION CADAVERIC DONOR

WITH ELEVATED SERUM CREATININE

Reza Mahdavi Zafarghandi, Arman Arghami, Elham Nazem and Meysam

Mahdavi Zafarghandi; Mashhad, Khorasan Razavi, Islamic Republic of Iran

P-724 SUCCESSFUL KIDNEY TRANSPLANTATION LOSE PERCENTAGE OF

WATER, MUSCLE AND BONE BUT GAIN LIPID IN EARLY PERIOD; A

BODY COMPOSITION ANALYSIS

Hiroshi Harada, Michiko Nakamura, Masayoshi Miura, Toshimori Seki, Masaki

Togashi, Chihoko Miyazaki and Tetsuo Hirano; Sapporo, Hokkaido, Japan

P-725 LATE ANTIBODY- MEDIATED REJECTION; SINGLE CENTRE

EXPERIENCE

Janka Slatinska, Eva Honsova, Antonij Slavcev, Marcela Burgelova and Ondrej

Viklicky; Prague, Czech Republic

P-726 RENAL TRANSPLANTATION FROM AGHBS POSITIVE DONORS TO

AGHBS NEGATIVE RECIPIENTS

Dorina Tacu, Cristina Bucsa, Eminee Kerezsy, Liliana Domnisor, Mihai Harza,

Marcian Manu, Bogdan Serbanescu, Bogdan Stefan, Ileana Constantinescu

and Ionel Sinescu; Bucharest, Romania

P-727 CADAVERIC KIDNEY TRANSPLANTATION WITH THYMOGLOBULIN

VERSUS MONOCLONAL ANTIBODY INDUCTION – A PAIRED KIDNEY

ANALYSIS

Claudia M.C. Oliveira, Diego M. Gomes, Camilo Reuber, Daniela C.O. Santos,

Maria Luisa M.B. Oliveira, Paula F.C.B. Fernandes, João B. Evangelista Jr and

Ronaldo M. Esmeraldo; Fortaleza, Brazil

P-728 EARLY DETECTION OF BKVIRUS ASSOCIATED TO URETERAL

NECROSISIN A RENAL ALLOGRAFT RECIPIENT

Jacqueline Pefaur, Jorge Aguiló, Alberto Fierro, Luis Contreras, Andres

Wurgaft, Rodrigo Orozco and Jorge Morales; Santiago, Chile

P-729 ASSESSMENT OF KIDNEYS PROCURED FROM EXPANDED CRITERIA

DONORS BEFORE TRANSPLANTATION

Piotr Domagala, Artur Kwiatkowski, Agnieszka Perkowska-Ptasinska, Michal

Wszola, Krzysztof Ostrowski and Andrzej Chmura; Warsaw, Poland

P-730 CORRELATION BETWEEN EXPANDED CRITERIA KIDNEY DONOR

PARAMETERS AND CHRONIC HISTOLOGICAL LESIONS

Piotr Domagala, Agnieszka Perkowska-Ptasinska, Artur Kwiatkowski, Michal

Wszola, Krzysztof Ostrowski, Katarzyna Cybula and Andrzej Chmura; Warsaw,

Poland

P-731 GENE EXPRESSION PROFILING UNDER DIFFERENT

IMMUNOSUPPRESSIVE PROTOCOLS

Hüseyin Töz, Sait Sen, Handan Ak Çelik, Mümtaz Yilmaz, Ender Hür, Cüneyt

Hoscoskun, Mehmet Özkahya and Hakan H. Aydin; Izmir, Turkey


P-732 THE INFLUENCE OF CHRONIC HISTOLOGICAL LESIONS ASSESSED

BY PERIOPERATIVE TRANSPLANT KIDNEY BIOPSY ON ITS FUNCTION

AND SURVIVAL

Piotr Domagala, Agnieszka Perkowska-Ptasinska, Artur Kwiatkowski, Michal

Wszola, Krzysztof Ostrowski, Leszek Paczek, Magdalena Durlik and Andrzej

Chmura; Warsaw, Poland

P-733 THE RISK FACTORS AND THE THERAPY FOR CHRONIC

DIARRHEA RELATED TO IMMUNOSUPPRESSIVE AFTER RENAL

TRANSPLANTATION

Jiqiu Wen, Leishi Li, Jinsong Chen, Dongrui Cheng, Qiquan Sun, Shuming Ji

and Zhihong Liu; Nanjing, China

P-734 MANAGEMENT OF RENAL PERFUSION IN DONORS DECEASED

FROM CARDIAC ARREST: COMPARISON OF IN SITU PERFUSION

AND NORMOTHERMIC ECMO

Karim Ferhi, Morgan Leguern, Frederic Thibault, Armelle Nicolas Robin,

Christophe Vaessen, Nadia Arzouk, Emmanuel Vanglabeke, Pascal Leprince,

Bruno Riou and Benoit Barrou; Paris, Ile de France, France

P-735 POST-RENAL TRANSPLANT ANEMIA (PTA): PREVALENCE, ASSOCIATED

FACTORS AND MANAGEMENT IN BRAZILIAN RECIPIENTS

Claudia M.C. Oliveira, Paula S. Timbo, Sanna R. Pinheiro, Janaina G.S. Leite,

Luciana S. Timbo and Ronaldo M. Esmeraldo; Fortaleza, Brazil

P-736 WITHDRAW

P-737 CURRENT STATUS AND TREND OF LAPAROSCOPIC LIVE DONOR

NEPHRECTOMY IN JAPAN

Kenji Yuzawa and Katashi Fukao; Higashiibaraki-gun, Ibaraki-ken, Japan and

Ichihara-shi, Chiba-ken, Japan

P-738 SUCCESSFUL LIVING DONOR KIDNEY TRANSPLANTATION ACROSS

POSITIVE CROSS-MATCH

Yang Jin Park, Sang Il Min, Sung Yup Kim, Seung-Kee Min, Jongwon Ha, Yon

Su Kim, Curie Ahn and Sang Joon Kim; Seoul, Korea

P-739 PREGNANCY AFTER KIDNEY TRANSPLANTATION- A SINGLE CENTRE

EXPERIENCE

Joanna Galgowska, Alicja Debska-Slizien, Wojciech Wolyniec, Anna Milecka,

Grazyna Moszkowska and Boleslaw Rutkowski; Gdansk, Poland

P-740 THE ECONOMIC IMPACT OF DIFFERENT REGIMENS TO PREVENT

CYTOMEGALOVIRUS DISEASE IN RENAL TRANSPLANT RECIPIENTS

Tomas Reischig, Lukas Kielberger, Pavel Jindra and Vladislav Treska; Pilsen,

Czech Republic

P-741 THE ROLE AND BENEFITS OF TRANSPLANT PHARMACISTS IN A

KIDNEY TRANSPLANT DISEASE MANAGEMENT CLINIC

Puay Hoon Lee, Petrina Yuen Wai Fan and Terence Yi Shern Kee; Singapore,

Singapore

P-742 SHORT AND LONG TERM COST-EFFECTIVENESS OF HYPOTHERMIC

MACHINE PERFUSION VERSUS STATIC COLD STORAGE IN KIDNEY

TRANSPLANTATION

Henk Groen, Cyril Moers, Jacqueline M. Smits, Jürgen Treckmann, Diethard

Monbaliu, Axel Rahmel, Andreas Paul, Jacques Pirenne, Rutger J. Ploeg and

Erik Buskens; Groningen, The Netherlands; Leiden, The Netherlands; Essen,

Germany and Leuven, Belgium

P-743 THYROIDIZATION (THYROID-LIKE APPEARANCE) IN RENAL

ALLOGRAFTS

Shinichi Ito, Yutaka Yamaguchi, Tomohiro Tsuchiya, Kenichiro Ishida and

Takashi Deguchi; Gifu-city, Gifu, Japan and Kashiwa-city, Chiba, Japan

190


191

POSTERS

P-744 RESULTS OF KIDNEYS TRANSPLANTATION PROCURED FROM

EXPANDED CRITERIA DONORS

Piotr Domagala, Artur Kwiatkowski, Michal Wszola, Jaroslaw Czerwinski,

Lukasz Panufnik, Krzysztof Ostrowski, Leszek Paczek, Magdalena Durlik and

Andrzej Chmura; Warsaw, Poland

P-745 HISTOLOGICAL CORRELATIONS IN PROSPECTIVELY OBSERVED

PATIENTS WITH CHRONIC ALLOGRAFT REJECTION/NEPHROPATHY

Andrzej Mroz, Zbigniew Lewandowski, Joanna Pazik and Magdalena Durlik;

Warsaw, Poland

P-746 CLINICAL RESULTS OF PROLIFERATION SIGNAL INHIBITORS

(PSI) BASED THERAPY FOLLOWING CONVERSION FROM

ANTICALCINEURINIC (CNI BASED INMUNOSUPRESSION IN RENAL

TRANSPLANT RECIPIENTS

Jacqueline Pefaur, Maria Carrera, Patricia Diaz, Andrea Fabianne and Rita

Panace; Santiago, Chile

P-747 COMPLICATIONS OF TRANSPLANTATION OF KIDNEYS PROCURED

FROM EXPANDED CRITERIA DONORS

Piotr Domagala, Artur Kwiatkowski, Michal Wszola, Jaroslaw Czerwinski,

Katarzyna Cybula, Janusz Trzebicki, Krzysztof Ostrowski and Andrzej Chmura;

Warsaw, Poland

P-748 INFECTIOUS COMPLICATIONS IN KIDNEY TRANSPLANTATION: A

RETROSPECTIVE ANALYSIS OF 114 PATIENTS

Maroun M. Abou-Jaoude, Walid J. Abou-Jaoude, Naji F. Nawfal, Robert

Najm and Joseph A. Shaheen; Beirut, Lebanon

P-749 PELVIC VASCULAR CALCIFICATION IN RENAL PATIENTS AWAITING

TRANSPLANTATION – CONTROLLABLE RISK FACTORS A WEST OF

SCOTLAND PERSPECTIVE

Sheila Ramjug, Laura Buist and David Kingsmore; Glasgow, United

Kingdom

P-750 CHRONIC TRANSPLANT GLOMERULOPATHY – IMPACT ON GRAFT

SURVIVAL

Agnieszka Perkowska-Ptasinska, Michal Ciszek, Arkadiusz Urbanowicz, Artur

Kwiatkowski, Zbigniew Galazka, Leszek Paczek, Maciej Glyda, Alicja Debska,

Andrzej Rydzewski, Kazimierz Dziewanowski and Magdalena Durlik; Warsaw,

Poland; Poznan, Poland; Gdansk, Poland and Szczecin, Poland

P-751 KIDNEY TRANSPLANTATION WITH MULTIPLE RENAL ARTERY GRAFTS

FROM DECEASED DONORS: PATIENT AND GRAFT OUTCOMES

Inass Laouad, Anne Bretagnol, Elodie Fabre, Jean-Michel Halimi, Azmi Al-

Najjar, Jean-Michel Boutin, Hubert Nivet, Yvon Lebranchu and Matthias

Büchler; Tours, France

P-752 URINARY COMPLICATIONS AFTER RENAL TRANSPLANTATION –

SINGLE CENTER EXPERIENCE

Andrzej Chmura, Piotr Domagala, Rafal Kieszej, Leszek Adadynski, Michal

Wszola, Krzysztof Ostrowski and Artur Kwiatkowski; Warsaw, Poland

P-753 MALIGNANT DISEASES IN RENAL TRANSPLANT RECIPIENTS IN

SLOVENIA

Janko Kovac, Miha Arnol, Andrej F. Bren and Aljosa Kandus; Ljubljana,

Slovenia

P-754 QUALITY OF LIFE AFTER LIVING KIDNEY DONATION IN POLAND –

EXPERIENCE OF ONE CENTRE

Monika Bieniasz, Artur Kwiatkowski, Piotr Domagala, Rafal Kieszek, Jolanta

Gozdowska, Anna Jakubowska-Winecka, Janusz Trzebicki, Arkadiusz

Darocha, Anna Deptula, Leszek Paczek, Magdalena Durlik and Andrzej

Chmura; Warsaw, Poland


P-755 THE ASSESSMENT OF RESIDUAL KIDNEY FUNCTION AFTER LIVING

DONOR NEPHRECTOMY

Monika Bieniasz, Artur Kwiatkowski, Piotr Domagala, Jolanta Gozdowska,

Rafal Kieszek, Lukasz Ostrowski, Anna Deptula, Janusz Trzebicki, Magdalena

Durlik, Leszek Paczek and Andrzej Chmura; Warsaw, Poland

P-756 HYPERTENSION AND CARDIOVASCULAR DISEASE IN LIVING KIDNEY

DONORS IN POLAND – ONE CENTRE EXPERIENCE

Monika Bieniasz, Artur Kwiatkowski, Piotr Domagala, Rafal Kieszek, Jolanta

Gozdowska, Magdalena Durlik, Leszek Paczek, Anna Deptula, Janusz

Trzebicki, Piotr Pruszczyk and Andrzej Chmura; Warsaw, Poland

P-757 THE LIPID PROFILE OF LIVING KIDNEY DONORS

Monika Bieniasz, Artur Kwiatkowski, Jolanta Gozdowska, Rafal Kieszek, Piotr

Domagala, Arkadiusz Darocha, Janusz Trzebicki, Magdalena Durlik, Leszek

Paczek and Andrzej Chmura; Warsaw, Poland

P-758 EXCELLENT VERSUS INTERMEDIATE EARLY KIDNEY GRAFT

FUNCTION AND CLINICAL OUTCOME

Paulo Fernandes, José Guerra, Alice Santana, Clara Mil Homens, Sónia Silva

and António G. da Costa; Lisbon, Portugal

P-759 PARATHYROID HORMONE IN LIVING KIDNEY DONORS AFTER

NEPHRECTOMY

Monika Bieniasz, Artur Kwiatkowski, Piotr Domagala, Jolanta Gozdowska,

Rafal Kieszek, Arkadiusz Darocha, Janusz Trzebicki, Magdalena Durlik, Leszek

Paczek and Andrzej Chmura; Warsaw, Poland

P-760 EXPANDED CRITERIA LIVING KIDNEY DONORS – SINGLE CENTER

EXPERIENCE

Piotr Domagala, Rafal Kieszek, Monika Bieniasz, Artur Kwiatkowski, Jolanta

Gozdowska, Janusz Trzebicki, Michal Wszola, Magdalena Durlik, Leszek

Paczek and Andrzej Chmura; Warsaw, Poland

P-761 EARLY POSTOPERATIVE COMPLICATIONS OF EXPANDED CRITERIA

LIVING KIDNEY DONORS NEPHRECTOMIES

Rafal Kieszek, Monika Bieniasz, Piotr Domagala, Jolanta Gozdowska, Artur

Kwiatkowski, Leszek Adadynski, Janusz Trzebicki, Magdalena Durlik, Leszek

Paczek and Andrzej Chmura; Warsaw, Poland

P-762 THERAPEUTIC DRUG MONITORING SAFELY SPARES DOSES OF

MYCOPHENOLATE MOFETIL IN MIDDLE-TERM RENAL ALLOGRAFT

RECIPIENTS

Masayoshi Miura, Naohiko Shimoda, Nobuyuki Fukuzawa, Tatsu Tanabe,

Hiroshi Harada, Sachiko Harada, Yoh Takekuma, Kazuto Achiwa, Tetsuo

Hirano and Katsuya Nonomura; Sapporo, Japan

P-763 CO-MORBID FACTORS RELATED TO SURGICAL COMPLICATIONS IN

200 KIDNEY TRANSPLANTATION PATIENTS

Maroun Aboujaoude, Joe Shahine, Naji Nawfal, Robert Najem and Walid

Aboujaoude; Hazmieh, Lebanon and Bsalim, Lebanon

P-764 RISK FACTORS AND EXPECTED CLINICAL OUTCOMES IN KIDNEY

TRANSPLANTATION BASED ON 1 YEAR SERUM CREATININE LEVELS

Walid Aboujaoude, Joe Shahine, Naji Nawfal, Robert Najem and Maroun

Aboujaoude; Bsalim, Lebanon and Hazmieh, Lebanon

P-765 WITHDRAW

P-766 BASELINE OSTEOPROTEGERIN LEVELS AS AN INDEX OF

PROGRESSION OF CORONARY CALCIFICATIONS FOLLOWING

KIDNEY TRANSPLANTATION

Valérie Garrigue, Anne Sophie Bargnoux, Fernando Vetromile, Jean Paul

Cristol and Georges Mourad; Montpellier, France

192


193

POSTERS

P-767 COMPARISON OF LONG-TERM POST-TRANSPLANT OUTCOMES IN

PATIENTS WITH AND WITHOUT NATIVE ARTERIO-VENOUS FISTULAE

FAILURES

Janis Jushinskis, Sergej Trushkov, Vadim Suhorukov, Ieva Ziedina, Janis Bicans

and Rafail Rozental; Riga, Latvia

P-768 PREVALENCE AND RISK FACTORS OF UNCONTROLLED

HYPERTENSION AFTER KIDNEY TRANSPLANTATION

Fernando Vetromile, Pierre Fesler, Ilan Szwarc, Valérie Garrigue and Georges

Mourad; Montpellier, France

P-769 POSTTRANSPLANT ENCAPSULATING PERITONEAL SCLEROSIS –

ONE CENTRE EXPERIENCE

Alicja Debska-Slizien, Beata Januszko-Giergielewicz, Joanna Konopa,

Wojciech Wolyniec, Andrzej Chamienia and Boleslaw Rutkowski; Gdansk,

Poland

P-770 EXPERIMENTAL KIDNEY TRANSPLANTATION IN A SWINE MODEL

Martin Schweiger, Philipp Stiegler, Daniela Kniepeiss, Michael Sereinigg and

Karlheinz Tscheliessnigg; Graz, Austria

P-771 KIDNEYS FROM LIVING DONORS WITH ANEURYSM IN RENAL

ARTERY CAN BE TRANSPLANTED, GETTING A GOOD RESULTS FOR

DONOR AND RECIPIENT

Carmen Gracida, Ramon Espinoza, Jorge D. Cancino, Araceli Ibarra and

Urbano Cedillo; Mexico, D.F., Mexico

P-772 QUALITY OF LIFE OF PATIENTS WITH KIDNEY TRANSPLANT IN

COMPARRISON TO GENERAL POPULATION

Bojan Knap, Zala Dragonja, Sara Dobnik, Jadranka Buturovic-Ponikvar, Aljosa

Kandus, Andrej Bren and Rafael Ponikvar; Ljubljana, Slovenia

P-773 POST-TRANSPLANT GLOMERULONEPHRITIS IN LIVE-DONOR RENAL

TRANSPLANT RECIPIENTS: CLINICAL COURSE AND RISK FACTORS

Hany Adel, Ahmed Akl, Ehab Wafa, Mona Abdel Reheem, Mohamed Salem,

Metwaly Elshahawy and Mohamed Ghoneim; Mansoura, DK, Egypt and

Benha, Egypt

P-774 KIDNEYS RETRIEVED FROM NON-HEART-BEATING DONORS (NHBD)

WITHIN THE OVERALL ACQUISITION PROGRAMME: MONOCENTRIC

FRENCH STUDY OVER 18 MONTHS

Annelise Foucher, Jean-Paul Jacob and Jean-Claude Granry; Angers,

France

P-775 DIFFERENT PARAOXONASE-1 (PON1) ACTIVITIES IN CHRONIC

KIDNEY DISEASE AND RENAL TRANSPLANT PATIENTS

Sanja Simic-Ogrizovic, Jelena Kotur-Stevuljevic, Violeta Dopsaj, Natasa

Bogavac-Stanojevic, Visnja Lezaic and Zorana Jelic-Ivanovic; Beograd,

Serbia

P-776 IMPACT OF BALANCED NUTRITIONAL INTERVENTION THERAPY IN

LONG TERM GRAFT SURVIVAL OF KIDNEY TRANSPLANT RECIPIENTS

RECEIVING MYCOPHENOLAT-MOFETIL (MMF) (THE DALMART-

STUDY)

Gerhard H. Wirnsberger, Ronald Otto, Andrea Sylle, Maria Leopold and

Regina E. Roller-Wirnsberger; Graz, Austria

P-777 THE MDRD AND COCKCROFT-GAULT FORMULAS FAIL TO CORRECTLY

DETECT A FAST GLOMERULAR FILTRATION RATE DECLINE IN RENAL

TRANSPLANT RECIPIENTS

Nicolas Maillard, Manolie Mehdi, Blandine Laurent, Lise Thibaudin, François

Berthoux, Eric Alamartine and Christophe Mariat; Saint-Etienne, France

P-778 USE OF HIGH DOSE HUMAN IMMUNOGLOBULIN IN HIGHLY

SENSITIZED PATIENTS ON KIDNEY TRANSPLANT WAITING LIST –

ONE CENTER EXPERIENCE

Jolanta Gozdowska, Arkadiusz Urbanowicz, Jacek Szmidt, Andrzej Chmura

and Magdalena Durlik; Warsaw, Poland


P-779 RISK FACTORS FOR LOW BONE MINERAL DENSITY IN LONG-TERM

RENAL TRANSPLANT RECIPIENTS: A CROSS-SECTIONAL AND

LONGITUDINAL STUDY

Spyros Dovas, Domniki Economidou, Aikaterini Papagianni, Eirini

Kazantzidou, Panagiotis Pateinakis, Georgios Efstratiadis, Dimitrios Takoudas

and Dimitrios Memmos; Thessaloniki, Greece

P-780 SMILE, A NEW MOLECULE INVOLVED IN OPERATIONAL TOLERANCE

IN TRANSPLANTATION?

Maud Racapé, Magali Giral, Jean-Paul Duong Van Huyen, Richard Danger,

Annaïck Pallier, Joanna Ashton-Chess, Emilie Dugast, Ségolène Pettré,

Béatrice Charreau, Jean-Paul Soulillou and Sophie Brouard; Nantes, France

P-781 CECAL PERFORATION COMPLICATING DISSEMINATED

HISTOPLASMOSIS AFTER KIDNEY TRANSPLANTATION

Mohamed Mongi Bacha, Ezzedine Abderrahim, Mondher Ounissi, Sonia

Trabelsi, Samira Khaled, Nadia Kourda, Michel Huerre, Taieb Ben Abdallah

and Adel Kheder; Tunis, Tunisia and Paris, France

P-782 RISK FACTORS FOR LATE OCCURING PNEUMOCYSTIS JIROVECI

PNEUMONIA IN RENAL TRANSPLANT RECIPIENTS: A CASE CONTROL

STUDY

Nathalie De Castro, Imad Abboud, Evangeline Pillebout, Raphael Porcher,

Denis Glotz, Jean-Michel Molina and Marie-Noelle Peraldi; Paris, France

P-783 ETIOLOGY OF DELAYED GRAFT FUNCTION (DGF) IN RENAL

TRANSPLANT RECIPIENTS UNDER DIFFERENT IMMUNOSUPPRESSIVE

REGIMENS

Alexander S. Nikonenko, Andrei V. Trailin, Tamara N. Nikonenko, Tatiana I.

Ostapenko and Nikolai N. Polyakov; Zaporizhzhya, Ukraine

P-784 SPECIFICITY OF ELICITED ANTI-HLA ANTIBODIES IN STABLE RENAL

TRANSPLANTED PATIENTS

Michela Seveso, Federica Besenzon, Lucrezia Furian, Manuela Lazzarin,

Maria Cappuccilli, Antonio Gargiulo, Margherita Mangino, Alberto Rosati,

Lorenzo Di Maria, Aldo Pozzetto, Giustina De Silvestro and Emanuele Cozzi;

Padua, Italy; Bologna, BO, Italy; Rome, Italy; Bari, Italy and Firenze, Italy

P-785 INITIAL EXPERIENCE WITH TRANSPLANT RENAL ARTERY

STENOSIS ANGIOPLASTY AND STENTING DOES NOT CONFIRM

ANTIHYPERTENSIVE OR RENAL FUNCTION BENEFIT

Rafal Kieszek, Krzysztof Ostrowski, Olgierd Rowinski, Magdalena Durlik,

Andrzej Chmura and Marcin Geremek; Warsaw, Poland

P-786 LIVING KIDNEY DONORS: LONG TERMS OUTCOME

Olga E. Guardia, Luis R. Leon, Demian H. Curcio, Jorgelina N. Petroni,

Maria Del Carmen Rial, Luis S. Re and Domingo H. Casadei; Buenos Aires,

Argentina

P-787 SKIN CANCER IN POLISH RENAL TRANSPLANT RECIPIENTS (RTR)

Beata Imko-Walczuk, Slawomir Lizakowski, Janusz Jaskiewicz, Waldemar

Placek, Boleslaw Rutkowski and Alicja Debska-Slizien; Gdansk, Poland and

Bydgoszcz, Poland

P-788 PREVALENCE OF ANEMIA IN KIDNEY TRANSPLANT RECIPIENTS AND

NON-TRANSPLANT PATIENTS WITH CHRONIC KIDNEY DISEASE

Ming Ju Wu, Kuo-Hsiung Shu, Chi Hung Cheng, Cheng-Hsu Chen, Dong

Ming Yu and Ya Wen Chuang; Taichung, Taiwan, Taiwan

P-789 KIDNEY TRANSPLANTATION IN ADULTS WITH AN ILEAL CONDUIT

FORMATION – THE ONLY CENTER IN POLAND EXPERIENCE

Andrzej Chmura, Andrzej Borkowski, Wojciech Rowinski, Piotr Radziszewski,

Janusz Trzebicki and Artur Kwiatkowski; Warsaw, Poland

P-790 THE SKIN CANCER AWARENESS AND QUALITY OF LIFE IN RENAL

TRANSPLANT RECIPIENTS

Magdalena Graczyk, Magdalena Kroban, Beata Imko-Walczuk, Janusz

Jaskiewicz, Waldemar Placek, Boleslaw Rutkowski, Alicja Debska-Slizien and

Zbigniew Wlodarczyk; Gdansk, Poland and Bydgoszcz, Poland

194


195

POSTERS

P-791 TREATMENT OF URINARY COMPLICATIONS AFTER KIDNEY

TRANSPLANTATION

Andrzej Chmura, Wojciech Rowinski, Janusz Walaszewski, Maciej Czaplicki,

Janusz Trzebicki and Artur Kwiatkowski; Warsaw, Poland

P-792 GIANT ANGIOMYXOID TUMOUR IN A RENAL ALLOGRAFT: A

DIAGNOSTIC DILEMMA

Sanjay Mehra, Forgacs Bence, Sarah Heap, Helen Denley, Riad Hany, Neil

R. Parrott, Titus A. Augustine and Babatunde Campbell; Manchester,

Lancashire, United Kingdom

P-793 THE IMPACT OF SKIN CANCER AWARENESS ON PROPHYLACTIC

BEHAVIOR AMONG RENAL TRANSPLANT RECIPIENTS

Magdalena Graczyk, Magdalena Kroban, Beata Imko-Walczuk, Janusz

Jaskiewicz, Waldemar Placek, Boleslaw Rutkowski, Alicja Debska-Slizien and

Zbigniew Wlodarczyk; Gdansk, Poland and Bydgoszcz, Poland

P-794 INNOVATIVE AND SUCCESSFUL USE OF KIDNEYS WITH RESECTED

SMALL RENAL CELL CARCINOMA OR URETERIC INJURY FOR KIDNEY

TRANSPLANTATION

Wai Lim, Bulang He, Andrew Mitchell and Luc Delriviere; Perth, WA,

Australia

P-795 MONITORING OF ANTI HLA-ANTIBODIES IN LIVING RELATED RENAL

ALLOGRAFT RECIPIENTS IN EARLY POST-TRANSPLANT PERIOD AND

CORRELATION WITH PROTOCOL HISTOLOGY

Mukut Minz, Ashish Sharma, Ranjana Walker Minz, Amardeep Yadav,

Sarabpreet Singh and Kusum Joshi; Chandigarh, India

P-796 INCIDENCE OF C4D DEPOSITION IN PROTOCOL BIOPSIES IN LIVING

RENAL ALLOGRAFT TRANSPLANTATION

Mukut Minz, Ashish Sharma, Ranjana Walker Minz, Tameem Ahmed,

Sarabpreet Singh and Kusum Joshi; Chandigarh, India

P-797 ROLE OF ROUTINE IMPLANTATION BIOPSY IN RENAL

TRANSPLANTATION

Mettu S. Reddy, Syed Raza, Claire Ecuyer, Derek Leitch, Richard Baker, Magdi

Attia, Krish Menon and Niaz Menon; Leeds, United Kingdom

P-798 OPERATIVE INTERVENTION FOR AUTOSOMAL DOMINANT

POLYCYSTIC KIDNEY AND LIVER DISEASE: A UK SINGLE CENTRE

EXPERIENCE

Yasha Johari and Michael L. Nicholson; Leicester, Leicestershire, United

Kingdom

P-799 LIVING DONOR KIDNEY TRANSPLANTATION (LDKT)- 10 YEARS

SINGLE CENTRE EXPERIENCE

Andrzej Chamienia, Alicja Debska-Slizien, Boleslaw Rutkowski, Grazyna

Moszkowska, Darek Zadrozny and Zbigniew Sledzinski; Gdansk, Poland

P-800 SUCCESSFUL ABO INCOMPATIBLE RENAL TRANSPLANTATION

WITHOUT SPLENECTOMY AND/OR LOW-DOSE RITUXIMAB

TREATMENT

Takaharu Nagasaka, Kazuharu Uchida, Norihiko Watarai, Norihiko Goto,

Tetsuhiko Sato, Takahisa Hiramitsu, Susumu Matsuoka, Yoshihiro Tominaga,

Kunio Morozumi, Asami Takeda and Takaaki Kobayashi; Nagoya, Aichi,

Japan

P-801 BIMODAL DISTRIBUTION OF MAJOR CARDIOVASCULAR EVENTS IN

KIDNEY ALLOGRAFT RECIPIENTS

Francesca Fior, Francesco Nacchia and Luigi Boschiero; Verona, Italy

P-802 URETERAL STENT PLACEMENT AT ADULT KIDNEY TRANSPLANTATION:

SINGLE CENTER EXPERIENCE

Aydin Dalgic, Hakan Sozen, Turgay Arinsoy, Sükrü Sindel and Enver

Hasanoglu; Anakara, Turkey and Ankara, Turkey


P-803 RISK OF MALIGNANT NEOPLASMS AFTER KIDNEY TRANSPLANTATION.

SINGLE CENTER EXPERIENCE

Mihai M. Lucan, Gheorghita Iacob, Ciprian V. Lucan, Florin Elec and Adrian

Barbos; Cluj-Napoca, Cluj, Romania

P-804 IS RENAL BIOPSY OF INTRA-PERITONEALLLY PLACED KIDNEY

TRANSPLANTS ASSOCIATED WITH AN EXCESSIVE RISK?

Mohamed A. Ilham, Ali Haque, Michael Pritchard, David Griffi ths and Argiris

Asderakis; Cardiff, United Kingdom

P-805 HEMOLYTIC-UREMIC SYNDROME (HUS) / THROMBOTIC

MICROANGIOPATHY (TMA) IN RENAL ALLOGRAFT RECIPIENTS-

PROGNOSTIC FACTORS

Olga Kozinska-Przybyl, Andrzej Mroz, Zbigniew Lewandowski, Andrzej

Chmura, Zbigniew Galazka and Magdalena Durlik; Warsaw, Poland

P-806 HORSESHOE KIDNEY: SHOULD BE CONSIDERED FOR

TRANSPLANTATION?

Mihai M. Lucan, Florin Elec, Ciprian V. Lucan and Gheorghita Iacob; Cluj-

Napoca, Cluj, Romania

P-807 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN

(NGAL): IS IT A GOOD MARKER FOR KIDNEY GRAFT FUNCTION?

Francesca Fior, Francesco Nacchia, Claudio Cocco, Beatrice Caruso, Paolo

Rizzotti and Luigi Boschiero; Verona, Italy

P-808 ABO INCOMPATIBLE TRANSPLANTATION WITH MINIMAL THERAPY;

AVOIDING IVIG AND POSTOPERATIVE IMMUNOABSORPTION

Nizam Mamode, David Curran, Vassilis Hadjianastassiou, Geoff Koffman and

Francis Calder; London, United Kingdom

P-809 FRECUENCY AND INFLUENCE OF HEMOCHROMATOSIS GENE

MUTATIONS IN KIDNEY TRANSPLANTED PATIENTS WITH OR

WITHOUT HEPATITIS C VIRUS INFECTION

Elisa Ramírez, Arantxa Patxo, Jose M. Morales, Estela Paz-Artal and Pablo

Morales; Madrid, Spain

P-810 POST TRANSPLANT RENAL ARTERY STENOSIS – DOES THE SOURCE

OF KIDNEY MATTER?

Manimaran Ranganathan, Adel Ilham and Nagappan Kumar; Cardiff, United

Kingdom

P-811 CORRELATION BETWEEN FIBROSCAN, LIVER BIOPSY AND CLINICAL

LIVER FUNCTION IN PATIENTS WTH HEPATITIS C VIRUS INFECTION

AFTER RENAL TRANSPLANTATION

Raquel Muñoz, Elisa Ramírez, Inmaculada Fernández, Marta Romero, Beatriz

Domínguez-Gil, Ana Hernández, Enrique Morales, Amado Andrés, Gregorio

Castellanos and Jose M. Morales; Madrid, Spain

P-812 LONG-TERM OUTCOMES IN RENAL TRANSPLANTATION AFTER

MORE THAN 25 YEARS OF GRAFT SURVIVAL

Asunción Ferrer Nadal, Itxiar Castaño, Fernanda Slon, Diana Izquierdo and

Pedro Errasti; Pamplona., Navarra, Spain

P-813 POST-TRANSPLANT ANEMIA (PTA) REDUCES LONG-TERM GRAFT

AND PATIENT SURVIVAL

Annamaria Maiorano, Anna Zito, Antonio Schena, Gianluigi Zaza, Vincenzo

Losappio, Francesco Paolo Schena and Giuseppe Grandaliano; Bari, Italy

P-814 DONOR-DERIVED INFLUENCE ON NON-INVASIVE FUNCTIONAL

HEMODYNAMIC MEASUREMENTS IN RENAL TRANSPLANTS: A

PAIRED KIDNEY ANALYSIS

Elizabeth Marti, Ivo P. Bergmann, Helmut Vorkauf, Felix F. Frey and Ute

Eisenberger; Bern, Switzerland

196


197

POSTERS

P-815 CONNECTION BETWEEN COAGULATION PARAMETERS AND GRAFT

FUNCTION IN EARLY PERIOD AFTER KIDNEY TRANSPLANTATION

Jacek Pawlicki, Lech Cierpka and Robert Król; Katowice, Poland

P-816 LIVE DONOR KIDNEY TRANSPLANTATION: UPDATING THE OCST

SITUATION

Renzo Pretagostini, Davide Stabile, Pamela Fiaschetti, Alessandra Oliveti,

Daniela Peritore and Francesco Gabbrielli; Rome, Italy

P-817 HLA CLASS-I (ABC) UP-REGULATION IN PERIPHERAL BLOOD CD8+ T

LYMPHOCYTE IS A POTENTIAL PREDICTOR FOR ACUTE REJECTION

IN RENAL TRANSPLANT

Jun Tian, Wenfeng Shi and Dianzheng Zhang; Jinan, Shandong, China; Jinan,

China and Philadelphia, United States

P-818 ASSESSMENT OF LIVER FIBROSIS IN KIDNEY TRANSPLANT

RECIPIENTS WITH HCV INFECTION: USEFULNESS OF TRANSIENT

ELASTOGRAPHY

Gloria Sanchez Antolin, Felix Garcia Pajares, Jose Maria Martinez, Maria

Antonia Vallecillo Sande, Alicia Mendiluce, Bustamante Jesus, Rosario Velicia

and Agustin Caro Paton; Valladolid, Spain

P-819 LAPAROSCOPIC DONOR NEPHRECTOMY: EFFECTS OF LARGE

VOLUME INTRA-OPERATIVE FLUID ADMINISTRATION

Aditya Kanwar, Vijayanand Dhakshinamoorthy, Hugh Wyrley-Birch,

Christopher Ray, Joe Cosgrove, Derek Manas, Naeem Soomro, David Talbot

and David Rix; Newcastle Upon Tyne, United Kingdom

P-820 THE IMPACT OF URETER ANASTOMOSIS TECHNIQUE ON

UROLOGICAL COMPLICATIONS AFTER KIDNEY TRANSPLANTATION

Edwin F. Dierselhuis, Christina Krikke, Jan Niesing, Jaap J. Homan van der

Heide and Rutger J. Ploeg; Groningen, The Netherlands

P-821 RISK FACTOR FOR CHRONIC REJECTION IN RECIPIENTS WITH DE

NOVO ANTIBODIES TO HLA ANTIGENS

Ines Humar, Zvonko Puretic, Ljubica Bubic, Maja Puc and Zeljko Kastelan;

Zagreb, Europa, Croatia

P-822 SUCCESSFUL DESENSITIZATION STRATEGIES USING LUMINEX

PRA IN ABO COMPATIBLE LIVING KIDNEY TRANSPLANTATION

ANALYSIS OF ACUTE REJECTION INCIDENT RATE WITHIN CASES OF

NEGATIVE PRA RESULT

Toshihito Hirai, Hideki ishida, Yuuki Miyauchi, Daisuke Tokita, Tomokazu

Shimizu, Hiroki Shirakawa, Kazuya Omoto and Kazunari Tanabe; Shinjuku-ku,

Tokyo, Japan

P-823 THE BURDEN OF MISDIAGNOSED RARE DISEASES IN RECIPIENT OF

RENAL TRANSPLANTATION

Andrea Airoldi, Elisa Lazzarich, Alberto Menegotto, Roberta Fenoglio, Marta

Tavecchia, Daniela Giachino, Giorgia Mandrile, Mario De Marchi, Giovanni

Fogazzi and Piero Stratta; Novara, Italy; Orbassano, Italy and Milano, Italy

P-824 HEPATITIS C VIRUS INFECTION AND THE OUTCOME OF THE KIDNEY

TRANSPLANTATION

Pavlina Dzekova Vidimliski, Marijan Bosevski, Irena Busletic Rambabova,

Jelka Masin Spasovska, Goce Spasovski, Ognen Ivanovski, Sonja Dzikova,

Aleksandar Sikole and Ninoslav Ivanovski; Skopje, Macedonia, The Former

Yugoslav Republic of

P-825 ELDERLY LIVE KIDNEY DONORS: SAFETY ON LONG-TERM

FOLLOW-UP

Leonienke F.C. Dols, Niels F.M. Kok, Noortje Wentink, Turkan Terkivatan,

Khe T.C. Tran, Willem Weimar and Jan N.M. Ijzermans; Rotterdam, The

Netherlands


P-826 ORGANS FROM DONORS WITH RENAL CELL CARCINOMA –

EXPERIENCES IN THE DSO-MIDDLE REGION

Kerstin Moench and Thomas Breidenbach; Mainz, Germany

P-827 LONG-TERM RESULTS OF RENAL TRANSPLANTATION IN PATIENTS

WITH ANTI HEPATITIS C ANTIBODIES

Beatriz Domínguez-Gil, Nuria Esforzado, Amado Andrés, Gregorio

Castellanos, Federico Oppenheimer, Josep M. Campistol and Jose M.

Morales; Madrid, Spain and Barcelona, Spain

P-828 REQUIEM FOR BK VIRUS NEPHROPATHY (BKN) – THREE-YEAR

EXPERIENCE OF SYSTEMATIC SCREENING

Björn S.W. Öqvist; Lund, Sweden

P-829 5-YEAR EXPERIENCE WITH THE EUROTRANSPLANT SENIOR

PROGRAM

Armin Thelen, Hans-Michael Tautenhahn, Michael Bartels, Dirk Uhlmann and

Sven Jonas; Leipzig, Germany

P-830 THE AVILABILITY OF 99 MTC-MAG3 RENOGRAPHY IN RENAL

TRANSPLANTATION FROM NON HEART BEATING DONORS

Ryohei Hattori, Tsuyoshi Majima, Kinukawa Tsuneo, Osamu Kamihira and

Shin Yamada; Nagoya, Aichi Prefecture, Japan; Okazaki, Aichi prefecture,

Japan and Komaki, Aichi Prefecture, Japan

P-831 APOPTOSIS OF TUBULAR EPITHELIAL CELLS IN PREIMPLANTATION

BIOPSIES OF KIDNEY GRAFTS WITH IMMEDIATE, SLOW AND

DELAYED FUNCTION

Robert Król, Jerzy Chudek, Henryk Karkoszka, Jacek Ziaja, Aureliusz Kolonko,

Jacek Pawlicki, Maciej Kajor, Andrzej Wiecek and Lech Cierpka; Ktowice,

Poland

P-832 RISK FACTORS FOR URINARY TRACT INFECTIONS IN RENAL

TRANSPLANTATION

Stephanie Grosch, Laurent Weekers, Martina Milicevic, Michel Meurisse and

Jean-Marie Krzesinski; Liege, Belgium

P-833 HAND-ASSISTED RETROPERITONEOSCOPIC VERSUS STANDARD

LAPAROSCOPIC DONOR NEPHRECTOMY

Leonienke F.C. Dols, Niels F.M. Kok, Turkan Terkivatan, Khe T.C. Tran, Ian P.J.

Alwayn, Willem Weimar and Jan N.M. Ijzermans; Rotterdam, The Netherlands

and Halifax, NS, Canada

P-834 PERITRANSPLANT NEPHRECTOMY IN AUTOSOMAL DOMINANT

POLYCYSTIC KIDNEY DISEASE– INDICATIONS AND OUTCOME

Sanjay Mehra, Lorna Mcwilliam, Colin D. Short, Tavakoli Afshin, Ravi

Pararajasingam, Babatunde Campbell, Hany N. Riad, Neil R. Parrott and

Titus A. Augustine; Manchester, Lancashire, United Kingdom

P-835 HIGH INCIDENCE OF PARATHYROIDECTOMY AND

NEPHROCALCINOSIS IN RENAL TRANSPLANT RECIPIENTS

DISCONTINUING CINACALCET AT THE TIME OF TRANSPLANTATION

Pieter Evenepoel, Ben Sprangers, Evelyne Lerut, Bert Bammens, Kathleen

Claes, Dirk Kuypers and Yves Vanrenterghem; Leuven, Belgium

P-836 LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING

LAPAROSCOPIC AND MINI-INCISION OPEN DONOR NEPHRECTOMY

Leonienke F.C. Dols, Niels F.M. Kok, Noortje Wentink, Khe T.C. Tran, Willij C.

Zuidema, Ine M. Dooper, Willem Weimar and Jan N.M. Ijzermans; Rotterdam,

The Netherlands and Nijmegen, The Netherlands

P-837 LONG TERM KIDNEY FUNCTION AFTER PREEMPTIVE KIDNEY

TRANSPLANTATION IN POLYCYSTIC LIVER ANS KIDNEY DISEASE

Hans-Michael Tautenhahn, Armin Thelen, Michael Bartels, Dirk Uhlmann and

Sven Jonas; Leipzig, Germany

198


199

POSTERS

P-838 KIDNEY TRANSPLANTATION MODIFIES THE CARDIOVASCULAR RISK

PROFILE OF HEMODYALISIS (HD) PATIENTS

Margherita Mangino, Annamaria Maiorano, Antonio Schena, Marco Ciccone,

Simona Simone, Giovanni Pertosa, Francesco Paolo Schena and Giuseppe

Grandaliano; Bari, Italy

P-839 LAPAROSCOPIC VERSUS OPEN DONOR NEPHRECTOMY – THE

EFFECT OF DONOR AGE AND BODY MASS INDEX ON OUTCOME

Rebecca Dawson, Dan Ridgway, Charles Newstead, Adrian Joyce, John

Cartledge, Magdi Attia, Stephen Pollard, Niaz Ahmad and Krish Menon;

Leeds, United Kingdom

P-840 CYTOKINE AND IMMUNE MODULATOR GENE EXPRESSION IN

PERIPHERAL BLOOD MONONUCLEAR CELLS OF ACUTE RENAL

ALLOGRAFT REJECTION

Byung-Mo Lee, Chang-Kwon Oh and Ji-Hye Kim; Suwon, Gyeong-gi, Korea

P-841 THE ROLE OF INTERLEUKIN-6 HAPLOTYPES ON CARDIOVASCULAR

OUTCOME IN A KIDNEY TRANSPLANT COHORT

Bernd Krüger, Andreas Walberer, Stefan Farkas, Aiman Obed, Hans J. Schlitt,

Bernhard Banas and Bernhard K. Krämer; Herne, Germany and Regensburg,

Germany

P-842 PREDICTION OF CARDIOVASCULAR AND RENAL OUTCOMES AFTER

KIDNEY TRANSPLANTATION THROUGH INFLAMMATION MARKERS

PRIOR TO TRANSPLANT

Bernd Krüger, Andreas Walberer, Jens Debler, Carsten A. Böger, Stefan

Farkas, Aiman Obed, Hans J. Schlitt, Michael Fischereder, Bernhard Banas

and Bernhard K. Krämer; Herne, Germany; Regensburg, Germany and

München, Germany

P-843 LAPAROSCOPIC VERSUS OPEN DONOR NEPHRECTOMY –

COMPARABLE OUTCOMES FROM A SINGLE CENTRE SERIES

Rebecca Dawson, Dan Ridgway, Charles Newstead, Adrian Joyce, John

Cartledge, Magdi Attia, Stephen Pollard, Niaz Ahmad and Krish Menon;

Leeds, United Kingdom

P-844 COMPARATIVE ANALYSES OF ELDERLY AND YOUNG DONORS FOR

RETROPERITONEOSCOPIC LIVE DONOR NEPHRECTOMY

Masahiro Yashi, Takashi Yagisawa, Akinori Nukui, Takehito Fujiwara, Yasunaru

Sakuma, Nobuo Ishikawa, Naoshi Miyamoto and Osamu Muraishi; Tochigi,

Japan and Tokyo, Japan

P-845 EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES

FOLLOWING RENAL TRANSPLANTATION: PRELIMINARY RESULTS OF

A MULTICENTER STUDY

Emanuele Cozzi, Franco Citterio, Francesco P. Schena, Maurizio Salvadori,

Sergio Stefoni, Giuseppe P. Segoloni, Mariapiera Scolari, Elisabetta Bertoni,

Giuseppe Grandaliano, Biagio Favoino, Michela Seveso, Federica Besenzon,

Lucrezia Furian and Paolo Rigotti; Padua, Italy; Rome, Italy; Bari, Italy; Firenze,

Italy; Bologna, Italy; Torino, Italy and Padua, Italy

P-846 IDENTIFYING IMMUNOLOGICAL RISK FACTORS IN KIDNEY

TRANSPLANTATION

Dietlind Tittelbach-Helmrich, Oliver Drognitz, Przemyslaw Pisarski and Oliver

Thomusch; Freiburg, Germany

P-847 CYCLOSPORIN A AND TACROLIMUS, COMBINED WITH

MYCOPHENOLIC ACID, ARE EQUALLY EFFECTIVE IN PREVENTING

THE ONSET OF DE NOVO ANTI-HLA ANTIBODIES

Federica Besenzon, Michela Seveso, Lucrezia Furian, Elena Ruffoni, Francesco

Marchini, Barbara Rossi, Luciana Bonfante, Piero Marson, Manuela Lazzarin,

Paola Todeschini, Alessia Formigari, Paolo Rigotti and Emanuele Cozzi;

Padua, Italy and Bologna, BO, Italy


P-848 IMPACT OF UTI ON THE LONG-TERM KIDNEY ALLOGRAFT FUNCTION

IN ADULTS WITH URINE COLLECTING SYSTEM RECONSTRUCTION

Joanna Pazik, Ewa Wazna, Zbigniew Lewandowski, Andrzej Chmura,

Slawomir Nazarewski and Magdalena Durlik; Warsaw, Poland

P-849 LATE SURGICAL COMPLICATIONS MIMICKING CHRONIC

ALLOGRAFT NEPHROPATHY

Luisa Berardinelli; Milan, Italy

P-850 IMPACT OF INDUCTION WITH BIOLOGICS IN KIDNEY TRANSPLANT

PATIENTS WITH A POSITIVE SEROLOGY FOR HEPATITIS C:

LONG-TERM ASSESSMENT IN A COLLABORATIVE STUDY

Beatriz Domínguez-Gil, Nuria Esforzado, Amado Andrés, Federico

Oppenheimer, Gregorio Castellanos, Josep M. Campistol and Jose M.

Morales; Madrid, Spain and Barcelona, Spain

P-851 FOURTH WHO GOAL IS “TO ADD LIFE TO YEARS”: FOR RENAL

TRANSPLANTED RECIPIENTS WE DID

Cristina Izzo, Katia Toffolo, Elisa Lazzarich, Cristina Cornella, Francesca

Cofano, Maria Cristina Barbè, Andrea Airoldi, Annalisa Ceruso, Daniela

Cella, Tiziana Cena and Piero Stratta; Novara, Italy

P-852 MIMINALLY INVASIVE LIVING DONOR NEPHRECTOMY: IMPROVED

RESULTS DURING RECENT YEARS – A SINGLE CENTER EXPERIENCE

Ole Øyen and Per F. Pfeffer; Oslo, Norway

P-853 WITHDRAW

P-854 CUSTODIOL VERSUS EUROCOLLINS: EFFECT ON EARLY GRAFT

RECOVERY AND 24 MONTHS OUTCOME AFTER LIVING RENAL

TRANSPLANTATION

Irena Rambabova-Busljetic, Zivko Popov, Jelka Masin, Goce Spasovski,

Gjulsen Selim, Perko Kolevski and Ninoslav Ivanovski; Skopje, MKD,

Macedonia, The Former Yugoslav Republic of

P-855 EPIDEMIOLOGY OF INFECTIOUS COMPLICATIONS AND THEIR

IMPACT ON THE OUTCOME OF RENAL TRANSPLANTATION

RECIPIENTS (RTR)

Taieb Ben Abdallah, Mejda Cherif, Mondher Ounissi, Ezzedine Abderrahim,

Samia Barbouch, Imad Helal, Adel Kheder and Yousr Gorgy; Tunis, Tunisia

P-856 INFLUENCE OF ADVANCED AGE OF THE DONOR ON THE

EVOLUTION OF RENAL TRANSPLANTATION

Hafed Ketata, Walid Charfi , Mahdi Bouacida, Ali Bahloul and Mohamed N.

Mhiri; Sfax, Tunisia

P-857 EVOLUTION OF KIDNEY TRANSPLANTATION USING MULTIPLE

ARTERIES RENAL GRAFTS

Mohamed N. Mhiri, Hafed Ketata, Walid Charfi , Mahdi Bouacida and Ali

Bahloul; Sfax, Tunisia

P-858 ABO INCOMPATIBLE LIVING DONOR TRANSPLANTATION- THE FIRST

CLINICAL EXPERIENCE IN SKOPJE

Ninoslav Ivanovski, Jelka Masin, Perko Kolevski, Galina Severova and Zivko

Popov; Skopje, MKD, Macedonia, The Former Yugoslav Republic of

P-859 ROLE OF CALCIUM PRELOADING IN PATIENTS UNDERGOING

PARATHYROIDECTOMY FOR RENAL HYPERPARATHYROIDISM

Debabrata Roy, Parvin Dhaliwal, David Hughes and Ashok Handa;

Headington, Oxford, United Kingdom

P-860 VASCULAR THROMBOSES AFTER RENAL TRANSPLANTATION

Hafed Ketata, Mahdi Bouacida, Walid Charfi , Mourad Hadj Slimen, Ali

Bahloul and Mohamed N. Mhiri; Sfax, Tunisia

200


201

POSTERS

P-861 EARLY MTOR INHIBITION BLOCKS GLOMERULAR HYPERTROPHY

AFTER RENAL MASS REDUCTION

Jordi Rovira, Josep M. Campistol, Joaquim Carreras, Marcelo Arellano,

Elisenda Banon-Maneus, María J. Ramirez-Bajo, Daniel Moya, Luis Quintana

and Fritz Diekmann; Barcelona, Spain and Berlin, Germany

P-862 MTOR INHIBITION BLOCKS CARDIAC HYPERTROPHY AFTER RENAL

MASS REDUCTION

Jordi Rovira, Marcelo Arellano, Joaquim Carreras, Daniel Moya, Elisenda

Banon-Maneus, María J. Ramirez-Bajo, Luis Quintana, Ignacio Revuelta, Fritz

Diekmann and Josep M. Campistol; Barcelona, Spain and Berlin, Germany

P-863 BENEFIT OF RENAL TRANSPLANT BIOPSIES

Saskia Merkel, Horst Doehring, Verena Broecker, Hermann Haller and Anke

Schwarz; Hannover, Germany

P-864 CLINICAL EVALUATION OF THE MECHANICAL SUTURE IN

VASCULAR OPERATIONS IN END STAGE RENAL FAILURE AND

POSTTRANSPLANT PATIENTS WITH COAGULOPATHY – AN OWN

EXERIENCE

Andrzej Chmura; Warsaw, Poland

P-865 FUNCTIONAL AND METABOLIC EFFECTS OF EVEROLIMUS-BASED

IMMUNOSUPPRESSION IN DUAL KIDNEY TRANSPLANTATION

Decenzio Bonucchi, Giulia Ghiandai, Claudio Americo, Giacomo Mori,

Vittorio Albertazzi, Sara De Amicis and Gianni Cappelli; Modena, Italy

P-866 ANAEMIA AND ERYTHROCYTOSIS AFTER KIDNEY TRANSPLANTATION

AND 5-YEAR GRAFT SURVIVAL

Joanna Pinocy-Mandok, Aureliusz Kolonko, Jerzy Chudek and Andrzej

Wiecek; Katowice, Poland

P-867 USE OF STENTING IN LIVE KIDNEY DONATION: DOES IT REDUCE

VESICOURETERAL COMPLICATIONS?

Leonienke F.C. Dols, Turkan Terkivatan, Niels F.M. Kok, Khe T.C. Tran,

Willem Weimar, Jan N.M. Ijzermans and Joke I. Roodnat; Rotterdam, The

Netherlands

P-868 EARLY PREDICTIVE RISK FACTORS OF RENAL DETERIORATION IN

TRANSPLANT RECIPIENT

Asunción Sancho Calabuig, Asunción Sancho Calabuig, Luis M. Pallardó

Mateu, Luis M. Pallardó Mateu, Eva Gavela Martínez, Eva Gavela Martínez,

Ana I. Avila Bernabeu, Ana I. Avila Bernabeu, Sandra Beltrán Catalán, Sandra

Beltrán Catalán and Josep F. Crespo Albiach; Valencia, Spain

P-869 COMPARATIVE ANALYSIS OF ELDERLY VS YOUNG RENAL TRANSPLANT

RECIPIENTS: SOUTH INDIAN EXPERIENCE

Asik Ali Mohamed Ali, Yogesh Reddy, S. Saravannan, Milly Mathew, Pallavi

Khanna and Georgi Abraham; Chennai, Tamil Nadu, India

P-870 RESULT OF KIDNEY TRANSPLANTATION, EVOLUTION OF RENAL

FUNCTION AND PROTEINURIA IN SPAIN IN THE ACTUAL

IMMUNOSUPPRESSIVE ERA

J.M. Morales, R. Marcen, D. Del Castillo, M. Gonzalez Molina and Grupo del

Forum Renal; Madrid, Spain; Cordoba, Spain and Malaga, Spain

P-871 THE INVOLVEMENT OF ACTIVATED T CELLS AND CYTOKINES

PRODUCTIONS CORRELATES WITH CLINICAL OUTCOMES IN

CHRONIC RENAL ALLOGRAFT REJECTION: HOW FAR/CLOSE WE

ARE?

Ines Humar, Zvonimir Puretic, Maja Puc, Ljubica Bubic and Zeljko Kastelan;

Zagreb, Europa, Croatia

P-872 DOES RENAL TRANSPLANTATION IMPROVE QUALITY OF LIFE?

Undine Ott, Uwe Wutzler, Thomas Steiner, Jörg Schubert and Gunter Wolf;

Jena, Germany and Stadtroda, Germany


P-873 COMBINED LIVER AND KIDNEY TRANSPLANTATION

(SIMULTANEOUS OR SEQUENTIAL) IN SPAIN

D. del Castillo, O. Bestard, N. Esforzado, M.L. González, C. Cantarell, J.J.

Amenábar, A. Moya, R. Marcén, A. Otero and PERLA Study Group; Córdoba,

Spain; Barcelona, Spain; Barcelona, Spain; Oviedo, Spain; Barakaldo, Vizcaya,

Spain; Valencia, Spain; Madrid, Spain and A Coruña, Spain

P-874 INFLUENCE OF URETHER CATHETERYSATION ON FREQUENCY OF

MAJOR UROLOGICAL COMPLICATIONS IN PATIENT UNDERWENT

RENAL TRANSPLANTATION

Justyna Bigda, Justyna Kostro, Dariusz Zadrozny, Walenty Adamonis and

Zbigniew Sledzinski; Gdansk, Poland

P-875 B CELL DEPLETION AT INDUCTION INCREASES ACUTE REJECTION

Menna R. Clatworthy, Chris Watson, Gemma Plotnek, Vicky Bardsley, J.

Andrew Bradley, Afzal N. Chaudhry and Ken G.C. Smith; Cambridge, United

Kingdom

P-876 DE NOVO BRONCHIOGENIC MALIGNANCIES FOLLOWING KIDNEY-

PANCREAS TRANSPLANTATION – A SINGLE CENTER REPORT

Manuel Maglione, Florian Augustin, Claudia Boesmueller, Thomas Schmid

and Raimund Margreiter; Innsbruck, Austria

P-877 POLYOMAVIRUS BK-SPECIFIC CYTOTOXIC T CELLS AFTER KIDNEY

TRANSPLANTATION: RATIONALE FOR A CELL THERAPY APPROACH

TO VIRUS-RELATED DISEASE

Patrizia Comoli, Antonella Gurrado, Michela Cioni, Angelica Parodi, Hans H.

Hirsch, Sabrina Basso, Iris Fontana, Giancarlo Barbano, Franco Locatelli and

Fabrizio Ginevri; Pavia, Italy; Genova, Italy and Basel, Switzerland

P-878 ADIPOSITAS IN KIDNEY TRANSPLANTATION – AN ADDITIONAL RISK

FACTOR IN RECIPIENTS OF THE EUROPEAN SENIOR PROGRAMME?

Heiner H. Wolters, Julia Unser, Christina Schleicher, Markus Utech, Daniel

Palmes, Barbara Suwelack, Jens G. Brockmann and Norbert Senninger;

Muenster, Germany and Oxford, United Kingdom

P-879 HIGH INCIDENCE OF OVARIAN CYSTS AFTER RENAL

TRANSPLANTATION UNDER IMMUNOSUPPRESSION WITH MTOR

INHIBITORS

Friederike Bachmann, Michael Dürr, Petra Glander, Torsten Slowinski, Fritz

Diekmann, Hans-Helmut Neumayer and Klemens Budde; Berlin, Germany

P-880 ANTIBODY MEDIATED MICROCIRCULATION DAMAGE PLAYS A KEY

ROLE IN LATE KIDNEY TRANSPLANT LOSS

G. Einecke, B. Sis, J. Reeve, L.G. Hidalgo, M. Mengel, B. Kaplan and P.F.

Halloran; Edmonton, AB, Canada and Tucson, AZ, United States

Liver & intestine II

P-881 THE USEFULNESS OF A NEW REFRIGERATOR FOR PRESERVATION

OF WHOLE BLOOD

Mami Kanamoto, Mitsuo Shimada, Jun Hanaoka, Yusuke Arakawa, Hirofumi

Kanemura, Yuji Morine, Satoru Imura, Hideaki Uchiyama, Nobuhiro Kurita,

Toru Utsunomiya and Hidenori Miyake; Tokushima, Japan

P-882 ENDOGENOUS PROTEASE INHIBITOR UPTAKE WITHIN THE GRAFT

DURING REPERFUSION IN HUMAN LIVER TRANSPLANTATION

Minna Ilmakunnas, Krister Höckerstedt, Heikki Mäkisalo, Sanna Siitonen,

Heikki Repo and Eero J. Pesonen; Helsinki, Finland

P-883 PROLONGED HYPOMAGNESAEMIA AFTER ADULT LIVING DONOR

LIVER TRANSPLANTATION (LDLT) FOR FULMINANT HEPATIC FAILURE

(FHF)

Hamed Elgendy, Walid Elmoghazy, Kazuhiko Fukuda and Shinji Uemoto;

Kyoto, Japan

202


P-884 WITHDRAW

203

POSTERS

P-885 LONG-TERM EFFECTS OF PROPHYLACTIC SPLENIC ARTERY

LIGATION ON PORTAL OVERPERFUSION IN LIVING DONOR LIVER

TRANSPLANTATION

Qian Zhan, Bai-Yong Shen, Yong-Jun Chen, Chen-Hong Peng and Hong-Wei

Li; Shanghai, China

P-886 ORTHOTOPIC LIVER TRANSPLANT: MODIFIED TOTAL HEPATECTOMY

WITHOUT ANHEPATIC PHASE

Lorenzo Jose and Santiesteban Neyla; Holguin, Cuba

P-887 EFFECT OF DONOR HEPATECTOMY TIME DURING MULTI-ORGAN

RETRIEVAL ON EARLY GRAFT FUNCTION FOLLOWING ADULT

CADAVERIC LIVER TRANSPLANTATION

Mettu S. Reddy, Syed Raza, James Pine, Rajendra Prasad and Niaz Ahmed;

Leeds, United Kingdom

P-888 ADVAGRAF IN LIVER TRANSPLANTATION: DOCE DE OCTUBRE

UNIVERSITY HOSPITAL EXPERIENCE, MADRID, SPAIN

Yiliam Fundora, Vanessa Barra, Santos Jiménez, Juan Carlos Menéu, Alberto

Gimeno, Manuel Abradelo, Carlos Jiménez, Vanessa López, Manuel O.

Salinas and Enrique Moreno; Madrid, Spain

P-889 BILIARY COMPLICATIONS IN LIVER TRANSPLANTATION: 12 DE

OCTUBRE UNIVERSITY HOSPITAL EXPERIENCE, MADRID, SPAIN

Yiliam Fundora, Juan Carlos Menéu, Baltasar Pérez, Manuel Abradelo,

Alberto Gimeno, Carlos Jiménez, Vanessa Barra, Santos Jiménez and Enrique

Moreno; Madrid, Spain

P-890 HIGH MELD SCORE AND ELDERLY PATIENTS: GOOD RESULTS FROM

BAD COMBINATIONS

Rogerio C. Afonso, Maria Paula V.C. Zurstrassen, Andre I. David, Marcio

D. Almeida, Bianca Della Guardia and Ben-Hur Ferraz-Neto; Sao Paulo, SP,

Brazil

P-891 THE INFLUENCE OF RETROGRADE REPERFUSION ON THE

ISCHAEMIA-/REPERFUSION INJURY AFTER LIVER TRANSPLANTATION

IN THE RAT

Hans Kern, Christian Bald, Falco Fend, Manfred Stangl and Edouard

Matevossian; Münster, Bavaria, Germany and Hamburg, Germany

P-892 PREOPERATIVE DIAGNOSIS OF POORLY DIFFERENTIATED GRADE

IN PATIENTS WITH LARGE HEPATOCELLULAR CARCINOMA: A

PROSPECTIVE CONTROLLED STUDY

Alessandro Vitale, Maria Guido, Maurina Costantin, Ambrogio Fassina,

Massimo Rugge, Francesco D’Amico, Giacomo Zanus, Alberto Brolese and

Umberto Cillo; Padua, Italy

P-893 COST-UTILITY OF THE MOLECULAR ADSORBENT RECYCLING

SYSTEM (MARS) TREATMENT

Taru P. Kantola, Suvi Mäklin, Anna-Maria Koivusalo, Pirjo Räsänen, Anne

Rissanen, Risto Roine, Harri Sintonen, Krister Höckerstedt and Helena

Isoniemi; Helsinki, Finland

P-894 SHORT AND LONG-TERM OVERALL RESULTS WITH LIVER

RETRANSPLANTATION: “12 DE OCTUBRE” HOSPITAL EXPERIENCE

DURING THE LAST 10 YEARS

Baltasar Pérez-Saborido, Santos Jiménez de los Galánes, Vanessa Barra-

Valencia, Verónica Molinero, María Sanz, María Concepción Fernández, Juan

Carlos Menéu-Díaz, Yillian Fundora-Suárez, Alberto Giméno-Calvo, Manuel

Abradelo de Usera and Enrique Moreno-González; Madrid, Spain


P-895 IS IT THE PREOPERATIVE ALPHAPHETOPROTEIN VALUE A

PROGNOSTIC FACTOR FOR THE LONG-TERM RESULTS OF PATIENTS

TRANSPLANTED WITH HEPATOCELLULAR CARCINOMA

Baltasar Pérez-Saborido, Juan Carlos Menéu-Díaz, María Donat-Garrido,

Vanessa Barra-Valencia, Santos Jiménez de los Galánes, Yillian Fundora-

Suárez, Almudena Moreno Elola-Olaso, Manuel Octavio Salinas, Vanesa

López-Jara, Carlos Jiménez-Romero and Enrique Moreno-González; Madrid,

Spain and Vallecas, Spain

P-896 THE RISK OF CHRONIC RENAL DYSFUNCTION IN LIVER TRANSPLANT

RECIPIENTS

Mariana Mihaila, Laurentiu Micu, Camelia Ionescu, Irinel Popescu and Mihai

Voiculescu; Bucharest, Romania

P-897 EXPERIENCES IN THE EARLY MOLECULAR ABSORBENT

RECIRCULATING SYSTEM (MARS) TREATMENT OF AMANITA

MUSHROOM POISONING

Taru P. Kantola, Teemu M. Kantola, Anna-Maria Koivusalo, Krister Höckerstedt

and Helena Isoniemi; Helsinki, Finland

P-898 LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARICNOMA:

CAN WE INCREASE THE MILAN CRITERIA TO INDICATE IT?

Baltasar Pérez-Saborido, María Donat-Garrido, Alberto Gimeno-Calvo,

Vanessa Barra-Valencia, Santos Jiménez de los Galánes, Yillian Fundora-

Suárez, Juan Carlos Menéu-Díaz and Enrique Moreno-González; Madrid,

Spain and Vallecas, Spain

P-899 PROPHYLACTIC INTRAVENOUS ANTIBIOTICS DO NOT INFLUENCE

THE OUTCOME OF ACUTE LIVER FAILURE

Ziad Hassoun, Claire Fournier and Jean-Pierre Villeneuve; Brussels, Belgium

and Montreal, QC, Canada

P-900 THE SUSTAINED VIROLOGICAL RESPONSE AS MARKER OF

IMMUNOLOGICAL COMPLICATIONS ASSOCIATED WITH TREATMENT

COMBINED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR

RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

Vanessa Barra-Valencia, Alberto Gimeno Calvo, Baltasar Pérez-Saborido,

Inmaculada Fernández, Francisco Colina Ruizdelgado, Yilliam Fundora

Suárez, Juan Carlos Meneu Díaz, Sergio Pedro Olivares Pizarro, Iago Justo

Alonso, Manuel Abradelo de Usera, Carlos Jiménez Romero and Enrique

Moreno González; Madrid, Spain

P-901 THE ROLE OF THE TRANSFORMING GROWTH FACTOR B-1

POLYMORPHISM (CODON 10 AND 25) IN THE DEVELOPMENT

OF GRAFT FIBROSIS AND FIBROSIS PROGRESSION AFTER LIVER

TRANSPLANTATION FOR HCV-INDUCED LIVER DISEASE

Dennis Eurich, Sabine Boas-Knoop, Johan Lock, Jennifer Golembus, Ruth

Neuhaus, Peter Neuhaus and Ulf P. Neumann; Berlin, Germany

P-902 EVEROLIMUS AS A RESCUE THERAPY IN LIVER TRANSPLANTATION:

EXPERIENCE OF THE DOCE DE OCTUBRE UNIVERSITY HOSPITAL,

MADRID

Yiliam Y. Fundora, Juan Carlos Meneu, Vanessa V. Barra, Baltasar B. Pérez,

Alberto A. Gimeno, Manuel M. Abradelo, Carlos C. Jiménez and Enrique E.

Moreno; Madrid, Spain

P-903 RESULTS OF LIVER TRANSPLANTATION FOR TYROSINEMIA IN IRAN:

A SINGLE CENTER EXPERIENCE

Saman Nikeghbalian, Heshmatollah Salahi, Bita Germizadeh, Ali Bahador,

Kourosh Kazemi, Seyed mohsen Dehghani, Farzad Kakaei, Sina Ghaffaripour,

Behnam Sanei, Alireza Shamsaeefar and Seyed Ali Malek-hosseini; Shiraz,

Islamic Republic of Iran

P-904 ONE THOUNITED STATESND LIVER TRANSPLANTS FROM A SINGLE

EUROPEAN CENTER

Mireia Caralt, Laura Alvarez, Robert Rodriguez, Jose Luis Lazaro, Itxarone

Bilbao, Javier Bueno, Laia Blanco, Cristina Dopazo, Gonzalo Sapisochin,

Joaquim Balsells and Ramon Charco; Barcelona, Spain and Granada, Spain

204


205

POSTERS

P-905 LIVER TRANSPLANTATION IN IRAN: A 15 YEARS EXPERIENCE

Saman Nikeghbalian, Ali Bahador, Heshmatollah Salahi, Kourosh Kazemi,

Farzad Kakaei, Alireza Shamsaeefar, Behnam Sanei and Seyed Ali Malekhosseini;

Shiraz, Islamic Republic of Iran

P-906 INTESTINAL AND MULTIVISCERAL TRANSPLANTATION IN ADULTS

RECIPIENTS: A THERAPEUTIC OPCION IN SPAIN

Vanessa Barra-Valencia, Baltasar Pérez-Saborido, Yilliam Fundora Suárez,

Almudena Moreno Elola-Olaso, Juan Carlos Meneu Díaz, Alberto Gimeno

Calvo, Manuel Abradelo de Usera, Carolina Ibarrola, Mercedes Catalán,

Sergio Pedro Olivares Pizarro, Carlos Jiménez Romero, Miguel León and

Enrique Moreno González; Madrid, Spain and Madrid, Spain

P-907 WITHDRAW

P-908 THE EVALUATION OF LEARNING EFFECT AND FUNCTIONAL

CAPACITY IN LIVER TRANSPLANTATION CANDIDATES WITH THE SIX

MINUTE WALK TEST

Carla M. Tobias, Renata M. Ancreotti, Fernanda D.M. Galhardo, Cristina A.V.

Guedes and Ilka F.S.F. Boin; Campinas, SP, Brazil

P-909 INFLUENCE THE OF USE OF INCENTIVE SPIROMETRY IN

RESPIRATORY MUSCLE STRENGTH ON CANDIDATE FOR LIVER

TRANSPLANTATION – CASE REPORT

Fernanda D.M. Gallardo, Cristina A.V. Guedes, Otavio O. Furian, Cassio C.

Coimbra and Ilka F.S.F. Boin; Campinas, SP, Brazil

P-910 LIVER TRANSPLANTATION FOR HOMOZYGOS FAMILIAL

HYPERCHOLESTROLEMIA

Saman Nikeghbalian, Kourosh Kazemi, Heshmatoolah Salahi, Ali Bahadoor,

Seyed mohsen Dehghani, Farzad Kakaei, Mohammad bagher Khosravee,

Alireza Shamsaeefar and Seyed Ali Malek-hosseini; Shiraz, Fars, Islamic

Republic of Iran

P-911 DONOR SERUM CYTOKINES AFFECT EARLY BUT NOT LATE LIVER

TRANSPLANT FUNCTION

Maciej Kosieradzki, Beata Lagiewska, Marek Pacholczyk, Dominika Gutowska,

Wojciech A. Rowinski and Andrzej Chmura; Warsaw, Poland and Olsztyn,

Poland

P-912 RISK FACTORS FOR NON-ANASTOMOTIC BILIARY STRICTURES

FOLLOWING LIVER TRANSPLANTATION

Michael A. Fink, Jessica Howell, Paul J. Gow and Robert M. Jones; Melbourne,

VC, Australia

P-913 NON-ANASTOMOTIC BILIARY STRICTURES AFTER LIVER

TRANSPLANTATION. A SINGLE CENTRE EXPERIENCE

James Pine, Mettu Reddy, Mervyn Davies, Giles Toogood, Stephen Pollard,

Peter Lodge and Rajendra Prasad; Leeds, United Kingdom

P-914 NEW THERAPEUTIC OPPORTUNITY IN MANAGMENT OF INFECTION

BY MULTIRESTENT GERMS IN PATIENTS UNDERGOING SOLID

ORGAN TRANSPLANTATION. ROLE OF A NEW TETRACICLIN

TIGECICLINE

Giancarlo Ferretti, Francesco Pugliese, Franco Ruberto, Luca Poli, Gilnardo

Novelli, Massimo Rossi, Gianmarco Raponi, Cristina Ghezzi and Pasquale

Berloco; Rome, Italy

P-915 CYTOMEGALOVIRUS, HUMAN HERPESVIRUS-6 AND RECURRENCE

OF HEPATITIS C VIRUS AFTER LIVER TRANSPLANTATION

Ana C.S. Guardia, Ana M. Sampaio, Raquel S.B. Stucchi, Marilia I. Leonardi,

Isabel W. Pereira, Sandra Costa and Ilka F.S.F. Boin; Campinas, SP, Brazil

P-916 CMV, HHV-6 AND HHV-7 IN ADULT LIVER TRANSPLANTATION

RECIPIENTS: DIAGNOSIS BASED ON ANTIGENEMIA

Ana M. Sampaio, Ana C.S. Guardia, Raquel S.B. Stucchi, Marilia I. Leonardi,

Sandra B. Costa and Ilka F.S.F. Boin; Campinas, SP, Brazil


P-917 RIGHT SUBCOSTAL INCISION IN LIVER TRANSPLANTATION

Matteo Donataccio, Giorgio Dalle Ore and Dino Donataccio; Verona, Italy

P-918 OPTIMIZATION ON THE WAITING-LIST USING DONORS OLDER

THAN 75 YEARS FOR HEPATOCARCINOMA

Pedro Cascales, Pablo Ramirez, Antonio Rios, Ricardo Robles, Francisco

Sanchez Bueno, Julio Domingo, Rocio Gonzalez Sanchez and Pascual Parrilla

Paricio; Murcia, Spain

P-919 AMANITINE INTOXICATION IN A PORCINE MODEL: WHEN

TRANSPLANT, WHEN WAIT FOR REGENERATION?

Martin Schenk, Christian Thiel, Karolin Thiel, Matthias H. Morgalla and Alfred

Koenigsrainer; Tuebingen, Germany

P-920 SALVAGE OF THE TRANSPLANTED LIVER IN A CASE OF KINKING OF

CAVOPORTAL ANASTOMOSIS

Doina Hrehoret, Simona Dima, Vladislav Brasoveanu, Emil Matei, Mirela

Boros and Irinel Popescu; Bucharest, Sector 2, Romania

P-921 ANTI-TUBERCULOUS THERAPY STRATEGY IN PATIENTS WITH ACUTE

LIVER FAILURE (ALF) BEFORE AND AFTER LIVER TRANSPLANTATION

(LT)

Philippe Ichai, Fadi Antoun, Faouzi Saliba, Teresa Maria Antonini, Lelia

Escaut, Denis Castaing and Didier Samuel; Villejuif, France

P-922 HEPATOCELLULAR CARCINOMA IN UNRELATED VIRAL CIRRHOSIS:

DOWNSTAGING AND LONG TERM RESULTS AFTER LIVER

TRANSPLANTATION

Stefano Di Sandro, Alessandro Giacomoni, Abdallah Slim, Andrea Lauterio,

Iacopo Mangoni, Plamen Mihaylov, Paolo Aseni and Luciano De Carlis;

Milan, Italy

P-923 INACCURACY OF PREOPERATIVE IMAGING AND THE INFLUENCE ON

PATIENTS WITH LIVER TRANSPLANTATION FOR HEPATOCELLULAR

CARCINOMA

Christopher K. Burghuber, Tamas Balas, Georg P. Gyoeri, Ivan Kristo,

Christoph Mayrhofer, Fritz Wrba, Ferdinand Muehlbacher and Rudolf

Steininger; Vienna, Austria

P-924 INITIAL EXPERIENCE OF MICRODIALYSIS AS A METHOD OF

MONITORING INFLAMMATORY, ISCHAEMIC AND IMMUNOLOGICAL

EVENTS FOLLOWING LIVER TRANSPLANTATION

Irum Amin, Margaret Negus, Andrew Butler and Paul Gibbs; Cambridge,

United Kingdom

P-925 FACTORS INFLUENCING THE INDOCYANINE GREEN (ICG) TEST:

ADDITIONAL IMPACT OF ACUTE CHOLESTASIS – A PILOT STUDY

Maciej Malinowski, Johan F. Lock, Daniel Seehofer, Peter Neuhaus and

Martin Stockmann; Berlin, Germany

P-926 LIVER TRANSPLANTATION FOR FULMINANT HEPATIC GVHD AFTER

BONE MARROW TRANSPLANT FROM THE SAME LIVING DONOR:

CASE REPORT

Kenji Uryuhara, Satoshi Kaihara, Takako Yamada and Koichi Tanaka; Kobe,

Japan

P-927 EFFECT OF ANGIOTESIN II AND BRADYKININ INHIBITION IN RAT

REDUCED-SIZE LIVER TRANSPLANTATION

Susagna Padrissa Altes, Rosa Franco Gou, Olivier Boillot, Carmen Peralta

and Joan Rosello-Catafau; Barcelona, Spain and Lyon, France

206


207

POSTERS

P-928 SEQUENTIAL TREATMENT OF HCC IN A PATIENT WITH HBV

CIRRHOSIS AND LUNG TUBERCOLOSIS CAVITATION: LOCAL

ABLATION, LEFT LUNG PNEUMONECTOMY, LIVER TRANSPLANTATION

Matteo Donataccio, Giorgio Dalle Ore, Dino Donataccio, Maurizio Dan and

Francesco Calabrò; Verona, Italy

P-929 PREDICTION OF TACROLIMUS BLOOD LEVELS DURING THE FIRST

WEEK AFTER LIVER TRANSPLANTATION BY THE NEW LIMAX TEST

Johan F. Lock, Nicolay Videv, Eugen Schwabauer, Johan Pratschke, Peter

Neuhaus and Martin Stockmann; Berlin, Germany

P-930 A MULTI-FACTORIAL BIOLOGICAL MODULATION PROTOCOL THAT

AMELIORATES ISCHEMIA-REPERFUSION INJURY SIMULTANEOUSLY

REDUCES BILESALT TOXICITY IN PORCINE LIVER TRANSPLANTATION

FROM NON-HEART BEATING DONORS

Diethard Monbaliu, Harm Hoekstra, Jacques Pirenne and Robert Porte;

Leuven, Belgium and Groningen, Belgium

P-931 WORSE PATIENT SURVIVAL IN LIVER TRANSPLANT RECIPIENTS WITH

HISTORY OF TOBACCO USE

Richard S. Mangus, Amanda Hall, Audrey Krause, Amy Bax, Jonathan

A. Fridell, Rodrigo M. Vianna, Jared D. Andersen and A. Joseph Tector;

Indianapolis, IN, United States

P-932 RESULTS OF LIVER TRANSPLANTATION IN THE TREATMENT OF

HEPATIC ALVEOLAR ECHINOCOCCOSIS

Marcin Kotulski, Anna Mackiewicz, Krzysztof Zieniewicz, Waldemar Patkowski,

Bogdan Michalowicz and Marek Krawczyk; Warsaw, Poland

P-933 THE RISK FACTORS OF EARLY DYSFUNCTION OF THE LIVER GRAFT

Bartosz Cieslak, Zbigniew Lewandowski and Marek Krawczyk; Warsaw,

Poland

P-934 THE USE OF EXPANDED CRITERIA DONORS IN LIVER

TRANSPLANTATION IN SWEDEN DOES NOT COMPROMISE GRAFT

OR PATIENT SURVIVAL

Anastasios Kaxiras, Henryk Wilczek, Annika Tibell, Bo-Göran Ericzon and

William Bennet; Stockholm, Sweden

P-935 LATE BILIARY COMPLICATION AFTER SPLIT-LIVER TRANSPLANTATION.

A REPORT OF A PERCUTANEOUS TRANSHEPATIC BILE DUCT

ABLATION WITH N-BUTYL CYANOACRILATE

Andrea Lauterio, Abdallah Slim, Stefano Di Sandro, Alessandro Giacomoni,

Rocco Corso, Iacopo Mangoni, Plamen Mihaylov, Vincenzo Pirotta, Paolo

Aseni and Luciano De Carlis; Milan, Italy

P-936 PSYCHOLOGICAL SUPPORT, QUALITY OF LIFE AND ADAPTATION

AFTER LIVER TRANSPLANTATION: THE VERONA EXPERIENCE

Gaetano Trabucco, Matteo Donataccio, Lorella Fontana, Giorgio Dalle Ore,

Elena Bravi, Dino Donataccio and Alessandra Magalini; Verona, Italy

P-937 RATIONALIZATION OF LIVING DONOR LIVER TRANSPLANTATION

USING NON MICROSCOPIC ARTERIAL RECONSTRUCTION

Takahito Yagi, Hiroshi Sadamori, Hiroaki Matsuda, Susumu Shinoura and

Ryuichi Yoshida; Okayama City, Okayama, Japan

P-938 FOREIGN BODY GRANULOMA: A RARE CAUSE OF BILIARY

OBSTRUCTION AFTER LIVER TRANSPLANTATION

Ali Bahador, Kourosh Kazemi, Heshmatollah Salahi, Saman Nikeghbalian,

Farzad Kakaei, Masood Dehghani and Seyed Ali Malek-hosseini; Shiraz,

Islamic Republic of Iran


P-939 PERCUTANEOUS RADIOFREQUENCY (PRFA) AS A BRIDGE TO

LIVER TRANSPLANTATION (LT) FOR HEPATOCELLULAR CARCINOMA

(HCC)

Allaoua Smail, Rene Adam, Mylene Sebagh, Eric Vibert, Chady Salloum,

Fabiano Perdigao Cotta, Amine Benkabbou, Jean-Charles Duclos-Vallee,

Faouzi Saliba, Daniel Azoulay, Didier Samuel, Catherine Guettier and Denis

Castaing; Villejuif, France and Creil, France

P-940 DIFFERENT IMMUNSUPRESSIVE DRUG SELECTION AFFECTS THE

QUALITY OF LIFE FOLLOWING LIVER TRANSPLANTATION

Christian P. Kaudel, Klaus Michel, Hanelore Barg-Hock, Stefan Jackobs, Mark

D. Jaeger, Heiko Aselmann, A. Hahn, Juergen Klempnauer and Michael

Neipp; Hannover, Germany and Itzehoe, Germany

P-941 WITHDRAW

P-942 WITHDRAW

P-943 THE IMPACT OF DIABETES MELLITUS IN LONG-TERM OUTCOME OF

LIVER TRANSPLANT PATIENTS FOR HEPATITIS C

Cristina Dopazo, Itxarone Bilbao, Gonzalo Sapisochin, Lluis Castells, Jose

Luis Lazaro, Laia Blanco, Mireia Caralt, Roberto Rodriguez and Ramon

Charco; Barcelona, Spain

P-944 DONORS AND RECIPIENTS CHARACTERISTICS ASSOCIATED WITH

LIVER GRAFT FAILURE IN CHIRROTIC RECIPIENTS: A EUROPEAN

SINGLE CENTRE EXPERIENCE

Maria C. Dezza, Stefano Fagiuoli, Vittorio Corno, Giovanna Gaffuri, Giuliana

Verga, Domenico Pinelli, Guido Bertolini, Alessandro Lucianetti and Michele

Colledan; Bergamo, Italy

P-945 WEIGHT GAIN AND METABOLIC SYNDROME AFTER LIVER

TRANSPLANTATION: INCIDENCE AND PREDISPOSING FACTORS

Judith Kahn,